{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Implementation of Comprehensiveness"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Evaluating Faithfulness on our model:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/h/u11/c0/00/ammcourt/miniconda3/envs/csc413/lib/python3.10/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "import argparse\n",
    "from pprint import pprint\n",
    "\n",
    "import evaluate\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import torch\n",
    "from torch import nn\n",
    "from datasets import load_dataset\n",
    "from peft import LoraConfig, TaskType, get_peft_model\n",
    "from transformers import (\n",
    "    AutoConfig,\n",
    "    AutoTokenizer,\n",
    "    AutoModelForSequenceClassification,\n",
    "    DataCollatorWithPadding,\n",
    "    EvalPrediction,\n",
    "    OPTForSequenceClassification,\n",
    "    Trainer,\n",
    "    TrainingArguments,\n",
    ")\n",
    "import wandb\n",
    "\n",
    "MODEL = \"facebook/opt-350m\"\n",
    "MAX_POSITION_EMBEDDINGS = 2048\n",
    "\n",
    "from dataclasses import dataclass\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
    "torch.backends.cuda.matmul.allow_tf32 = True\n",
    "torch.backends.cudnn.allow_tf32 = True"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "CHECKPOINT_DIR = \"OPT-350m-mimic-full\"\n",
    "VAL_DATASET_PATH = \"data/val_9.csv\"\n",
    "CODE_PATH = \"data/icd9_codes.csv\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load dataset\n",
    "tokenizer = AutoTokenizer.from_pretrained(MODEL, use_fast=True, device=device)\n",
    "\n",
    "code_labels = pd.read_csv(\"data/icd9_codes.csv\")\n",
    "dataset = load_dataset(\"csv\", data_files=VAL_DATASET_PATH)\n",
    "\n",
    "# Create class dictionaries\n",
    "classes = [class_ for class_ in code_labels[\"icd_code\"] if class_]\n",
    "class2id = {class_: id for id, class_ in enumerate(classes)}\n",
    "id2class = {id: class_ for class_, id in class2id.items()}\n",
    "\n",
    "\n",
    "def multi_labels_to_ids(labels: list[str]) -> list[float]:\n",
    "    ids = [0.0] * len(class2id)  # BCELoss requires float as target type\n",
    "    for label in labels:\n",
    "        ids[class2id[label]] = 1.0\n",
    "    return ids\n",
    "\n",
    "\n",
    "def preprocess_function(example):\n",
    "    result = tokenizer(\n",
    "        example[\"text\"], truncation=True, max_length=MAX_POSITION_EMBEDDINGS\n",
    "    )\n",
    "    result[\"labels\"] = [multi_labels_to_ids(eval(label)) for label in example[\"labels\"]]\n",
    "    return result\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of OPTForSequenceClassification were not initialized from the model checkpoint at facebook/opt-350m and are newly initialized: ['score.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    }
   ],
   "source": [
    "config, unused_kwargs = AutoConfig.from_pretrained(\n",
    "    MODEL,\n",
    "    num_labels=len(classes),\n",
    "    id2label=id2class,\n",
    "    label2id=class2id,\n",
    "    problem_type=\"multi_label_classification\",\n",
    "    return_unused_kwargs=True,\n",
    ")\n",
    "\n",
    "if unused_kwargs:\n",
    "    print(f\"Unused kwargs: {unused_kwargs}\")\n",
    "\n",
    "model = OPTForSequenceClassification.from_pretrained(\n",
    "    MODEL,\n",
    "    config=config,\n",
    ").to(device)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "model.load_adapter(CHECKPOINT_DIR)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'text': \"Sex:   M\\n \\nService: SURGERY\\n \\nAllergies: \\nGrass ___, Standard / Lactose\\n \\n ___.\\n \\nChief Complaint:\\nright popliteal aneurysm\\n \\nMajor Surgical or Invasive Procedure:\\n___: popliteal artery stent graft\\n\\n \\nHistory of Present Illness:\\nMr. ___ has a fairly focal aneurysm in the\\nmid right popliteal artery and is mostly full of thrombus and\\nmeasures 3.1 cm.  It is patent and does have palpable pedal\\npulse distally.  He has need of upcoming ankle surgery as well.\\nHe has a past medical history notable for breast cancer status\\npost mastectomy and chemotherapy/radiation therapy with duodenal\\nulcer, pseudogout, depression, hypothyroidism, microvascular\\ncerebrovascular disease, hyperlipidemia, and COPD.  He had vein\\nmapping performed today which shows the lesser saphenous veins\\nto be small and noncompressible bilaterally.  He has the\\nthrombosis of the right greater saphenous at the level of the\\nknee.  The left greater saphenous is adequate as are both\\nbasilic and cephalic veins.  It was decided that he would best \\nbe served by a stent graft. He was set up to have this done \\nelectively\\n \\nPast Medical History:\\nDepression\\nPseudogout\\nThyroid nodule\\nHx Duodenal ulcer ___ dx at OSH; ? secondary to ASA per pt.\\nHypothyroidism\\nCNS microvascular disease\\nHypercholesterolemia\\nNon-ulcer dyspepsia\\nAnemia\\nX-rays showing COPD although no smoking hx per pt.\\nBreast Cancer - T2, N1 ___ nodes), M0, grade III, double \\nhormone\\nreceptor positive and HER-2/neu negative infiltrating ductal\\ncarcinoma.  Lymphovascular invasion was also present.  He was\\ntreated with a total mastectomy, adjuvant chemotherapy with four\\ncycles of Taxotere and Cytoxan, followed by postmastectomy\\nradiation.  Currently on anastrozole.\\n\\n \\nPSH: Umbilical hernia repair ___, Right mastoid operation as \\na teenager, total mastectomy\\n\\n \\nSocial History:\\n___\\nFamily History:\\nnon contributory\\n \\nPhysical Exam:\\nvss afebrile\\n\\nGen - Elderly appearing male in nad, alert and oriented x 3\\nCV - RRR\\nLungs - CTA bilat\\nAbd - soft no m/t/o\\nExtremities - R ankle weakness (baseline). Full ROM of bilat ___. \\nRLE edema 1+. No LLE edema. R groin puncture c/d/i\\nPulses - femoral/dp/pt palpable bilat\\n \\nPertinent Results:\\n___ 09:20PM BLOOD WBC-4.4 RBC-3.96* Hgb-11.6* Hct-34.4* \\nMCV-87 MCH-29.4 MCHC-33.8 RDW-13.0 Plt ___\\n___ 07:30AM BLOOD WBC-5.5 RBC-3.99* Hgb-11.7* Hct-34.8* \\nMCV-87 MCH-29.4 MCHC-33.7 RDW-13.1 Plt ___\\n___ 09:20PM BLOOD Glucose-88 UreaN-12 Creat-0.9 Na-142 \\nK-4.3 Cl-105 HCO3-26 AnGap-15\\n___ 07:30AM BLOOD Glucose-144* UreaN-14 Creat-1.0 Na-139 \\nK-4.5 Cl-103 HCO3-30 AnGap-11\\n___ 09:20PM BLOOD Calcium-8.7 Phos-2.9 Mg-1.9\\n___ 07:30AM BLOOD Calcium-8.9 Phos-3.7 Mg-2.5\\n \\nBrief Hospital Course:\\nMr. ___ was admitted, preop'd, consented and taken for right \\npopliteal stent graft. Just prior to the operation he had an \\nepisode of sinus tachycardia, but quickly returned to his \\nbaseline which is sinus bradycardia. He tolerated the procedure \\nwell and was transfered to the PACU where he remained \\nhemodynamicaly stable. He did have another episode of sinus \\ntachycardia in the PACU and received several doses of IV \\nmetoprolol.  He rapidly converted to sinus bradycardia with \\nrates in the ___.  His blood pressure was stable throughout \\nthese episodes and he was completely asymptomatic. He was \\ntransfered to the VICU for monitoring overnight. He remained in \\nsinus rhythm with heart rate stable in the ___. Review of \\nrecords and discussion with his PCP revealed that he has had \\nother episodes of sinus tach in the setting of procedures and \\noutpatient work up did not reveal anything significant. His \\nbaseline HR is sinus bradycardia in the high ___.  We had our \\nelectrophysiology team here see him and they felt there was no \\nacute issue. They did recommend he follow up with his PCP or \\ncardiologist and have an outpatient echo.  Mr. ___ was \\nfeeling well on POD 1. His lab values were stable, he tolerated \\na regular diet and voided without difficulty.  He did walk with \\nhis cane but was a bit unsteady. ___ evaluated him and felt he \\nwould benefit from a walker and home ___. He was deemed stable \\nfor d/c home with family with a walker and a ___ and home ___. He \\nwill follow up with vascular, and his pcp in the near future. \\n \\nMedications on Admission:\\n anastrozole 1 mg qd;  \\n  colchicine 0.6 mg qd' DIAZEPAM 5MG prn;  levothyroxine 75 mcg \\nqd;  pravastatin 80 mg qd; ranitidine HCl 300 mg bid;        \\n  aspirin 325 qd\\n \\nDischarge Medications:\\n1. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet \\nPO Q6H (every 6 hours) as needed for pain.\\nDisp:*10 Tablet(s)* Refills:*0*\\n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day): while on narcotics.  \\n3. levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. pravastatin 80 mg Tablet Sig: One (1) Tablet PO once a day.  \\n5. anastrozole 1 mg Tablet Sig: One (1) Tablet PO once a day.  \\n6. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO once a day.  \\n7. diazepam 5 mg Tablet Sig: One (1) Tablet PO at bedtime as \\nneeded for insomnia.  \\n8. ranitidine HCl 150 mg Tablet Sig: Two (2) Tablet PO BID (2 \\ntimes a day).  \\n9. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n10. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily) for 1 months: for 1 month then stop.\\nDisp:*30 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nR popiteal artery anuerysm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\nLower Extremity Angioplasty/Stent Discharge Instructions\\n\\nMedications:\\n\\x95Take Aspirin 325mg (enteric coated) once daily \\n\\x95If instructed, take Plavix (Clopidogrel) 75mg once daily\\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\n\\x95It is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and ultrasound \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\ngreen drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office ___. If bleeding does not stop, call \\n___ for transfer to closest Emergency Room.\\n\\nYou need to follow up with your cardiologist and primary care \\ndoctor regarding your baseline bradycardia.  You should have \\nyour thyroid function followed closely.  \\n \\nFollowup Instructions:\\n___\", 'labels': \"['d-496', 'd-2720']\"}\n"
     ]
    }
   ],
   "source": [
    "untokenized_dataset = load_dataset(\"csv\", data_files=VAL_DATASET_PATH)\n",
    "\n",
    "print(untokenized_dataset['train'][0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "import lime\n",
    "from lime import lime_text\n",
    "from lime.lime_text import LimeTextExplainer\n",
    "from lime.lime_text import IndexedString\n",
    "import numpy as np\n",
    "import torch.nn.functional as F\n",
    "from time import time\n",
    "\n",
    "\n",
    "explainer = LimeTextExplainer(class_names=classes, bow=False)\n",
    "\n",
    "def predictor_opt(texts):\n",
    "    tk = tokenizer(texts, return_tensors=\"pt\",truncation=True, max_length=MAX_POSITION_EMBEDDINGS).to(device)\n",
    "    outputs = model(**tk)\n",
    "    tensor_logits = outputs[0]\n",
    "    probas = F.sigmoid(tensor_logits).detach().cpu().numpy()\n",
    "    return probas\n",
    "\n",
    "# used by the faithfulness function\n",
    "def predictor_model(texts, model, tokenizer):\n",
    "    tk = tokenizer(texts, return_tensors=\"pt\",truncation=True, max_length=MAX_POSITION_EMBEDDINGS).to(device)\n",
    "    outputs = model(**tk)\n",
    "    tensor_logits = outputs[0]\n",
    "    probas = F.sigmoid(tensor_logits).detach().cpu().numpy()\n",
    "    return probas"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The instances are formatted as a list of strings, where each string is one word used by lime. The rationales mask is a list of indices, where the first list refers to the index of the sample the label corresponds to and the second list is the index of string used in that rationale."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Test code for faithfulness calculation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "15\n",
      "[\"Sex:   M\\n \\nService: SURGERY\\n \\nAllergies: \\nGrass ___, Standard / Lactose\\n \\n ___.\\n \\nChief Complaint:\\nright popliteal aneurysm\\n \\nMajor Surgical or Invasive Procedure:\\n___: popliteal artery stent graft\\n\\n \\nHistory of Present Illness:\\nMr. ___ has a fairly focal aneurysm in the\\nmid right popliteal artery and is mostly full of thrombus and\\nmeasures 3.1 cm.  It is patent and does have palpable pedal\\npulse distally.  He has need of upcoming ankle surgery as well.\\nHe has a past medical history notable for breast cancer status\\npost mastectomy and chemotherapy/radiation therapy with duodenal\\nulcer, pseudogout, depression, hypothyroidism, microvascular\\ncerebrovascular disease, hyperlipidemia, and COPD.  He had vein\\nmapping performed today which shows the lesser saphenous veins\\nto be small and noncompressible bilaterally.  He has the\\nthrombosis of the right greater saphenous at the level of the\\nknee.  The left greater saphenous is adequate as are both\\nbasilic and cephalic veins.  It was decided that he would best \\nbe served by a stent graft. He was set up to have this done \\nelectively\\n \\nPast Medical History:\\nDepression\\nPseudogout\\nThyroid nodule\\nHx Duodenal ulcer ___ dx at OSH; ? secondary to ASA per pt.\\nHypothyroidism\\nCNS microvascular disease\\nHypercholesterolemia\\nNon-ulcer dyspepsia\\nAnemia\\nX-rays showing COPD although no smoking hx per pt.\\nBreast Cancer - T2, N1 ___ nodes), M0, grade III, double \\nhormone\\nreceptor positive and HER-2/neu negative infiltrating ductal\\ncarcinoma.  Lymphovascular invasion was also present.  He was\\ntreated with a total mastectomy, adjuvant chemotherapy with four\\ncycles of Taxotere and Cytoxan, followed by postmastectomy\\nradiation.  Currently on anastrozole.\\n\\n \\nPSH: Umbilical hernia repair ___, Right mastoid operation as \\na teenager, total mastectomy\\n\\n \\nSocial History:\\n___\\nFamily History:\\nnon contributory\\n \\nPhysical Exam:\\nvss afebrile\\n\\nGen - Elderly appearing male in nad, alert and oriented x 3\\nCV - RRR\\nLungs - CTA bilat\\nAbd - soft no m/t/o\\nExtremities - R ankle weakness (baseline). Full ROM of bilat ___. \\nRLE edema 1+. No LLE edema. R groin puncture c/d/i\\nPulses - femoral/dp/pt palpable bilat\\n \\nPertinent Results:\\n___ 09:20PM BLOOD WBC-4.4 RBC-3.96* Hgb-11.6* Hct-34.4* \\nMCV-87 MCH-29.4 MCHC-33.8 RDW-13.0 Plt ___\\n___ 07:30AM BLOOD WBC-5.5 RBC-3.99* Hgb-11.7* Hct-34.8* \\nMCV-87 MCH-29.4 MCHC-33.7 RDW-13.1 Plt ___\\n___ 09:20PM BLOOD Glucose-88 UreaN-12 Creat-0.9 Na-142 \\nK-4.3 Cl-105 HCO3-26 AnGap-15\\n___ 07:30AM BLOOD Glucose-144* UreaN-14 Creat-1.0 Na-139 \\nK-4.5 Cl-103 HCO3-30 AnGap-11\\n___ 09:20PM BLOOD Calcium-8.7 Phos-2.9 Mg-1.9\\n___ 07:30AM BLOOD Calcium-8.9 Phos-3.7 Mg-2.5\\n \\nBrief Hospital Course:\\nMr. ___ was admitted, preop'd, consented and taken for right \\npopliteal stent graft. Just prior to the operation he had an \\nepisode of sinus tachycardia, but quickly returned to his \\nbaseline which is sinus bradycardia. He tolerated the procedure \\nwell and was transfered to the PACU where he remained \\nhemodynamicaly stable. He did have another episode of sinus \\ntachycardia in the PACU and received several doses of IV \\nmetoprolol.  He rapidly converted to sinus bradycardia with \\nrates in the ___.  His blood pressure was stable throughout \\nthese episodes and he was completely asymptomatic. He was \\ntransfered to the VICU for monitoring overnight. He remained in \\nsinus rhythm with heart rate stable in the ___. Review of \\nrecords and discussion with his PCP revealed that he has had \\nother episodes of sinus tach in the setting of procedures and \\noutpatient work up did not reveal anything significant. His \\nbaseline HR is sinus bradycardia in the high ___.  We had our \\nelectrophysiology team here see him and they felt there was no \\nacute issue. They did recommend he follow up with his PCP or \\ncardiologist and have an outpatient echo.  Mr. ___ was \\nfeeling well on POD 1. His lab values were stable, he tolerated \\na regular diet and voided without difficulty.  He did walk with \\nhis cane but was a bit unsteady. ___ evaluated him and felt he \\nwould benefit from a walker and home ___. He was deemed stable \\nfor d/c home with family with a walker and a ___ and home ___. He \\nwill follow up with vascular, and his pcp in the near future. \\n \\nMedications on Admission:\\n anastrozole 1 mg qd;  \\n  colchicine 0.6 mg qd' DIAZEPAM 5MG prn;  levothyroxine 75 mcg \\nqd;  pravastatin 80 mg qd; ranitidine HCl 300 mg bid;        \\n  aspirin 325 qd\\n \\nDischarge Medications:\\n1. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet \\nPO Q6H (every 6 hours) as needed for pain.\\nDisp:*10 Tablet(s)* Refills:*0*\\n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day): while on narcotics.  \\n3. levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. pravastatin 80 mg Tablet Sig: One (1) Tablet PO once a day.  \\n5. anastrozole 1 mg Tablet Sig: One (1) Tablet PO once a day.  \\n6. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO once a day.  \\n7. diazepam 5 mg Tablet Sig: One (1) Tablet PO at bedtime as \\nneeded for insomnia.  \\n8. ranitidine HCl 150 mg Tablet Sig: Two (2) Tablet PO BID (2 \\ntimes a day).  \\n9. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n10. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily) for 1 months: for 1 month then stop.\\nDisp:*30 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nR popiteal artery anuerysm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\nLower Extremity Angioplasty/Stent Discharge Instructions\\n\\nMedications:\\n\\x95Take Aspirin 325mg (enteric coated) once daily \\n\\x95If instructed, take Plavix (Clopidogrel) 75mg once daily\\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\n\\x95It is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and ultrasound \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\ngreen drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office ___. If bleeding does not stop, call \\n___ for transfer to closest Emergency Room.\\n\\nYou need to follow up with your cardiologist and primary care \\ndoctor regarding your baseline bradycardia.  You should have \\nyour thyroid function followed closely.  \\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNifedipine / latex / IV Dye, Iodine Containing Contrast Media\\n \\n ___.\\n \\nChief Complaint:\\nInitiating dialysis\\n \\nMajor Surgical or Invasive Procedure:\\nRight sided Tunnelled dialysis catheter ___\\n\\n \\nHistory of Present Illness:\\n___ yo M w/ PMH of ___ s/p right nephrectomy, stage IV CKD, \\n92215htn, gout, CHF is admitted following placement of an HD \\nline for iniation of dialysis. Pt has had stage V CKD and has \\nnoted worsening nausea but no vomiting and overall feeling \\nunwell recently. He had a LUE AV fistual created on ___ \\nhowever as it is too soon to use this and given his symptoms it \\nwas decided to place a tunnelled catheter while this amtures. he \\nwas admitted following this ___ procedure and his first session \\nof dialysis. He denies recent fevers or chills or cough. He does \\nreport decreased urine output with \"discomfort\" on urinating but \\nno burning. He reports abdominal discomfort and nausea but no \\nchanges in his bowel habits or vomiting. He deneis tremor or \\nchest pain. He reports using his CPAP occasionally at night. The \\npatient was seen as he finished his first session of dialysis \\nand reports it was going well.  \\n \\nROS: per HPI, denies fever, chills, night sweats, headache, \\nvision changes, rhinorrhea, congestion, sore throat, cough, \\nshortness of breath, chest pain, abdominal pain, vomiting, \\ndiarrhea, constipation, BRBPR, melena, hematochezia, dysuria, \\nhematuria.  \\n\\n \\nPast Medical History:\\n-renal cell carcinoma s/p right nephrectomy in ___  \\n-CKD IV- felt secondary to HTN on the left kidney  \\n-CAD  \\n-Gout  \\n-OSA  \\n-CHF  \\n-Malingnat hyperthermia  \\n-hypercholesterolemia  \\nPast surgical history:  \\nright nephrectomy ___  \\nLeft brachiobasilic arteriovenous fistula ___  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nHis mother is alive at the age of ___ with history of \\nhypertension and hip replacement. His father is also alive. The \\npatient has six siblings who are doing well. He has two adult \\ndaughters who are healthy.\\n \\nPhysical Exam:\\nAdmission Physical Exam\\nVS - 98.7, 158/103, 70, 16, 99RA\\nGENERAL - NAD, comfortable, appropriate, lying in bed getting \\ndialysis\\nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear\\nNECK - supple, no thyromegaly, no JVD\\nHEART - RRR, no MRG appreciated\\nLUNGS -auscultated anteriorly ___ being on dialysis CTAB\\nABDOMEN - NABS, soft/NT/ND, no masses or HSM, no \\nrebound/guarding\\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)\\nSKIN - no rashes or lesions\\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, gait and \\nstrength testing deferred given he was on dialysis \\n\\nDischarge Physical Exam\\nVS: 98.9, 148/96, 74, 20, 98RA BS 139-374\\nGENERAL - well appearing AA male in NAD\\nHEENT - PEERLA\\nCHEST- Right tunnelled catheter in place, no surrounding \\nerythema\\nNECK - supple, no thyromegaly, no JVD\\nHEART - RRR, no MRG appreciated\\nLUNGS -CTAB\\nABDOMEN - NABS, soft/NT/ND, no masses or HSM, no \\nrebound/guarding\\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)\\nSKIN - no rashes or lesions\\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, gait and \\nstrength testing deferred given he was on dialysis \\n \\nPertinent Results:\\nAdmission Labs:\\n___ 09:45AM BLOOD WBC-14.2* RBC-3.75* Hgb-10.5* Hct-32.6* \\nMCV-87 MCH-28.0 MCHC-32.3 RDW-14.3 Plt ___\\n___ 09:45AM BLOOD ___\\n___ 09:45AM BLOOD Glucose-313* Creat-6.2* Na-144 K-4.2 \\nCl-100 HCO3-24 AnGap-24*\\n___ 09:45AM BLOOD Albumin-4.1 Calcium-8.7 Phos-5.6*# \\nIron-42*\\n\\nPertinent labs\\n___ 09:45AM BLOOD calTIBC-248* Ferritn-279 TRF-191*\\n___ 09:45AM BLOOD PTH-532*\\n___ 09:45AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE \\nHBcAb-NEGATIVE\\n___ 09:45AM BLOOD HCV Ab-NEGATIVE\\n\\nDischarge labs:\\n___ 07:40AM BLOOD WBC-12.2* RBC-3.76* Hgb-10.6* Hct-33.1* \\nMCV-88 MCH-28.2 MCHC-32.0 RDW-14.4 Plt ___\\n___ 07:40AM BLOOD Glucose-200* UreaN-60* Creat-4.7* Na-141 \\nK-4.0 Cl-100 HCO3-30 AnGap-15\\n___ 07:40AM BLOOD Calcium-9.1 Phos-5.0* Mg-2.0\\n\\nUrine\\n___ 06:49AM URINE Color-Straw Appear-Clear Sp ___\\n___ 06:49AM URINE Blood-TR Nitrite-NEG Protein-100 \\nGlucose-300 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\\n___ 06:49AM URINE RBC-1 WBC-<1 Bacteri-NONE Yeast-NONE \\nEpi-0\\n\\nMicro:\\n URINE CULTURE (Final ___:    NO GROWTH. \\n\\nImaging:\\nHD line placement: IMPRESSION:   Successful placement of a \\ntunneled HD catheter through the right internal jugular vein \\napproach.  The tip is located in the right atrium and the \\ncatheter is ready for use.\\n \\n \\nBrief Hospital Course:\\nMr. ___ is a  ___ yo M w/ PMH of RCC s/p nephrectomy and now \\nwith ESRD who was initiated on dialysis via newly placed right \\ntunneled dialysis ___ adn is admitted for initiation of \\ndialysis. \\n\\n#ESRD- patient had a R sided tunneled line placement in ___ on \\n___ and he received 3 sessions of dialysis while inpatient \\nwithout complication through this line. He had hepatitis \\nserologies checked which were negative and a PPD was placed and \\nread and was negative at 48hrs.  He continued to make some urine \\nand tolerated the sessions.  His weight on discharge 105.3kg.  \\n-he will continue dialysis via his R tunnelled line MWF schedule\\n-patient started nephrocaps\\n-furosemide was held\\n-potassium supplements were held\\n-patient was instructed to eat a low phos, low sodium diabetic \\ndiet\\n\\n#Hypertension- the patient has significant hypertension and was \\non 5 antihypertensives on admission. Initially there was concern \\nthat with the initiation of dialysis he would require an \\nadjustment to these, however his blood pressures continued to \\nreamin mildly elevated at 140s-150s/90s-100s.  He had no \\nheadaches or vision changes.  \\nPPD was placed on ___ at 1730 on the right medial forearm\\n\\n#Gout- patient was experiencing a gout flare in his right foot \\non admission and had already been taking his steroids in a self \\ndictated taper.He had taken 40mg of prednisone the day prior to \\nadmission and this was felt to likely be the cause of his . He \\nrecieved a taper down to 20mg of prednisone on ___ with \\nimprovement in the pain.\\n\\n#Type II Diabetes- patient had elevated blood sugars during this \\nadmission. His home glipizide was held and he was on novolog \\nsliding scale.  His hyperglycemia was likely ___ a combination \\nof his steroid use and nonadherence to a diabetic diet, drinking \\nlarge amounts of\\n-he was discharged on glipizide 10mg (his home dose) and will \\ncontinue to check his blood sugars at home\\n\\nTransitional Issues:\\n-Patient will start outpatient dilayiss on a MWF schedule\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. benazepril *NF* 40 mg Oral daily \\n2. calcitriol *NF* 0.25 mcg Oral daily \\n3. Carvedilol 25 mg PO BID \\nhold for sbp<100 or hr<60 \\n4. Felodipine 10 mg PO DAILY \\nhold for sbp<100 or hr<60 \\n5. Furosemide 160 mg PO BID \\nhold for sbp<100 or hr<60 \\n6. GlipiZIDE 10 mg PO BID \\n7. HydrALAzine 150 mg PO BID \\nhold for sbp<100 or hr<60 \\n8. irbesartan *NF* 150 mg Oral daily \\nhold for sbp<100 or hr<60 \\n9. Potassium Chloride 40 mEq PO BID Duration: 24 Hours \\nHold for K > \\n10. PredniSONE 40 mg PO DAILY \\n11. Rosuvastatin Calcium 20 mg PO DAILY \\n12. Aspirin 81 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1. Aspirin 81 mg PO DAILY \\n2. benazepril *NF* 40 mg ORAL DAILY \\n3. Carvedilol 25 mg PO BID \\nhold for sbp<100 or hr<60 \\n4. Felodipine 10 mg PO DAILY \\nhold for sbp<100 or hr<60 \\n5. HydrALAzine 150 mg PO BID \\nhold for sbp<100 or hr<60 \\n6. irbesartan *NF* 150 mg Oral daily \\nhold for sbp<100 or hr<60 \\n7. Rosuvastatin Calcium 20 mg PO DAILY \\n8. Calcium Carbonate 500 mg PO TID W/MEALS \\n9. Nephrocaps 1 CAP PO DAILY \\nRX *B complex-vitamin C-folic acid [Nephrocaps] 1 mg 1 \\ncapsule(s) by mouth daily Disp #*30 Capsule Refills:*0\\n10. GlipiZIDE 10 mg PO BID \\n11. PredniSONE  MD to order daily dose PO DAILY \\n12. Acetaminophen 325-650 mg PO Q6H:PRN pain \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nESRD\\nDiabetes Type II\\nGout\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\nIt was a pleasure taking care of you while you were here at \\n___.\\nYou were admitted to the hospital to start dialysis which you \\nhad 3 sessions of and tolerated well.  You will continue to \\nreceive dialysis as an outpatient on a ___ schedule.  You were \\ntreated for a gout flare while you were here with a steroid \\ntaper. As some of your medications may need to be adjusted such \\nas your glipizide while you are getting dialysis it will be \\nimportant to discuss any changes needed with your outpatient \\nproviders.  \\n\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nibuprofen\\n \\n ___\\n \\nChief Complaint:\\nERCP\\n \\nMajor Surgical or Invasive Procedure:\\nERCP\\nFindings: Esophagus: Limited exam of the esophagus was normal \\nStomach: J-shaped stomach \\nDuodenum: Limited exam of the duodenum was normal \\nMajor Papilla: Normal major papilla \\nCannulation: Cannulation of the pancreatic duct was successful \\nand superficial with a sphincterotome using a free-hand \\ntechnique. Contrast medium was injected resulting in partial \\nopacification.   A 5cm by ___ pancreatic stent was placed \\nsuccessfully using a sphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique. Contrast medium was \\ninjected resulting in complete opacification.\\n \\nBiliary Tree/Biliary Cannulation: The common bile duct, common \\nhepatic duct, right and left hepatic ducts, biliary radicles, \\ncystic duct, and gallbladder were filled with contrast and well \\nvisualized. The course and caliber of the structures were normal \\nwith no evidence of filling defects except in the distal bile \\nduct.  Two round stones ranging in size from 2 mm to 3 mm were \\nseen at the lower third of the common bile duct. A \\nsphincterotomy was performed in the 12 o'clock position using a \\nsphincterotome over an existing guidewire. A small stone as well \\nas sludge were extracted successfully using a Extraction \\nBalloon.   \\n  \\nImpression: Limited exam of the esophagus was normal. \\nJ-shaped stomach.  \\nLimited exam of the duodenum was normal.  \\nCannulation of the pancreatic duct was successful and \\nsuperficial with a sphincterotome using a free-hand technique.   \\n\\nA 5cm by ___ pancreatic stent was placed successfully using a \\nsphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique.  \\nTwo round stones ranging in size from 2 mm to 3 mm were seen at \\nthe lower third of the common bile duct.  \\nOtherwise, the cholangiogram was normal. \\nA sphincterotomy was performed in the 12 o'clock position using \\na sphincterotome over an existing guidewire. \\nA small stone as well as sludge were extracted successfully \\nusing an RX Extraction Balloon.\\n \\nRecommendations: Admit to hospital for monitoring \\nNPO overnight with aggressive IV hydration with LR at 200 cc/hr \\nIf no abdominal pain in the morning, advance diet to clear \\nliquids and then advance as tolerated \\nRecommend interval cholecystectomy. \\nNo aspirin, Plavix, NSAIDS, Coumadin for 5 days. \\nContinue with antibiotics - Ciprofloxacin 500mg BID x 5 days. \\nRepeat ERCP in 2 weeks for pancreatic stent pull \\nFollow-up with Dr. ___ as previously scheduled. \\nFollow for response and complications. If any abdominal pain, \\nfever, jaundice, gastrointestinal bleeding please call ERCP \\nfellow on call ___\\n \\nAdditional notes: Procedure done by Dr ___ fellow. The \\nattending was present for the entire procedure. \\n\\n \\nHistory of Present Illness:\\nHMED Admission Note\\nDate of note: ___, time seen 6 pm\\n\\nPCP:  ___\\n\\nCC:  pancreatitis\\n\\nHPI: Mr. ___ is a ___ yo male with diabetes, new atrial \\nfibrillation and hypertension, here for ERCP after recent \\nepisode of pancreatitis in ___.  At that time, he was \\nhospitalized at an outside hospital, and there was no clear \\ncause of his pancreatitis, which was attributed to a diabetes \\nmedication.  He then presented here for EUS in the end of ___, \\nwhich showed gallbladder sludge, and a fatty pancreas.  He \\npresented today for ERCP with stent placement and \\nsphincterotomy.  Two gallstones were found, and one small stone \\nand sludge was extracted.  \\n\\nIn recovery, he received hydromorphone 0.5 mg X 2, as well as IV \\nfluids.  Indomethacin was not given due to an allergy.  At \\npresent, he continues to complain of right mid abdominal pain, \\nwithout radiation.  He also complains of slight headache and \\ndizziness.\\n\\nHe has overall felt relatively poorly over the ___, since his \\ninitial diagnosis of pancreatitis in late ___.  He has had \\nepisodes of dizziness when he has abdominal pain, which usually \\ngoes away when he lies down for a period of time.  He had a pain \\nin his right leg, which was evaluated with an ultrasound by his \\npcp and was not found to have a DVT.  He had palpitations early \\nthis ___, but now that he is back in sinus, these have gone \\naway.  He has lost 27 lbs this summer.  He gets spikes of \\nabdominal pain with dietary changes, and re-addition of fat into \\nhis diet.  He has been able to work for the most part.\\n\\nROS as above - otherwise, negative in 6 other systems.\\n\\n \\nPast Medical History:\\nHypertension\\nHyperlipidemia\\nAtrial fibrillation\\nType II diabetes mellitus\\nGERD\\nPancreatitis\\nGallstones\\n \\nSocial History:\\n___\\nFamily History:\\nNo family history of gallstones as far as he knows.\\n \\nPhysical Exam:\\n                                                     \\n\\nPhysical exam\\nafebrile, HR in ___, BP 158/41  97% RA\\nGen:  appears uncomfortable\\nHEENT:  EOMI.  No scleral icterus.  No conjunctival injection.   \\nMucous membranes moist.  \\nNeck:  Supple, no LAD, no JVP elevation.\\nLungs: CTA bilaterally, no wheezes, rales, rhonchi.  Normal \\nrespiratory effort.\\nCV:  bradycardic, regular, no murmurs\\nAbdomen:  soft, tender in Right mid abdomen, with no rebound or \\nguarding.  No hepatosplenomegaly appreciated, and no epigastric \\ntenderness.\\nExtremities:  warm and well perfused, no edema.  Area of \\ntenderness in right lateral calf, with muscle knot.\\nNeurological:  somnolent, but alert and oriented X 3, C face \\nsymmetric.  Following all commands, moving freely in bed.  \\nSkin:  No rashes or ulcers or jaundice.\\nPsychiatric:  Appropriate.\\nGU:  deferred.\\n\\n \\nPertinent Results:\\nRelevant data:\\nNa 136 K 4.6  Cl 103 CO2 24 BUN  24 cr 1.0     \\nALT: 25 AP: 74 Tbili: 0.5 AST: 29 Dbili: 0.1  ___: 100 Lip: 40   \\n  \\nwbc  6.1  Hgb 12.6  Hct 36.3  plts 188\\n___: 11.6  PTT: 31.7  INR: 1.1  \\n\\nERCP:\\nImpression: Limited exam of the esophagus was normal. \\nJ-shaped stomach.  \\nLimited exam of the duodenum was normal.  \\nCannulation of the pancreatic duct was successful and \\nsuperficial with a sphincterotome using a free-hand technique.   \\n\\nA 5cm by ___ pancreatic stent was placed successfully using a \\nsphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique.  \\nTwo round stones ranging in size from 2 mm to 3 mm were seen at \\nthe lower third of the common bile duct.  \\nOtherwise, the cholangiogram was normal. \\nA sphincterotomy was performed in the 12 o'clock position using \\na sphincterotome over an existing guidewire. \\nA small stone as well as sludge were extracted successfully \\nusing an RX Extraction Balloon.\\n\\n \\nBrief Hospital Course:\\n___ yo male here for ERCP after recent development of \\npancreatitis in ___.  He does have significant abdominal pain \\nafter the procedure, without rebound or guarding, hopefully only \\nrelated to post procedure pain and not post ERCP pancreatitis.  \\nHe is bradycardic, in normal sinus, possibly with too much sinus \\nblock on board in sinus after recent development of atrial \\nfibrillation.  This may be causing dizziness, but blood pressure \\nis preserved.  CHADS2 is 1 - but he was started on xarelto, \\ncurrently off, and on hold after procedure.  Initial episode of \\npancreatitis most likely related to gallstones, and will require \\ncholecystectomy after stent removed. \\n\\n##  Cholelithiasis/gallstone pancreatitis: ERCP tolerated well. \\nCannulation of pancreatic duct, sphincterotomy, successful \\npancreatic stent placement. 2 stones were seen in CBD. 1 stone \\nwas extracted. Tolerated procedure well, did not receive \\nindomethacin due to allergy. Xarelto stopped for 5d and started \\n5d course of ciprofloxacin. Was NPO overnight, tolerated clears \\nand advanced diet prior to discharge. \\n\\n##  Recent atrial fibrillation, with bradycardia: noted to have \\nasymptomatic sinus bradycardia to ___, with some improvement on \\ncessation of atenolol. Atenolol is therefore being held on \\ndischarge. Pt has had no episodes of AF or RVR since his \\npancreatitis episode. As above, Xarelto held for 5d. CHADS2 \\nscore of 1. \\n\\n##  type II diabetes mellitus: mildly hyperglycemic overnight \\noff home metformin/glyburide, but resuming on discharge. \\n\\n## Hypertension: as above, held atenolol. BP well controlled \\nwith home lisinopril. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Ferrous Sulfate 65 mg PO DAILY \\n2. FoLIC Acid 1 mg PO DAILY \\n3. Lisinopril 40 mg PO DAILY \\n4. Atenolol 50 mg PO DAILY \\n5. Simvastatin 10 mg PO QPM \\n6. GlyBURIDE 5 mg PO DAILY \\n7. MetFORMIN (Glucophage) 500 mg PO BID \\n8. Rivaroxaban 20 mg PO DAILY \\n9. Omeprazole 20 mg PO DAILY \\n10. Magnesium Oxide 400 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1. Lisinopril 40 mg PO DAILY \\n2. Omeprazole 20 mg PO DAILY \\n3. Ciprofloxacin HCl 500 mg PO Q12H \\nPlease complete 5d course to end evening of ___ \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*7 Tablet Refills:*0\\n4. Ferrous Sulfate 65 mg PO DAILY \\n5. FoLIC Acid 1 mg PO DAILY \\n6. GlyBURIDE 5 mg PO DAILY \\n7. Magnesium Oxide 400 mg PO DAILY \\n8. MetFORMIN (Glucophage) 500 mg PO BID \\n9. Simvastatin 10 mg PO QPM \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\ngallstones, stent placement, sphincterotomy, extraction of \\nsludge and stone\\n\\n \\nDischarge Condition:\\npleasant, NAD\\nmildly bradycardic, no mrg; JVP flat\\nCTAB\\nsntnd, NABS\\nwwp, neg edema\\nA&O grossly, moving all 4, no facial droop\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\nIt was a pleasure caring for you. You were admitted for \\nobservation after your endoscopic retrograde cholangiogram, \\nwhich you tolerated well. \\nOn discharge, please complete your course of antibiotics as \\nprescribed. We have stopped your atenolol given your slow heart \\nrates. We have also held your blood thinner for 5 days. Please \\nresume your blood thinner after that. \\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint:\\nright leg weakness\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ male with h/o sciatica, afib on coumadin, gout, prostate \\ncancer presenting with with acute onset RLE weakness and \\ninability to walk.  Two weeks ago, he had decreased RLE strenth \\ncausing him to trip during tennis.  He fell on his right hip.  4 \\ndays ago, he had pain and weakness in his right him.  He was \\nadmitted 2d ago to cardiology service for new onset afib with \\nrvr requiring cardioversion and coumadin.  He had no \\nintravascular interventions.  \\n.\\nHe complains of difficulty getting leg off bed and trouble \\nwalking from inability to raise right foot.\\n\\nIn the ED, initial VS:  97.5 88 101/65 26 98.  Exam showed R \\ngluteus hematoma, tracking.  Good hip flexion ___, decreased \\nplanter and knee strength.  For his INR of 3.8, he got 10 mg Vit \\nK, FFP.  For pain, 4 mg morphine.  He had a WBC 27 treated with \\n1gm ceftriaxone.  A foley was placed with 700 cc UOP.  Neuro \\nwanted MRI spine to r/o epidural hematoma.  This was showed age \\nrelated changes but was essentially unchanged.  Ortho felt this \\nwas likely compression of sciatic nerve from bleeding and not \\nc/w compartment syndrome.  He got 1L IVF.  For his AFib: Dr. \\n___ cardiologist) saw in ED for ___ time. Dr. ___ \\n___ changing to ___, but family did not want to. Prior \\nto transfer, VS: 96 141/82 19 100/RA, Access: 1 PIV.\\n.\\nOn the floor, he felt well.  His family refused further studies, \\nsuch as the x-rays that were ordered.  He denied pain.\\n\\n \\nPast Medical History:\\n1. Sciatica for \"several years,\" unable to clarify further. \\nTypical pain is centered in R. knee and is worst upon waking.\\n2. Prostate CA, dx ___ ago, managed conservatively: saw ___\\nand observation only.\\n3. AFib with RVR diagnosed and treated 4 days ago at ___. \\nStarted on Coumadin with Lovenox bridge.\\n4. ? Gout given presence of allopurinol in his med list, but not\\nreported by patient or in past notes\\n \\nSocial History:\\n___\\nFamily History:\\nFather with MI at ___, later developed colon CA.  Mother died \\nsuddenly, cause unknown, at ___ Brother with multi-vessel CABG \\nin his late ___ No known family members with stroke\\n \\nPhysical Exam:\\nDischarge PE:\\nTm=99.9=Tc, HR=70s-100s, BP=130s/50s-60s, RR=12, POx=95% RA; \\nBMx1\\nGENERAL:  elderly male lying in bed in NAD, comfortable\\nHEENT:  anicteric sclera, dry MM, EOMI, PERRL, OP clear, neck \\nsupple\\nCARDIAC:  Tachycardic, regular rhythm, no m/r/g\\nLUNG:  CTAB\\nABDOMEN:  Soft, NT/ND, NABS\\nEXT:  Large ecchymosis and extensive associated swelling \\nextending from right lower back down to mid-thigh, no clubbing \\nor lower extremity edema, good capillary refill in bilateral \\nextremities with palpable DP pulses \\nNEURO:  A+Ox3, CN ___ intact, Sensation improved in right lower \\nleg, but continues to have sensation deficit around his right \\nlarge toe.  His right leg motor exam was significant for weak \\n___ ankle flexors, ___ ankle extensors, ___ hamstrings, ___ \\nquads, and ___ right iliopsoas.  He can only minimally wiggle \\nhis toes.  Motor strength and sensory is preserved in his left \\nleg.  He has absent reflexes bilaterally.\\n\\n \\nPertinent Results:\\n___ 08:15AM   ___ PTT-35.6* ___\\n___ 08:15AM   NEUTS-89.4* LYMPHS-7.7* MONOS-2.7 EOS-0.1 \\nBASOS-0.1\\n___ 08:15AM   PLT COUNT-236\\n___ 08:15AM   WBC-27.1*# RBC-3.52*# HGB-10.4*# HCT-31.0*# \\nMCV-88 MCH-29.5 MCHC-33.5 RDW-15.2\\n___ 08:15AM   GLUCOSE-194* UREA N-37* CREAT-1.9* SODIUM-137 \\nPOTASSIUM-4.1 CHLORIDE-99 TOTAL CO2-21* ANION GAP-21*\\n___ 08:24AM   HGB-11.6* calcHCT-35\\n___ 09:38AM   LACTATE-4.1*\\n.\\n___ CXR:  \\nIMPRESSION: No evidence of acute cardiopulmonary process. \\n.\\n___ CT head w/o contrast: \\nIMPRESSION: No acute intracranial process.\\n.\\n___ MRI of T- and L- spine:\\nMPRESSION: \\n1. No evidence of hematoma within the thoracic or lumbar spine. \\n2. Severe degenerative changes of the lumbar spine, including \\nsevere spinal canal stenosis at L5/S1 level with impingement on \\nbilateral traversing S1 and the right exiting L5 nerve roots, \\nare stable since the ___ examination. \\n3. Multilevel degenerative changes of the thoracic spine, most \\nsevere at \\nT2-3, with impingement upon the exiting left T2 nerve root \\nimpingement and moderate spinal canal stenosis. \\n4. Status post C5-C7 fusion with posterior fixation hardware and \\nassociated post-surgical changes seen on STIR sequence, \\nincompletely imaged. \\n.\\n___ MRI of pelvis: \\nIMPRESSION: \\n1. Extensive intramuscular hematoma and hypertrophy of the right \\ngluteal \\nmuscles and right piriformis muscle, causing mass effect on the \\nright S1, S2, and S3 nerve roots. \\n2. Narrowed caliber of the right gluteal canal, causing mass \\neffect on the right sciatic nerve. \\n3. Well-circumscribed, benign-appearing left iliac bone lesion, \\nwith imaging features that are most likely compatible with \\nhemangioma. \\n4. Moderate to severe endplate degenerative changes at L4/L5 and \\nL5/S1. \\n.\\n___ Hip X-ray:  \\nIMPRESSION: There is no evidence of an acute bony injury. \\n.\\n___ blood culture: Negative to date\\n \\nBrief Hospital Course:\\nThis is an ___ year old male with PMH of sciatica, prostate CA, \\nand recently diagnosed atrial fibrillation s/p recent \\nhospitalization ___ for cardioversion requiring initiation \\nof Lovenox/Coumadin for stroke prevention presenting with \\nmassive hematoma, RLE weakness, and urinary retention.\\n.\\n#. Hematoma:  The patient developed a large hematoma extending \\nfrom his right flank to his right mid-thigh in the setting of a \\nrecent mechanical fall and initiation of anticoagulation with \\nLovenox and Coumadin with an INR of 3.8 on admission.  His INR \\nwas successfully reversed with vitamin K and FFP in the ED.  His \\nhematocrit fell significantly from a baseline of 46 to 22.8 the \\nAM of ___ and he required 3 units of pRBC transfusion to bring \\nhis hematocrit to around 30 at time of discharge.  No CTA was \\nneeded to rule out extravasation as it appeared that his \\nbleeding stopped after reversal of his INR as evidenced by his \\nappropriate hematocrit response to blood transfusions. He also \\nhad compressive neuropathy from the mass effect of the hematoma \\ncausing limited right lower extremity movement and initial \\nconcern for compartment syndrome.  The mass effect of the \\nhematoma was also likely causing urinary retention which \\nrequired the placement of a Foley catheter.  The urinary \\nretention quickly resolved as the hematoma resorbed and he had a \\nsuccessful trial of void prior to discharge.  Given the lower \\nextremity weakness and urinary retention, spinal cord \\ncompression was ruled out by an MRI on admission.  Orthopedics, \\nvascular, and neurology were all consulted to help manage his \\nacute presentation due to concern for compartment syndrome, \\nconcern for active extravasation and falling hematocrit, and \\nweakness; respectively.  It was determined that the patient did \\nnot have compartment syndrome, so there was no need for surgical \\nintervention.  His physical exam was monitored closely and he \\nnever developed a cold extremity or lost peripheral pulses.  His \\nmotor strength and sensory of his right lower extremity improved \\ndramatically throughout his admission and are documented in the \\nPE section of this document.  With the help of ___, the patient \\nwas able to ambulate with a walker.  An AFO brace was provided \\nfor his right foot given the foot drop he developed as a result \\nof the compressive neuropathy from the hematoma.  Oxycodone was \\nprescribed as needed and worked well for pain control secondary \\nto swelling and compression of his sciatic nerve.  He was \\nadvised not to drive given his new foot drop and use of opiates \\nthat will cause drowsiness. \\n.\\n#. Atrial fibrillation: The patient was diagnosed with new onset \\natrial fibrillation on ___ and was successfully cardioverted.  \\nHe remained in normal sinus rhythm on telemetry throughout his \\nadmission.  After his last hospitalization for cardioversion, he \\nwas discharged on Lovenox/Coumadin and presented to the ED with \\nan INR of 3.8 and evidence of a large hematoma on exam.  \\nCardiology/EP was consulted in the ED to guide further \\nmanagement and recommended starting amiodarone 200mg TID for 1 \\nweek, 200mg BID for 1 week, and then continue on 200mg daily in \\nan attempt to prevent recurrence of atrial fibrillation in the \\nacute period as he is at high risk given the significant amount \\nof stress due to the bleed, pain, and anemia.  It was also \\nagreed that all anticoagulation needed to be discontinued for \\nthe time being as his risk of continued bleeding currently \\noutweighed the preventive stroke benefits of anticoagulation.  \\nFortunately, it was deemed that the left atrial appendage \\nvelocity was vigorous on ECHO and there was no spontaneous ECHO \\ncontrast and no significant aortic thrombus making his risk of \\nstroke reduced, but not non-existent. Unfortunately, he \\ndeveloped a diffuse, pruritic skin rash on his back and chest a \\nfew days after starting amiodarone which was attributed to the \\ndrug.  Therefore, amiodarone was discontinued prior to discharge \\nand no other anti-arrythmics or beta blockers were started.  He \\nwill follow up with Dr. ___ as an outpatient in ___ clinic. \\n \\n.\\n#. CODE: Full code this admission, but DNR/DNI per last \\ndischarge summary\\n \\nMedications on Admission:\\n1. Lovenox ___ mg/mL Syringe Sig: One (1)  Subcutaneous once a \\nday for 3 days.\\n2. Allopurinol ___ mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \\n\\n3. Warfarin 2.5 mg Tablet Sig: Two (2) Tablet PO once a day.\\n4. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO every six (6) \\nhours as needed for pain: do not exceed 4 gram in 24 hours.  \\n5. Multivitamin Tablet Sig: One (1) Tablet PO once a day.  \\n6. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr PO \\nonce a day.\\n \\nDischarge Medications:\\n1. Allopurinol ___ mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \\n\\n2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \\nhours) as needed for pain/fever.  \\n3. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n4. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every ___ hours \\nas needed for pain.\\nDisp:*20 Tablet(s)* Refills:*0*\\n5. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*0*\\n6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as \\nneeded for constipation.\\nDisp:*30 Tablet(s)* Refills:*0*\\n7. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \\nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \\nconstipation.\\nDisp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*0*\\n8. Sarna Anti-Itch 0.5-0.5 % Lotion Sig: Apply  Topical four \\ntimes a day as needed for itching.\\nDisp:*1 bottle* Refills:*0*\\n9. Benadryl Allergy 12.5 mg/5 mL Liquid Sig: Five (5) mL PO \\nevery six (6) hours as needed for itching.\\nDisp:*1 bottle* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary Diagnoses:\\n-Hematoma\\n-Compressive neuropathy\\n-Urinary retention\\n.\\nSecondary diagnosis:\\n-Atrial fibrillation s/p successful cardioversion, now in sinus \\nrhythm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nYou were admitted to ___ \\nfurther evaluation of right leg weakness and urinary retention.  \\nYou were found to have a large collection of blood called a \\nhematoma that extended from your right flank all the way down to \\nyour right thigh that was compressing the nerves which \\ncontrolled your right leg and bladder.  The hematoma was likely \\nas a result of your fall in combination with the blood thinning \\ndrugs called Lovenox and Coumadin that you were prescribed to \\nprevent a stroke given your recent atrial fibrillation.  You had \\nsignificant bleeding into this hematoma and actually lost half \\nof your blood stores.  You required 4 units of blood \\ntransfusions to restore your blood to a safe level.  You also \\nrequired a urinary catheter to drain your bladder until you \\nregained bladder function.  You will be discharged on opiates \\nfor pain control and should not drive or operate heavy machinery \\nwhile on these drugs.  You should not drive until your right \\nsided foot drop improves.  You were initially started on \\namiodarone to control your heart rate, but developed a skin rash \\nreaction and it was stopped.\\n.\\nThe following changes have been made to your home medication \\nregimen:\\n- You should stop taking Lovenox and Coumadin\\n- You should take oxycodone as needed for the pain\\n- You should take docusate, senna, and bisacodyl while on \\noxycodone to prevent constipation   \\n- You should use Sarna lotion as needed for your itchy rash and \\nyou can use Benadryl 12.5 mg as needed for itch that does not \\nrespond to the lotion.\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___.\\n \\nChief Complaint:\\nHypokalemia\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ hx EtOH cirrhosis, on transplant list, DM2, MDS ___ \\nhypokalemia to 2.4 from ___ clinic with Dr. ___. His \\nESLD has been complicated by encephalopathy, jaundice and edema. \\nHe was previously maintained on aldactone/lasix, however his \\naldactone was d/c'd ___ and was started on metolazone 1 month \\nprior. After starting metolazone he developed hypokalemia to \\n1.9, after which he was started on K supplementation.  \\nPresented today to transplant clinic for routine follow-up, \\nfound to have K 2.1 with ___ Cr 2.2 from baseline ~1.5. Took \\nMetolazone w/ kalor this AM. His hepatologist today discontinued \\nmetolazone and restarted aldactone.  \\nROS notable for palpitations which he states are intermittent \\nand chronic. No f/c/n/v/d, no abd pain, urinary sx. Returned \\nfrom ___ this weekend, swelling worse in legs from walking. \\nLabs: BUN 55, K 2.1, HCO3 33 c/w contraction alkalosis likely \\n___ diuretic use.  \\nIn the ED, initial vs were 98.8 71 139/69 18 100%. EKG was \\nreportedly negative, although upon review on the floor it shows \\nU-waves. The patient was not given crystalloid/colloid \\nresuscitation or potassium repletion while in the ED.  \\nOn arrival to the floor, patient reports feeling well with \\nminimal complaints.  \\n\\n \\nPast Medical History:\\n- EtOH cirrhosis; complicated by hepatic encephalopathy, \\nesophageal varices (no EGD on record, only per patient report), \\nand jaundice  \\n- Aplastic anemia (per pt, diagnosed in ___ several years \\nago) \\n- Insulin-dependent diabetes mellitus  \\n- Chronic kidney disease  \\n- Hypertension  \\n- Breast surgery ___ - ___ with resultant \\nhematoma evacuation x 2\\n \\nSocial History:\\n___\\nFamily History:\\nFather died of alcohol cirrhosis. Extended family members had \\nCVAs, age ___. \\n \\nPhysical Exam:\\nAdmission Exam:\\nVS 98.2 138/73 86 20 98%RA  \\nGEN Alert, oriented, no acute distress  \\nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \\nNECK supple, no JVD, no LAD  \\nPULM Good aeration, CTAB no wheezes, rales, ronchi  \\nCV RRR normal S1/S2, no mrg  \\nABD soft NT ND normoactive bowel sounds, +hepatomegaly with \\nliver edge ~3cm below costal margin, nontender. No shifting \\ndullness.  \\nEXT WWP 2+ pulses palpable bilaterally, 2+ pedal edema.  \\nNEURO CNs2-12 intact, motor function grossly normal. -asterixis  \\n\\nSKIN no ulcers or lesions  \\n\\nDischarge Exam:\\n98.3 116/58 64 20 100\\nGen: No acute distress. Well nourished\\nHEENT: EOMI. Icteric sclera. NCAT\\nNeck: No JVD\\nCV: RRR. ___ holosystolic murmur. NS1&S2\\nResp: CTAB. Good air flow\\nExt: No c/c/e\\n\\n \\nPertinent Results:\\nAdmission Labs:\\n___ 08:55AM BLOOD WBC-9.1# RBC-3.90*# Hgb-13.4*# Hct-39.1*# \\nMCV-100* MCH-34.3* MCHC-34.3 RDW-14.6 Plt Ct-94*\\n___ 08:55AM BLOOD ___\\n___ 08:55AM BLOOD UreaN-51* Creat-2.2* Na-135 K-2.4* Cl-91* \\nHCO3-32 AnGap-14\\n___ 08:55AM BLOOD ALT-57* AST-94* AlkPhos-161* TotBili-6.2*\\n___ 08:55AM BLOOD Albumin-4.1 Calcium-9.7 Phos-3.4 Mg-2.1\\n.\\nDischarge Labs:\\n___ 06:55AM BLOOD WBC-4.0 RBC-2.85* Hgb-10.0* Hct-28.9* \\nMCV-101* MCH-35.0* MCHC-34.5 RDW-14.6 Plt Ct-46*\\n___ 06:55AM BLOOD ___ PTT-38.7* ___\\n___ 06:20AM BLOOD Creat-1.2 Na-141 K-3.5 Cl-104\\n___ 06:55AM BLOOD ALT-36 AST-62* AlkPhos-90 TotBili-6.7*\\n___ 06:55AM BLOOD Calcium-9.3 Phos-2.4* Mg-2.2\\n.\\nImaging:\\n___: Sinus rhythm. The Q-T interval is prolonged. \\nNon-specific ST-T wave changes. Compared to the previous tracing \\nof ___ the Q-T interval is longer. \\n___: Artifact is present. Sinus rhythm. The Q-T interval is \\nprolonged at 480 milliseconds. Non-specific ST-T wave changes. \\nCompared to the previous tracing of ___ there is no \\ndiagnostic change. \\n\\n \\nBrief Hospital Course:\\n___ yo M with h/o EtOH cirrhosis c/b hepatic encephalopathy that \\npresented to the ED from clinic with a K of 2.1. \\n.\\nActive Issues:\\n#Hypokalemia: Patient was taking thiazide and loop diuretic, \\nincluding metolazone. U-waves present on EKG. Patient reported \\nfatigue and muscle cramps for several weeks prior to admission. \\nDiuretics stopped, and K was repleted. Lasix and spironolactone \\nrestarted 24 hours later. Patient was stable on this regimen and \\nd/c'ed home with K of 3.5. U-waves resolved on EKG at time of \\ndischarge.\\n.\\n#AOCKD: Cr on admission 2.2 likely ___ overdiuresis. Responded \\nwell to IV albumin, and returned to baseline 1.2 on discharge.\\n.\\nChronic Issues\\n.\\n#EtOH Cirrhosis: Pt is on liver transplant list with MELD of 30 \\nin presentation. He has a history of hepatic encephalopathy, so \\nlactulose and rifaximin were continued in-house. No ascites on \\npresentation and no history of paracentesis. History of portal \\ngastropathy on EGD, so nadolol continued. Will return for \\ntransplant work-up.\\n.\\n#Thrombocytopenia: Chronic. S/p BM biopsy on ___ which showed \\nhypocellular marrow with mild dyspoesis of the erythroid and \\nmegakaryocytic lineages. This was felt secondary to chronic \\nconditions rather than MDS.\\n.\\n#IDDM: Well controlled in-house, and d/c'ed on home dose of \\nlantus and SSI\\n.\\nTransitional Issues:\\n#Will need PFTs, ECHO, routine labs for transplant work-up\\n#Will need lytes checked at outpt follow-up after recent med \\nchanges\\n \\nMedications on Admission:\\nPreadmission medications listed are correct and complete.  \\nInformation was obtained from PatientwebOMR.\\n1. Lactulose 30 mL PO QID \\n2. Nadolol 20 mg PO DAILY \\n3. MetFORMIN (Glucophage) 500 mg PO BID \\n4. Furosemide 40 mg PO BID \\n5. Spironolactone 100 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Thiamine 100 mg PO DAILY \\n8. Ascorbic Acid ___ mg PO DAILY \\n9. Glargine 60 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n\\n \\nDischarge Medications:\\n1. Ascorbic Acid ___ mg PO DAILY \\n2. Furosemide 40 mg PO DAILY \\n3. Glargine 60 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n4. Lactulose 30 mL PO QID \\n5. Nadolol 20 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Spironolactone 100 mg PO DAILY \\n8. Thiamine 100 mg PO DAILY \\n9. MetFORMIN (Glucophage) 500 mg PO BID \\n10. Outpatient Lab Work\\nPlease obtain Basic Metabolic Profile (electrolytes, BUN, \\ncreatinine) and fax results to :\\n\\n ___. \\nLocation: ___ MEDICAL GROUP \\nAddress: ___, ___ \\nPhone: ___ \\nFax: ___ \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary Diagnosis:\\nHypokalemia\\nAcute kidney injury secondary to pre-renal azotemia\\n\\nSecondary Diagnosis:\\nAlcoholic cirrhosis\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nIt was a pleasure caring for you at ___. You were admitted \\nbecause you had a low potassium level. This was likely due to \\none of your medications, metolazone. The low potassium was the \\nlikely cause of your weakness and muscle cramping prior to being \\nadmitted. You were given potassium through your veins and by \\nmouth, and your metolazone was discontinued. At discharge your \\npotassium level was within normal limits. \\n\\nYour diuretics to treat your cirrhosis were initially held on \\nadmission. Both furosemide and spironolactone were started after \\nwe corrected your potassium. Please continue taking these \\nmedications at home. \\n\\nYour kidney function was slightly abnormal on admission. We \\nbelieve that is because you did not have enough fluid going to \\nthem. After giving you albumin, your kidney function returned to \\nnormal. Please remember to drink plenty of fluids at discharge, \\nas your diuretics have a tendency to dry you out.\\n\\nPlease obtain blood work to follow up your electrolytes and \\nrenal function on your current medication regimen within 5 days \\nof discharge.\\n\\n \\nFollowup Instructions:\\n___\", \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPercocet / Codeine\\n \\n ___.\\n \\nChief Complaint:\\nabdominal pain\\n \\nMajor Surgical or Invasive Procedure:\\n___ ERCP\\n___ Percutaneous placement of biliary drain\\n___ Biliary brushings \\n\\n \\nHistory of Present Illness:\\n___ man with stage IIB pancreatic adenocarcinoma s/p \\nWhipple and gemcitabine who presents with right upper quadrant \\nabdominal pain and increasing LFTs. For the past several days he \\nhas intermittent, dull RUQ pain that is 2 out of 10 on the pain \\nscale, lasting 30 minutes to a few hours, without any apparent \\nalleviating or precipitating factor. No nausea, vomiting, \\ndiarrhea, constipation. No fever or chill. \\n.\\nHis LFTs have been rising since in the past month: AST 34 -> 330 \\n(from ___ to ___, ALT 59 -> 369, AP 401 -> 2957, total \\nbili 0.5 -> 3.0 (direct bili 2.0). He had an ultrasound on \\n___ that showed intrahepatic ductal dilation. Admitted for \\nfurther management.\\n.\\nReview of Systems:  \\n(+) Per HPI  \\n(-) Denies fever, chills, night sweats, recent weight loss or \\ngain. Denies blurry vision, diplopia, loss of vision, \\nphotophobia. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denies chest pain or tightness, palpitations, lower \\nextremity edema. Denies cough, shortness of breath, or wheezes. \\nDenies nausea, vomiting, diarrhea, constipation, melena, \\nhematemesis, hematochezia. Denies abnormal bleeding, bruising, \\nlymphadenopathy. Denies dysuria, stool or urine incontinence. \\nDenies arthralgias or myalgias. Denies rashes or skin breakdown. \\nNo numbness/tingling in extremities. All other systems negative.\\n \\nPast Medical History:\\nONCOLOGIC HISTORY:\\n# T3N1M0, stage IIB pancreatic adenocarcinoma \\n- developed painless jaundice in the end of ___.\\n- underwent ERCP on ___, which revealed malignant-appearing \\nstricture in the lower common bile duct and brushings were \\nnegative for malignancy. A CT angiogram was performed and showed \\na possible pancreatic tumor in the head of the pancreas \\n- pancreatic FNA performed on ___ revealed atypical cells.  \\n- underwent a Whipple resection with SMV reconstruction on \\n___, and his postoperative course had been complicated by \\ndelayed gastric emptying. Pathology revealed a pT3 1.9 cm poorly \\ndifferentiated ductal adenocarcinoma, which involved ___ lymph \\nnodes involved. In addition, the distal pancreatic margin was \\ninvolved and there was disease in the SMV. \\n- discharged home on ___ but then developed nausea, vomiting, \\nand likely aspiration leading to pneumonia and was hospitalized \\non ___.  \\n- commenced single-agent gemcitabine 1000 mg/m2 weekly 3 of 4 \\nweeks on ___ receiving one cycle in advance of radiation \\ntherapy with concomitant capecitabine (1000 mg BID) which \\nfinished on ___.\\n.\\nOTHER MEDICAL HISTORY:\\nHypertension\\nDiet-controlled diabetes\\n \\nSocial History:\\n___\\nFamily History:\\nFather had IDDM and HTN, brother with DM, HTN \\n \\nPhysical Exam:\\nVS: T 97.1, BP 130/80, HR 75, RR 18, 100%RA\\nGEN: Middle-aged man in NAD, awake, alert  \\nHEENT: EOMI, sclera anicteric, conjunctivae clear, OP moist and \\nwithout lesion\\nNECK: Supple, no JVD  \\nCV: Reg rate, normal S1, S2. No m/r/g.   \\nCHEST: Resp unlabored, no accessory muscle use. CTAB, no \\ncrackles, wheezes or rhonchi.  \\nABD: Soft, NT, negative ___, ND, no HSM, bowel sounds \\npresent\\nMSK: normal muscle tone and bulk\\nEXT: No c/c/e, 2+ ___ bilaterally\\nSKIN: No rash, warm skin\\nPSYCH: appropriate, pleasant\\n \\nPertinent Results:\\n___ 11:18AM   UREA N-10 CREAT-0.7\\n___ 11:18AM   ALT(SGPT)-369* AST(SGOT)-330* ALK PHOS-2957* \\nTOT BILI-3.0* DIR BILI-2.0* INDIR BIL-1.0\\n___ 11:18AM   ALBUMIN-4.1\\n___ 11:18AM   WBC-5.1 RBC-3.49* HGB-10.5* HCT-32.5* MCV-93 \\nMCH-30.1 MCHC-32.4 RDW-15.6*\\n___ 11:18AM   NEUTS-77.2* LYMPHS-12.8* MONOS-7.5 EOS-1.4 \\nBASOS-1.1\\n___ 11:18AM   PLT COUNT-446*#\\n.\\nIMAGING:\\n___ RIGHT UPPER QUADRANT ULTRASOUND: Evaluation of the left \\nlobe of the liver is limited due to overlying bowel gas in the \\nmidline. The remainder of the liver shows no focal hepatic mass. \\nThere is mild-to-moderate intrahepatic biliary ductal \\ndilatation, consistent with the history of prior Whipple. Color \\nflow images of the main portal vein show normal hepatopetal \\nflow. Though full doppler examination was not completed, the \\nanterior right portal vein remains thrombosed (as per history) \\non color flow imaging. The common bile duct measures 6 mm at the \\nlevel of the hepatic artery. The patient is status post \\ncholecystectomy. The pancreas is not well visualized.   \\nIMPRESSION:   \\n1. Normal hepatic echotexture without definite focal lesion, \\nthough limited evaluation of the left lobe of the liver due to \\noverlying bowel gas.\\n.   \\n2. Mild-to-moderate intrahepatic biliary ductal dilatation with \\nnormal CBD caliber measuring 6 mm.\\n.  \\n3. Patent main portal vein with persistent thrombosis of the \\nanterior right portal vein on color flow imaging.  \\n.\\n___ MRCP:IMPRESSION: \\n1. Near occlusion of a narrowed main portal vein from mostly \\nchronic \\nappearing thrombus extending from the confluence to the \\nbifurcation, with thrombus that may minimally extend into the \\nright portal vein, new since the ___. Chronic \\nthrombosis of the right anterior portal vein with expected \\nparenchymal evolution of mild scarring.\\n. \\n2. Mild increase in the intra- and extra-hepatic bile ducts, \\nwithout evidence of an obstructing mass at the hepaticojejunal \\nanastomosis, likely reflecting an early stenosis at the site of \\nanastomosis, likely secondary to radiation/surgical changes. No \\nconcerning hepatic lesions. An arterially enhancing hepatic \\nlesion in segment IVb, likely represents active fibrosis.\\n.  \\n3. Extensive progressively enhancing soft tissue extending \\nbetween \\npancreaticojejunal and hepaticojejunal anastomosis, in the porta \\nhepatis and around the interposed jejunostomy loop, likely \\nrepresents post-radiation fibrosis/inflammationintermixed tumor \\ninfiltration cannot be excluded. \\n.\\n4. Diffuse abnormality of the pancreatic parenchyma has \\nprogressed and likely represents chronic pancreatitis and \\nradiation change.\\n.  \\n5. Single rim-enhancing pre-aortic lymph node is concerning for \\npossible metastatic disease, and needs attention on followup \\nimaging.  \\n\\n \\nBrief Hospital Course:\\n___ man with stage IIB pancreatic adenocarcinoma s/p \\nWhipple and adjuvant Gemcitabine followed by chemo(xeloda)/XRT \\nand subsequent additional gemcitabine for a positive surgical \\nmargin and involved LN's who presented with mild right upper \\nquadrant abdominal pain and rapidly rising LFTs without fever. \\nHis most recent chemotherapy was cycle 4 Gemcitabine Day \\n___.\\n.\\n# Elevated LFTs/RUQ pain: An ultrasound was perfomed on \\nadmission and showed ductal dilatation. The patient was admitted \\nfor further work up and treated with prn pain medication. An \\nMRCP was performed on ___ and demonstrated extension of \\nportal vein thrombosis and increase in the intra- and \\nextra-hepatic bile ducts, without evidence of an obstructing \\nmass at the hepaticojejunal anastomosis with the appearance of \\nstenosis rather than disease recurrence. There was enhancing \\nsoft tissue extending between pancreaticojejunal and \\nhepaticojejunal anastomosis, in the porta hepatis and around the \\ninterposed jejunostomy loop, thought to be post-radiation \\nfibrosis, but recurrence could not be ruled out. In addition \\nthere was a suspicious preaortic lypmh node. An ERCP was \\nattempted on ___ but failed. On ___ a successful \\npercutaneous biliary drainage was placed by interventional \\nradiology. The patient's LFT's subsequently decreased and pain \\nwas also relieved. On ___ biliary brushings were done via the \\nexisting biliary tube by ___ for diagnosis of the cause of \\nobstruction prior to the placement of an internal metal stent. \\nPost this procedure pt developed a temp of 100.4 and was started \\non unasyn.Blood cultures were obtained and remained sterile. Pt \\nto continue a course of cipro and flagyl at home fo ra \\ncompletionof 7 days antibiotics.Pt will be contacted by ___ for \\nplacement of  metal stent after results of cytology. \\n.\\n# Diet controlled diabetes: The patient has a history of \\ndiabetes that is diet controlled at home. However, he was \\nmarkedly hyperglycemic throughout this hospital admission and \\nmanaged with an insulin sliding scale. HBA1C was also elevated \\nat 9.2. The ___ service was consulted and recommended to \\nstart glipizide 2.5 mg po bid as patient was very reluctant to \\nstart insulin. Pt will likely need an additional oral \\nhypoglycemic medication ( metformin) and he will follow with his \\nPCP.\\n.\\n# Hypertension: The patient has a history of hypertension, but \\nwas not taking antihypertensive medications on his admission and \\nwas not noted to be hypertensive during his hospitalization.\\n.\\n#Urine fungus: Pt had a urine culture obtained because of fever \\npost procedure, as described above. Urine was positive for \\nfungus. As he was asymptomatic he was not treated.Pt to have a \\nrepeat urine culture as an outpatinet and if has persistent \\nfungus in his urine, given his diabetes, should be treated.\\n\\n \\nMedications on Admission:\\nlorazepam 0.5 mg q4-6hr prn nausea\\nondansetron 4 mg tid prn nausea\\nascorbic acid ___ mg q12h\\naspirin 325 mg daily\\ncalcium carbonate\\n\\n \\nDischarge Medications:\\n1. glipizide 5 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day): \\nhold if you are not eating/vomiting.\\nDisp:*30 Tablet(s)* Refills:*0*\\n2. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 3 \\ndays.\\nDisp:*6 Tablet(s)* Refills:*0*\\n3. metronidazole 500 mg Tablet Sig: One (1) Tablet PO three \\ntimes a day for 3 days.\\nDisp:*9 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nBiliary obstruction\\nElevated LFTs\\nDiabetes\\nAsymptomatic Candiduria \\nHypertension\\nh/o renal lithiasis\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nYou were admitted with liver (biliary) blockage and increased \\nliver function tests. An ERCP was unsuccessful, but the \\ninterventional radiolgy team was able to place a bile drain \\nthrough your skin and into your liver ducts to relieve the \\nblockage. You also had brushings done by ___ that were sent for \\ncytology studies to determine the cause of the obstruction. You \\ndeveloped fever after the brushings, blood and urine cultures \\nwere obtained and you were started on IV antibiotics.You should \\ncontinue oral antibiotics at home. While you were in the \\nhospital, your blood sugars were quite elevated and you required \\ninsulin shots to manage them.The ___ diabetes service was \\nconsulted and recommeded to start glipizide for now , however,  \\nyou may need to start metformin as well and in the future,you \\nmay need to start insulin.You should continue to check blood \\nsugars at home.\\nNew medications:\\n1. Ciprofloxacin 500 mg po bid x 3 days\\n2. Metronidazole 500 mg po tid x 3 days\\n3. glipizide 2.5 mg po bid\\n \\n \\nFollowup Instructions:\\n___\", \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nAdhesive\\n \\n ___.\\n \\nChief Complaint:\\nSeizure\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ woman with melanoma with brain mets s/p chemo, XRT, \\nsurgical resection, immunotherapy presents with likely seizure. \\nThe patient was at home, brushing her dog's teeth, when her \\nhusband noticed that patient had about 30 seconds of garbled \\nspeech, staring into space, with subsequent confusion. She \\nreports no symptom before the episode. No urine or stool \\nincontinence. She has had 2 similar seizures with transient \\nspeech difficulty in the past 6 months. She reports being \\ncompliant with her lamotrigine. No fevers, chills, ___ trauma, \\nlocalized weakness.\\n.\\nIn the ED, T 98.6, HR 60, BP 117/69, RR 16, 100%RA. Neuro exam \\nwas nonfocal. ___ CT revealed known extensive melanoma \\nmetastasis, with larger, layering hemorrhage in a metastatic \\nlesion centered in the left parietal lobe, with interval \\ndilation of the temporal horns. Neurosurg was aware. Neuro-onc \\nadvised admission to OMED for further management.\\n\\n \\nPast Medical History:\\nONCOLOGIC HISTORY:\\n# Metastatic melanoma:\\n  (1) completed whole brain cranial irradiation on ___ at\\n___,\\n  (2) s/p 1 cycle of temozolomide at ___ schedule at ___ \\n___,\\n  (3) s/p craniotomy by ___ on ___ for removal  \\nright frontal brain metastasis, and\\n  (4) s/p Cyberknife radiosurgery to 4 metastases on ___ \\nand\\n___: 2,000 cGy to left superior metastasis, 1,600 cGy to\\nright frontal resection cavity, 1,800 cGy to right high parietal\\nmetastasis, and 2,200 cGy to left temporal metastasis, \\n  (5) s/p Cyberknife radiosurgery to a right posterior temporal\\nlobe metastasis on ___ to 2,200 cGy, \\n  (6) received temozolomide at a dose of 150 mg/m2/day x 5 days\\nfrom ___ to ___, \\n  (7) started CTLA-4/ipilimumab compassionate use from ___ \\nto ___, \\n  (8) s/p resection of a right deep jugular metastasis on \\n___ ___, M.D.,\\n  (9) s/p Cyberknife to right upper lung metastasis to 4500 cGy\\n(1500 cGy x 3 fractions) from ___ to ___, and\\nCyberknife to left lower lung metastasis to 4500 cGy (1500 cGy x\\n3 ___ to ___,\\n  (10) s/p Cyberknife radiosurgery on ___ to left parietal \\n(to 2200 cGy), left thalamic (to ___ cGy), and right frontal\\nmetastases, and \\n  (11) s/p Cyberknife radiiosurgery on ___ to rt \\ncerebellar, lt occipital and lt frontal metastases, all to\\n2200 cGy at 79% isodose line.\\n  (12) status post Ommaya reservoir placement on ___ ___\\n  (___) started ipilimumab (CTLA-4) on ___.\\n.\\nOTHER MEDICAL HISTORY:\\nHand surgery in ___  \\nC-section in ___  \\nBreast implants in ___  \\nDepression\\n \\nSocial History:\\n___\\nFamily History:\\nNon-contributory\\n \\nPhysical Exam:\\nOn admission:\\nGen: middle-aged woman in no acute distress\\nHEENT: EOMI, PERRL, conjunctivae clear, sclerae anicteric, OP \\nwithout lesion\\nNeck: supple\\nLungs: CTAB\\nCV: no JVD, regular rhythm, normal rate, normal S1/S2, no m/r/g\\nAbd: soft, NT, ND, BS presents\\nExt: no c/c/e\\nNeuro: awake, oriented x 3, CNs II-XII grossly intact, ___ \\nstrength throughout\\n\\nOn discharge:\\nTm/Tc: 98.3/98.0  BP: 108/62 (108-120/62-72)  P: 64 (59-71)  R: \\n18  Sat: 99%RA\\nI/O: ___\\nGen: middle-aged woman in no acute distress, AAOx3  \\nHEENT: EOMI, PERRL, conjunctivae clear, sclerae anicteric, MMM, \\nOP without lesions  \\nNeck: supple, no cervical or supraclavicular LAD\\nLungs: CTAB, no w/r/r audible  \\nCV: RRR, normal S1/S2, no m/r/g audible\\nAbd: soft, NTND, BS normoactive, no hepatosplenomegaly, no \\nrebound tenderness or guarding\\nExt: WWP, no c/c/e  \\nNeuro: awake, oriented x 3, CNs II-XII grossly intact, ___ \\nstrength throughout all extremities, 2+ reflexes in all \\nextremities \\n \\nPertinent Results:\\n___ 09:25PM   GLUCOSE-100 UREA N-14 CREAT-0.7 SODIUM-143 \\nPOTASSIUM-3.6 CHLORIDE-106 TOTAL CO2-28 ANION GAP-13\\n___ 09:25PM   WBC-4.6 RBC-3.40* HGB-11.4* HCT-32.2* MCV-95 \\nMCH-33.6* MCHC-35.4* RDW-13.8\\n___ 09:25PM   NEUTS-54.5 ___ MONOS-7.7 EOS-4.5* \\nBASOS-0.9\\n___ 09:25PM   PLT COUNT-225\\n___ 09:25PM   ___ PTT-28.0 ___\\n.\\nIMAGING:\\n# ___ CT ___:\\n1. Known innumerable brain metastases are more fully appreciated \\non previous MRI examinations. Interval increase in size of the \\npredominantly cystic lesion centered in the left parietal lobe, \\nnow with an increased layering high attenuation component most \\ncompatible with increase in hemorrhage. Otherwise, no new large \\nmass lesions are appreciated. \\n2. Right frontal approach ventriculostomy catheter is in stable \\nposition with tip terminating in the third ventricle with stable \\nconfiguration and size of the lateral ventricles; however, there \\nhas been apparent interval increase in size of the right greater \\nthan left temporal ventricular horns. \\n3. Stable extensive post-radiation and post-surgical change.\\n.\\nMR ___ ___:\\nIMPRESSION: \\n1. Overall, progression of metastatic disease with new lesion \\nseen within the right frontal lobe and increase in size of \\nmultiple other lesions as described above. Some metastatic \\nlesions have decreased in size or disappeared. \\n2. Diffuse white matter FLAIR hyperintensity, stable, consistent \\nwith \\nradiation related changes and post-surgical changes. \\n.\\nCT Chest/Abd/Pelvis ___:\\nIMPRESSION: \\n1. Post-radiation changes in the left lower lung and right \\nperihilar lung. \\n2. No evidence of new metastases. \\n.\\n# CXR ___: Fudicial markers within the right upper and left \\nlower lobes with adjacent linear opacities likely representing \\npost-treatment changes. No pneumonia. \\n.\\n\\nOn discharge:\\n\\n___ 08:05AM BLOOD WBC-3.5* RBC-3.57* Hgb-11.3* Hct-34.2* \\nMCV-96 MCH-31.7 MCHC-33.0 RDW-13.6 Plt ___\\n___ 08:05AM BLOOD Glucose-87 UreaN-12 Creat-0.7 Na-141 \\nK-4.3 Cl-105 HCO3-30 AnGap-10\\n___ 08:05AM BLOOD Calcium-9.5 Phos-3.4 Mg-2.___ woman with melanoma with brain metastases presents \\nwith recurrent seizure.\\n.\\n# Seizure: manifested as speech abnormality, most likely \\ntriggered by brain metastases with associated hemorrhage.  No \\ninjury was sustained during the episode. Patient has had similar \\nseizures in the past 6 months. There was no fever, no evidence \\nof CNS infection.  Lamotrigine dose was increased on admission \\nand upon discharge for further control.\\n.\\n# Metastatic melanoma: patient was found on MRI to have new \\nmetastatic changes on ___ MRI, suggesting progression of \\ndisease.  A CT torso was also performed, which showed no further \\nmetastases.  Radiation oncology was consulted, along with \\nneurosurgery and neuro-oncology, and planned on dicussing \\nfurther treatment strategy after patient's discharge.  Patient \\nhad close follow-up with Dr. ___ Dr. ___ discharge \\nto discuss further management of care.\\n.\\n# Depression:  patient's home dose of escitalopram was continued \\non admission and discharge.\\n\\n \\nMedications on Admission:\\nacetaminophen-codeine 300-30 mg q6h prn pain\\nescitalopram 10 mg daily\\nlamotrigine 125 mg bid\\nlorazepam 0.5 m gbid prn\\nmethylphenidate 10 mg bid\\nzolpidem ___ mg qhs\\ndocusate sodium\\nferrous sulfate 325 mg daily\\nflaxseed oil\\nMVI\\nfish oil\\n \\nDischarge Medications:\\n1. Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday) as needed for anxiety.  \\n3. Zolpidem 5 mg Tablet Sig: ___ Tablets PO HS (at bedtime) as \\nneeded for insomnia.  \\n4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).  \\n5. Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) \\nTablet PO DAILY (Daily).  \\n6. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n7. Omega-3 Fatty Acids     Capsule Sig: One (1) Capsule PO BID \\n(2 times a day).  \\n8. Acetaminophen-Codeine  Oral\\n9. Flaxseed Oil  Oral\\n10. Lamictal 100 mg Tablet Sig: 1.5 Tablets PO twice a day.\\nDisp:*90 Tablet(s)* Refills:*0*\\n11. Methylphenidate 10 mg Tablet Sig: One (1) Tablet PO BID (2 \\ntimes a day).  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary diagnosis: \\n\\nSeizure, recurrent\\n\\nSecondary diagnosis: \\n\\nMetastatic melanoma\\nDepression\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear. Ms. ___,\\n\\nIt was a pleasure taking care of you at the ___.  You came for \\nfurther evaluation of speech difficulty.  You most likely had a \\nseizure.  While you were here, it was found that you have new \\nbrain lesions, likely representing melanoma metastasis, based on \\nan MRI that was performed.  It is important that you continue to \\ntake your medications and that you follow up with your \\noncologist and neurologist.\\n\\nThe following changes have been made to your medications:\\n\\nWe INCREASED your Lamictal dose to 150 mg twice a day to better \\ncontrol your seizures.\\n \\nFollowup Instructions:\\n___\", 'Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nA.C.E Inhibitors / Codeine / Lidocaine / Vicodin\\n \\n ___.\\n \\nChief Complaint:\\nDizziness and Low Blood Pressure\\n \\nMajor Surgical or Invasive Procedure:\\nhemodialysis\\n \\nHistory of Present Illness:\\n___ yo F with ESRD on HD, DM1, CAD s/p CABG ___, CHF EF 30%(s/p \\nICD) who was sent to ED from dialysis after experiencing \\nhypotension and dizziness. She had been treated with cefazolin \\n___ and Vanc ___ at HD for positive Coag neg staph \\nbacteremia. On ___, patient underwent exchange over a wire \\nof left femoral tunneled hemodialysis catheter because of \\npersisent bacteremia with coag negative staph.\\n\\n.  \\n\\nIn the ED, initial VS: 98.7 94 105/47 18 97% 2L on SBP 75-80. \\nFSBG low. Refusing central lines, refusing labs, got 22G in arm. \\nGiven Got vanco in ED. CXR unchanged. VS: 98.6 82 100/33 12. \\n\\n.  \\n\\nCurrently, patient reported fatigue and some nausea at dialysis. \\nShe reported that the antibiotics made her feels sick. She \\nreportst that normally her blood pressures run low SBP in \\n70-80s. She reports poor appetie and poor PO intake over the \\nweekend.  Her boyfriend reports that she has had nausea, \\nvomiting, and diarrhea in the past 3 weeks after dialysis. Also \\nshe reports a lesion on her finger.  \\n\\n.  \\n\\nROS: Denies fever, chills, night sweats, headache, vision \\nchanges, rhinorrhea, congestion, sore throat, cough, shortness \\nof breath, chest pain, abdominal pain, constipation, BRBPR, \\nmelena, hematochezia, dysuria, hematuria.  \\n\\n \\n\\n \\nPast Medical History:\\n- ESRD: Initially HD, transitioned to PD (___)- now back on HD; \\n\\n\\nper renal fellow (___), patient has repeatedly been \\n\\nclotting off catheters so was started on low dose coumadin. No \\n\\nINR target was set - pt was just given 1mg per day. Her INR was \\n\\ninitially 2.5 but is now 1.8. Does make urine still; urinates \\n\\n1x/day.\\n\\n-PE (Occurred in setting of catheter placement and SVC \\nthrombosis in ___, but was asymptomatic at that \\ntime)-maintained on coumadin \\n\\n- DM Type I: Diagnosed ___ yr ago (Hgb A1C ___\\n\\n- CAD s/p CABG (___), MI x2\\n\\n- CHF (EF 30%) s/p ICD\\n\\n- h/o non-sustained v-tach s/p ICD\\n\\n- Hyperlipidemia\\n\\n- Chronic anemia\\n\\n- Hypothyroidism\\n\\n- Cholecystectomy\\n\\n- Osteoporosis\\n\\n- L knee nondisplaced patellar fracture ___\\n\\n- gout   \\n\\n \\nSocial History:\\n___\\nFamily History:\\nFather with DM, CAD, MI. Mother with stroke and ___. \\n \\nPhysical Exam:\\nVital Signs\\n Hemodynamic monitoring\\n Fluid Balance\\n 24 hours\\n Since ___ AM\\n \\nTmax: 35.9 C (96.7 F)\\n\\nTcurrent: 35.9 C (96.7 F)\\n\\nHR: 89 (78 - 89) bpm\\n\\nBP: 95/39(54) {86/30(42) - 96/44(54)} mmHg\\n\\nRR: 16 (15 - 21) insp/min\\n\\nSpO2: 92% \\n\\nHeart rhythm: SR (Sinus Rhythm)\\n\\nHeight: 63 Inch\\n\\n \\n  \\n Total In:\\n  \\n 358 mL\\n \\nPO:\\n  \\n  \\n \\nTF:\\n  \\n  \\n \\nIVF:\\n  \\n 358 mL\\n \\nBlood products:\\n  \\n  \\n \\nTotal out:\\n 0 mL\\n 0 mL\\n \\nUrine:\\n  \\n  \\n \\nNG:\\n  \\n  \\n \\nStool:\\n  \\n  \\n \\nDrains:\\n  \\n  \\n \\nBalance:\\n 0 mL\\n 358 mL\\n \\n\\n \\n\\nRespiratory\\n \\nO2 Delivery Device: None\\n SpO2: 92%\\n \\n\\n \\n\\nPhysical Examination\\n\\nGeneral Appearance: Well nourished, No acute distress, Thin, \\nAnxious\\n\\nEyes / Conjunctiva: PERRL, Pupils dilated, Conjunctiva pale, \\nSclera edema\\n\\nHead, Ears, Nose, Throat: Normocephalic\\n\\nCardiovascular: (PMI Normal), (S1: Normal), (S2: Normal), S4\\n\\nPeripheral Vascular: (Right radial pulse: Not assessed), (Left \\nradial pulse: Not assessed), (Right DP pulse: Present), (Left DP \\npulse: Present)\\n\\nRespiratory / Chest: (Expansion: Symmetric), (Breath Sounds: \\nClear : , Diminished: bases)\\n\\nExtremities: Right lower extremity edema: Trace, Left lower \\nextremity edema: Trace\\n\\nSkin:  Warm\\n\\nNeurologic: Attentive, Follows simple commands, Responds to: \\nVerbal stimuli, Oriented (to): , Movement: Purposeful, Tone: Not \\nassessed\\n \\n\\n \\nPertinent Results:\\n___ 06:39PM   ___ PO2-59* PCO2-40 PH-7.37 TOTAL CO2-24 \\nBASE XS--1\\n___ 06:21PM   GLUCOSE-98 UREA N-26* CREAT-4.0* SODIUM-136 \\nPOTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-22 ANION GAP-18\\n___ 06:21PM   estGFR-Using this\\n___ 06:21PM   ALT(SGPT)-7 AST(SGOT)-16 CK(CPK)-18* ALK \\nPHOS-271* TOT BILI-0.2\\n___ 06:21PM   CK-MB-NotDone cTropnT-0.10*\\n___ 06:21PM   CALCIUM-7.5* PHOSPHATE-5.9* MAGNESIUM-1.6\\n___ 06:21PM   CORTISOL-16.0\\n___ 06:21PM   WBC-20.4*# RBC-3.38* HGB-10.8* HCT-34.6* \\nMCV-103* MCH-32.1* MCHC-31.3 RDW-17.5*\\n___ 06:21PM   NEUTS-93.5* LYMPHS-3.9* MONOS-1.9* EOS-0.2 \\nBASOS-0.3\\n___ 06:21PM   PLT COUNT-450*#\\n___ 11:15AM   ___\\n.\\nCXR ___. Femoral dialysis catheter tip advanced to the junction of the \\nSVC and right atrium. Please correlate for positional adequacy. \\n2. Cardiomegaly.  \\n.\\nEcho ___\\nThe left atrium is moderately dilated. The right atrium is \\nmoderately dilated. No atrial septal defect is seen by 2D or \\ncolor Doppler. Left ventricular wall thicknesses are normal. The \\nleft ventricular cavity is moderately dilated. There is severe \\nglobal left ventricular hypokinesis (LVEF = 20 %). No masses or \\nthrombi are seen in the left ventricle. Tissue Doppler imaging \\nsuggests an increased left ventricular filling pressure \\n(PCWP>18mmHg). with moderate global free wall hypokinesis. The \\naortic valve leaflets (3) are mildly thickened but aortic \\nstenosis is not present. No masses or vegetations are seen on \\nthe aortic valve. No aortic regurgitation is seen. The mitral \\nvalve leaflets are mildly thickened. No mass or vegetation is \\nseen on the mitral valve. Mild (1+) mitral regurgitation is \\nseen. The left ventricular inflow pattern suggests a restrictive \\nfilling abnormality, with elevated left atrial pressure. The \\ntricuspid valve leaflets are mildly thickened. There is moderate \\npulmonary artery systolic hypertension. There is no pericardial \\neffusion. \\n\\nCompared with the prior study (images reviewed) of ___, no \\nvegetations are seen.  \\n\\nCT Scan ___\\nCT OF THE ABDOMEN WITH INTRAVENOUS CONTRAST: In the visualized \\nthorax, there \\nis a small left pleural effusion and associated relaxation \\natelectasis. \\nAtelectatic changes are also seen at the right lung base, though \\nsome regions \\nsuggest possibility of aspiration as well. The heart is top \\nnormal in size.  \\nThere are dense coronary artery calcifications. There is no \\npericardial \\neffusion. \\n  \\nThere is a small amount of pneumoperitoneum with the bulk of \\nfree air located \\nanterior to the liver. Locules of gas seen anteriorly throughout \\nthe abdomen \\nand inferiorly to below the pelvis (series 2, image 57). \\n  \\nIn the abdomen, evaluation of the solid organs is limited \\nwithout intravenous \\ncontrast. Linear regions of low density adjacent to calcified \\nhepatic \\narteries, particularly in the left ___ be dilated bile \\nducts. The \\natrophic pancreas, spleen, and adrenals appear normal. Vessels \\nare densely \\ncalcified suggesting diabetes. Both kidneys are again atrophic. \\n  \\nThere is distention of small bowel loops to 2.7 cm (series 300B, \\nimage 10). \\nThere is effacement of fat about the small bowel and thickened \\nwalls in the \\nupper loops of bowel. Small locules of air also seen in the \\nsuperior and \\nanterior central small bowel loops (series 2, image 39). No \\ndefinite \\npneumatosis is seen.  \\n  \\nThere is effactment of fat about large bowel. Bowel wall \\nthickness is \\ndifficult to establish without oral contrast but appears \\nabnormal the \\ndescending colon. There is a locule of gas abutting a portion of \\nhepatic \\nflexure of the colon (series 2, image 39). Fluid is seen \\nadjacent to the \\ndescending colon towards the sigmoid (series 2, image 51; series \\n300B, image \\n22).  \\n  \\nThere is no pathologic abdominal lymphadenopathy. The takeoffs \\nof the celiac \\nand superior mesenteric arteries are densely calcified as are \\nall the \\nintra-abdominal vessels. Given no intravenous contrast was \\nadministered, \\nassessing patency is not possible with this study. \\n  \\nCT OF THE PELVIS WITH INTRAVENOUS CONTRAST: A left femoral \\nvenous central \\nline is seen with tip terminating in the right atrium. The \\nbladder \\ndemonstrates air anteriorly, probably from instrumentation. \\nMultiple calcific \\nround densities within the bulky anteverted uterus suggest \\ndystrophic \\ncalcification within fibroids. Fluid tracks down the paracolic \\ngutters more on \\nthe left than right. Adnexa are unremarkable. There is no pelvic \\n\\nlymphadenopathy. \\n  \\nMUSCULOSKELETAL: There is no suspicious osteolytic or \\nosteoblastic lesion. \\nMultilevel degenerative changes are seen in the spine. A small \\numbilical fat- \\ncontaining hernia is seen. \\n  \\nIMPRESSION: \\n  \\n1. Pneumoperitoneum. \\n  \\n2. Abnormal small bowel loops, gas distended, probably will wall \\nthickening \\nand demonstrate fat pericolonic fat effacement. A larger locules \\nof gas is \\nseen abutting a segment of small bowel centrally suggestive of a \\nfocus of \\nperforation. \\n  \\n3. Possible bowel wall thickening involving the colon and \\npericolonic fat \\neffacement involving all large bowel. This may be seen in \\ncolitis \\n(nonspecific). Fluid tracks down the paracolic gutters more on \\nthe left than \\nright. A locule of air abutting a segment of hepatic flexure. \\n  \\n4. Densely calcified aorta and celiac and superior mesenteric \\nartery takeoffs \\nin this context is suspiscious for an ischemic component. \\nHowever, given that \\nno IV contrast was administered, cannot assess vessel patency. \\n  \\n5. Left pleural effusion and associated relaxation atelectasis. \\n  \\n6. Dense vascular calcifications. \\n  \\n7. Small fat-containing umbilical hernia. \\n  \\n8. Atrophic kidneys and pancreas. \\n  \\n\\n \\nBrief Hospital Course:\\nMICU Course:\\n\\nThe patient was admitted to the medical ICU for hypotension and \\nconcern for recurrent bacteremia after dialysis. She did not \\nrequire vasopressor agents, and was treated with vancomycin, on \\nan HD protocol. She was empirically treated for C. diff though \\nresults did not return while she was in the ICU. Echocardiogram \\nshowed no masses or vegetations, though did show her EF was now \\n20%, similar to 25% from most recent other echocardiogram. Renal \\nrecommended starting Florinef after she had an appropriate ___ \\nstim. Her metoprolol was held. \\n\\nDuring an episode of dialysis, she became again hypotensive and \\ndeveloped increased abdominal pain following completion. Serial \\nKUBs became positive for free air, and CT scan of the abdomen \\nconfirmed viscous perforation. She was started on broad spectrum \\nantibiotics, and a surgical consultation was obtained. \\nUnfortunately, given the risk of surgery, it was felt that she \\nwould likely not survive the operation. The surgical risk was \\ndiscussed with the patient, and a plan to pursue comfort \\noriented goal of care was put into place. Palliative care \\nfollowed in consultation. She was continued on antibiotics, and \\nalso on norepinephrine that had been started the evening of the \\nct findings. Dialysis was stopped, and on ___ she had a \\ncardiac arrest, and was declared dead at 1625 without \\nresuscitation efforts. Family was at the bedside. \\n\\n \\nMedications on Admission:\\n-ALLOPURINOL - 100 mg Tablet - 1 Tablet(s) by mouth every other \\nday  \\n-AMIODARONE - 200 mg Tablet - 1 (One) Tablet(s) by mouth once a \\nday  \\n-AMOXICILLIN - 500MG Capsule - TAKE 4 TABLETS ONE HOUR BEFORE \\nPROCEDURE  \\n-NEPHROCAPS 1 mg by mouth once a day  \\n-CALCIUM ACETATE [PHOSLO] 667 mg Capsule PO TID  \\n-HUMALOG - 100 U/ML Solution - SS  \\n-INSULIN GLARGINE [LANTUS]- 100 unit/mL Solution - ___ units \\ndaily  \\n-LEVOTHYROXINE [SYNTHROID] - 125 mcg Tablet - 1 Tablet(s) by \\nmouth once a day, alternating with 112mcg daily  \\n-METOPROLOL SUCCINATE [TOPROL XL] - 25 mg by mouth daily on non \\ndialysis days  \\n-NITROGLYCERIN - 0.4MG Tablet, Sublingual - TAKE AS DIRECTED  \\n-OMEPRAZOLE [PRILOSEC] - 20 mg Capsule, Delayed Release(E.C. by \\nmouth twice a day  \\n-PRAVASTATIN - 40 mg Tablet - by mouth once a day in the evening \\n \\n-WARFARIN - 2 mg Tablet - ___ Tablet(s) by mouth daily or as \\ndirected by ___ clinic  \\n-ASPIRIN - (OTC) - 325 mg Tablet, Delayed Release (E.C.) by \\nmouth once a day  \\n\\n \\nDischarge Disposition:\\nExpired\\n \\nDischarge Diagnosis:\\nHypotension\\nBowel Perforation\\nMesenteric Ischemia\\nCardiac Arrest\\nEnd Stage Renal Disease\\n \\nDischarge Condition:\\nExpired\\n \\n                             ___, MPH ___\\n \\nCompleted by: ___', \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nMorphine / Keflex\\n \\n ___.\\n \\nChief Complaint:\\nWeakness\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ y.o woman with past medical history significant for left \\nsided breast cancer ___ years ago, s/p lumpectomy, radiation and \\nchemotherapy, with left hip bony metastasis ___ years later who \\npresents today with left lower extremity weakness as well as \\nurinary and bowel incontinence of 3 weeks duration.  The patient \\nreports that she has a history of peripheral neuropathy \\nsecondary to her previous chemotherapy and thought that was the \\ncase when she developed ascending numbness to her groin 3 weeks \\nago.  The numbness then progressed up to the level of her \\numbilicus, and she began becoming more weak on her left side.  \\nShe previously had been ambulatory with a walker.\\n.\\nThe patient had been in ___ for the winter, but returned to \\n___ with her worsening symptoms and presented to the ED \\nyesterday ___.  She received an MRI of her spine that showed no \\ncord compression but a signal abnormality at T10 that was \\nsuspicious for metastatic disease.  Neurosurgery was consulted \\nbut saw no cord compression, therefore thought that there was no \\nindication for emergent laminectomy.\\n.\\nThis morning, the patient continues to complain of the leg \\nweakness.  She denies nausea/vomiting/shortness of breath/chest \\npain.  Of note, the patient reports not having a bowel movement \\nsince the weekend.\\n \\nPast Medical History:\\nMetastatic breast CA\\nHTN\\nHypothyroidism\\nPSVT\\n\\nONC History\\nBreast CA ___\\n- ___ mets to bone\\n- s/p 12 lines of chemotherapy\\n \\nSocial History:\\n___\\nFamily History:\\nfather died MI in ___, mother died age ___ brain aneurysm\\n \\nPhysical Exam:\\nAdmission exam:\\n\\nGEN: No acute distress.\\nHEENT: Mucous membranes moist, no lesions noted\\nCV: Regular rate and rhythm, no murmurs, rubs ___\\nPULM: Clear to auscultation bilaterally, no wheezes, rales or \\nrhonchi.\\nABD: Soft, non-tender, non distended, bowel sounds present.\\nEXTR: No edema, 2+ Dorsalis pedis and radial pulses bilaterally.\\nNEURO: Alert and oriented x3.  CN II-XII intact.  Motor exam ___ \\nbiceps, triceps, deltoids bilaterally.  Right ___ ___ iliopsoas, \\n___ quadriceps, ___ gastrocnemius and anterior tibialis.  Left \\n___ ___ iloposas, ___ quadriceps, ___ gastrocnemius and anterior \\ntibialis.  Babinski equivocal bilaterally.\\nRectal exam: decreased tone per report.\\n\\nDischarge exam:\\n\\nGEN: No acute distress.\\nHEENT: Mucous membranes moist, no lesions noted\\nCV: Regular rate and rhythm, no murmurs, rubs ___\\nPULM: Clear to auscultation bilaterally, no wheezes, rales or \\nrhonchi.\\nABD: Soft, non-tender, non distended, hyperactive bowel sounds \\npresent.\\nEXTR: No edema, 2+ Dorsalis pedis and radial pulses bilaterally.\\nNEURO: Alert and oriented x3.  Paresthesias up to level of \\numbilicus.  Motor exam ___ biceps, triceps, deltoids \\nbilaterally.  Right ___ ___ iliopsoas, ___ quadriceps, ___ \\ngastrocnemius and anterior tibialis.  Left ___ ___ iloposas, ___ \\nquadriceps, ___ gastrocnemius ___ anterior tibialis.  Babinski \\nequivocal bilaterally.\\n \\nPertinent Results:\\nMR THORACIC SPINE WITHOUT AND WITH CONTRAST, ___\\nFINDINGS: Again seen is evidence of widespread vertebral body \\nmetastatic\\ndisease with abnormal signal in essentially every vertebral body \\nimaged.\\nThere is also hyperintensity in a number of vertebral bodies on \\nthe short TR images suggesting radiation change. At the T9 and \\nT10 levels, again seen is abnormal increased signal intensity in \\nthe spinal cord on the long TR images with slight expansion of \\nthe cord. This area enhances faintly after contrast \\nadministration. As discussed previously, the differential \\ndiagnosis includes radiation myelopathy or intramedullary \\nmetastatic disease. The enhancing component of the lesion \\nappears unusually linear for an intramedullary neoplasm, and \\nthis finding would favor radiation myelitis. There have been no \\nchanges since the prior examination. No new areas of enhancement \\nare detected.\\n \\nCONCLUSION: Better demonstration of enhancing focus at T9 and \\nT10 within the spinal cord associated with increased signal on \\nthe long TR images and slight expansion of the cord. The pattern \\nis more suggestive of radiation myelopathy than of metastatic \\ndisease.\\n\\nMR ___ ___ - Again at T10 level, linear increased \\nsignal on T1- and T2-weighted images identified within the cord \\nwith subtle enhancement. The pattern of signal changes is more \\nsuggestive of radiation myelopathy than intramedullary \\nmetastasis as suggested previously, but clinical correlation and \\nfollowup would be helpful. No significant change is seen. Bony \\nmetastatic lesion identified in the thoracic vertebral bodies as \\nbefore. No significant new abnormalities. \\n\\nAdmission labs:\\n\\n___ 02:30PM   ___ PTT-60.1* ___\\n___ 02:10PM   GLUCOSE-142* UREA N-14 CREAT-0.7 SODIUM-139 \\nPOTASSIUM-3.7 CHLORIDE-103 TOTAL CO2-24 ANION GAP-16\\n___ 02:10PM   estGFR-Using this\\n___ 02:10PM   ALT(SGPT)-18 AST(SGOT)-24 ALK PHOS-121* TOT \\nBILI-0.4\\n___ 02:10PM   LIPASE-11\\n___ 02:10PM   WBC-6.8 RBC-3.67* HGB-11.2* HCT-33.9* MCV-92 \\nMCH-30.6 MCHC-33.1 RDW-17.0*\\n___ 02:10PM   NEUTS-80.4* LYMPHS-14.6* MONOS-4.0 EOS-0.7 \\nBASOS-0.4\\n___ 02:10PM   PLT COUNT-177\\n\\nDischarge labs:\\n\\n___ 12:40AM BLOOD WBC-14.3* RBC-3.45* Hgb-10.6* Hct-32.7* \\nMCV-95 MCH-30.8 MCHC-32.5 RDW-16.8* Plt ___\\n___ 12:40AM BLOOD Glucose-280* UreaN-32* Creat-0.8 Na-133 \\nK-3.5 Cl-94* HCO3-25 AnGap-18\\n___ 12:40AM BLOOD Calcium-8.7 Phos-3.4 Mg-2.___ F with metastatic cancer admitted with neurogical signs \\nconsistent with spinal cord compression, evidence of T10 \\nintramedullary lesion but no evidence of external metastasis.  \\nMRI from yesterday of ___ was more suggestive of radiation \\nmyelopathy than extrinsic compression.  \\n\\n# Weakness: The patient presented with severe weakness of her \\nLLE, stool and bowel incontinence and numbness in the T10-L2 \\ndermatomes.  On initial whole spine MRI in the emergency room, \\nthere was concern for a possible intramedullary lesion in the \\nspinal cord consistent with this lesion at the T10 level.  \\nConcern for extrinsic compression of the spine by metastatic \\ntumor led to urgent consultation of radiation oncology, \\ninitiation of dexamethasone and 1 session of 400milligray XRT.  \\nHowever, subsequent imaging of the affected area with dedicated \\n___ MRI showed the lesion to be more in line with radiation \\nmyelitis as the patient had previously been irradiated in that \\narea for metastatic disease.  Nevertheless, the patient's \\nneurological exam improved with much improved strength in the \\nlower extremities, but persistent numbness in the aforementioned \\nregions.  The patient remained incontinent throughout her stay.  \\nShe was discharged on 4mg dexamethasone q6h along with bactrim \\nprophylaxis, to be followed up by her outpatient ___ \\n___ oncologist.\\n\\n# Urinary/bowel incontinence: Given radiation myelitis, \\nimprovement of this is unlikely.  Urinary retention was likely, \\nand the patient recieved straight catheterization and will need \\nteaching in rehab for eventual discharge with scheduled \\ncatheterization to empty bladder.  \\n\\n# Hypertension - The patient was hypertensive throughout her \\nstay, which was attributed to the dexamethasone.  Her metoprolol \\n50mg bid was changed to labetolol at the dose of 300 mg BID. She \\nwas also started on chlorthalidone, and her lisinopril was \\nincreased to 40mg daily.  These will likely need to be titrated \\nas blood pressure improves after stabilized on decadron.\\n\\n# Hyperglycemia - the patient also was quite hyperglycemic while \\non the dexamethasone.  She was started on lantus long-acting \\ninsulin, which will need to be titrated down as the \\ndexamethasone is tapered given the patient has no previous \\nhistory of diabetes.\\n\\n# Metastatic breast CA - further treatment deferred to \\noutpatient oncologist.\\n \\nMedications on Admission:\\nVerapamil 240mg SA daily\\nLevoxyl 75mcg daily\\nZoledronic acid 4mg q3months\\nLisinopril 20mg daily\\nLorazepam 1mg qhs\\nMetoprolol 50mg twice daily\\n \\nDischarge Medications:\\n1. Verapamil 240 mg Tablet Sustained Release Sig: One (1) Tablet \\nSustained Release PO Q24H (every 24 hours).  \\n2. Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n3. Zoledronic Acid 4 mg/5 mL Solution Sig: Four (4) mg \\nIntravenous Q3Months.  \\n4. Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \\n \\n5. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). \\n \\n6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday).  \\n7. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1) \\nPacket\\nPacket PO DAILY (Daily) as needed for constipation.  \\n8. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \\n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \\n9. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \\nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \\nconstipation.  \\n10. Dexamethasone 2 mg Tablet Sig: Two (2) Tablet PO Q6H (every \\n6 hours): Continue until you follow-up with your ___ oncologist\\n.  \\n11. Chlorthalidone 25 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily): For duration of steroids. Will need to be adjusted by \\nrehab MD.\\n.  \\n12. Insulin Glargine 100 unit/mL Solution Sig: Eight (8) units \\nSubcutaneous once a day: For duration of steroids. Will need to \\nbe adjusted by rehab MD.\\n.  \\n13. Sulfamethoxazole-Trimethoprim 400-80 mg Tablet Sig: One (1) \\nTablet PO DAILY (Daily): For duration of steroids.  \\n14. Labetalol 100 mg Tablet Sig: Three (3) Tablet PO BID (2 \\ntimes a day): For duration of steroids. Will need to be adjusted \\nby rehab MD.\\n.  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\n1. Radiation myelitis\\n2. Metastatic breast cancer\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\n1. You were admitted for leg weakness and incontinence, and we \\nwere concerned that you had cord compression from your cancer. \\nAfter multiple MRIs, we determined in conjunction with the \\nRadiation Oncologists that this was due to radiation myelitis, \\nor damage from prior radiation therapy.  You are receiving \\nsteroids for this, which will continue on discharge until you \\nfollow-up with your ___ Oncologist. The instructions for this \\nare:\\nDexamethasone 4 mg by mouth every 6 hours.\\n\\n2. You also had problems with high blood pressure, and we \\nchanged your blood pressure medications.  You also had problems \\nwith high blood glucose (or sugar) levels, and are getting \\ntreated with insulin. You will need to continue your new blood \\npressure medications and insulin until you stop your steroids. \\nThese medications should be adjusted by the MD on call at your \\nrehab facility as necessary.\\n\\n3. It is very important that you take your medications as \\nprescribed.\\n\\n4. It is very important that you make all of your doctors \\n___.\\n \\nFollowup Instructions:\\n___\", \"Sex:   M\\n \\nService: SURGERY\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___.\\n \\nChief Complaint:\\nAAA\\n \\nMajor Surgical or Invasive Procedure:\\nEVAR w L to R fem-fem bypass \\n\\n \\nHistory of Present Illness:\\nMr. ___ is seen in followup today for his aortic aneurysm.\\nAt his visit couple of weeks ago, ultrasound suggested a 6-mm\\ngrowth over the past six months to a size of 5.4 cm.  Based on\\nthis enlargement, pt was scheduled for surgery.\\n \\nPast Medical History:\\n- CAD s/p ___nd stenting x4\\n- DM2 (diet controlled)\\n- HTN \\n- HLD (on Lipitor for ___ yrs, then simvastatin for past ___ yrs)\\n- Rectal cancer, s/p resection and XRT ___ years ago, with \\ncolostomy\\n \\nSocial History:\\n___\\nFamily History:\\nMother died at ___ of CAD.  Father died at ___ of asthma\\n\\n \\nPhysical Exam:\\nPHYSICAL EXAMINATION  \\nVitals: T: 97.6 degrees Farenheit, BP: 118-145/40s-50s mmHg\\nsupine, HR ___ bpm, RR 18 bpm, O2: 98 % on RA.  \\nGen: Pleasant, calm  \\nHEENT: No conjunctival pallor. No icterus. MMM.  \\nNECK: JVP normal. Normal carotid upstroke.  \\nCV: PMI in ___ intercostal space, mid clavicular line. RRR.\\nnormal S1,S2. No murmurs, rubs, clicks, ___  \\nLUNGS: CTAB. No wheezes, rales, or rhonchi.  \\nABD: Bilateral incisions with JP drain in place on left.  \\nEXT: WWP, NO CCE.   \\nNEURO: A&Ox3.   \\n\\n \\nPertinent Results:\\nTELEMETRY: Sinus rhythm at 78bppm \\n\\nECG:  sinus rhythm with rate at 65bpm LBBB with slightly more\\ndownsloping TW in 1 and AVL and upward TW in V5 and V6 (inverted\\non prior ECG) ___\\n \\nCardiac Cath at ___ ___\\n Hemodynamics:  The aortic pressure was 120/70, left ventricular\\nend-diastolic pressure was 18.\\n      Left ventricular angiogram visualized discrete\\ninferoposterior hypokinesis with left ventricular ejection\\nfraction of 60%.  There is no mitral regurgitation.\\n       The left main exhibited 20% ostial stenosis.\\n       The left anterior descending is occluded after the first\\nlarge septal and small diagonal.  There is a 20 -30% narrowing \\nof\\nthe left anterior descending before it gives the septal and the\\ndiagonal.  There is a  40% narroeing of the diagonal.\\n      The left circumflex is occluded proximally.\\n      The right coronary artery is also occluded proximally.\\n      The graft arteriogram revealed an occluded graft to the\\nright coronary artery.\\n      There is an occluded graft to the circumflex and the\\ndiagonal artery.\\n       \\n      The left internal mammary artery is patent with good\\ninsertion into the left anterior descending with good filling of\\nthe left anterior descending that exhibits mild diffuse \\nplaquing.\\nThere is good filling retrograde of the circumflex marginal from\\nthe left anterior descending and there is a good filling of the\\ndistal right coronary artery that appeared a posterolateral\\nbranch.  I did not revisualize the posterior descending artery.\\n       The native vessels on the left that fills retrograde the\\nright coronary artery via collateral mainly coming from the\\nseptal branches of the left anterior descending\\n\\n___ 09:50AM BLOOD WBC-5.9 RBC-4.88 Hgb-14.9 Hct-41.6 MCV-85 \\nMCH-30.5 MCHC-35.8* RDW-13.2 Plt ___\\n___ 02:46PM BLOOD Hgb-10.9*# Hct-30.2*# Plt ___\\n___ 05:11AM BLOOD WBC-10.2# Hgb-11.6* Hct-32.3* Plt ___\\n___ 08:00AM BLOOD WBC-10.1 RBC-3.60*# Hgb-10.9* Hct-30.3* \\nMCV-84 MCH-30.4 MCHC-36.1* RDW-13.0 Plt ___\\n___ 08:10AM BLOOD WBC-7.9 RBC-3.37* Hgb-10.5* Hct-28.8* \\nMCV-85 MCH-31.2 MCHC-36.5* RDW-13.1 Plt ___\\n___ 03:10AM BLOOD WBC-5.5 RBC-2.98* Hgb-9.1* Hct-25.2* \\nMCV-84 MCH-30.5 MCHC-36.1* RDW-12.8 Plt ___\\n___ 04:10PM BLOOD WBC-5.3 Hct-32.5*# Plt ___\\n___ 08:05AM BLOOD WBC-4.7 RBC-3.82*# Hgb-11.5*# Hct-33.7* \\nMCV-88 MCH-30.2 MCHC-34.2 RDW-12.9 Plt ___\\n___ 09:50AM BLOOD ___ PTT-22.8 ___\\n___ 09:50AM BLOOD Plt ___\\n___ 08:05AM BLOOD Plt ___\\n___ 09:50AM BLOOD UreaN-19 Creat-1.0 Na-144 K-3.8 Cl-109* \\nHCO3-25 AnGap-14\\n___ 02:46PM BLOOD Glucose-139* UreaN-15 Creat-0.7 Na-138 \\nK-3.5 Cl-110* HCO3-21* AnGap-11\\n___ 05:11AM BLOOD Glucose-175* UreaN-11 Creat-0.7 Na-138 \\nK-3.9 Cl-108 HCO3-23 AnGap-11\\n___ 01:51AM BLOOD Glucose-98 UreaN-12 Creat-0.7 Na-140 \\nK-4.1 Cl-107 HCO3-23 AnGap-14\\n___ 08:00AM BLOOD Glucose-108* UreaN-12 Creat-0.8 Na-139 \\nK-3.8 Cl-104 HCO3-22 AnGap-17\\n___ 08:40PM BLOOD Glucose-116* UreaN-19 Creat-0.8 Na-139 \\nK-3.2* Cl-101 HCO3-16* AnGap-25*\\n___ 08:10AM BLOOD Glucose-113* UreaN-18 Creat-0.9 Na-140 \\nK-3.8 Cl-103 HCO3-26 AnGap-15\\n___ 03:10AM BLOOD Glucose-106* UreaN-20 Creat-0.8 Na-140 \\nK-3.8 Cl-105 HCO3-28 AnGap-11\\n___ 08:05AM BLOOD Glucose-104* UreaN-17 Creat-0.7 Na-139 \\nK-4.1 Cl-106 HCO3-26 AnGap-11\\n___ 02:46PM BLOOD ALT-11 AST-15 CK(CPK)-26* AlkPhos-40\\n___ 05:11AM BLOOD ALT-12 AST-17 CK(CPK)-27* AlkPhos-44 \\nTotBili-0.3\\n___ 12:45PM BLOOD CK(CPK)-32*\\n___ 01:51AM BLOOD CK(CPK)-40*\\n___ 09:00AM BLOOD CK(CPK)-86\\n___ 03:00PM BLOOD CK(CPK)-199\\n___ 08:40PM BLOOD CK(CPK)-217\\n___ 08:10AM BLOOD CK(CPK)-169\\n___ 05:25PM BLOOD CK(CPK)-105\\n___ 03:10AM BLOOD CK(CPK)-67\\n___ 09:25AM BLOOD CK(CPK)-52\\n___ 04:10PM BLOOD CK(CPK)-47\\n___ 12:57AM BLOOD CK(CPK)-46*\\n___ 08:05AM BLOOD CK(CPK)-48\\n___ 02:46PM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 05:11AM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 01:51AM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 09:00AM BLOOD CK-MB-11* MB Indx-12.8* cTropnT-0.05*\\n___ 03:00PM BLOOD CK-MB-25* MB Indx-12.6* cTropnT-0.26*\\n___ 08:40PM BLOOD CK-MB-20* MB Indx-9.2* cTropnT-0.35*\\n___ 08:10AM BLOOD CK-MB-11* MB Indx-6.5* cTropnT-0.33*\\n___ 05:25PM BLOOD CK-MB-6 cTropnT-0.35*\\n___ 03:10AM BLOOD CK-MB-5 cTropnT-0.55*\\n___ 09:25AM BLOOD CK-MB-4 cTropnT-0.47*\\n___ 04:10PM BLOOD CK-MB-3 cTropnT-0.54*\\n___ 12:57AM BLOOD CK-MB-3 cTropnT-0.76*\\n___ 08:05AM BLOOD CK-MB-3 cTropnT-0.80*\\n___ 08:00AM BLOOD %HbA1c-5.8 eAG-120\\n___ 05:11AM BLOOD Triglyc-89 HDL-32 CHOL/HD-4.9 LDLcalc-107\\n \\nBrief Hospital Course:\\nThe patient was admitted to the Vascular Surgical Service for \\nevaluation and treatment of a AAA. Pt underwent a EVAR with left \\nto right fem fem BPG. He was extubated in the OR.\\n\\nAfter a brief, uneventful stay in the PACU, the patient arrived \\non the floor NPO, on IV fluids and antibiotics, with a foley \\ncatheter, and IV meds for pain control. The patient was \\nhemodynamically stable.\\n\\nNeuro: The patient received IV pain medications with good effect \\nand adequate pain control. When tolerating oral intake, the \\npatient was transitioned to oral pain medications.\\n\\nCV: Pt with known PAD and stable angina. Pt started experiencing \\nchest pain on POD 1. His ECG was unchanged and initial cardiac \\nenzymes were negative. Cardiology was consulted and his cardiac \\nenzymes were cycled. He did rule in for MI. Troponins peaked at \\n0.8. He remained on telemetry and continued his beta blocker, \\nplavix, aspirin, statin. His most recent cardiac cath films were \\nsent over and cardiac surgery was consulted for redo CABG. Per \\ncardiac surgery, he is not a surgical candidate as he does not \\nhave targets. Cardiology felt that he did not have any PCI \\noptions as well and recommended medical management. We titrated \\nhis isosorbide from 20 to 40mg TID with resolution of his chest \\npain. On the day of discharge, he was ambulating independently \\nand walked up the stairs with physical therapy without anginal \\nsymptoms. \\n\\nPulmonary: The patient remained stable from a pulmonary \\nstandpoint; vital signs were routinely monitored. Good pulmonary \\ntoilet, early ambulation and incentive spirrometry were \\nencouraged throughout hospitalization.\\n\\nGI: Post-operatively, the patient was made NPO with IV fluids. \\nDiet was advanced when appropriate, which was well tolerated. \\n\\nGU: Patient's intake and output were closely monitored, and IV \\nfluid was adjusted when necessary. \\n\\nFEN: Electrolytes were routinely followed, and repleted when \\nnecessary.\\n\\nID: The patient's white blood count and fever curves were \\nclosely watched for signs of infection. Wound care included \\nsterile dressings. Pt did recieve perioperative antibiotics.\\n\\nEndocrine: The patient's blood sugar was monitored throughout \\nhis stay; insulin dosing was adjusted accordingly.\\n\\nHematology: The patient's complete blood count was examined \\nroutinely; he required 2units of PRBCs on ___ for hct of 25.2.\\nProphylaxis: The patient received subcutaneous heparin and \\nvenodyne boots were used during this stay; he was encouraged to \\nget up and ambulate as early as possible.\\n\\nAt the time of discharge, the patient was doing well, afebrile \\nwith stable vital signs. The patient was tolerating a regular \\ndiet, ambulating, voiding without assistance, and pain was well \\ncontrolled, and he was chest pain free. The patient received \\ndischarge teaching and follow-up instructions with understanding \\nverbalized and agreement.\\n \\nMedications on Admission:\\nASA 325', amlodipine 10', detrol LA 4', gemfibrozil 600', \\nibuprofen 600''', isosorbide mononitrate 20''', metoprolol \\nsuccinate 200', nitroglycerin PRN, plavix 75', risperidone 0.5', \\ntrazodone 50' \\n \\nDischarge Medications:\\n1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday).  \\n3. risperidone 0.5 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n5. atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily): See PCP or cardiologist for refills.\\nDisp:*30 Tablet(s)* Refills:*0*\\n6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*2*\\n7. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 \\nhours) as needed for pain.  \\n8. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.  \\n9. isosorbide mononitrate 20 mg Tablet Sig: Two (2) Tablet PO \\nthree times a day.\\nDisp:*180 Tablet(s)* Refills:*2*\\n10. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \\nSublingual Sublingual PRN (as needed) as needed for Chest pain: \\nTake 1 pill and wait 5 minutes. If still have chest pain take \\n___ pill and wait 5 minutes. If still with chest pain take ___ \\npill and call ___. .  \\n11. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at \\nbedtime).  \\n12. metoprolol succinate 200 mg Tablet Extended Release 24 hr \\nSig: One (1) Tablet Extended Release 24 hr PO once a day: Divide \\ninto 2 doses if better tolerated.  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nInfrarenal AAA\\nnstableangina - r/i MI, mayneed redo CABG\\nHTN,  DM2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\n\\nEndovascular Abdominal Aortic Aneurysm (AAA) Discharge \\nInstructions\\n\\nMedications:\\n\\x95If instructe,take Aspirin 325mg (enteric coated) once daily \\n\\x95Do not stop Aspirin unless your Vascular Surgeon instructs you \\nto do so. \\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\nIt is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and CTA \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\n___ drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site or \\nincision)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office. If bleeding does not stop, call ___ for \\ntransfer to closest Emergency Room. \\n\\n \\nFollowup Instructions:\\n___\", \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint:\\nL-sided CP, SOB \\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ F w/ hx of COPD w/ recent admission exacerbation in ___, \\nschitzophrenia, OA who p/w CP and SOB x1d. Normally w/ her COPD \\npt is on home 02 is always SOB, but can walk 3 flights of stairs \\nwithout stopping, occasional cough, and will rarely have sharp \\nepisodes of L-sided CP sometimes pleuritic in nature. Yesterday \\nshe tripped and twisted her L ankle fell to her knees, and later \\ndeveloped R hip pain the next day. Then today her husband \\nnoticed that her breathing was more labored and SOB throughout \\nthe day, no orthopnea. Pt could still go up 3 flights of stairs. \\nShe tired using her combivent and home ___ without significant \\nchange. Around midnight or 1am she had sharp left-sided chest \\npain that lasted a couple seconds 3 times in a row and associate \\ndiaphoresis. No associated n/v, radiation. No further episodes \\nof CP afterward. Denied any \\nfever/chills/melana/hematochezia/sorethroat/URI symptoms.  \\n.  \\nROS: dysuria, 1 episode of loose BM yesterday  \\n\\n \\nPast Medical History:\\n1. COPD/emphysema - no PFTs in our system \\n2. Schizophrenia  \\n3. Psychogenic polydypsia  \\n4. Osteoarthritis  \\n5. Status post hernia repair ___  \\n6. History of fecal and urinary incontinence without spinal cord \\ninjury, possibly worsened by drug side effect  \\n7. Atrial arrhythmia (MAT vs.wandering pacemaker)  \\n8. Positive PPD - unclear history  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nUnknown (raised in foster care)\\n \\nPhysical Exam:\\nVitals: 96.0, 160/90, 86, 36, 92%4L  \\nGeneral: pleasant, mild respiratory distress  \\nHEENT: poor dentition, NC/AT, anicteric, MMM, oropharynx clear  \\nNeck: supple, JVP not elevated, no LAD  \\nLungs: shallow breaths, CTAB, no wheezes, rales, ronchi  \\nCV: RRR, normal S1 + S2, no murmurs, rubs, gallops  \\nAbdomen: +BS NT/ND, soft  \\nExt: 1+ LLE pedal edema, normal ROM at L ankle, no pain or point \\ntenderness  \\nNeuro: AOx3, CN II-XII grossly intact, no focal deficits  \\n\\n \\nPertinent Results:\\nTrop-T: <0.01 CK: 135 MB: 3  \\n.  \\n145 108 13  \\n----------------< 102  \\n4.1 28 0.7  \\n.  \\nMCV: 95  \\n      12.8  \\n5.7 >---------< 275  \\n      38.9  \\nN:59.1 L:32.7 M:5.0 E:2.7 Bas:0.5  \\n.  \\n___: 14.6 PTT: 28.7 INR: 1.3  \\n.  \\nMicro: none  \\n\\n \\nBrief Hospital Course:\\n___ F w/ hx of COPD w/ recent admission exacerbation in ___, \\nschitzophrenia, OA who p/w CP and SOB x1d  \\n \\n# COPD exacerbation- Pt appeared to have a mild COPD \\nexacerbation, unlikely to be from infection, no cough/wbc/fevers \\nand cxr clear. Pt was requiring 4L/NC and has increased work of \\nbreathing, and incr RR, suggesting mild exacerbation. Pt \\ncontinues to smoke. No PFTs completed, did not f/u only taking \\ncombivent. It is also possible pt had anxiety/pain ___ ankle \\ninjury and tachypnea from this, but currently denies pain and \\nstill tachyneic. PE unlikely, w/o tachycardia, and recent CTA \\nnegative - no h/o to suggest provoked. Also ___ was negative. \\nThe next day pt was 92%RA, and 96% ambulating on 1L. Pt's was \\nchanged over to prednisone 60mg on day of discharge and to get 3 \\nmore days of prednisone. Pt was also started on Advair 250/50 \\nBID for her COPD, given a pneumococcal vacine, and needs PFTs as \\noutpt.\\n.  \\n# CP- Pt was having sharp pain that was likely pleuritic ___ \\nCOPD exacerbation. Not typical CP to suggest ACS. Not \\nreproducible.  Pt was ruled out with CE x3. \\n \\n#. LLE edema - Pt likely ___ ankle sprain, exam not suggestive \\nof fx. No current ankle pain As asymetric will r/o dvt. ___ was \\nnegative bilaterlly. The next morning pt did not have any LLE \\nswelling any longer, and did not complain of any pain.\\n\\n#. UA- Pt complained of dysuria as inpatint and we checked a UA \\nwhich was negative for a UTI. It did show trace proteins and glc \\nof 250. As inpatient her fasting glucose remained < 100. The \\nprotinuria/glucosuria ___ need to be followed as outpatient. \\n  \\n# Pulmonary nodules- Seen on CTA on ___, needs outpt f/u CT. \\n \\n# Schitzophrenia - Continued psych meds, No issues.  \\n\\n \\nMedications on Admission:\\n- Aripiprazole 10mg QDay  \\n- Risperdal 50mg IM q2wks  \\n- Celexa 40mg Qday  \\n- Combivent ___ puffs  \\n- MVI  \\n- ASA 325  \\n- Naproxen 375 q8 prn  \\n- Nicotene 21 mcg  \\n- Prednisone 40mg taper last dose ___  \\n- home 02 uncertain amount  \\n\\n \\nDischarge Medications:\\n1. Prednisone 20 mg Tablet Sig: Three (3) Tablet PO DAILY \\n(Daily) for 3 days.\\nDisp:*9 Tablet(s)* Refills:*0*\\n2. Aripiprazole 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n3. Risperdal Consta 50 mg/2 mL Syringe Sig: One (1)  \\nIntramuscular q2 weeks.  \\n4. Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \\n \\n5. Combivent ___ mcg/Actuation Aerosol Sig: ___ puffs \\nInhalation four times a day.  \\n6. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n7. Nicotine 21 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \\nTransdermal DAILY (Daily).  \\n8. Advair Diskus 250-50 mcg/Dose Disk with Device Sig: One (1)  \\nInhalation twice a day.\\nDisp:*1 discus* Refills:*2*\\n9. Naproxen 375 mg Tablet Sig: One (1) Tablet PO every eight (8) \\nhours.  \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary diagnosis:\\n- COPD exacerbation\\n- chest pain, non-cardiogenic\\n\\nSecondary diagnosis:\\n- Schitzophrenia\\n- history of atrial tachycardia\\n\\n \\nDischarge Condition:\\nGood, ambulatory sat 96% on 1L, 92% on RA\\n\\n \\nDischarge Instructions:\\nYou had chest pain that was not due to a heart attack from the \\ntests we did. Instead the pain is probably referred pain from \\nyour COPD flare. For this you were given steriods and 02, which \\nis now improved. Also you had an ultrasound that also ruled out \\na clot in the deep veins of your legs, and the swelling was \\nprobably from the injury you had. \\n\\nIt is also very important that you stop smoking for the \\ntreatment of your COPD.\\n\\nIf at any point your symptoms return and significantly worsen - \\nincluding shortness of breath, chest pain, or fevers > 101 - \\nplease return to the ED.\\n\\nMedication changes:\\n- Advair was added to help manage your COPD, take this twice per \\nday\\n- Take prednisone for 3 more days for your COPD flare\\n\\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint:\\nPrimary Care Physician: ___, MD/MPH  \\n.  \\nChief Complaint: Shortness of breath, chest pain  \\n\\n \\nMajor Surgical or Invasive Procedure:\\nfoley catheter placement.\\n\\n \\nHistory of Present Illness:\\nMr. ___ is a ___ ___ speaking patient with a h/o CAD s/p \\nCABG in ___, DM2, HTN, HL, diastolic HF who c/o 3 months of \\nworsening shortness of breath and more recently, worsening chest \\npain.  He can no longer take more than ___ steps without feeling \\nboth chest pain and shortness of breath.  In terms of the chest \\npain, he describes it as a piercing sensation on the left side \\nof his chest, no radiation to the left side but comes with a \\n\"choking feeling\" or pressure up to his neck.  It is not \\nassociated with sweating, nausea, palpitations, inspiration, or \\nhis eating habits.  It lasts 3 minutes and prompts him to clutch \\nhis chest but resolves spontaneously.  He experiences it with \\nactivity but has also recently felt it at rest or while lying \\ndown.  \\n.\\nHe believes his shortness of breath has also worsened over the \\nlast 3 months, particularly on exertion.  It often accompanies \\nthe chest pain.  He is not on O2 at home.  He has noticed the \\ndevelopment of a dry cough recently.  He continues to sleep with \\n2 pillows per usual at night and denies PND.  He has noticed \\nincreased leg swelling recently.  He was largely unable to \\ncharacterize time periods so corroboration by his PCP or ___ \\nwould be useful.  \\n.\\nHe reports being diligent about taking his medications \\nregularly.\\n.\\nHe was referred to HCA by ___ at ___, patient was felt to be \\nfluid overloaded, and chest pain felt to be strain secondary to \\ndecompensated heart failure. He was given ASA 325mg PO x1 and \\nplaced on oxygen 2L NC. Given albuterol nebulizer in ambulance.  \\n\\n.\\nIn the ED, 97.5 66 120/93 24 100% 2L by NC. Physical examination \\nnotable for trace pitting edema to knees bilaterally. Laboratory \\ndata significant for creatinine 2.1 (baseline 1.5-1.6), \\nhematocrit 31.9 (baseline), BNP ___, first set \\ncardiac markers WNL. EKG unchanged from baseline. CXR 2V with \\nquestion of perihilar fullness, no consolidations. Foley placed \\nby urology following dilatation of urethral stricture. \\nIntermittently hypertensive to sBP 190s. Given furosemide 40mg \\nIV x1 after Foley placed.  \\n.  \\nOn arrival to the medicine service, patient reports feeling much \\nbetter. He is without chest pain or shortness of breath at \\npresent.\\n.  \\nROS:\\n(+) per HPI\\n(-) for headache, dizziness, increased sweating, syncope, \\nfevers, chills, abdominal pain, changes in bladder habits, \\nweakness, paresthesias, difficulty with coordination, gait \\ndisturbances\\n \\nPast Medical History:\\nCAD s/p CABG in ___ (last stress normal in ___  \\nDM  \\nHypertension  \\nHyperlipidemia  \\nDiastolic CHF\\n \\nSocial History:\\n___\\nFamily History:\\nFather died of heart attack at age ___.\\n \\nPhysical Exam:\\nVS: Tc 97.5 Tmax 97.9  HR 51 BP 191/84 RR 18 O2sat 100% 2L\\nGeneral: Comfortable, laying on 2 pillows\\nHEENT: Sclera anicteric; conjunctiva non-injected; dry mucous \\nmembranes; oropharynx clear without lesions, exudate\\nCV: Bradycardic, regular rhythm, no m/r/g  \\nLungs: CTAB without rales or wheezes\\nAbd: Obese, +BS, soft, NT/ND \\nExt: 1+ lower extremity edema to knees bilaterally; 2+ ___ \\npulses\\nSkin: WWP, no rashes\\n \\nPertinent Results:\\n___ 05:08PM   GLUCOSE-158* UREA N-26* CREAT-2.1* SODIUM-139 \\nPOTASSIUM-4.8 CHLORIDE-100 TOTAL CO2-28 ANION GAP-16\\n___ 05:08PM   CK(CPK)-42*\\n___ 05:08PM   cTropnT-<0.01\\n___ 05:08PM   CK-MB-2 ___ 05:08PM   WBC-6.8 RBC-3.57* HGB-10.4* HCT-31.9* MCV-89 \\nMCH-29.2 MCHC-32.7 RDW-15.9*\\n___ 05:08PM   NEUTS-75.1* LYMPHS-17.3* MONOS-4.6 EOS-2.6 \\nBASOS-0.3\\n___ 05:08PM   PLT COUNT-218\\n\\nCXR 2V (___): Stable chest x-ray examination. Please note \\nthe previous left humerus dislocation has been reduced on the \\ncurrent study. No acute pulmonary process identified.  \\n.  \\nEKG ___, 22:42): NSR @ 52.  Leftward axis deviation.  \\nIntervals WNL.  Isolated Q wave in III.  Biphasic T-wave changes \\nin V4-V6, changed from ___.  \\n.  \\nTTE (___): Mild symmetric left ventricular hypertrophy with \\npreserved global biventricular systolic function. Dilated \\nascending aorta.\\nCompared with the prior report (images unavailable for review) \\nof ___, the findings are similar.\\n.  \\nNuclear stress (___): Atypical/non-anginal type symptoms in \\nthe absence of ischemic EKG changes. The image quality is \\nlimited due to soft tissue attenuation and tracer activity \\nadjacent to the heart.  \\n.  \\n \\nBrief Hospital Course:\\n___ ___ speaking patient with a h/o CAD s/p CABG in ___, \\nDM2, HTN, HL, diastolic HF who c/o 3 months of worsening \\nshortness of breath and more recently, worsening chest pain.    \\n.\\n# Chest pain: Known CAD and s/p 4 vessel CABG. Description of \\nchest pain resembled unstable angina, though stress test from \\n___ negative for ischemic changes.  ACS ruled out with 3 \\nsets of negative cardiac enzymes.  EKG showed biphasic T waves \\nin V4-V6, likely attributable to hypertension due to holding of \\nmeds. Chest pain could have been related to hypertension. Pt was \\nstarted on ASA during the admission. He will follow up with his \\nPCP in the outpatient setting to determine if any additional w/u \\nis needed.\\n.\\n# Shortness of breath: Patient described 3 months of worsening \\nSOB on exertion, often accompanying chest pain from above.  \\nPatient denied orthopnea or PND.  BNP was ___ (higher than \\nbaseline from ___, but exam and radiography not concerning for \\nacute exacerbation of diastolic HF.  Last echo in ___ was \\nunremarkable, EF 60-70%.  Performed echo while inpatient showing \\nno change from ___.  Pt was given additiona doses of lasix \\nearly in the admission with good effect. His symptoms were \\nlikely related to mild acute diastolic heart failure. He will be \\ndischarged on home dose of lasix given creatinine bump while \\ninpatient.  \\n.\\n# Renal insufficiency: Cr was 2.1 on admission. Fe urea 47%, \\nsuggestive of intrinsic renal process.  Latest Cr from ___ \\nvisit in early ___ was also 2.1. No microalbuminuria indicating \\ndiabetic nephropathy, likely ___ to chronic uncontrolled HTN.  \\nCr bumped to 2.4 on ___, likely due to increased lasix dosing \\nand resuming of lisinopril on ___ for HTN control. Lasix and \\nlisinopril held for 1 day and resumed on day of discharge with \\nCr 2.3. Pt with difficult to control HTN and responds very well \\nto lisinopril and lasix. Thus, they were continued on admission \\ndoses. He will have a repeat Cr at his PCP\\'s office ___.\\n.\\n# HTN: Pt with SBP in the 220 range when holding lasix and \\nlisinopril. This was treated effectively with hydralazine and \\namlodipine. Pt was started on amlodipine and this was increased \\nto 10mg daily. In addition, metoprolol dosing was decreased \\nsecondary to bradycardia. Despite adding amlodipine, with SBP \\n160\\'s (also likely secondary to decreased metoprolol dosing) and \\ntherefore lasix and lisinopril were added back with good effect. \\nPts BP is much better controlled on these medications. He will \\nfollow up with his PCP this week for further titration if \\nneeded.\\n.\\n# Bradycardia: Patient\\'s HR consistently stayed in the ___, \\nlikely ___ to metoprolol and possibly tizanidine. Pt\\'s \\nmetoprolol was decreased to 25mg BID. \\n.\\n#urinary retention-Likely related to pt\\'s prior history of \\nurinary strictures. Pt with urinary retention in the ED and \\nfoley catheter was placed, but with some difficulty. Therefore, \\nhe was discharged with the foley in place. He will follow up \\nwith urology this week for voiding trial.\\n.\\n# Hyperkalemia: K 5.2 on admission.  Likely ___ to ACEI and/or \\nchronic renal insufficiency.  No findings on EKG.  Resolved.\\n.    \\n# DM2: Held oral hypoglycemics, started HISS.  BG up to 330s x \\n1, responded to humalog.\\n.  \\n#. Hyperlipidemia: Continued statin per home regimen. \\n.  \\n#. Anemia: At baseline, continued ferrous sulfate per home \\nregimen.   \\n.  \\n# FEN: Heart healthy, diabetic diet; fluid restriction 1.5L; \\nreplete lytes as needed  \\n.\\n# Prophylaxis: Heparin SC TID; home PPI; bowel regimen\\n \\nMedications on Admission:\\nATORVASTATIN [LIPITOR] - 10 mg Tablet - 1 Tablet(s) by mouth \\nonce  \\na day  \\nDIABETIC SHOES - - Use as directed. ICD code: 250.8.  \\nFUROSEMIDE - 40 mg Tablet - 1 Tablet(s) by mouth once a day  \\nGLIPIZIDE - 10 mg Tablet Extended Rel 24 hr - 1 Tab,Sust Rel  \\nOsmotic Push 24hr(s) by mouth twice a day  \\nLIDOCAINE [LIDODERM] - 5 %(700 mg/patch) Adhesive Patch,  \\nMedicated - one patch once a day apply to back for 12 of 24 \\nhours  \\nper day  \\nLISINOPRIL - 5 mg Tablet - 1 Tablet(s) by mouth once a day  \\nLORAZEPAM - 1MG Tablet - ONE BY MOUTH AT BEDTIME AS NEEDED FOR  \\nSLEEPING  \\nMETFORMIN - 1,000 mg Tablet - one Tablet(s) by mouth twice a day \\n \\ntake with morning and evening meal  \\nMETFORMIN HCL - 500 mg Tablet - 1 Tablet(s) by mouth once a day  \\n\\ntake at lunch  \\nMETOPROLOL TARTRATE - 50 mg Tablet - 1 Tablet(s) by mouth twice \\na  \\nday **** dose change ****  \\nNITROGLYCERIN [NITROSTAT] - 0.4 mg Tablet, Sublingual - 1  \\nTablet(s) sublingually prn chest pain  \\nOMEPRAZOLE - 20 mg Capsule, Delayed Release(E.C.) - 1 (One)  \\nCapsule(s) by mouth once a day  \\nPIOGLITAZONE [ACTOS] - 15 mg Tablet - 1 Tablet(s) by mouth once \\na day  \\nPREGABALIN [LYRICA] - 75 mg Capsule - 1 Capsule(s) by mouth once \\na day  \\nTERAZOSIN - 10 mg Capsule - 1 Capsule(s) by mouth twice a day  \\nTIZANIDINE - 4 mg Tablet - 1 Tablet(s) by mouth twice a day  \\nBLOOD SUGAR DIAGNOSTIC - Strip - test tid to qid  \\nFERROUS SULFATE - 325 mg (65 mg) Tablet - 1 Tablet(s) by mouth  \\nonce a day  \\nLAC-HYDRIN - 12 % Cream - apply to hands twice a day  \\n \\nDischarge Medications:\\n1. Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. Glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.  \\n3. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \\nOne (1)  Topical as directed.  \\n4. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO at bedtime.  \\n5. Metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. \\n \\n6. Metformin 500 mg Tablet Sig: One (1) Tablet PO once a day: at \\nlunch  time.  \\n7. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \\nSublingual as directed.  \\n8. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \\n9. Actos 15 mg Tablet Sig: One (1) Tablet PO once a day.  \\n10. Lyrica 75 mg Capsule Sig: One (1) Capsule PO once a day.  \\n11. Terazosin 10 mg Capsule Sig: One (1) Capsule PO once a day.  \\n\\n12. Tizanidine 4 mg Capsule Sig: One (1) Capsule PO twice a day. \\n \\n13. Furosemide 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n14. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.\\nDisp:*30 Tablet(s)* Refills:*2*\\n15. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n16. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n17. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \\n(2 times a day).\\nDisp:*60 Tablet(s)* Refills:*2*\\n18. Iron 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO once \\na day.  \\n19. Amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.\\nDisp:*30 Tablet(s)* Refills:*2*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nMajor:\\nchest pain-angina\\nacute diastolic heart failure\\nHTN\\nurinary retention\\nbradycardia\\n.\\nMinor:\\nCAD\\nDM2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nYou were admitted because you had chest pain and leg swelling. \\nFor this, you had blood tests that showed that you did not have \\na heart attack. You were given a medication to improve your leg \\nswelling and breathing. We also did an ultrasound (an \\nechocardiogram) that did not show any changes from the last one. \\nYou had episodes of high blood pressure and were therefore \\nstarted on a new medication called amlodipine. In addition, you \\nexperienced urinary retention and had the placement of a foley \\ncatheter. You should leave this catheter in place until your \\nurology appointment.\\n.\\nMedication changes:\\nYou were started on an aspirin 81mg daily.\\nYou were started on amlodipine 10mg for blood pressure.\\nYour metoprolol was decreased to 25mg twice a day\\n\\nPlease be sure to follow up with your providers as per below.\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___.\\n \\nChief Complaint:\\nFall ___ suspected seizure\\n \\nMajor Surgical or Invasive Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\n___ y/o male with h/o Mental Retardation, HTN, gout, no previous \\nseizure hx brought in by EMS from group home with syncope and \\npossible seizure.  \\n.  \\nOf note, the patient is unable to give a good hx, and most of \\nthis was obtained from the group home director (contact \\ninformation below). As per the director, the pt was in the \\nkitchen drinking a cup of coffee, chatting with other residents \\nwhen all of sudden, his right arm started shaking rhythmically. \\nHe started spilling coffee all over, and the shaking spread to \\nthe rest of his body. All four limbs were shaking and the \\npatient fell into the corner and slumped down on the floor. He \\ndid not hit his head on the way down. The shaking lasted \\napproximately 1:15 minutes, and the director states there was no \\nevidence of urinary or bowel incontinence. The pt himself denies \\na sore tongue, and the director denies evidence of blood from \\nthe mouth. Pt vomited x 1 with small amount (NBNB). After the \\nrhythmic shaking, he was found to be breathing deeply. He opened \\nhis eyes and he had a very red face and eyes. He could not \\nreally speak and seemed confused for 10 minutes. When EMS \\narrived later, he began to pull at the O2 mask that they palced \\non him, but still could not really respond to questions when he \\nleft the group home. The director states he has been a resident \\nat the group home for ___ years now, and has never been known to \\nhave a seizure disorder. He was active today without any \\ncomplaints of bloody stools or bloody urine. Pt has taken all \\nmeds on time with no extra or missed doses.  \\n.  \\nIn the ED, initial vs were: 97 91 112/59 18 97%. later, he was \\nfound to be hypotensive to sbp ___. He was bolused with fluid \\n(1L) and his BP responded appropriately. Labs notable for \\nlactate 1.6, troponin 0.01, K 3.0, Cr 1.3, AG 21, LFTs wnl, \\nserum tox negative, Hct 39.7, INR 1.1. Patient was given 40 meq \\npotassium. By the time he was transferred to the floor, the pt \\nwas A+Ox3 and responding appropriately to questions. CT Head, \\nCXR, EKG were done (see below).  \\n.  \\nOn the floor, the patient is comfortable and is unable to answer \\nmost questions about his hx. He denies any LH or dizziness at \\nthis time.  \\n.  \\nReview of sytems:  \\n(+) Per HPI  \\n(-) Denies fever, chills, night sweats, recent weight loss or \\ngain. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denied cough, shortness of breath. Denied chest pain \\nor tightness, palpitations. Denied nausea, vomiting, diarrhea, \\nconstipation or abdominal pain. No recent change in bowel or \\nbladder habits. No dysuria. Denied arthralgias or myalgias.  \\n\\n \\nPast Medical History:\\nHypertension  \\n- Gout  \\n- mental retardation  \\n\\n \\nSocial History:\\n___\\nFamily History:\\npt unable to give extensive FH due to MR. ___ died of MI \\n \\nPhysical Exam:\\nVitals: T98, BP 144/86, P76, RR 18, 99/RA  \\nOrthostatics: Sit: ___ Stand: 119/82 - 94  \\nGeneral: Alert, oriented, no acute distress  \\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck: supple, JVP not elevated (5 cm)  \\nLungs: Clear to auscultation bilaterally, no wheezes, rales, \\nronchi  \\nCV: Regular rate and rhythm, normal S1 + S2, no rubs, gallops, \\nGrade III/VI holosystolic murmur best heard at the apex with \\nradiation throughout the precordium  \\nAbdomen: soft, non-tender, non-distended, bowel sounds present, \\nno rebound tenderness or guarding, no organomegaly  \\nGU: no foley  \\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema  \\nNeuro: CNs2-12 intact, sensation intact bilaterally, motor ___ \\nthroughout. 2+ reflexes in biceps and patella.  \\n\\n \\nPertinent Results:\\nADMISSION LABS\\n___ 02:01PM BLOOD WBC-6.9 RBC-4.85 Hgb-14.2 Hct-39.7* \\nMCV-82 MCH-29.4 MCHC-35.9* RDW-13.2 Plt ___\\n___ 02:01PM BLOOD Neuts-57.4 ___ Monos-5.4 Eos-1.6 \\nBaso-1.1\\n___ 02:01PM BLOOD ___ PTT-24.5 ___\\n___ 02:01PM BLOOD Glucose-125* UreaN-21* Creat-1.3* Na-139 \\nK-3.0* Cl-96 HCO3-22 AnGap-24*\\n___ 02:01PM BLOOD ALT-25 AST-32 LD(LDH)-174 AlkPhos-50 \\nTotBili-0.4\\n___ 02:01PM BLOOD Albumin-4.5 Calcium-9.2 Phos-3.0 Mg-2.5\\n___ 02:01PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \\nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\\n___ 07:20AM BLOOD calTIBC-299 Ferritn-77 TRF-230\\n___ 04:56PM BLOOD Lactate-1.6\\n\\nCT HEAD\\nIMPRESSION: No acute intracranial injury.\\n\\nMRI HEAD\\nIMPRESSION: Extremely motion degraded study without evidence of \\nacute \\nintracranial abnormality. \\n\\nCHEST XRAY\\nIMPRESSION: No acute intrathoracic process.\\n\\nEEG: (official read pending, prelim read below)\\nMinimally slow ___ Hz) consistent with mild diffuse \\nencephalopathy, with rare left temporal slowing, no seizure \\nactivity.\\n \\nBrief Hospital Course:\\nThis is a ___ with MR, HTN, gout, who p/w syncope vs seizure. \\nGiven the hx provided by the director of the group home, seizure \\nseems most likely for this gentleman, which is concerning given \\nhis age at his first seizure. Also possible is syncope ___ \\northostasis given his orthostatic VS here, however less likely \\ngiven the convincing HPI for seizure.  \\n.  \\n# Syncope: DDx is broad, however given the patient's story, I am \\nmost concerned for seizure. Other etiologies are certainly \\npossible, however given the history, I think it is important to \\nevaluate him as a seizure patient. Most notable is his \\northostasis on the floor, and we will have to address that as \\nwell. Other causes of syncope that are easy to r/o and that \\nshould be done are infx, arrhythmia, electrolyte disturbances. \\nThe pt does have a 1st degree AV block, however this is usually \\nnot a malignant process and is not symptomatic. AS is not likely \\nas murmur is not c/w AS, rather MR.  \\n.\\nGiven that we were most concerned with seizure, we did a brain \\nMRI (which did not show any pathology) and a 20 minute EEG \\n(pending at time of discharge, however prelim read without \\nseizure activity).  We also c/s neurology who felt that he did \\nnot need any antiepileptics, but rather can f/u with outpt \\nneurology.\\n.  \\n# Orthostatic VS: Pt seems to be volume down given exam and \\northostatic VS.  We hydrated with IVF and held BP meds.  The \\npt's BP meds were held and we discharged the pt without his BP \\nmedications as his BP has been normotensive here without the \\nlisinopril/HCTZ\\n.  \\n# ARF: Pt's Cr is 1.3 up from a baseline of 1.0. Most likely is \\nprerenal, especially given orthostatic VS. We hydrated. We held \\nlisinopril as well.  Unfortunately, the pt did undergo a \\ngadolinium load during his hospitalization.  Regardless, we feel \\nthis can be f/u as an outpatient with a repeat Chem-7 in one \\nweek's time. We asked the patient to avoid NSAIDs as an \\noutpatient and we continued to hold his lisinopril.\\n.  \\n# HTN: As above, we held the lisinopril/HCTZ, even at time of \\ndischarge as he remained normotensive without antihypertensives. \\n This can be readdressed as an outpatient.\\n  \\n# gout: continued colchicine  \\n \\nMedications on Admission:\\nCOLCHICINE 0.6 mg PO daily  \\nLISINOPRIL-HYDROCHLOROTHIAZIDE 20 mg-25 mg Tablet PO daily  \\nACETAMINOPHEN 650 mg Tablet Sustained Release -prn pain  \\nIBUPROFEN [ADVIL] - 200-400 mg prn foot pain  \\n\\n \\nDischarge Medications:\\n1. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. acetaminophen 650 mg Tablet Sustained Release Oral\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPRIMARY:\\n1. fall, suspected seizure\\n\\n \\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nIt was a pleasure taking care of you during your \\nhospitalization.\\nYou were admitted to ___ for a fall and a question of \\nseizure-like activity. You underwent an MRI of your head which \\nshowed nothing abnormal, and an EEG which showed no seizure \\nactivity. We had the inpatient neurology team see you who felt \\nthat you did not need any new medications, and that you should \\nfollow up with an outpatient neurologist soon.\\n.\\nAlso, your Blood pressures were normal without blood pressure \\nmedicine, so we think you can stop taking your blood pressure \\nmedicine for now, and readdress this with your PCP when you see \\nhim next ___.\\n.\\nMEDICATION CHANGES:\\n- Try to avoid using Ibuprofen as your kidneys showed a little \\ndamage.  This will likely go away, however to be safe, we feel \\nyou should avoid Ibuprofen for now.\\n- STOP taking LISINOPRIL/HYDROCHLOROTHIAZIDE\\n.\\nPlease continue your medications as prescribed. Please continue \\nyour appointments as noted below.\\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: NEUROLOGY\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___\\n \\nChief Complaint:\\naltered mental status\\n \\nMajor Surgical or Invasive Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\nThe patient is a ___ yo man with extensive medical history\\nremarkable for old RT parietal stroke, HTN, hypothyroidism, BPH,\\nchronic, anemia, bowel, bladder incontinence, COPD, dementia,\\nanxiety, and schizoaffecctive d/o. He was brought in to the ED\\nfrom ___ with AMS. \\n\\nPer the nursing home staff pt at baseline is awake, alert,\\noriented and conversational, but hard of hearing. Hereqiores\\nassistance for all ADLs and is wheelchair bound. This am he was\\nfound staring, drooling, only responsive to sternal rub to which\\nhe grimaced. The staff also noted him to have weaker RT hadgrasp\\nthan usual. He reportedly was not acting like himself, and did\\nnot have breakfast as usual.\\n\\nHe was evaluated by the ED service, no focal deficits found and\\nhead CT ordered. Per nursing staff on arrival to the ED he was\\nnot very talkative, but able to answer \"okay\" when asked\\nquestions. He gradually returned to baseline within one hour of\\nthis episode.\\n\\nPer the patient he reports he had a stroke the night prior to\\nadmission, as complains he had pain all over, as well as \\nweakness\\nof his right arm, which has improved upon arrival to the\\nhospital. \\n\\n \\nPast Medical History:\\n. Previous RT parietal ___\\n2. Hypothyroidism\\n3. HTN\\n4. Gout\\n5. COPD\\n6. BPH\\n7. Bowel and bladder incontinence\\n8. Remote hx of alcohol abuse\\n9. Anxiety\\n10. Dementia\\n11. Schizoaffective d/o\\n12. Chronic anemia \\n\\n \\nSocial History:\\n___\\nFamily History:\\nunknown\\n \\nPhysical Exam:\\nOn admission:\\nGeneral:  NAD\\nHEENT: NCAT,  no oropharyngeal lesions, neck supple\\n___: RRR, no M/R/G\\nPulmonary: Coarse sounds throughout\\nAbdomen: Soft, NT, ND, +BS, no guarding\\nExtremities: Warm, no edema, LT had contracture, BLE in knee\\nflexion.\\n\\nNeurologic Examination:\\nAwake, alert, oriented x 3. Able to relate history without\\ndifficulty. Slightly innatentive, unable to name ___ backward\\nwithout difficulty. Speech is fluent with full sentences, intact\\nrepetition, and intact verbal comprehension. Naming intact.  No\\nparaphasias.  No dysarthria. Normal prosody. Able to register 3\\nobjects and recall ___ at 5 minutes without prompting. No\\napraxia. No evidence of hemineglect. No left-right confusion. \\nAble to follow both midline and appendicular commands.\\n\\n- Cranial Nerves - Lt pupil 3->2 brisk, RT pupil 2 not reactive\\nto light. EOMI, no nystagmus. V1-V3 without deficits to light\\ntouch bilaterally. No facial movement asymmetry. Hearing \\nseverely\\ndiminished but able to carry a conversation.  Palate elevation\\nsymmetric. SCM/Trapezius strength ___ bilaterally. Tongue\\nmidline.\\n\\n- Motor - Decreased bulk and increased tone on LUE. No tremor or\\nasterixis.\\n  Delt Bic Tri  FFl FE  IO IP Quad Ham Gastroc \\nL  -    5   4+   -  -   -   3+  3+  3+    -       \\nR  -    5   4+   4+  4+  4+ 3+  3+  3+    -     \\n\\n- Sensory - No deficits to light touch bilaterally.\\n\\n-DTRs:\\n  Bi  Tri ___ Pat Ach\\nL  2+  2    2+   2+  0\\nR  2+  2    2+   2+  0\\nPlantar response upgoing on the left, and downgoing on the \\nright.\\n\\n- Coordination - attempted finger to nose but patient unable to\\nfollow.\\n\\n- Gait - not tested.\\n\\n---\\nOn discharge:\\nMental status: Awake, alert, oriented x 3. Speech is fluent with \\nfull sentences. No dysarthria. Normal prosody. No evidence of \\nhemineglect. No left-right confusion. Able to follow both \\nmidline and appendicular commands. Otherwise unchanged.\\n\\n \\nPertinent Results:\\nImaging:\\n\\nCXR: 5.7 x 4.5 cm well-circumscribed mass at the right lung \\nbase.  The right heart border is not well visualized suggesting \\na right middle lobe location. However, given the deformity of \\nthe underlying right tenth rib and the density of the lesion, \\nthis may reflect a chest wall lesion and Chest CT is recommended \\nfor further evaluation. \\n\\nCT chest: 1. 6.1 x 3.2 x 4.5 cm mass in the right lower lobe, \\nwhich exerts mass effect upon basal segment bronchi with \\nresultant volume loss. Findings are concerning for lung cancer. \\n2. Additional nodules in the right middle lobe. \\n3. Incompletely characterized nodule in the right adrenal gland, \\nbut \\nstatistically likely an adenoma. Attention on followup is \\nadvised. \\n4. Severe centrilobular and paraseptal emphysema. \\n5. Compression deformity of the L1 vertebral body of unclear \\nchronicity. \\n\\nCT abdomen/pelvis with contrast: \\n1. 11 mm right adrenal gland nodule statistically likely to \\nrepresent an adenoma, but in the setting of a lung mass, \\nmetastatic disease cannot be excluded.  Recommend evaluation \\nwith non-contrast CT scan. \\n2. 4.5 cm intra-luminal eccentric lesion in the right colon. \\nThis is not fully evaluated on this single phase scan but is \\nconcerning for colon cancer. Recommend evaluation with a \\nnon-contrast abdominal CT scan to assess. \\n\\nCT abdomen/pelvis without contrast: \\n1. Right colon mass seen on prior examination is enhancing and \\nis highly suspicious for colon cancer. \\n2. There is an 11 mm right adrenal adenoma. \\n\\nNon-contrast head CT: \\n1. No evidence of acute large territorial infarct or hemorrhage. \\n\\n2. Age-related involutional changes and sequela of chronic small \\nvessel \\nischemic disease. \\n3. Sinus disease, as described above. \\n\\nMRI head:\\n1. No acute intracranial abnormality without evidence of stroke \\nor mass. \\n2. Confluent periventricular and subcortical white matter FLAIR \\nsignal hyperintensity with background diffuse cortical volume \\nloss, likely representing sequela of chronic microangiopathy. \\n3. Sinus disease. \\n\\nCXR:\\nThe previously described masslike opacity since ___ has \\nsignificantly improved, with residual heterogeneous opacity, \\nsuggesting focal infection or atelectasis over malignancy. There \\nis new mild opacity in the right middle lobe, which could also \\nrepresent worsening pneumonia in the appropriate clinical \\nsetting. \\n\\nLabs:\\n___ 06:10AM BLOOD WBC-9.5 RBC-3.46* Hgb-12.0* Hct-37.0* \\nMCV-107* MCH-34.7* MCHC-32.4 RDW-13.6 RDWSD-53.6* Plt ___\\n___ 06:10AM BLOOD Neuts-70.1 Lymphs-16.2* Monos-9.3 Eos-3.2 \\nBaso-0.4 Im ___ AbsNeut-6.66* AbsLymp-1.54 AbsMono-0.88* \\nAbsEos-0.30 AbsBaso-0.04\\n___ 06:10AM BLOOD Glucose-85 UreaN-22* Creat-1.2 Na-143 \\nK-4.3 Cl-113* HCO3-18* AnGap-16\\n___ 06:05AM BLOOD VitB12-506\\n___ 05:15AM BLOOD %HbA1c-5.2 eAG-103\\n___ 05:15AM BLOOD Triglyc-79 HDL-47 CHOL/HD-2.8 LDLcalc-67\\n___ 05:15AM BLOOD TSH-2.0\\n \\nBrief Hospital Course:\\nMr. ___ is a ___ man with prior R MCA stroke, dementia, and \\nschizoaffective disorder who was admitted for altered mental \\nstatus with blank staring and drooling that lasted for 1hr and \\nalso R sided weakness. He main complaint is back pain, and he \\nwas uncooperative on exam but oriented to date, location, and \\npresident. L sided weakness compared to R that is old per pt and \\nguardian. Mental status back to baseline as of 6pm ___. TIA \\nworkup started as possible cause of AMS, MRI head negative for \\nstroke/mass lesion, no diabetes or HLD found, echo unable to \\nassess for PFO. \\n\\nOf note, found incidental lung lesion on routine CXR in ED. CT \\ntorso showed RLL lung mass, R adrenal gland nodule, and \\nintraluminal R colon lesion concerning for colon cancer. Also L1 \\nvertebral body compression that may explain back pain. Pt and \\nlegal guardian are aware of results from CT scans. Heme/onc was \\nconsulted for help with further management. They have \\nrecommended outpatient workup. This has been communicated to his \\nPCP, ___. Of note, repeat CXR on ___ demonstrated \\ninterval decrease in the size of the lung mass, suggesting \\ninstead an infectious etiology. \\n\\nAlso developed a UTI for which he was treated with IV \\nantibiotics. Discharged home with po antibiotics for 7 days for \\ncomplicated UTI. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Levothyroxine Sodium 125 mcg PO DAILY \\n2. BuPROPion 300 mg PO DAILY \\n3. Colchicine 0.6 mg PO EVERY OTHER DAY \\n4. Fluticasone Propionate 110mcg 1 PUFF IH BID \\n5. TraMADOL (Ultram) 50 mg PO BID:PRN pain \\n6. Lorazepam 0.5 mg PO TID \\n7. Lactulose 30 mL PO QHS \\n8. Doxazosin 4 mg PO HS \\n9. Ibuprofen 200 mg PO DAILY \\n10. Prochlorperazine 5 mg PO Q8H:PRN nausea \\n11. LOPERamide 2 mg PO Q6H:PRN diarhhea \\n12. Guaifenesin 5 mL PO Q4H:PRN cough \\n13. Bisacodyl 10 mg PO DAILY:PRN constipation \\n14. Fleet Enema ___AILY:PRN constipation \\n\\n \\nDischarge Medications:\\n1. BuPROPion 300 mg PO DAILY \\n2. Bisacodyl 10 mg PO DAILY:PRN constipation \\n3. Colchicine 0.6 mg PO EVERY OTHER DAY \\n4. Doxazosin 4 mg PO HS \\n5. Fleet Enema ___AILY:PRN constipation \\n6. Fluticasone Propionate 110mcg 1 PUFF IH BID \\n7. Levothyroxine Sodium 125 mcg PO DAILY \\n8. Lorazepam 0.5 mg PO TID \\n9. TraMADOL (Ultram) 50 mg PO BID:PRN pain \\n10. Acetaminophen 650 mg PO TID:PRN pain, fever \\n11. Aspirin 81 mg PO DAILY \\n12. Multivitamins 1 TAB PO DAILY \\n13. Guaifenesin 5 mL PO Q4H:PRN cough \\n14. Lactulose 30 mL PO QHS \\n15. LOPERamide 2 mg PO Q6H:PRN diarhhea \\n16. Prochlorperazine 5 mg PO Q8H:PRN nausea \\n17. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*14 Tablet Refills:*0\\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nAltered mental status of unknown cause, possible TIA, lung mass, \\nR colonic mass\\n\\n \\nDischarge Condition:\\neating po, awake, alert, oriented, voiding\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\n\\nYou were admitted to the hospital because you seemed to have an \\nepisode of confusion and right sided weakness at your care \\nfacility. The MRI of your head did not show any strokes or \\nmasses, and your EEG did not show evidence that you were having \\na prolonged seizure. Thankfully, you returned to your baseline \\nmental status by the next afternoon. We have pursued a transient \\nischemia attack workup given your possible right sided weakness \\nand altered mental status, and it is normal. \\n\\nWhile you were in the Emergency room, you had a chest Xray that \\nshowed a mass in your right lung, which was confirmed by a CT \\nscan of your chest. A CT scan of your abdomen also showed a R \\ncolonic mass. As we have discussed with you and your legal \\n___, these findings are concerning for \\ncancer. Oncology has seen you in the hospital but are unable to \\nmake any recommendations until a biopsy of either the lung or \\nthe colon is obtained. You will need to be closely followed in \\nthe outpatient setting for further diagnostic workup and \\ntreatment. \\n \\nFollowup Instructions:\\n___', 'Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPenicillins / Erythromycin Base / Streptomycin / Citric Acid / \\nAtenolol / Torsemide / Heparin Agents\\n \\n ___.\\n \\nChief Complaint:\\nRespiratory Distress, Hypotension\\n \\nMajor Surgical or Invasive Procedure:\\nRight internal jugular (CVL) (discontinued) \\nArterial line (discontinued)\\nPICC (placed ___\\n \\nHistory of Present Illness:\\n___ year old male with multiple co-morbidities, including rectal \\ncancer s/p resection and radiation in ___, coronary artery \\ndisease s/p stents, systolic CHF, dilated cardiomyopathy, atrial \\nfibrillation, history of cardiac arrest and complete heart blood \\ns/p AICD/pacemaker, recent trach/peg who presented with \\nrespiratory distress, fevers and hypotension. The patient \\ndesaturated one day before admission to 85% at ___ \\nalthough improved to 92% with suctioning out copious amounts of \\nthick yellow, brown secretions. Per his wife and daughter, he \\nhad been doing well with the trach, often having it capped in \\nthe last week - up until ___ days ago when he needed to be on \\nthe vent more frequently. He reportedly had a fever to ___ \\nyesterday and 102.0 today at rehab and had a CXR performed there \\nshowing LLL pneumonia; he was treated with Vancomycin 1 gram X1 \\nthere.\\n.\\nOn arrival to the ___ ___, the patient was being bagged by EMS \\nupon arrival, hypotensive to SBP80s, not tachypneic, never \\nfebrile, satting stably on his trach settings. He was mentating \\nwell, complaining only of buttocks pain (stable) and answering \\nquestions appropriately. CXR ___ similar to priors and he was \\ntreated with Levofloxacin and Cefepime. Given persistent \\nhypotension SBP80s and decreased UOP ___ hours) despite \\n1.5L IVF, a RIJ CVL was placed and levophed started at 0.06. He \\nalso had a midline IV from before and 18 gauge PIV. His troponin \\nwas 0.11 so he was also given aspirin 325mg. VS on transfer to \\nMICU: Afebrile, HR70, BP86/40, RR16, 95% on PEEP5, FiO2 60%, \\nTV500.\\n.\\nUpon arrival to the MICU, the patient was resting comfortably in \\nbed. \\n.\\nReview of systems:  \\n(+) Per HPI  \\n(-) Denies headache, sinus tenderness, congestion. Denies chest \\npain, chest pressure, palpitations, or weakness. Denies nausea, \\nvomiting, diarrhea, constipation, abdominal pain, or changes in \\nbowel habits. \\n\\n \\nPast Medical History:\\n- Rectal cancer s/p excision and XRT (___)\\n- CAD s/p stents  \\n- Complete heart block s/p pacemaker \\n- h/o cardiac arrest (now with AICD)  \\n- Afib \\n- Systolic CHF (EF 40-45%)  \\n- s/p Fall with multiple rib fractures (___)  \\n- h/o GI bleed\\n \\nSocial History:\\n___\\nFamily History:\\nFather died in ___ from MI. Mother died in ___ from PE. No \\nfamily history of colon, breast, uterine, or ovarian cancer. No \\nfamily history of seizures. \\n \\nPhysical Exam:\\nAdmission Exam:\\nVitals: T: Afebrile BP: 105/47 P: 61 R: 13 O2: 100%   \\nGeneral: oriented, no acute distress, sleepy\\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck: Supple, RIJ CVL\\nLungs: Diffusely rhonchorous, rales; no wheezes \\nCV: RRR, ___ holosystolic murmur heard best over apex with \\ndulling of S1 and S2 over apex. Otherwise S1 S2 clear and of \\ngood quality over rest of precordium.\\nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \\nno rebound tenderness or guarding; ostomy bag in place  \\nGU: three way irrigation foley \\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema; dry stasis changes on bilateral lower extremities  \\n  \\nDischarge Exam: \\nVS 98.9 73 133/69 24 95% trach collar 50%F1O2   \\nGeneral Appearance: No acute distress, breathing comfortably on \\ntrach collar.\\nHEENT: PERRL, Conjunctiva pale, Normocephalic, Poor dentition\\nCardiovascular: RRR, ___ holosystolic murmur heard best over \\nRespiratory:  mild rhonchi throughout all lung fields with \\noccasional expiratory wheezes\\nAbdominal: Soft, non-tender, colostomy, PEG, + BS \\nExtremities: Bilateral ___ edema L>R, Chronic skin changes over \\nbilateral ___ suggestive of chronic venous stasis, right knee \\ntender to palpation \\nSkin:  Warm, well perfused\\nNeurologic: Attentive, Follows simple commands, Responds to: \\nVerbal stimuli, Movement: Purposeful, Tone: Normal, localizes \\npain. Able to point out letters on chart for communicating, \\nappropriate\\n\\n \\nPertinent Results:\\nBlood Counts\\n___ 08:00AM BLOOD WBC-28.2*# RBC-2.71* Hgb-7.9* Hct-24.0* \\nMCV-88 MCH-29.1 MCHC-33.1 RDW-16.6* Plt ___\\n___ 02:30PM BLOOD WBC-11.6* RBC-3.00* Hgb-8.8* Hct-26.6* \\nMCV-89 MCH-29.3 MCHC-33.1 RDW-16.6* Plt ___\\n___ 02:53AM BLOOD WBC-8.0 RBC-2.81* Hgb-8.3* Hct-25.0* \\nMCV-89 MCH-29.4 MCHC-33.0 RDW-16.1* Plt Ct-80*\\n\\nElectrolytes\\n___ 08:00AM BLOOD Glucose-139* UreaN-45* Creat-1.5* Na-136 \\nK-5.0 Cl-99 HCO3-29 AnGap-13\\n___ 02:57AM BLOOD Glucose-106* UreaN-50* Creat-1.3* Na-138 \\nK-4.4 Cl-107 HCO3-25 AnGap-10\\n___ 02:53AM BLOOD Glucose-144* UreaN-48* Creat-1.2 Na-139 \\nK-4.3 Cl-103 HCO3-29 AnGap-11\\n\\n \\nBrief Hospital Course:\\nHOSPITAL COURSE\\n___ PMHx rectal cancer s/p resection and XRT w ostomy, systolic \\nCHF (LVEF40-45%), recent trach/peg who presented with \\nrespiratory distress, found to have a pnuemonia, with blood and \\nsputum cultures growing out MRSA, now improved to baseline \\nrespiratory status being discharged to ___ on 2 week course of \\nIV antibioitics\\n.\\nACTIVE\\n# Healthcare Associated Pnuemonia and MRSA Bacteremia - Patient \\npresented with increasing O2 requirements, leukocytosis and \\nhypotension; CXR demonstrated LLL PNA; accompanying elevated \\nLactate, High SvO2 (93%), hypotension and tachycardia suggested \\nsepsis; blood and sputum cultures grew out MRSA.  Patient was \\ninitially fluid resuscitated and briefly required vasopressors.  \\nHe was treated with vancomycin (initially with cefepime and \\nlevofloxacin as well, which were stopped based upon culture \\ndata).  Patient respiratory status improved, and patient was \\nable to be weaned off vent to trach collar.  Given MRSA \\nbacteremia, patient had PICC line changed and underwent TTE that \\ndid not demonstrate signs of valvular lesions; patient was \\nplanned for 2 week course with IV vancomycin.  \\n.\\n# Sacral decubitus ulcer: Significant, likely stage IV.  \\nAppropriate wound care was provided and his pain regimen was \\nincreased to Oxycodone to ___ mg q4 PRN for pain which \\nsuccessfully curbed decubitus pain.\\n.\\n# Coronary artery disease: Stable, continued carvedilol; held \\nlisinopril given hypotension and will need to be restarted; \\nstarted ASA (had been held previously given history of GI \\nbleeds).  \\n.\\n# Afib: CHADS4, but off anticoagulation ___ hemothorax ___.  \\nDiscussed with primary cardiologist who recommended considering \\nrestarting coumadin as outpatient. \\n\\nINACTIVE\\n# Anemia - Continued iron supplementation\\n.\\n# Systolic CHF: EF 40-45%, continued lasix\\n.  \\nTransitional Issues:\\n- Patient is full code\\n- Will need primary care doctors to discuss ___ as \\noutpatient\\n- Continue vancomycin for 2 weeks total course\\n \\nMedications on Admission:\\nMedications (per D/C summary and ___ records): \\n* Acetaminophen 650mg q8 hours PRN pain \\n* Acetaminophen 325mg q8 hours PRN pain \\n* Lidocaine patch X2 \\n* Trazodone 25mg qHS \\n* Carvedilol 3.125mg twice daily \\n* Citalopram 20mg daily \\n* Docusate 10mL twice daily \\n* Ferrous sulfate 325mg elixir daily \\n* Folate 1mg daily \\n* Lasix 40mg daily \\n* Gabapentin 300mg twice daily \\n* Lisinopril 2.5mg daily \\n* Multivitamin daily \\n* Omeprazole 20mg \\n* Protein supplements daily \\n* Albuterol HFA inhaler \\n* Simethicone 80mg every 8 hours \\n* Oxycodone 5 every four hours PRN tracheal pain, dressing \\nchanges\\n* Miconazole powrder qHS \\n* Levofloxacin 750mg daily, completed course ___ \\n* Gentamicin nebulizer 80mg q12 hours nebulizer\\n\\n \\nDischarge Medications:\\n1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every \\n4 hours) as needed for pain.  \\n2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \\nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 \\nhours on, 12 hours off.  \\n3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as \\nneeded for insomnia.  \\n4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) mL PO BID (2 \\ntimes a day).  \\n6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1) \\ndose PO DAILY (Daily).  \\n7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n\\n8. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \\n10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \\nTwo (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, \\nwheeze.  \\n11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, \\nChewable PO TID (3 times a day).  \\n12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS \\n(at bedtime).  \\n13. oxycodone 5 mg Tablet Sig: ___ Tablets PO every four (4) \\nhours as needed for pain: Hold for Sedation or RR<12.  \\n14. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \\nPO DAILY (Daily).  \\n15. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n16. Please change and care for lines per nursing routine\\n17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO twice a \\nday.  \\n18. vancomycin 750 mg Recon Soln Sig: One (1) solution \\nIntravenous twice a day for 24 days.  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPRIMARY\\nHealthcare Associated Pneumonia\\nStaph Bacteremia\\n\\nSECONDARY\\nSystolic CHF \\nAtrial Fibrillation\\n\\n \\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Lethargic but arousable.\\nActivity Status: Bedbound.\\n\\n \\nDischarge Instructions:\\nMr. ___--\\n\\nIt was a pleasure treating you at ___. You were admitted with \\ndifficulty breathing and low blood pressure.  You were found to \\nhave a pneumonia and an infection in your blood. You were \\ntreated with antibiotics and improved.  You will need to \\ncontinue your antibiotics for 2 weeks total.\\n  \\nThe following changes to your medications were made:\\n- STARTED vancomycin (continue until ___\\n- STARTED aspirin\\n- STOPPED inhaled gentamycin\\n \\nFollowup Instructions:\\n___']\n",
      "[['Sex' ':   ' 'M' ... '' '' '']\n",
      " ['Sex' ':   ' 'M' ... '' '' '']\n",
      " ['Sex' ':   ' 'M' ... '' '' '']\n",
      " ...\n",
      " ['Sex' ':   ' 'M' ... '' '' '']\n",
      " ['Sex' ':   ' 'M' ... '' '' '']\n",
      " ['Sex' ':   ' 'M' ... '' '' '']]\n",
      "[[   0    0    0 ...   14   14   14]\n",
      " [ 454  927 1225 ... 1174  794  385]]\n",
      "[[False False False ... False False False]\n",
      " [ True False  True ... False False False]\n",
      " [False False False ... False False False]\n",
      " ...\n",
      " [False False False ... False False False]\n",
      " [False False False ... False False False]\n",
      " [False False False ... False False False]]\n",
      "[\"Sex:   M\\n \\n : SURGERY Allergies: \\nGrass ___, Standard / Lactose\\n \\n ___.\\n \\nChief Complaint right popliteal aneurysm\\n \\nMajor Surgical or Invasive Procedure:\\n___:   artery stent graft\\n\\n \\nHistory of Present Illness:\\nMr. ___ has a fairly   aneurysm in  \\nmid right popliteal artery and is mostly full of thrombus and\\nmeasures 3.1 cm.  It is patent and does have palpable pedal\\npulse distally.  He has   of upcoming ankle surgery as well.\\nHe has a past medical   notable for   cancer status\\npost mastectomy and chemotherapy/radiation therapy with duodenal\\nulcer,  , depression,  , microvascular\\n  disease, hyperlipidemia, and COPD.  He had vein\\nmapping performed today which shows the lesser saphenous veins\\nto be small and noncompressible bilaterally.  He has the\\nthrombosis of the right greater   at the level of the\\nknee.  The left greater saphenous is adequate as are both\\n  and cephalic veins.  It was   that he would best \\nbe served by a stent graft. He was set up to have this done \\nelectively\\n \\nPast Medical History:\\nDepression\\nPseudogout\\nThyroid nodule\\nHx Duodenal ulcer ___ dx at OSH; ? secondary to ASA per pt.\\nHypothyroidism\\nCNS microvascular disease\\nHypercholesterolemia\\nNon-ulcer dyspepsia\\nAnemia\\nX-rays showing COPD although no smoking hx per pt.\\nBreast Cancer - T2, N1 ___ nodes),  ,   III, double \\nhormone\\nreceptor positive and  -2/neu negative infiltrating ductal\\n .  Lymphovascular invasion was also present.  He was\\ntreated with a total mastectomy, adjuvant chemotherapy with  \\ncycles of Taxotere and Cytoxan, followed by postmastectomy\\nradiation.  Currently on anastrozole PSH: Umbilical hernia repair ___, Right mastoid operation as \\na teenager, total mastectomy\\n\\n \\nSocial History ___\\nFamily History:\\nnon contributory\\n \\nPhysical Exam:\\nvss afebrile\\n\\nGen - Elderly appearing male in nad, alert and oriented   3\\nCV - RRR\\nLungs - CTA bilat\\nAbd - soft no m/t/o\\nExtremities - R ankle weakness (baseline). Full ROM of bilat ___. \\nRLE edema 1+. No LLE edema. R groin puncture c/d/i\\nPulses - femoral/dp/pt palpable bilat\\n \\nPertinent Results:\\n___ 09:20PM BLOOD WBC-4.4 RBC-3.96* Hgb-11.6* Hct-34.4* \\nMCV-87 MCH-29.4 MCHC-33.8 RDW-13.0 Plt ___\\n___ 07:30AM BLOOD WBC-5.5 RBC-3.99* Hgb-11.7* Hct-34.8* \\nMCV-87 MCH-29.4 MCHC-33.7 RDW-13.1 Plt ___\\n___ 09:20PM BLOOD Glucose-88 UreaN-12 Creat-0.9 Na-142 \\nK- .  Cl-105 HCO3-26 AnGap-15\\n___ 07:30AM BLOOD Glucose-144* UreaN-14 Creat- .0 Na-139 \\nK-4.5 Cl-103 HCO3-30 AnGap-11\\n___ 09:20PM BLOOD Calcium-8.7 Phos-2.9 Mg-1.9\\n___ 07:30AM BLOOD Calcium-8.9 Phos- .7 Mg-2.5\\n \\nBrief Hospital Course:\\nMr ___ was admitted,  'd, consented and taken for right \\npopliteal   graft. Just prior to the operation he had an \\nepisode of sinus tachycardia, but quickly returned to his \\nbaseline which   sinus bradycardia. He tolerated the procedure \\nwell and was transfered to the PACU where he remained \\nhemodynamicaly stable. He did have another episode of sinus \\ntachycardia in the PACU and received several doses of IV \\nmetoprolol.  He rapidly converted to sinus bradycardia with \\nrates in the ___.  His blood pressure was stable throughout \\nthese episodes and he was completely asymptomatic. He was \\ntransfered to the VICU for monitoring overnight. He remained in \\nsinus rhythm with heart rate stable in the ___. Review of \\nrecords and discussion with his PCP revealed that he has had \\nother episodes of sinus tach in the setting of procedures and \\noutpatient work up did not reveal anything significant. His \\nbaseline HR is sinus bradycardia in the high ___.  We had our \\nelectrophysiology team here see   and they felt there was no \\nacute  . They did recommend he follow up with his PCP or \\ncardiologist and have an outpatient echo.  Mr. ___ was \\nfeeling well on POD 1. His lab values were stable, he tolerated \\na regular diet and voided without difficulty.  He did walk with \\nhis cane but was a bit unsteady. ___ evaluated him and felt he \\nwould benefit from a walker and home ___. He was deemed stable \\nfor d/c home with family with a walker and a ___ and home ___. He \\nwill follow up with vascular, and his pcp in the near future. \\n \\nMedications on Admission:\\n anastrozole 1 mg qd;  \\n  colchicine 0.6 mg qd' DIAZEPAM 5MG prn;  levothyroxine 75 mcg \\nqd;  pravastatin 80 mg qd; ranitidine HCl 300 mg bid;        \\n  aspirin 325 qd\\n \\nDischarge Medications:\\n1. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet \\nPO Q6H (every 6 hours) as needed for pain.\\nDisp:*10 Tablet(s)* Refills:*0*\\n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day): while on narcotics.  \\n3. levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. pravastatin 80 mg Tablet Sig: One (1) Tablet PO once a day.  \\n5. anastrozole 1 mg Tablet Sig: One (1) Tablet PO once a day.  \\n6. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO once a day.  \\n7. diazepam 5 mg Tablet Sig: One (1) Tablet PO at bedtime as \\nneeded for insomnia.  \\n8. ranitidine HCl 150 mg Tablet Sig: Two (2) Tablet PO BID (2 \\ntimes a day).  \\n9. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n10. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily) for 1 months: for 1 month then stop.\\nDisp:*30 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nR popiteal artery anuerysm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\nLower Extremity Angioplasty/Stent Discharge Instructions\\n\\nMedications:\\n\\x95Take Aspirin 325mg (enteric coated) once daily \\n\\x95If instructed, take Plavix (Clopidogrel) 75mg once daily\\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\n\\x95It is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and ultrasound \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\ngreen drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office ___. If bleeding does not stop, call \\n___ for transfer to closest Emergency Room.\\n\\nYou need to follow up with your cardiologist and primary care \\ndoctor regarding your baseline bradycardia.  You should have \\nyour thyroid function followed closely.  \\n \\nFollowup Instructions:\\n___\", ' :    \\n \\nService:  \\n \\n : \\nNifedipine /   / IV Dye, Iodine   Contrast Media ___.\\n \\nChief Complaint:\\nInitiating  \\n \\nMajor Surgical or   Procedure:\\nRight sided   dialysis catheter ___\\n\\n \\n  of Present  :\\n___ yo M w/ PMH of   s/p right nephrectomy, stage IV CKD, \\n , gout, CHF   admitted following placement of an HD \\nline for iniation of dialysis. Pt has had   V   and has \\nnoted     but no vomiting and overall feeling \\nunwell  . He had a LUE AV fistual created on ___ \\nhowever as it is too     use this and given his symptoms it was   to place a tunnelled catheter while this amtures. he \\nwas admitted following this ___ procedure and his first session \\nof dialysis. He denies recent fevers or chills or cough. He does \\nreport decreased urine output with \"discomfort\" on   but \\nno burning. He reports abdominal discomfort and nausea but no \\nchanges in his bowel habits or vomiting. He deneis tremor or \\nchest pain He reports using his CPAP occasionally at night. The \\npatient was seen as he finished his first session of dialysis \\nand reports it was going  .  \\n \\nROS: per HPI, denies fever, chills, night sweats, headache, \\nvision changes, rhinorrhea, congestion, sore throat, cough, \\nshortness of breath, chest pain, abdominal pain, vomiting, \\ndiarrhea, constipation, BRBPR, melena, hematochezia, dysuria, \\nhematuria.  \\n\\n \\nPast Medical History:\\n-renal cell carcinoma s/p right nephrectomy in ___  \\n-CKD IV- felt secondary to HTN on the left kidney  \\n-CAD  \\n-Gout  \\n-OSA  \\n-CHF  \\n-Malingnat hyperthermia  \\n-hypercholesterolemia  \\nPast surgical history:  \\nright nephrectomy ___  \\nLeft brachiobasilic arteriovenous fistula ___  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nHis mother is alive at the age of ___ with history of \\nhypertension and hip replacement. His father is also alive. The \\npatient has six siblings who are doing well. He has two adult \\ndaughters who are healthy.\\n \\nPhysical Exam:\\nAdmission Physical Exam\\nVS - 98.7, 158/103, 70, 16, 99RA\\nGENERAL - NAD, comfortable, appropriate, lying in bed getting \\ndialysis\\nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear\\nNECK - supple, no thyromegaly, no JVD\\nHEART - RRR, no MRG appreciated\\nLUNGS -auscultated anteriorly ___ being on dialysis CTAB\\nABDOMEN - NABS, soft/NT/ND, no masses or HSM, no \\nrebound/guarding\\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)\\nSKIN - no rashes or lesions\\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, gait and \\nstrength testing deferred given he was on dialysis \\n\\nDischarge Physical Exam\\nVS: 98.9, 148/96, 74, 20, 98RA BS 139-374\\nGENERAL - well appearing AA male in NAD\\nHEENT - PEERLA\\nCHEST- Right tunnelled catheter in place, no surrounding \\nerythema\\nNECK - supple, no thyromegaly, no JVD\\nHEART - RRR, no   appreciated\\nLUNGS -CTAB\\nABDOMEN - NABS, soft/NT/ND, no   or HSM, no \\nrebound/guarding\\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)\\nSKIN - no rashes or lesions\\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, gait and \\nstrength testing deferred given he was on dialysis \\n \\nPertinent Results:\\nAdmission Labs:\\n___ 09:  BLOOD WBC-14.2* RBC-3.75* Hgb-10.5* Hct-32.6* \\nMCV-87 MCH-28.0 MCHC-32.3 RDW-14.3 Plt ___\\n___ 09:45AM BLOOD ___ ___ 09:45AM BLOOD Glucose-313* Creat-6.2*  -144 K-4.2 \\nCl-100 HCO3-24 AnGap-24*\\n___ 09:45AM BLOOD Albumin-4.1 Calcium-8.7 Phos-5.6*# \\nIron-42*\\n\\nPertinent labs\\n___ 09:45AM BLOOD calTIBC-248* Ferritn-279 TRF-191*\\n___ 09:45AM BLOOD PTH-532*\\n___ 09:45AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE \\nHBcAb-NEGATIVE\\n___ 09:45AM BLOOD HCV Ab-NEGATIVE\\n\\nDischarge labs:\\n___ 07:40AM BLOOD WBC-12. * RBC-3. * Hgb-10.6* Hct-33.1* \\nMCV-88 MCH-28.2 MCHC-32.0 RDW-14.4 Plt ___\\n___ 07:40AM BLOOD  -200* UreaN-60* Creat-4.7* Na-141 \\nK-4.0 Cl-100 HCO3-30 AnGap-15\\n___ 07:40AM BLOOD Calcium-9.1 Phos-5.0* Mg-2.0\\n\\nUrine\\n___ 06:49AM URINE Color-Straw Appear-Clear Sp ___\\n___ 06:49AM URINE Blood-TR Nitrite-NEG Protein-100 \\nGlucose-300 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\\n___ 06:49AM URINE RBC-1 WBC-<1 Bacteri-NONE Yeast-NONE \\nEpi-0\\n\\nMicro:\\n URINE CULTURE (Final ___:    NO GROWTH. \\n\\nImaging:\\nHD line placement: IMPRESSION:   Successful placement of a \\ntunneled HD catheter through the right internal jugular vein \\napproach.  The tip is located in the right atrium and the \\ncatheter is ready for use.\\n \\n \\nBrief Hospital Course:\\nMr. ___ is a  ___ yo M w/ PMH of RCC s/p nephrectomy and now \\nwith ESRD who was initiated on dialysis via newly placed right \\ntunneled dialysis ___ adn is admitted for initiation of \\ndialysis. \\n\\n#ESRD- patient had a R sided tunneled line placement in ___ on \\n___ and he received 3 sessions of dialysis while inpatient \\nwithout complication through this line. He had hepatitis \\nserologies checked which were negative and a PPD was placed and \\nread and was negative at 48hrs.  He continued to make some urine \\nand tolerated the sessions.  His weight on discharge 105.3kg.  \\n-he will continue dialysis via his R tunnelled line MWF schedule\\n-patient started nephrocaps\\n-furosemide was held\\n-potassium supplements were held\\n-patient was instructed to eat a low phos, low sodium diabetic \\ndiet\\n\\n#Hypertension- the patient has significant hypertension and was \\non 5 antihypertensives on admission. Initially there was concern \\nthat with the initiation of dialysis he would require an \\nadjustment to these, however his blood pressures continued to \\nreamin mildly elevated at 140s-150s/90s-100s.  He had no \\nheadaches or vision changes.  \\nPPD was placed on ___ at 1730 on the right medial forearm\\n\\n#Gout- patient was experiencing a gout flare in his right foot \\non admission and had already been taking his steroids in a self \\ndictated taper.He had taken 40mg of prednisone the day prior to \\nadmission and this was felt to likely be the cause of his . He \\nrecieved a taper down to 20mg of prednisone on ___ with \\nimprovement in the pain.\\n\\n#Type II Diabetes- patient had elevated blood sugars during this \\nadmission. His home glipizide was held and he was on novolog \\nsliding scale.  His hyperglycemia was likely ___ a combination \\nof his steroid use and nonadherence to a diabetic diet, drinking \\nlarge amounts of\\n-he was discharged on glipizide 10mg (his home dose) and will \\ncontinue to check his blood sugars at home\\n\\nTransitional Issues:\\n-Patient will start outpatient dilayiss on a MWF schedule\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. benazepril *NF* 40 mg Oral daily \\n2. calcitriol *NF* 0.25 mcg Oral daily \\n3. Carvedilol 25 mg PO BID \\nhold for sbp<100 or hr<60 \\n4. Felodipine 10 mg PO DAILY \\nhold for sbp<100 or hr<60 \\n5. Furosemide 160 mg PO BID \\nhold for sbp<100 or hr<60 \\n6. GlipiZIDE 10 mg PO BID \\n7. HydrALAzine 150 mg PO BID \\nhold for sbp<100 or hr<60 \\n8. irbesartan *NF* 150 mg Oral daily \\nhold for sbp<100 or hr<60 \\n9. Potassium Chloride 40 mEq PO BID Duration: 24 Hours \\nHold for K > \\n10. PredniSONE 40 mg PO DAILY \\n11. Rosuvastatin Calcium 20 mg PO DAILY \\n12. Aspirin 81 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1. Aspirin 81 mg PO DAILY \\n2. benazepril *NF* 40 mg ORAL DAILY \\n3. Carvedilol 25 mg PO BID \\nhold for sbp<100 or hr<60 \\n4. Felodipine 10 mg PO DAILY \\nhold for sbp<100 or hr<60 \\n5. HydrALAzine 150 mg PO BID \\nhold for sbp<100 or hr<60 \\n6. irbesartan *NF* 150 mg Oral daily \\nhold for sbp<100 or hr<60 \\n7. Rosuvastatin Calcium 20 mg PO DAILY \\n8. Calcium Carbonate 500 mg PO TID W/MEALS \\n9. Nephrocaps 1 CAP PO DAILY \\nRX *B complex-vitamin C-folic acid [Nephrocaps] 1 mg 1 \\ncapsule(s) by mouth daily Disp #*30 Capsule Refills:*0\\n10. GlipiZIDE 10 mg PO BID \\n11. PredniSONE  MD to order daily dose PO DAILY \\n12. Acetaminophen 325-650 mg PO Q6H:PRN pain \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nESRD\\nDiabetes Type II\\nGout\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\nIt was a pleasure taking care of you while you were here at \\n___.\\nYou were admitted to the hospital to start dialysis which you \\nhad 3 sessions of and tolerated well.  You will continue to \\nreceive dialysis as an outpatient on a ___ schedule.  You were \\ntreated for a gout flare while you were here with a steroid \\ntaper. As some of your medications may need to be adjusted such \\nas your glipizide while you are getting dialysis it will be \\nimportant to discuss any changes needed with your outpatient \\nproviders.  \\n\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nibuprofen\\n \\n ___\\n \\nChief Complaint:\\nERCP\\n \\nMajor Surgical or Invasive Procedure:\\n \\nFindings: Esophagus: Limited exam of the esophagus was normal \\nStomach: J-shaped stomach \\nDuodenum: Limited exam of the duodenum was normal \\nMajor  : Normal major papilla \\nCannulation: Cannulation of the pancreatic duct was successful   superficial with a sphincterotome using a free-hand \\ntechnique. Contrast medium   injected resulting in partial \\nopacification.   A   by ___ pancreatic stent was placed \\nsuccessfully   a sphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\n  using a free-hand technique. Contrast medium was \\ninjected resulting in complete opacification.\\n \\nBiliary Tree/Biliary Cannulation: The common bile duct common \\nhepatic duct, right and left hepatic ducts, biliary radicles, \\ncystic duct, and gallbladder were filled with contrast and well \\nvisualized. The course and caliber of the structures were normal \\nwith no evidence of filling defects   in the distal bile \\nduct.  Two round stones ranging in size from 2 mm to 3 mm were \\nseen at   lower third of the common bile duct. A \\nsphincterotomy was performed in the 12 o'clock position using a \\nsphincterotome over an existing guidewire.   small stone as well \\nas sludge were extracted successfully using a Extraction \\nBalloon.   \\n  \\nImpression: Limited exam of the esophagus was normal. \\nJ-shaped stomach.  \\nLimited exam of the duodenum was normal.  \\nCannulation of the pancreatic duct was successful and superficial with a sphincterotome using a free-hand technique.   \\n\\nA 5cm by ___ pancreatic stent was placed successfully using a \\nsphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique.  \\nTwo round stones ranging in size from 2 mm to 3 mm were seen at \\nthe lower third of the common bile duct.  \\nOtherwise, the cholangiogram was normal. \\nA sphincterotomy was performed in the 12  'clock position using \\na sphincterotome over an existing guidewire. \\nA small stone as well as sludge were extracted successfully \\nusing an RX   Balloon.\\n \\nRecommendations: Admit   hospital for monitoring \\nNPO overnight with aggressive IV hydration with LR at 200 cc/hr \\nIf no abdominal pain in the morning, advance diet to clear \\nliquids and   advance as tolerated \\nRecommend interval cholecystectomy. \\nNo aspirin, Plavix, NSAIDS, Coumadin for 5 days. \\nContinue with antibiotics - Ciprofloxacin 500mg BID x 5 days. \\nRepeat ERCP in 2 weeks for pancreatic stent pull \\nFollow-up with Dr. ___ as previously scheduled. \\nFollow for response and complications. If any abdominal pain, \\nfever, jaundice, gastrointestinal bleeding please call ERCP \\nfellow on call ___\\n \\nAdditional notes: Procedure done by Dr ___ fellow. The \\nattending was present for the entire procedure. \\n\\n \\nHistory of   Illness:\\n  Admission Note Date of note: ___, time seen 6 pm\\n\\nPCP:  ___\\n\\nCC:  pancreatitis\\n\\nHPI: Mr. ___ is a ___ yo male with diabetes new atrial \\nfibrillation and hypertension, here for ERCP after recent \\nepisode of pancreatitis in ___.  At that time, he was \\nhospitalized at an outside hospital, and there was no clear \\ncause of his pancreatitis, which was attributed to a diabetes \\nmedication.  He then presented here for EUS in the end of ___ which showed gallbladder sludge, and a fatty pancreas.  He \\npresented today for ERCP with stent placement and \\nsphincterotomy.  Two gallstones were found, and   small stone \\nand sludge was extracted.  \\n\\nIn recovery, he received hydromorphone 0.5 mg X 2, as well as IV \\nfluids.  Indomethacin   not given due to an allergy.  At \\npresent, he   to complain of   mid abdominal pain, \\nwithout radiation.  He also complains of slight headache and \\ndizziness.\\n\\nHe has overall felt relatively poorly over the ___, since his \\ninitial diagnosis of pancreatitis in late ___.  He   had \\nepisodes of dizziness when he has abdominal pain, which usually \\ngoes away when he lies down for a period of time.  He had a   \\nin his right leg, which was evaluated with an ultrasound by his \\npcp and was not found to have a DVT.  He had palpitations early \\nthis ___, but now that he is back in sinus, these have gone \\naway.  He has lost 27 lbs this summer.  He gets spikes of \\nabdominal pain with dietary changes, and re-addition of fat into \\nhis diet.  He has been able to work for the most part.\\n\\nROS as above - otherwise, negative in 6 other systems.\\n\\n \\nPast Medical History:\\nHypertension\\nHyperlipidemia\\nAtrial fibrillation\\nType II diabetes mellitus\\nGERD\\nPancreatitis\\nGallstones\\n \\nSocial History:\\n___\\nFamily History:\\nNo family history of gallstones as far as he knows.\\n \\nPhysical Exam:\\n                                                     \\n\\nPhysical exam\\nafebrile, HR in ___, BP 158/41  97% RA\\nGen:  appears uncomfortable\\nHEENT:  EOMI.  No scleral icterus.  No conjunctival injection.   \\nMucous membranes moist.  \\nNeck:  Supple, no LAD, no JVP elevation.\\nLungs: CTA bilaterally, no wheezes, rales, rhonchi.  Normal \\nrespiratory effort.\\nCV:  bradycardic, regular, no murmurs\\nAbdomen:  soft, tender in Right mid abdomen, with no rebound or \\nguarding.  No hepatosplenomegaly appreciated, and no epigastric \\ntenderness.\\nExtremities:  warm and well perfused, no edema.  Area of \\ntenderness in right lateral calf, with muscle knot.\\nNeurological:  somnolent, but alert and oriented X 3, C face \\nsymmetric.  Following all commands, moving freely in bed.  \\nSkin:  No rashes or ulcers or jaundice.\\nPsychiatric:  Appropriate.\\nGU:  deferred.\\n\\n \\nPertinent Results:\\nRelevant data:\\nNa 136 K 4.6  Cl 103 CO2 24 BUN  24 cr 1.0     \\nALT: 25 AP: 74 Tbili: 0.5 AST: 29 Dbili: 0.1  ___: 100 Lip: 40   \\n  \\nwbc  6.1  Hgb 12.6  Hct 36.3  plts 188\\n___: 11.6  PTT: 31.7  INR: 1.1  \\n\\nERCP:\\nImpression: Limited exam of the esophagus was normal. \\nJ-shaped stomach.  \\nLimited exam of the duodenum was normal.  \\nCannulation of the pancreatic duct was successful and \\nsuperficial with a sphincterotome using a free-hand technique.   \\n\\nA 5cm by ___ pancreatic stent was placed successfully using a \\nsphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique.  \\nTwo round stones ranging in size from 2 mm to 3 mm were seen at \\nthe lower third of the common bile duct.  \\nOtherwise, the cholangiogram was normal. \\nA sphincterotomy was performed in the 12 o'clock position using \\na sphincterotome over an existing guidewire. \\nA small stone as well as sludge were extracted successfully \\nusing an RX Extraction Balloon.\\n\\n \\nBrief Hospital Course:\\n___ yo male here for ERCP after recent development of \\npancreatitis in ___.  He does have significant abdominal pain \\nafter the procedure, without rebound or guarding, hopefully only \\nrelated to post procedure pain and not post ERCP pancreatitis.  \\nHe is bradycardic, in normal sinus, possibly with too much sinus \\nblock on board in sinus after recent development of atrial \\nfibrillation.  This may be causing dizziness, but blood pressure \\nis preserved.  CHADS2 is 1 - but he was started on xarelto, \\ncurrently off, and on hold after procedure.  Initial episode of \\npancreatitis most likely related to gallstones, and will require \\ncholecystectomy after stent removed. \\n\\n##  Cholelithiasis/gallstone pancreatitis: ERCP tolerated well. \\nCannulation of pancreatic duct, sphincterotomy, successful \\npancreatic stent placement. 2 stones were seen in CBD. 1 stone \\nwas extracted. Tolerated procedure well, did not receive \\nindomethacin due to allergy. Xarelto stopped for 5d and started \\n5d course of ciprofloxacin. Was NPO overnight, tolerated clears \\nand advanced diet prior to discharge. \\n\\n##  Recent atrial fibrillation, with bradycardia: noted to have \\nasymptomatic sinus bradycardia to ___, with some improvement on \\ncessation of atenolol. Atenolol is therefore being held on \\ndischarge. Pt has had no episodes of AF or RVR since his \\npancreatitis episode. As above, Xarelto held for 5d. CHADS2 \\nscore of 1. \\n\\n##  type II diabetes mellitus: mildly hyperglycemic overnight \\noff home metformin/glyburide, but resuming on discharge. \\n\\n## Hypertension: as above, held atenolol. BP well controlled \\nwith home lisinopril. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Ferrous Sulfate 65 mg PO DAILY \\n2. FoLIC Acid 1 mg PO DAILY \\n3. Lisinopril 40 mg PO DAILY \\n4. Atenolol 50 mg PO DAILY \\n5. Simvastatin 10 mg PO QPM \\n6. GlyBURIDE 5 mg PO DAILY \\n7. MetFORMIN (Glucophage) 500 mg PO BID \\n8. Rivaroxaban 20 mg PO DAILY \\n9. Omeprazole 20 mg PO DAILY \\n10. Magnesium Oxide 400 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1. Lisinopril 40 mg PO DAILY \\n2. Omeprazole 20 mg PO DAILY \\n3. Ciprofloxacin HCl 500 mg PO Q12H \\nPlease complete 5d course to end evening of ___ \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*7 Tablet Refills:*0\\n4. Ferrous Sulfate 65 mg PO DAILY \\n5. FoLIC Acid 1 mg PO DAILY \\n6. GlyBURIDE 5 mg PO DAILY \\n7. Magnesium Oxide 400 mg PO DAILY \\n8. MetFORMIN (Glucophage) 500 mg PO BID \\n9. Simvastatin 10 mg PO QPM \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\ngallstones, stent placement, sphincterotomy, extraction of \\nsludge and stone\\n\\n \\nDischarge Condition:\\npleasant, NAD\\nmildly bradycardic, no mrg; JVP flat\\nCTAB\\nsntnd, NABS\\nwwp, neg edema\\nA&O grossly, moving all 4, no facial droop\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\nIt was a pleasure caring for you. You were admitted for \\nobservation after your endoscopic retrograde cholangiogram, \\nwhich you tolerated well. \\nOn discharge, please complete your course of antibiotics as \\nprescribed. We have stopped your atenolol given your slow heart \\nrates. We have also held your blood thinner for 5 days. Please \\nresume your blood thinner after that. \\n \\nFollowup Instructions:\\n___\", 'Sex M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint right leg weakness\\n \\nMajor Surgical or Invasive  :\\nNone\\n\\n \\nHistory of Present Illness:\\n___ male with h/o sciatica, afib on coumadin, gout, prostate \\ncancer presenting with with acute onset RLE weakness   \\n  to walk.  Two weeks ago, he had decreased RLE strenth \\ncausing him to trip during tennis.  He fell on his right hip.  4 \\ndays ago, he had pain and weakness in his right him He was \\nadmitted 2d ago to cardiology service for new onset     \\nrvr requiring cardioversion and coumadin.  He had no \\nintravascular interventions.  \\n.\\nHe complains of difficulty getting leg off bed   trouble \\nwalking   inability to raise right foot.\\n\\nIn   ED, initial VS:  97.5 88 101/65 26 98.  Exam showed R \\ngluteus hematoma, tracking.  Good hip flexion ___, decreased \\nplanter and knee strength.    his INR of 3.8, he got 10 mg Vit \\nK, FFP.  For pain, 4 mg morphine.  He had a WBC 27 treated with \\n1gm ceftriaxone.  A foley was placed with 700 cc UOP.  Neuro \\nwanted MRI spine to r/o epidural hematoma.  This was showed age \\nrelated changes but   essentially unchanged.  Ortho felt this \\nwas likely compression of sciatic nerve from     not \\nc/w compartment syndrome.  He got 1L IVF For his AFib: Dr. \\n___ cardiologist) saw in ED for ___  . Dr.   \\n___ changing to ___, but family did not want to Prior \\nto transfer, VS: 96 141/82 19 100/RA, Access: 1 PIV.\\n.\\nOn the floor, he felt well.  His family refused further studies, \\nsuch as the x-rays that were ordered.  He denied pain.\\n\\n \\nPast Medical History:\\n1. Sciatica for \"several years,\" unable to clarify further. \\nTypical pain is centered in R. knee   is worst upon waking.\\n2. Prostate CA, dx ___ ago, managed conservatively: saw ___\\nand observation only.\\n3. AFib with RVR diagnosed and treated 4 days ago at ___. \\nStarted on Coumadin with Lovenox bridge.\\n4. ? Gout given presence of allopurinol in his med list, but not\\n  by patient or in past notes\\n \\nSocial History ___\\nFamily History:\\nFather with MI at ___, later developed colon CA.  Mother died \\nsuddenly, cause unknown at ___ Brother with multi-vessel CABG \\nin his late ___ No known family members with stroke\\n \\nPhysical Exam:\\nDischarge PE:\\nTm=99.9=Tc, HR=70s-100s, BP=130s/50s-60s,  =12, POx=95% RA; \\nBMx1\\nGENERAL:  elderly male lying in bed in NAD, comfortable\\nHEENT:    sclera, dry MM, EOMI, PERRL, OP clear, neck \\nsupple\\nCARDIAC:  Tachycardic, regular rhythm, no m/r/g\\nLUNG:  CTAB\\nABDOMEN:  Soft, NT/ND, NABS\\nEXT:  Large ecchymosis and extensive associated swelling \\nextending from right lower back down to mid-thigh, no clubbing \\nor lower extremity edema, good capillary refill in bilateral \\nextremities with palpable DP pulses \\nNEURO:  A+Ox3, CN ___ intact, Sensation improved in right lower \\nleg, but continues to have sensation deficit around his right \\n  toe.  His right leg motor exam was significant for weak ___ ankle flexors, ___ ankle extensors,   hamstrings, ___ \\nquads,   ___ right iliopsoas.  He can only minimally wiggle \\nhis toes.  Motor strength and sensory is preserved in his left \\nleg.  He has absent reflexes bilaterally.\\n\\n \\nPertinent Results:\\n___ 08:15AM   ___ PTT-35.6*  \\n___ 08:15AM   NEUTS-89.4* LYMPHS-7.7* MONOS-2.7 EOS-0.1 \\nBASOS-0.1\\n___ 08:15AM   PLT COUNT-236\\n___ 08:15AM   WBC-27.1*# RBC-3.52*# HGB-10.4*# HCT-31.0*# \\nMCV-88 MCH-29.5 MCHC-33.5 RDW-15.2\\n___ 08:15AM   GLUCOSE-194* UREA N-37* CREAT-1.9* SODIUM-137 \\nPOTASSIUM-4.1 CHLORIDE-99 TOTAL CO2-21* ANION GAP-21*\\n___ 08:24AM   HGB-11.6* calcHCT-35\\n___ 09:38AM   LACTATE-4.1*\\n.\\n___ CXR:  \\nIMPRESSION: No evidence of acute cardiopulmonary process. \\n.\\n___ CT head w/o contrast: \\nIMPRESSION: No acute intracranial process.\\n.\\n___ MRI of T- and L- spine:\\nMPRESSION: \\n1. No   of hematoma within the thoracic or lumbar spine. \\n2. Severe degenerative changes of the lumbar spine, including \\nsevere spinal canal stenosis at L5/S1 level with impingement on \\nbilateral traversing S1 and the right exiting L5 nerve roots, \\nare stable since the ___ examination. \\n3. Multilevel degenerative changes of the thoracic spine, most \\nsevere at \\nT2-3, with impingement upon the exiting left T2 nerve root \\nimpingement and moderate spinal canal stenosis. \\n4. Status post C5-C7 fusion with posterior fixation hardware and \\nassociated post-surgical changes seen on STIR sequence, \\nincompletely imaged. \\n.\\n___ MRI of pelvis: \\nIMPRESSION: \\n1. Extensive intramuscular hematoma and hypertrophy of the right \\ngluteal \\nmuscles and right piriformis muscle, causing mass effect on the \\nright S1, S2, and S3 nerve roots. \\n2. Narrowed caliber of the right gluteal canal, causing mass \\neffect on the right sciatic nerve. \\n3. Well-circumscribed, benign-appearing left iliac bone lesion, \\nwith imaging features that are most likely compatible with \\nhemangioma. \\n4. Moderate to severe endplate degenerative changes at L4/L5 and \\nL5/S1. \\n.\\n___ Hip X-ray:  \\nIMPRESSION: There is no evidence of an acute bony injury. \\n.\\n___ blood culture: Negative to date\\n \\nBrief Hospital Course:\\nThis is an ___ year old male with PMH of sciatica, prostate CA, \\nand recently diagnosed atrial fibrillation s/p recent \\nhospitalization ___ for cardioversion requiring initiation \\nof Lovenox/Coumadin for stroke prevention presenting with \\nmassive hematoma, RLE weakness, and urinary retention.\\n.\\n#. Hematoma:  The patient developed a large hematoma extending \\nfrom his right flank to his right mid-thigh in the setting of a \\nrecent mechanical fall and initiation of anticoagulation with \\nLovenox and Coumadin with an INR of 3.8 on admission.  His INR \\nwas successfully reversed with vitamin K and FFP in the ED.  His \\nhematocrit fell significantly from a baseline of 46 to 22.8 the \\nAM of ___ and he required 3 units of pRBC transfusion to bring \\nhis hematocrit to around 30 at time of discharge.  No CTA was \\nneeded to rule out extravasation as it appeared that his \\nbleeding stopped after reversal of his INR as evidenced by his \\nappropriate hematocrit response to blood transfusions. He also \\nhad compressive neuropathy from the mass effect of the hematoma \\ncausing limited right lower extremity movement and initial \\nconcern for compartment syndrome.  The mass effect of the \\nhematoma was also likely causing urinary retention which \\nrequired the placement of a Foley catheter.  The urinary \\nretention quickly resolved as the hematoma resorbed and he had a \\nsuccessful trial of void prior to discharge.  Given the lower \\nextremity weakness and urinary retention, spinal cord \\ncompression was ruled out by an MRI on admission.  Orthopedics, \\nvascular, and neurology were all consulted to help manage his \\nacute presentation due to concern for compartment syndrome, \\nconcern for active extravasation and falling hematocrit, and \\nweakness; respectively.  It was determined that the patient did \\nnot have compartment syndrome, so there was no need for surgical \\nintervention.  His physical exam was monitored closely and he \\nnever developed a cold extremity or lost peripheral pulses.  His \\nmotor strength and sensory of his right lower extremity improved \\ndramatically throughout his admission and are documented in the \\nPE section of this document.  With the help of ___, the patient \\nwas able to ambulate with a walker.  An AFO brace was provided \\nfor his right foot given the foot drop he developed as a result \\nof the compressive neuropathy from the hematoma.  Oxycodone was \\nprescribed as needed and worked well for pain control secondary \\nto swelling and compression of his sciatic nerve.  He was \\nadvised not to drive given his new foot drop and use of opiates \\nthat will cause drowsiness. \\n.\\n#. Atrial fibrillation: The patient was diagnosed with new onset \\natrial fibrillation on ___ and was successfully cardioverted.  \\nHe remained in normal sinus rhythm on telemetry throughout his \\nadmission.  After his last hospitalization for cardioversion, he \\nwas discharged on Lovenox/Coumadin and presented to the ED with \\nan INR of 3.8 and evidence of a large hematoma on exam.  \\nCardiology/EP was consulted in the ED to guide further \\nmanagement and recommended starting amiodarone 200mg TID for 1 \\nweek, 200mg BID for 1 week, and then continue on 200mg daily in \\nan attempt to prevent recurrence of atrial fibrillation in the \\nacute period as he is at high risk given the significant amount \\nof stress due to the bleed, pain, and anemia.  It was also \\nagreed that all anticoagulation needed to be discontinued for \\nthe time being as his risk of continued bleeding currently \\noutweighed the preventive stroke benefits of anticoagulation.  \\nFortunately, it was deemed that the left atrial appendage \\nvelocity was vigorous on ECHO and there was no spontaneous ECHO \\ncontrast and no significant aortic thrombus making his risk of \\nstroke reduced, but not non-existent. Unfortunately, he \\ndeveloped a diffuse, pruritic skin rash on his back and chest a \\nfew days after starting amiodarone which was attributed to the \\ndrug.  Therefore, amiodarone was discontinued prior to discharge \\nand no other anti-arrythmics or beta blockers were started.  He \\nwill follow up with Dr. ___ as an outpatient in ___ clinic. \\n \\n.\\n#. CODE: Full code this admission, but DNR/DNI per last \\ndischarge summary\\n \\nMedications on Admission:\\n1. Lovenox ___ mg/mL Syringe Sig: One (1)  Subcutaneous once a \\nday for 3 days.\\n2. Allopurinol ___ mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \\n\\n3. Warfarin 2.5 mg Tablet Sig: Two (2) Tablet PO once a day.\\n4. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO every six (6) \\nhours as needed for pain: do not exceed 4 gram in 24 hours.  \\n5. Multivitamin Tablet Sig: One (1) Tablet PO once a day.  \\n6. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr PO \\nonce a day.\\n \\nDischarge Medications:\\n1. Allopurinol ___ mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \\n\\n2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \\nhours) as needed for pain/fever.  \\n3. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n4. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every ___ hours \\nas needed for pain.\\nDisp:*20 Tablet(s)* Refills:*0*\\n5. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*0*\\n6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as \\nneeded for constipation.\\nDisp:*30 Tablet(s)* Refills:*0*\\n7. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \\nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \\nconstipation.\\nDisp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*0*\\n8. Sarna Anti-Itch 0.5-0.5 % Lotion Sig: Apply  Topical four \\ntimes a day as needed for itching.\\nDisp:*1 bottle* Refills:*0*\\n9. Benadryl Allergy 12.5 mg/5 mL Liquid Sig: Five (5) mL PO \\nevery six (6) hours as needed for itching.\\nDisp:*1 bottle* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary Diagnoses:\\n-Hematoma\\n-Compressive neuropathy\\n-Urinary retention\\n.\\nSecondary diagnosis:\\n-Atrial fibrillation s/p successful cardioversion, now in sinus \\nrhythm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nYou were admitted to ___ \\nfurther evaluation of right leg weakness and urinary retention.  \\nYou were found to have a large collection of blood called a \\nhematoma that extended from your right flank all the way down to \\nyour right thigh that was compressing the nerves which \\ncontrolled your right leg and bladder.  The hematoma was likely \\nas a result of your fall in combination with the blood thinning \\ndrugs called Lovenox and Coumadin that you were prescribed to \\nprevent a stroke given your recent atrial fibrillation.  You had \\nsignificant bleeding into this hematoma and actually lost half \\nof your blood stores.  You required 4 units of blood \\ntransfusions to restore your blood to a safe level.  You also \\nrequired a urinary catheter to drain your bladder until you \\nregained bladder function.  You will be discharged on opiates \\nfor pain control and should not drive or operate heavy machinery \\nwhile on these drugs.  You should not drive until your right \\nsided foot drop improves.  You were initially started on \\namiodarone to control your heart rate, but developed a skin rash \\nreaction and it was stopped.\\n.\\nThe following changes have been made to your home medication \\nregimen:\\n- You should stop taking Lovenox and Coumadin\\n- You should take oxycodone as needed for the pain\\n- You should take docusate, senna, and bisacodyl while on \\noxycodone to prevent constipation   \\n- You should use Sarna lotion as needed for your itchy rash and \\nyou can use Benadryl 12.5 mg as needed for itch that does not \\nrespond to the lotion.\\n \\nFollowup Instructions:\\n___', \"Sex:   M Service: MEDICINE Allergies: \\nNo Known Allergies / Adverse Drug  \\n \\n ___.\\n \\nChief Complaint:\\nHypokalemia\\n \\n  Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ hx EtOH  , on transplant list, DM2,   ___ \\nhypokalemia to 2.4 from ___ clinic with Dr. ___. His \\nESLD has been complicated by encephalopathy, jaundice and edema. \\nHe was previously maintained on aldactone/lasix, however his \\naldactone was d/c'  ___ and was started on metolazone 1 month \\nprior. After starting metolazone he developed hypokalemia to \\n1.9, after which he was started on K supplementation.  \\nPresented   to transplant clinic for routine  -up found to have K 2.1 with ___ Cr 2.2 from baseline ~1.5. Took \\nMetolazone w/ kalor this AM. His hepatologist today discontinued \\nmetolazone and restarted aldactone.  \\nROS notable for palpitations which he states are intermittent \\nand chronic. No f/c/n/v/d, no abd pain, urinary sx. Returned \\nfrom ___ this weekend, swelling worse in legs from walking. \\nLabs: BUN 55, K 2.1, HCO3 33 c/w contraction alkalosis likely \\n___ diuretic use.  \\nIn the ED, initial vs were 98.8 71 139/69 18 100%. EKG was \\nreportedly negative, although upon review on the floor it shows \\nU-waves. The patient was not given crystalloid/colloid \\nresuscitation or potassium repletion while in the ED.  \\nOn arrival to the floor, patient reports feeling well with \\nminimal complaints.  \\n\\n \\nPast Medical History:\\n- EtOH cirrhosis; complicated by hepatic encephalopathy, \\nesophageal varices (no EGD on record, only per patient report), \\nand jaundice  \\n- Aplastic anemia (per  , diagnosed in ___ several years \\nago) \\n- Insulin-dependent diabetes mellitus  \\n- Chronic kidney disease  \\n- Hypertension  \\n- Breast surgery ___ - ___ with resultant \\nhematoma evacuation x 2\\n \\nSocial History:\\n___\\nFamily History:\\nFather died of alcohol cirrhosis. Extended family members had \\nCVAs, age ___. \\n \\nPhysical Exam:\\nAdmission Exam:\\nVS 98.2 138/73 86 20 98%RA  \\nGEN Alert, oriented, no acute distress  \\nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \\nNECK  , no JVD, no LAD  \\nPULM Good aeration, CTAB no wheezes, rales, ronchi  \\nCV RRR normal S1/S2, no mrg  \\nABD soft NT ND normoactive bowel sounds, +hepatomegaly with \\nliver edge ~3cm below costal margin, nontender. No shifting \\ndullness.  \\nEXT WWP 2+ pulses palpable bilaterally, 2+ pedal edema.  \\nNEURO CNs2-12 intact, motor function grossly normal. -asterixis  \\n\\nSKIN no ulcers or lesions  \\n\\nDischarge Exam:\\n98.3 116/58 64 20 100\\nGen No acute distress. Well nourished\\nHEENT: EOMI. Icteric sclera. NCAT\\nNeck: No JVD\\nCV: RRR. ___ holosystolic murmur. NS1&S2\\nResp:  . Good air flow\\nExt: No c/c/e\\n\\n \\nPertinent Results:\\nAdmission Labs:\\n___ 08 55AM BLOOD WBC-9.1# RBC-3.90*# Hgb-13.4*# Hct-39 1*# \\nMCV-100* MCH-34.3* MCHC-34.3 RDW-14.6 Plt Ct-94*\\n___ 08:55AM BLOOD ___\\n___ 08:55AM BLOOD UreaN-51* Creat-2.2* Na-135 K-2.4* Cl-91* \\nHCO3-32 AnGap-14\\n___ 08:55AM BLOOD  -57* AST-94* AlkPhos-161* TotBili-6.2*\\n___ 08:55AM BLOOD Albumin-4.1 Calcium-9.7 Phos-3.4 Mg-2.1\\n.\\nDischarge Labs:\\n___ 06:55AM BLOOD WBC-4.0 RBC-2.85* Hgb-10.0* Hct-28.9* \\nMCV-101* MCH-35.0* MCHC-34.5 RDW-14.6 Plt Ct-46*\\n___ 06:55AM BLOOD ___ PTT-38.7* ___\\n___ 06:20AM BLOOD Creat-1.2 Na-141 K-3.5 Cl-104 ___ 06:55AM BLOOD ALT-36 AST-62* AlkPhos-90 TotBili-6.7*\\n___ 06:55AM BLOOD Calcium-9.3 Phos-2.4* Mg-2.2\\n.\\nImaging:\\n___: Sinus rhythm. The Q-T interval is prolonged. \\nNon-specific ST-T wave changes. Compared to the previous tracing \\nof ___ the Q-T interval is longer. \\n___: Artifact is present. Sinus rhythm. The Q-T interval is \\nprolonged at 480 milliseconds. Non-specific ST-T wave changes. \\nCompared to the previous tracing of ___ there is no \\ndiagnostic change. \\n\\n \\nBrief Hospital Course:\\n___ yo M with h/o EtOH cirrhosis c/b hepatic encephalopathy that \\npresented to the ED from clinic with a K of 2.1. \\n.\\nActive Issues:\\n#Hypokalemia: Patient was taking thiazide and loop diuretic, \\nincluding metolazone. U-waves present on EKG. Patient reported \\nfatigue and muscle cramps for several weeks prior to admission. \\nDiuretics stopped, and K was repleted. Lasix and spironolactone \\nrestarted 24 hours later. Patient was stable on this regimen and \\nd/c'ed home with K of 3.5. U-waves resolved on EKG at time of \\ndischarge.\\n.\\n#AOCKD: Cr on admission 2.2 likely ___ overdiuresis. Responded \\nwell to IV albumin, and returned to baseline 1.2 on discharge.\\n.\\nChronic Issues\\n.\\n#EtOH Cirrhosis: Pt is on liver transplant list with MELD of 30 \\nin presentation. He has a history of hepatic encephalopathy, so \\nlactulose and rifaximin were continued in-house. No ascites on \\npresentation and no history of paracentesis. History of portal \\ngastropathy on EGD, so nadolol continued. Will return for \\ntransplant work-up.\\n.\\n#Thrombocytopenia: Chronic. S/p BM biopsy on ___ which showed \\nhypocellular marrow with mild dyspoesis of the erythroid and \\nmegakaryocytic lineages. This was felt secondary to chronic \\nconditions rather than MDS.\\n.\\n#IDDM: Well controlled in-house, and d/c'ed on home dose of \\nlantus and SSI\\n.\\nTransitional Issues:\\n#Will need PFTs, ECHO, routine labs for transplant work-up\\n#Will need lytes checked at outpt follow-up after recent med \\nchanges\\n \\nMedications on Admission:\\nPreadmission medications listed are correct and complete.  \\nInformation was obtained from PatientwebOMR.\\n1. Lactulose 30 mL PO QID \\n2. Nadolol 20 mg PO DAILY \\n3. MetFORMIN (Glucophage) 500 mg PO BID \\n4. Furosemide 40 mg PO BID \\n5. Spironolactone 100 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Thiamine 100 mg PO DAILY \\n8. Ascorbic Acid ___ mg PO DAILY \\n9. Glargine 60 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n\\n \\nDischarge Medications:\\n1. Ascorbic Acid ___ mg PO DAILY \\n2. Furosemide 40 mg PO DAILY \\n3. Glargine 60 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n4. Lactulose 30 mL PO QID \\n5. Nadolol 20 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Spironolactone 100 mg PO DAILY \\n8. Thiamine 100 mg PO DAILY \\n9. MetFORMIN (Glucophage) 500 mg PO BID \\n10. Outpatient Lab Work\\nPlease obtain Basic Metabolic Profile (electrolytes, BUN, \\ncreatinine) and fax results to :\\n\\n ___. \\nLocation: ___ MEDICAL GROUP \\nAddress: ___, ___ \\nPhone: ___ \\nFax: ___ \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary Diagnosis:\\nHypokalemia\\nAcute kidney injury secondary to pre-renal azotemia\\n\\nSecondary Diagnosis:\\nAlcoholic cirrhosis\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nIt was a pleasure caring for you at ___. You were admitted \\nbecause you had a low potassium level. This was likely due to \\none of your medications, metolazone. The low potassium was the \\nlikely cause of your weakness and muscle cramping prior to being \\nadmitted. You were given potassium through your veins and by \\nmouth, and your metolazone was discontinued. At discharge your \\npotassium level was within normal limits. \\n\\nYour diuretics to treat your cirrhosis were initially held on \\nadmission. Both furosemide and spironolactone were started after \\nwe corrected your potassium. Please continue taking these \\nmedications at home. \\n\\nYour kidney function was slightly abnormal on admission. We \\nbelieve that is because you did not have enough fluid going to \\nthem. After giving you albumin, your kidney function returned to \\nnormal. Please remember to drink plenty of fluids at discharge, \\nas your diuretics have a tendency to dry you out.\\n\\nPlease obtain blood work to follow up your electrolytes and \\nrenal function on your current medication regimen within 5 days \\nof discharge.\\n\\n \\nFollowup Instructions:\\n___\", \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPercocet / Codeine\\n \\n ___.\\n \\nChief Complaint:\\nabdominal pain\\n \\nMajor Surgical or Invasive Procedure:\\n___ ERCP\\n___ Percutaneous placement of biliary drain\\n___ Biliary brushings \\n\\n \\nHistory of Present Illness ___ man with stage IIB pancreatic adenocarcinoma s/  \\nWhipple and gemcitabine who presents with   upper quadrant \\nabdominal pain and increasing LFTs. For the past several days he \\nhas intermittent, dull RUQ pain that is 2 out of 10 on the pain scale, lasting 30 minutes to a few hours, without any apparent \\nalleviating or precipitating factor. No nausea,   diarrhea, constipation. No fever or chill. \\n.\\nHis LFTs have been   since   the past  : AST 34 -> 330 \\n(from ___ to ___, ALT 59 -> 369, AP 401 -> 2957, total \\nbili     -> 3.0 (direct bili 2.0). He had an ultrasound on \\n___ that showed intrahepatic ductal dilation. Admitted for \\nfurther management.\\n.\\nReview of Systems:  \\n(+) Per HPI  \\n(-) Denies  , chills, night sweats   weight loss or \\ngain. Denies blurry vision, diplopia, loss of vision photophobia. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denies   pain or tightness,  , lower \\nextremity edema. Denies cough, shortness of breath, or wheezes. \\nDenies nausea, vomiting, diarrhea, constipation, melena, \\nhematemesis, hematochezia. Denies   bleeding, bruising, \\nlymphadenopathy.   dysuria, stool or urine incontinence. \\nDenies   or myalgias. Denies rashes or skin breakdown. \\nNo numbness/tingling in extremities. All other systems negative.\\n \\nPast Medical History:\\nONCOLOGIC HISTORY:\\n# T3N1M0, stage IIB pancreatic adenocarcinoma \\n- developed painless jaundice in the end of ___.\\n- underwent ERCP on ___, which revealed malignant-appearing \\nstricture in the lower common bile duct and brushings were \\nnegative for malignancy. A CT angiogram was performed and showed \\na possible pancreatic tumor in the head of the pancreas \\n- pancreatic FNA performed on ___ revealed atypical cells.  \\n- underwent a Whipple resection with SMV reconstruction on \\n___, and his postoperative course had been complicated by \\ndelayed gastric emptying. Pathology revealed a pT3 1.9 cm poorly \\ndifferentiated ductal adenocarcinoma, which involved ___ lymph \\nnodes involved. In addition, the distal pancreatic margin was involved and there was disease in the SMV. \\n- discharged home on ___ but then developed nausea, vomiting, \\nand likely aspiration leading to pneumonia and was hospitalized \\non ___.  \\n- commenced single agent gemcitabine 1000 mg/m2 weekly 3 of 4 \\nweeks on ___ receiving one cycle in advance of radiation \\ntherapy with concomitant capecitabine (1000 mg  ) which \\nfinished on ___.\\n.\\nOTHER MEDICAL HISTORY:\\nHypertension\\nDiet-controlled diabetes\\n \\nSocial History:\\n___\\nFamily History:\\nFather had IDDM and HTN, brother with DM, HTN \\n \\nPhysical Exam:\\nVS: T 97.1, BP 130/80, HR 75, RR 18, 100%RA\\nGEN: Middle-aged man in NAD, awake, alert  \\nHEENT: EOMI, sclera anicteric, conjunctivae clear, OP moist and \\nwithout lesion\\nNECK: Supple, no JVD  \\nCV: Reg rate, normal S1, S2. No m/r/g.   \\nCHEST: Resp unlabored, no accessory muscle use CTAB, no \\ncrackles, wheezes or rhonchi.  \\nABD: Soft, NT, negative ___, ND, no HSM, bowel sounds \\npresent\\nMSK: normal muscle tone and bulk\\nEXT: No c/c/e, 2+ ___ bilaterally\\nSKIN: No rash, warm skin\\nPSYCH: appropriate, pleasant\\n \\nPertinent Results:\\n___ 11 18AM   UREA N-10 CREAT-0.7\\n___ 11:18AM   ALT(SGPT)-369* AST(SGOT)-330* ALK PHOS-2957* \\nTOT BILI-3.0* DIR BILI-2.0* INDIR BIL-1.0\\n___ 11:18AM   ALBUMIN-4 1\\n___ 11:18AM   WBC-5.1 RBC-3.49* HGB-10.5* HCT-32.5* MCV-93 \\nMCH-30.1 MCHC-32.4 RDW-15.6*\\n___ 11:18AM   NEUTS-77.2* LYMPHS-12.8*  -7.5 EOS-1.4 \\nBASOS-1.1\\n___ 11:18AM   PLT COUNT-446*#\\n.\\nIMAGING:\\n___ RIGHT UPPER QUADRANT ULTRASOUND: Evaluation of the left \\nlobe of   liver is limited due to overlying bowel gas in the \\nmidline. The remainder of the liver shows no focal hepatic mass. \\nThere is mild-to-moderate intrahepatic biliary ductal \\ndilatation, consistent with the history of prior Whipple. Color flow images of the main portal vein show normal hepatopetal \\nflow. Though full doppler examination was not completed, the \\nanterior right portal vein remains thrombosed (as per history) \\non color flow imaging. The common bile duct measures 6 mm at the \\nlevel of the hepatic artery. The patient is status post \\ncholecystectomy. The pancreas is not well visualized.   \\nIMPRESSION:   \\n1. Normal hepatic echotexture without definite focal lesion, \\nthough limited evaluation of the left lobe of the liver due to \\noverlying bowel gas.\\n.   \\n2. Mild-to-moderate intrahepatic biliary ductal dilatation with \\nnormal CBD caliber measuring 6 mm.\\n.  \\n3. Patent main portal vein with persistent thrombosis of the \\nanterior right portal vein on color flow imaging.  \\n.\\n___ MRCP:IMPRESSION: \\n1. Near occlusion of a narrowed main portal vein from mostly \\nchronic \\nappearing thrombus extending from the confluence to the \\nbifurcation, with thrombus that may minimally extend into the \\nright portal vein, new since the ___. Chronic \\nthrombosis of the right anterior portal vein with expected \\nparenchymal evolution of mild scarring.\\n. \\n2. Mild increase in the intra- and extra-hepatic bile ducts, \\nwithout evidence of an obstructing mass at the hepaticojejunal \\nanastomosis, likely reflecting an early stenosis at the site of \\nanastomosis, likely secondary to radiation/surgical changes. No \\nconcerning hepatic lesions. An arterially enhancing hepatic \\nlesion in segment IVb, likely represents active fibrosis.\\n.  \\n3. Extensive progressively enhancing soft tissue extending \\nbetween \\npancreaticojejunal and hepaticojejunal anastomosis, in the porta \\nhepatis and around the interposed jejunostomy loop, likely \\nrepresents post-radiation fibrosis/inflammationintermixed tumor \\ninfiltration cannot be excluded. \\n.\\n4. Diffuse abnormality of the pancreatic parenchyma has \\nprogressed and likely represents chronic pancreatitis and \\nradiation change.\\n.  \\n5. Single rim-enhancing pre-aortic lymph node is concerning for \\npossible metastatic disease, and needs attention on followup \\nimaging.  \\n\\n \\nBrief Hospital Course:\\n___ man with stage IIB pancreatic adenocarcinoma s/p \\nWhipple and adjuvant Gemcitabine followed by chemo(xeloda)/XRT \\nand subsequent additional gemcitabine for a positive surgical \\nmargin and involved LN's who presented with mild right upper \\nquadrant abdominal pain and rapidly rising LFTs without fever. \\nHis most recent chemotherapy was cycle 4 Gemcitabine Day \\n___.\\n.\\n# Elevated LFTs/RUQ pain: An ultrasound was perfomed on \\nadmission and showed ductal dilatation. The patient was admitted \\nfor further work up and treated with prn pain medication. An \\nMRCP was performed on ___ and demonstrated extension of \\nportal vein thrombosis and increase in the intra- and \\nextra-hepatic bile ducts, without evidence of an obstructing \\nmass at the hepaticojejunal anastomosis with the appearance of \\nstenosis rather than disease recurrence. There was enhancing \\nsoft tissue extending between pancreaticojejunal and \\nhepaticojejunal anastomosis, in the porta hepatis and around the \\ninterposed jejunostomy loop, thought to be post-radiation \\nfibrosis, but recurrence could not be ruled out. In addition \\nthere was a suspicious preaortic lypmh node. An ERCP was \\nattempted on ___ but failed. On ___ a successful \\npercutaneous biliary drainage was placed by interventional \\nradiology. The patient's LFT's subsequently decreased and pain \\nwas also relieved. On ___ biliary brushings were done via the \\nexisting biliary tube by ___ for diagnosis of the cause of \\nobstruction prior to the placement of an internal metal stent. \\nPost this procedure pt developed a temp of 100.4 and was started \\non unasyn.Blood cultures were obtained and remained sterile. Pt \\nto continue a course of cipro and flagyl at home fo ra \\ncompletionof 7 days antibiotics.Pt will be contacted by ___ for \\nplacement of  metal stent after results of cytology. \\n.\\n# Diet controlled diabetes: The patient has a history of \\ndiabetes that is diet controlled at home. However, he was \\nmarkedly hyperglycemic throughout this hospital admission and \\nmanaged with an insulin sliding scale. HBA1C was also elevated \\nat 9.2. The ___ service was consulted and recommended to \\nstart glipizide 2.5 mg po bid as patient was very reluctant to \\nstart insulin. Pt will likely need an additional oral \\nhypoglycemic medication ( metformin) and he will follow with his \\nPCP.\\n.\\n# Hypertension: The patient has a history of hypertension, but \\nwas not taking antihypertensive medications on his admission and \\nwas not noted to be hypertensive during his hospitalization.\\n.\\n#Urine fungus: Pt had a urine culture obtained because of fever \\npost procedure, as described above. Urine was positive for \\nfungus. As he was asymptomatic he was not treated.Pt to have a \\nrepeat urine culture as an outpatinet and if has persistent \\nfungus in his urine, given his diabetes, should be treated.\\n\\n \\nMedications on Admission:\\nlorazepam 0.5 mg q4-6hr prn nausea\\nondansetron 4 mg tid prn nausea\\nascorbic acid ___ mg q12h\\naspirin 325 mg daily\\ncalcium carbonate\\n\\n \\nDischarge Medications:\\n1. glipizide 5 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day): \\nhold if you are not eating/vomiting.\\nDisp:*30 Tablet(s)* Refills:*0*\\n2. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 3 \\ndays.\\nDisp:*6 Tablet(s)* Refills:*0*\\n3. metronidazole 500 mg Tablet Sig: One (1) Tablet PO three \\ntimes a day for 3 days.\\nDisp:*9 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nBiliary obstruction\\nElevated LFTs\\nDiabetes\\nAsymptomatic Candiduria \\nHypertension\\nh/o renal lithiasis\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nYou were admitted with liver (biliary) blockage and increased \\nliver function tests. An ERCP was unsuccessful, but the \\ninterventional radiolgy team was able to place a bile drain \\nthrough your skin and into your liver ducts to relieve the \\nblockage. You also had brushings done by ___ that were sent for \\ncytology studies to determine the cause of the obstruction. You \\ndeveloped fever after the brushings, blood and urine cultures \\nwere obtained and you were started on IV antibiotics.You should \\ncontinue oral antibiotics at home. While you were in the \\nhospital, your blood sugars were quite elevated and you required \\ninsulin shots to manage them.The ___ diabetes service was \\nconsulted and recommeded to start glipizide for now , however,  \\nyou may need to start metformin as well and in the future,you \\nmay need to start insulin.You should continue to check blood \\nsugars at home.\\nNew medications:\\n1. Ciprofloxacin 500 mg po bid x 3 days\\n2. Metronidazole 500 mg po tid x 3 days\\n3. glipizide 2.5 mg po bid\\n \\n \\nFollowup Instructions:\\n___\", \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nAdhesive\\n \\n ___.\\n \\nChief Complaint:\\nSeizure\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present  :\\n___ woman with melanoma with brain mets s/p chemo, XRT, \\nsurgical resection, immunotherapy presents with likely seizure The patient was at home,   her   s teeth, when   \\nhusband noticed that patient had about 30 seconds of garbled \\nspeech, staring into space,   subsequent confusion. She reports no symptom before the episode. No urine   stool \\nincontinence. She has had 2 similar seizures with   \\nspeech difficulty   the past 6 months.   reports   \\ncompliant with her lamotrigine. No fevers,  , ___ trauma, \\nlocalized weakness.\\n.\\nIn the ED, T 98.6, HR 60   117/69, RR 16, 100%RA. Neuro exam \\nwas nonfocal. ___ CT revealed   extensive melanoma \\nmetastasis, with larger, layering hemorrhage in a metastatic \\nlesion centered in the left parietal lobe, with interval \\ndilation of the temporal horns   was aware Neuro-onc \\nadvised admission to OMED for further management.\\n\\n \\nPast Medical History:\\nONCOLOGIC HISTORY:\\n# Metastatic melanoma:\\n  (1) completed whole brain cranial   on ___ at\\n___,\\n  (2) s/p 1 cycle of temozolomide at ___ schedule at ___ \\n___ 3)  /p craniotomy by ___ on ___ for removal  \\nright frontal brain metastasis, and\\n  (4) s/p Cyberknife radiosurgery to 4 metastases on ___ \\nand\\n___: 2,000 cGy to left superior metastasis, 1,600 cGy to\\nright frontal resection cavity, 1,800 cGy to right high parietal\\nmetastasis, and 2,200 cGy to left temporal metastasis, \\n  (5) s/p   radiosurgery to a right posterior temporal\\nlobe metastasis on ___ to 2,200 cGy, \\n  (6) received temozolomide at a dose of 150 mg/m2/day x 5 days\\nfrom ___ to ___, \\n  (7) started CTLA-4/ipilimumab compassionate use from ___ \\nto ___, \\n  (8) s/p resection of a right deep jugular metastasis on \\n___ ___, M.D.,\\n  (9) s/p Cyberknife to right upper lung metastasis to 4500 cGy\\n(1500 cGy x 3 fractions) from ___ to ___, and\\nCyberknife to   lower lung metastasis to 4500 cGy (1500 cGy x\\n3 ___ to ___,\\n  (10) s/p Cyberknife radiosurgery on ___ to left parietal \\n(to 2200 cGy), left thalamic to ___ cGy), and right frontal\\nmetastases, and \\n  (11) s/p Cyberknife radiiosurgery on ___ to rt \\ncerebellar, lt occipital and lt frontal metastases, all to\\n2200 cGy at 79% isodose line.\\n  (12) status post Ommaya reservoir placement on ___ ___\\n  (___) started ipilimumab (CTLA-4) on ___.\\n.\\nOTHER MEDICAL HISTORY:\\nHand surgery in ___  \\nC-section in ___  \\nBreast implants in ___  \\nDepression\\n \\nSocial History:\\n___\\nFamily History:\\nNon-contributory\\n \\nPhysical Exam:\\nOn admission:\\nGen: middle-aged woman in no acute distress\\nHEENT: EOMI, PERRL, conjunctivae clear, sclerae anicteric, OP \\nwithout lesion\\nNeck: supple\\nLungs: CTAB\\nCV: no JVD, regular rhythm, normal rate, normal S1/S2, no m/r/g\\nAbd: soft, NT, ND BS presents\\nExt: no c/c/e\\nNeuro: awake, oriented x 3, CNs II-XII grossly intact, ___ \\nstrength throughout\\n\\nOn discharge:\\nTm/Tc: 98.3/98.0  BP: 108/62 (108- /62-72 P: 64 (59-71)  R: \\n18  Sat: 99%RA\\nI/O: ___\\nGen: middle-aged woman in no acute distress, AAOx3  \\nHEENT: EOMI, PERRL, conjunctivae clear, sclerae anicteric, MMM, \\nOP without lesions  \\nNeck supple, no cervical or supraclavicular LAD\\nLungs: CTAB, no  /r/r audible  \\nCV: RRR, normal S1/S2, no m/r/g audible\\nAbd: soft, NTND, BS normoactive, no hepatosplenomegaly, no \\nrebound tenderness or guarding\\nExt: WWP, no c/c/e  \\nNeuro: awake, oriented x 3, CNs II-XII   intact, ___ \\nstrength throughout all extremities, 2+ reflexes in all \\nextremities \\n \\nPertinent Results:\\n___  :25PM   GLUCOSE-100 UREA N-  CREAT-0.7 SODIUM-143 \\nPOTASSIUM-3.6 CHLORIDE-106 TOTAL CO2-28 ANION GAP-13\\n___ 09:25PM    -4.6 RBC-3.40* HGB-11.4* HCT-32.2* MCV-95 \\nMCH-33.6* MCHC-35.4* RDW-13.8\\n___ 09:25PM   NEUTS-54.5 ___ MONOS-7.7 EOS-4.5* \\nBASOS-0.9\\n___ 09:25PM   PLT COUNT-225\\n___  :25PM   ___ PTT-28.0 ___\\n.\\nIMAGING:\\n# ___ CT ___:\\n1. Known innumerable brain metastases are more fully appreciated \\non previous MRI examinations. Interval increase in size of the \\npredominantly cystic lesion centered in the left parietal lobe, \\nnow with an increased layering high attenuation component most \\ncompatible with increase in hemorrhage. Otherwise, no new large \\nmass lesions are appreciated. \\n2. Right frontal approach ventriculostomy catheter is in stable \\nposition with tip terminating in the third ventricle with stable \\nconfiguration and size of the lateral ventricles; however, there \\nhas been apparent interval increase in size of the right greater \\nthan left temporal ventricular horns. \\n3. Stable extensive post-radiation and post-surgical change.\\n.\\nMR ___ ___:\\nIMPRESSION: \\n1. Overall, progression of metastatic disease with new lesion \\nseen within the right frontal lobe and increase in size of \\nmultiple other lesions as described above. Some metastatic \\nlesions have decreased in size or disappeared. \\n2. Diffuse white matter FLAIR hyperintensity, stable, consistent \\nwith \\nradiation related changes and post-surgical changes. \\n.\\nCT Chest/Abd/Pelvis ___:\\nIMPRESSION: \\n1. Post-radiation changes in the left lower lung and right \\nperihilar lung. \\n2. No evidence of new metastases. \\n.\\n# CXR ___: Fudicial markers within the right upper and left \\nlower lobes with adjacent linear opacities likely representing \\npost-treatment changes. No pneumonia. \\n.\\n\\nOn discharge:\\n\\n___ 08:05AM BLOOD WBC-3.5* RBC-3.57* Hgb-11.3* Hct-34.2* \\nMCV-96 MCH-31.7 MCHC-33.0 RDW-13.6 Plt ___\\n___ 08:05AM BLOOD Glucose-87 UreaN-12 Creat-0.7 Na-141 \\nK-4.3 Cl-105 HCO3-30 AnGap-10\\n___ 08:05AM BLOOD Calcium-9.5 Phos-3.4 Mg-2.___ woman with melanoma with brain metastases presents \\nwith recurrent seizure.\\n.\\n# Seizure: manifested as speech abnormality, most likely \\ntriggered by brain metastases with associated hemorrhage.  No \\ninjury was sustained during the episode. Patient has had similar \\nseizures in the past 6 months. There was no fever, no evidence \\nof CNS infection.  Lamotrigine dose was increased on admission \\nand upon discharge for further control.\\n.\\n# Metastatic melanoma: patient was found on MRI to have new \\nmetastatic changes on ___ MRI, suggesting progression of \\ndisease.  A CT torso was also performed, which showed no further \\nmetastases.  Radiation oncology was consulted, along with \\nneurosurgery and neuro-oncology, and planned on dicussing \\nfurther treatment strategy after patient's discharge.  Patient \\nhad close follow-up with Dr. ___ Dr. ___ discharge \\nto discuss further management of care.\\n.\\n# Depression:  patient's home dose of escitalopram was continued \\non admission and discharge.\\n\\n \\nMedications on Admission:\\nacetaminophen-codeine 300-30 mg q6h prn pain\\nescitalopram 10 mg daily\\nlamotrigine 125 mg bid\\nlorazepam 0.5 m gbid prn\\nmethylphenidate 10 mg bid\\nzolpidem ___ mg qhs\\ndocusate sodium\\nferrous sulfate 325 mg daily\\nflaxseed oil\\nMVI\\nfish oil\\n \\nDischarge Medications:\\n1. Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday) as needed for anxiety.  \\n3. Zolpidem 5 mg Tablet Sig: ___ Tablets PO HS (at bedtime) as \\nneeded for insomnia.  \\n4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).  \\n5. Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) \\nTablet PO DAILY (Daily).  \\n6. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n7. Omega-3 Fatty Acids     Capsule Sig: One (1) Capsule PO BID \\n(2 times a day).  \\n8. Acetaminophen-Codeine  Oral\\n9. Flaxseed Oil  Oral\\n10. Lamictal 100 mg Tablet Sig: 1.5 Tablets PO twice a day.\\nDisp:*90 Tablet(s)* Refills:*0*\\n11. Methylphenidate 10 mg Tablet Sig: One (1) Tablet PO BID (2 \\ntimes a day).  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary diagnosis: \\n\\nSeizure, recurrent\\n\\nSecondary diagnosis: \\n\\nMetastatic melanoma\\nDepression\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear. Ms. ___,\\n\\nIt was a pleasure taking care of you at the ___.  You came for \\nfurther evaluation of speech difficulty.  You most likely had a \\nseizure.  While you were here, it was found that you have new \\nbrain lesions, likely representing melanoma metastasis, based on \\nan MRI that was performed.  It is important that you continue to \\ntake your medications and that you follow up with your \\noncologist and neurologist.\\n\\nThe following changes have been made to your medications:\\n\\nWe INCREASED your Lamictal dose to 150 mg twice a day to better \\ncontrol your seizures.\\n \\nFollowup Instructions:\\n___\", 'Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nA.C.E Inhibitors / Codeine / Lidocaine /  \\n \\n ___ Chief Complaint:\\nDizziness and Low Blood Pressure\\n \\nMajor Surgical   Invasive Procedure:\\nhemodialysis\\n \\nHistory of Present Illness:\\n___ yo F with ESRD on HD, DM1, CAD s/p CABG ___, CHF EF 30%(s/  ICD) who was sent   ED from dialysis after experiencing \\nhypotension and dizziness. She had been treated with cefazolin \\n___ and Vanc ___ at HD for positive Coag neg staph \\nbacteremia. On ___, patient underwent exchange over a wire \\nof left femoral tunneled hemodialysis catheter because of \\npersisent bacteremia with coag negative staph.\\n\\n.  \\n\\nIn the ED, initial VS: 98.7 94 105/47 18 97% 2L on SBP 75-80. \\nFSBG low. Refusing central lines, refusing labs, got 22G in arm. \\nGiven Got vanco in ED. CXR unchanged. VS: 98.6 82 100/33 12. \\n\\n.  \\n\\nCurrently, patient reported fatigue and some nausea at dialysis. \\nShe reported that the antibiotics made her feels sick. She \\nreportst that normally her blood pressures run low SBP in \\n70-80s   reports poor   and   PO   over the \\nweekend.  Her boyfriend reports that she has had nausea, \\nvomiting, and diarrhea in the past 3 weeks after dialysis. Also \\nshe reports a lesion on her finger.  \\n\\n.  \\n\\nROS: Denies fever, chills, night sweats, headache, vision \\nchanges, rhinorrhea, congestion, sore throat, cough, shortness \\nof  , chest pain,   pain, constipation, BRBPR, \\nmelena, hematochezia, dysuria, hematuria.  \\n\\n \\n\\n \\nPast   History:\\n- ESRD: Initially HD, transitioned to PD (___)- now back   HD; \\n\\n\\nper renal fellow (___), patient has repeatedly been \\n\\nclotting off catheters so was started on low dose coumadin. No \\n\\nINR target was set - pt was just given 1mg per day. Her INR was \\n\\ninitially 2.5 but   now 1.8. Does make   still; urinates \\n\\n1x/day.\\n\\n-PE (Occurred in setting of catheter placement and SVC \\nthrombosis in ___, but was asymptomatic at that time)-maintained on coumadin \\n\\n- DM Type I: Diagnosed ___ yr ago (Hgb A1C ___\\n\\n- CAD s/p CABG (___), MI x2\\n\\n- CHF (EF 30%) s/p ICD\\n\\n- h o non-sustained v-tach  /p ICD\\n\\n- Hyperlipidemia\\n\\n-   anemia\\n\\n- Hypothyroidism\\n\\n- Cholecystectomy\\n\\n- Osteoporosis\\n\\n- L knee nondisplaced patellar fracture ___\\n\\n- gout   \\n\\n \\nSocial History:\\n___ Family History:\\nFather with DM, CAD MI. Mother with stroke and ___. \\n \\nPhysical Exam:\\nVital Signs\\n Hemodynamic monitoring\\n Fluid Balance\\n 24 hours\\n Since ___ AM\\n \\nTmax: 35.9 C (96.7 F)\\n\\nTcurrent: 35.9 C (96.7 F HR: 89 (78 - 89) bpm\\n\\nBP: 95/39(54) {86/30(42) - 96/44(54 mmHg\\n\\nRR: 16 (15 - 21) insp/min\\n\\nSpO2: 92% \\n\\nHeart rhythm: SR (Sinus Rhythm)\\n\\nHeight: 63 Inch\\n\\n \\n  \\n Total In:\\n  \\n 358 mL\\n \\nPO:\\n  \\n  \\n \\nTF:\\n  \\n  \\n \\nIVF:\\n  \\n 358 mL\\n \\nBlood products:\\n  \\n  \\n \\nTotal out 0 mL\\n 0 mL\\n \\nUrine:\\n  \\n  \\n \\nNG:\\n  \\n  \\n \\nStool:\\n  \\n  \\n \\nDrains:\\n  \\n  \\n \\nBalance:\\n 0 mL\\n 358 mL\\n \\n\\n \\n\\nRespiratory\\n \\nO2 Delivery Device: None\\n SpO2: 92%\\n \\n\\n \\n\\nPhysical Examination\\n\\nGeneral Appearance: Well nourished, No acute distress,  , \\nAnxious\\n\\nEyes / Conjunctiva: PERRL, Pupils dilated, Conjunctiva pale, \\nSclera edema\\n\\nHead, Ears, Nose, Throat: Normocephalic\\n\\nCardiovascular: (PMI Normal), (S1: Normal), (S2: Normal), S4\\n\\nPeripheral Vascular: (Right radial pulse: Not assessed), (Left \\nradial pulse: Not assessed), (Right DP pulse: Present), (  DP \\npulse: Present)\\n\\nRespiratory / Chest: (Expansion: Symmetric), (Breath Sounds: \\nClear : , Diminished: bases)\\n\\nExtremities: Right lower extremity edema: Trace, Left lower \\nextremity edema: Trace\\n\\nSkin:  Warm\\n\\nNeurologic: Attentive,   simple commands, Responds to: \\nVerbal stimuli, Oriented (to): , Movement: Purposeful, Tone: Not \\nassessed\\n \\n\\n \\nPertinent Results:\\n___ 06:39PM   ___ PO2-59* PCO2-40 PH-7.37 TOTAL CO2-24 \\nBASE XS--1\\n___ 06:21PM   GLUCOSE-98 UREA N-26* CREAT-4.0* SODIUM-136 \\nPOTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-22 ANION GAP-18\\n___ 06:21PM   estGFR-Using this ___ 06 21PM   ALT(SGPT)-7 AST(SGOT)-16 CK(CPK)-18* ALK \\nPHOS-271* TOT BILI-0.2\\n___ 06:21PM   CK-MB-NotDone cTropnT-0.10*\\n___ 06:21PM   CALCIUM-7.5* PHOSPHATE-5.9* MAGNESIUM-1.6\\n  06:21PM   CORTISOL-16. \\n___ 06:21PM   WBC-20.4*# RBC-3.38* HGB-10.8* HCT-34.6* \\nMCV-103* MCH 32.1* MCHC-31.3 RDW 17.5*\\n___ 06:21PM   NEUTS-93.5* LYMPHS-3.9* MONOS-1.9* EOS-0.2 \\nBASOS-0.3\\n___ 06:21PM   PLT COUNT-450*#\\n___ 11:15AM   ___\\n.\\nCXR ___. Femoral dialysis catheter tip advanced to the junction of the \\nSVC and right atrium. Please correlate for positional adequacy. \\n2. Cardiomegaly.  \\n.\\nEcho ___\\nThe left atrium is moderately dilated. The right atrium is \\nmoderately dilated. No atrial septal defect is seen by 2D or \\ncolor Doppler. Left ventricular wall thicknesses are normal. The \\nleft ventricular cavity is moderately dilated. There is severe \\nglobal left ventricular hypokinesis (LVEF = 20 %). No masses or \\nthrombi are seen in the left ventricle. Tissue Doppler imaging \\nsuggests an increased left ventricular filling pressure \\n(PCWP>18mmHg). with moderate global free wall hypokinesis. The \\naortic valve leaflets (3) are mildly thickened but aortic \\nstenosis is not present. No masses or vegetations are seen on \\nthe aortic valve. No aortic regurgitation is seen. The mitral \\nvalve leaflets are mildly thickened. No mass or vegetation is \\nseen on the mitral valve. Mild (1+) mitral regurgitation is \\nseen. The left ventricular inflow pattern suggests a restrictive \\nfilling abnormality, with elevated left atrial pressure. The \\ntricuspid valve leaflets are mildly thickened. There is moderate \\npulmonary artery systolic hypertension. There is no pericardial \\neffusion. \\n\\nCompared with the prior study (images reviewed) of ___, no \\nvegetations are seen.  \\n\\nCT Scan ___\\nCT OF THE ABDOMEN WITH INTRAVENOUS CONTRAST: In the visualized \\nthorax, there \\nis a small left pleural effusion and associated relaxation \\natelectasis. \\nAtelectatic changes are also seen at the right lung base, though \\nsome regions \\nsuggest possibility of aspiration as well. The heart is top \\nnormal in size.  \\nThere are dense coronary artery calcifications. There is no \\npericardial \\neffusion. \\n  \\nThere is a small amount of pneumoperitoneum with the bulk of \\nfree air located \\nanterior to the liver. Locules of gas seen anteriorly throughout \\nthe abdomen \\nand inferiorly to below the pelvis (series 2, image 57). \\n  \\nIn the abdomen, evaluation of the solid organs is limited \\nwithout intravenous \\ncontrast. Linear regions of low density adjacent to calcified \\nhepatic \\narteries, particularly in the left ___ be dilated bile \\nducts. The \\natrophic pancreas, spleen, and adrenals appear normal. Vessels \\nare densely \\ncalcified suggesting diabetes. Both kidneys are again atrophic. \\n  \\nThere is distention of small bowel loops to 2.7 cm (series 300B, \\nimage 10). \\nThere is effacement of fat about the small bowel and thickened \\nwalls in the \\nupper loops of bowel. Small locules of air also seen in the \\nsuperior and \\nanterior central small bowel loops (series 2, image 39). No \\ndefinite \\npneumatosis is seen.  \\n  \\nThere is effactment of fat about large bowel. Bowel wall \\nthickness is \\ndifficult to establish without oral contrast but appears \\nabnormal the \\ndescending colon. There is a locule of gas abutting a portion of \\nhepatic \\nflexure of the colon (series 2, image 39). Fluid is seen \\nadjacent to the \\ndescending colon towards the sigmoid (series 2, image 51; series \\n300B, image \\n22).  \\n  \\nThere is no pathologic abdominal lymphadenopathy. The takeoffs \\nof the celiac \\nand superior mesenteric arteries are densely calcified as are \\nall the \\nintra-abdominal vessels. Given no intravenous contrast was \\nadministered, \\nassessing patency is not possible with this study. \\n  \\nCT OF THE PELVIS WITH INTRAVENOUS CONTRAST: A left femoral \\nvenous central \\nline is seen with tip terminating in the right atrium. The \\nbladder \\ndemonstrates air anteriorly, probably from instrumentation. \\nMultiple calcific \\nround densities within the bulky anteverted uterus suggest \\ndystrophic \\ncalcification within fibroids. Fluid tracks down the paracolic \\ngutters more on \\nthe left than right. Adnexa are unremarkable. There is no pelvic \\n\\nlymphadenopathy. \\n  \\nMUSCULOSKELETAL: There is no suspicious osteolytic or \\nosteoblastic lesion. \\nMultilevel degenerative changes are seen in the spine. A small \\numbilical fat- \\ncontaining hernia is seen. \\n  \\nIMPRESSION: \\n  \\n1. Pneumoperitoneum. \\n  \\n2. Abnormal small bowel loops, gas distended, probably will wall \\nthickening \\nand demonstrate fat pericolonic fat effacement. A larger locules \\nof gas is \\nseen abutting a segment of small bowel centrally suggestive of a \\nfocus of \\nperforation. \\n  \\n3. Possible bowel wall thickening involving the colon and \\npericolonic fat \\neffacement involving all large bowel. This may be seen in \\ncolitis \\n(nonspecific). Fluid tracks down the paracolic gutters more on \\nthe left than \\nright. A locule of air abutting a segment of hepatic flexure. \\n  \\n4. Densely calcified aorta and celiac and superior mesenteric \\nartery takeoffs \\nin this context is suspiscious for an ischemic component. \\nHowever, given that \\nno IV contrast was administered, cannot assess vessel patency. \\n  \\n5. Left pleural effusion and associated relaxation atelectasis. \\n  \\n6. Dense vascular calcifications. \\n  \\n7. Small fat-containing umbilical hernia. \\n  \\n8. Atrophic kidneys and pancreas. \\n  \\n\\n \\nBrief Hospital Course:\\nMICU Course:\\n\\nThe patient was admitted to the medical ICU for hypotension and \\nconcern for recurrent bacteremia after dialysis. She did not \\nrequire vasopressor agents, and was treated with vancomycin, on \\nan HD protocol. She was empirically treated for C. diff though \\nresults did not return while she was in the ICU. Echocardiogram \\nshowed no masses or vegetations, though did show her EF was now \\n20%, similar to 25% from most recent other echocardiogram. Renal \\nrecommended starting Florinef after she had an appropriate ___ \\nstim. Her metoprolol was held. \\n\\nDuring an episode of dialysis, she became again hypotensive and \\ndeveloped increased abdominal pain following completion. Serial \\nKUBs became positive for free air, and CT scan of the abdomen \\nconfirmed viscous perforation. She was started on broad spectrum \\nantibiotics, and a surgical consultation was obtained. \\nUnfortunately, given the risk of surgery, it was felt that she \\nwould likely not survive the operation. The surgical risk was \\ndiscussed with the patient, and a plan to pursue comfort \\noriented goal of care was put into place. Palliative care \\nfollowed in consultation. She was continued on antibiotics, and \\nalso on norepinephrine that had been started the evening of the \\nct findings. Dialysis was stopped, and on ___ she had a \\ncardiac arrest, and was declared dead at 1625 without \\nresuscitation efforts. Family was at the bedside. \\n\\n \\nMedications on Admission:\\n-ALLOPURINOL - 100 mg Tablet - 1 Tablet(s) by mouth every other \\nday  \\n-AMIODARONE - 200 mg Tablet - 1 (One) Tablet(s) by mouth once a \\nday  \\n-AMOXICILLIN - 500MG Capsule - TAKE 4 TABLETS ONE HOUR BEFORE \\nPROCEDURE  \\n-NEPHROCAPS 1 mg by mouth once a day  \\n-CALCIUM ACETATE [PHOSLO] 667 mg Capsule PO TID  \\n-HUMALOG - 100 U/ML Solution - SS  \\n-INSULIN GLARGINE [LANTUS]- 100 unit/mL Solution - ___ units \\ndaily  \\n-LEVOTHYROXINE [SYNTHROID] - 125 mcg Tablet - 1 Tablet(s) by \\nmouth once a day, alternating with 112mcg daily  \\n-METOPROLOL SUCCINATE [TOPROL XL] - 25 mg by mouth daily on non \\ndialysis days  \\n-NITROGLYCERIN - 0.4MG Tablet, Sublingual - TAKE AS DIRECTED  \\n-OMEPRAZOLE [PRILOSEC] - 20 mg Capsule, Delayed Release(E.C. by \\nmouth twice a day  \\n-PRAVASTATIN - 40 mg Tablet - by mouth once a day in the evening \\n \\n-WARFARIN - 2 mg Tablet - ___ Tablet(s) by mouth daily or as \\ndirected by ___ clinic  \\n-ASPIRIN - (OTC) - 325 mg Tablet, Delayed Release (E.C.) by \\nmouth once a day  \\n\\n \\nDischarge Disposition:\\nExpired\\n \\nDischarge Diagnosis:\\nHypotension\\nBowel Perforation\\nMesenteric Ischemia\\nCardiac Arrest\\nEnd Stage Renal Disease\\n \\nDischarge Condition:\\nExpired\\n \\n                             ___, MPH ___\\n \\nCompleted by: ___', \"Sex:    \\n \\nService: MEDICINE\\n \\nAllergies: \\nMorphine / Keflex\\n \\n ___.\\n \\nChief Complaint:\\nWeakness\\n \\n  Surgical or Invasive  :\\nNone\\n\\n \\nHistory of Present Illness:\\n___     woman with past   history significant for left \\nsided breast cancer ___ years ago, s/p lumpectomy, radiation and \\nchemotherapy, with left hip bony metastasis ___ years later who \\npresents today with left lower extremity weakness as well as \\nurinary and bowel incontinence of 3 weeks duration.  The patient \\nreports that she has a history of peripheral neuropathy \\nsecondary to her previous chemotherapy and thought that was the \\ncase when she developed ascending numbness to her groin 3 weeks \\nago.  The numbness then progressed up to the level of her \\numbilicus, and she began becoming more weak on her left side.  \\nShe previously had been ambulatory with a walker.\\n.\\n  patient had been in ___ for the winter, but returned to \\n___ with her worsening symptoms and presented to the ED \\nyesterday ___.  She received an MRI of her spine that showed no \\ncord compression but a signal abnormality at T10 that was \\nsuspicious for metastatic disease.  Neurosurgery was consulted \\nbut saw no cord compression, therefore   that there was no \\nindication for emergent laminectomy.\\n.\\nThis morning, the patient continues to complain of the leg \\nweakness.  She denies nausea/vomiting/shortness of breath/chest \\npain.  Of note, the patient reports not having a bowel movement \\nsince the weekend.\\n \\nPast Medical History:\\nMetastatic breast CA\\nHTN\\nHypothyroidism\\nPSVT\\n\\nONC History\\nBreast CA  \\n- ___ mets to bone\\n- s/p 12 lines of chemotherapy\\n \\nSocial History:\\n___\\nFamily History:\\nfather died MI in ___, mother died age ___ brain aneurysm\\n \\nPhysical Exam:\\nAdmission exam:\\n\\nGEN: No acute distress.\\nHEENT Mucous membranes moist, no lesions noted\\nCV: Regular rate and rhythm, no murmurs, rubs ___\\nPULM: Clear to auscultation bilaterally, no wheezes, rales or \\nrhonchi.\\nABD:  , non-tender, non distended, bowel sounds present.\\nEXTR: No edema, 2+ Dorsalis pedis and radial pulses bilaterally.\\nNEURO: Alert and oriented x3.  CN II-XII intact.  Motor exam   \\nbiceps, triceps, deltoids bilaterally.  Right ___ ___ iliopsoas, \\n___ quadriceps, ___ gastrocnemius and anterior tibialis.  Left \\n___ ___ iloposas, ___ quadriceps, ___ gastrocnemius and anterior \\ntibialis.  Babinski equivocal bilaterally.\\nRectal exam: decreased tone per report.\\n\\nDischarge  :\\n\\nGEN: No acute distress.\\nHEENT: Mucous membranes moist, no lesions noted\\nCV: Regular rate and rhythm, no murmurs, rubs ___\\nPULM: Clear to auscultation bilaterally, no wheezes, rales or \\nrhonchi.\\nABD: Soft, non-tender, non distended, hyperactive bowel sounds \\npresent.\\nEXTR: No edema, 2+ Dorsalis pedis and radial pulses bilaterally.\\nNEURO: Alert and oriented x3.  Paresthesias up to level of \\numbilicus.  Motor exam ___ biceps, triceps, deltoids \\nbilaterally.  Right ___ ___ iliopsoas, ___ quadriceps, ___ \\ngastrocnemius and anterior tibialis.  Left ___ ___ iloposas, ___ quadriceps, ___ gastrocnemius ___ anterior tibialis.  Babinski \\nequivocal bilaterally.\\n \\nPertinent Results:\\nMR THORACIC SPINE WITHOUT AND WITH CONTRAST, ___\\nFINDINGS: Again seen is evidence of widespread vertebral body \\nmetastatic\\ndisease with abnormal signal in essentially every vertebral body \\nimaged.\\nThere is also hyperintensity in a number of vertebral bodies on \\nthe short TR images suggesting radiation change. At the T9 and \\nT10 levels, again seen is abnormal increased signal intensity in \\nthe spinal cord on the long TR images with slight expansion of \\nthe cord. This area enhances faintly after contrast \\nadministration. As discussed previously, the differential \\ndiagnosis includes radiation myelopathy or intramedullary \\nmetastatic disease. The enhancing component of the lesion \\nappears unusually linear for an intramedullary neoplasm, and \\nthis finding would favor radiation myelitis. There have been no \\nchanges since the prior examination. No new areas of enhancement \\nare detected.\\n \\nCONCLUSION: Better demonstration of enhancing focus at T9 and \\nT10 within the spinal cord associated with increased signal on \\nthe long TR images and   expansion of the cord. The pattern \\n  more suggestive of radiation myelopathy than of metastatic \\ndisease.\\n\\nMR ___ ___ - Again at T10 level, linear increased \\nsignal on T1- and T2-weighted images identified within the cord \\nwith subtle enhancement. The pattern of signal changes is more suggestive of radiation myelopathy than intramedullary \\nmetastasis as suggested previously but clinical correlation and \\nfollowup would be helpful. No significant change is seen. Bony \\nmetastatic lesion identified in the thoracic vertebral bodies as \\nbefore. No significant new abnormalities. \\n\\nAdmission labs:\\n\\n___ 02:30PM   ___ PTT-60.1* ___\\n___ 02:10PM   GLUCOSE-142* UREA N-14 CREAT-0.7 SODIUM-139 \\nPOTASSIUM-3.7 CHLORIDE-103 TOTAL CO2-24 ANION GAP-16\\n___ 02:10PM   estGFR-Using this\\n___ 02:10PM   ALT(SGPT)-18 AST(SGOT)-24 ALK PHOS-121* TOT \\nBILI-0.4\\n___ 02:10PM   LIPASE-11\\n___ 02:10PM   WBC-6.8 RBC-3.67* HGB-11.2* HCT-33.9* MCV-92 \\nMCH-30.6 MCHC-33.1 RDW-17.0*\\n___ 02:10PM   NEUTS-80.4* LYMPHS-14.6* MONOS-4.0 EOS-0.7 \\nBASOS-0.4\\n___ 02:10PM   PLT COUNT-177\\n\\nDischarge labs:\\n\\n___ 12:40AM BLOOD WBC-14.3* RBC-3.45* Hgb-10.6* Hct-32.7* \\nMCV-95 MCH-30.8 MCHC-32.5 RDW-16.8* Plt ___\\n___ 12:40AM BLOOD Glucose-280* UreaN-32* Creat-0.8 Na-133 \\nK-3.5 Cl-94* HCO3-25 AnGap-18\\n___ 12:40AM BLOOD Calcium-8.7 Phos-3.4 Mg-2.___ F with metastatic cancer admitted with neurogical signs \\nconsistent with spinal cord compression, evidence of T10 \\nintramedullary lesion but no evidence of external metastasis.  \\nMRI from yesterday of ___ was more suggestive of radiation \\nmyelopathy than extrinsic compression.  \\n\\n# Weakness: The patient presented with severe weakness of her \\nLLE, stool and bowel incontinence and numbness in the T10-L2 \\ndermatomes.  On initial whole spine MRI in the emergency room, \\nthere was concern for a possible intramedullary lesion in the \\nspinal cord consistent with this lesion at the T10 level.  \\nConcern for extrinsic compression of the spine by metastatic \\ntumor led to urgent consultation of radiation oncology, \\ninitiation of dexamethasone and 1 session of 400milligray XRT.  \\nHowever, subsequent imaging of the affected area with dedicated \\n___ MRI showed the lesion to be more in line with radiation \\nmyelitis as the patient had previously been irradiated in that \\narea for metastatic disease.  Nevertheless, the patient's \\nneurological exam improved with much improved strength in the \\nlower extremities, but persistent numbness in the aforementioned \\nregions.  The patient remained incontinent throughout her stay.  \\nShe was discharged on 4mg dexamethasone q6h along with bactrim \\nprophylaxis, to be followed up by her outpatient ___ \\n___ oncologist.\\n\\n# Urinary/bowel incontinence: Given radiation myelitis, \\nimprovement of this is unlikely.  Urinary retention was likely, \\nand the patient recieved straight catheterization and will need \\nteaching in rehab for eventual discharge with scheduled \\ncatheterization to empty bladder.  \\n\\n# Hypertension - The patient was hypertensive throughout her \\nstay, which was attributed to the dexamethasone.  Her metoprolol \\n50mg bid was changed to labetolol at the dose of 300 mg BID. She \\nwas also started on chlorthalidone, and her lisinopril was \\nincreased to 40mg daily.  These will likely need to be titrated \\nas blood pressure improves after stabilized on decadron.\\n\\n# Hyperglycemia - the patient also was quite hyperglycemic while \\non the dexamethasone.  She was started on lantus long-acting \\ninsulin, which will need to be titrated down as the \\ndexamethasone is tapered given the patient has no previous \\nhistory of diabetes.\\n\\n# Metastatic breast CA - further treatment deferred to \\noutpatient oncologist.\\n \\nMedications on Admission:\\nVerapamil 240mg SA daily\\nLevoxyl 75mcg daily\\nZoledronic acid 4mg q3months\\nLisinopril 20mg daily\\nLorazepam 1mg qhs\\nMetoprolol 50mg twice daily\\n \\nDischarge Medications:\\n1. Verapamil 240 mg Tablet Sustained Release Sig: One (1) Tablet \\nSustained Release PO Q24H (every 24 hours).  \\n2. Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n3. Zoledronic Acid 4 mg/5 mL Solution Sig: Four (4) mg \\nIntravenous Q3Months.  \\n4. Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \\n \\n5. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). \\n \\n6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday).  \\n7. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1) \\nPacket\\nPacket PO DAILY (Daily) as needed for constipation.  \\n8. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \\n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \\n9. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \\nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \\nconstipation.  \\n10. Dexamethasone 2 mg Tablet Sig: Two (2) Tablet PO Q6H (every \\n6 hours): Continue until you follow-up with your ___ oncologist\\n.  \\n11. Chlorthalidone 25 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily): For duration of steroids. Will need to be adjusted by \\nrehab MD.\\n.  \\n12. Insulin Glargine 100 unit/mL Solution Sig: Eight (8) units \\nSubcutaneous once a day: For duration of steroids. Will need to \\nbe adjusted by rehab MD.\\n.  \\n13. Sulfamethoxazole-Trimethoprim 400-80 mg Tablet Sig: One (1) \\nTablet PO DAILY (Daily): For duration of steroids.  \\n14. Labetalol 100 mg Tablet Sig: Three (3) Tablet PO BID (2 \\ntimes a day): For duration of steroids. Will need to be adjusted \\nby rehab MD.\\n.  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\n1. Radiation myelitis\\n2. Metastatic breast cancer\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\n1. You were admitted for leg weakness and incontinence, and we \\nwere concerned that you had cord compression from your cancer. \\nAfter multiple MRIs, we determined in conjunction with the \\nRadiation Oncologists that this was due to radiation myelitis, \\nor damage from prior radiation therapy.  You are receiving \\nsteroids for this, which will continue on discharge until you \\nfollow-up with your ___ Oncologist. The instructions for this \\nare:\\nDexamethasone 4 mg by mouth every 6 hours.\\n\\n2. You also had problems with high blood pressure, and we \\nchanged your blood pressure medications.  You also had problems \\nwith high blood glucose (or sugar) levels, and are getting \\ntreated with insulin. You will need to continue your new blood \\npressure medications and insulin until you stop your steroids. \\nThese medications should be adjusted by the MD on call at your \\nrehab facility as necessary.\\n\\n3. It is very important that you take your medications as \\nprescribed.\\n\\n4. It is very important that you make all of your doctors \\n___.\\n \\nFollowup Instructions:\\n___\", \"Sex M\\n \\nService:  \\n \\n : \\nNo Known Allergies / Adverse Drug Reactions\\n \\n  .\\n \\nChief Complaint:\\nAAA\\n \\nMajor Surgical or Invasive Procedure:\\nEVAR w L to R   fem bypass \\n\\n \\nHistory of Present Illness:\\nMr. ___ is seen in followup today for his aortic aneurysm.\\nAt his visit couple of weeks ago, ultrasound suggested a 6-mm\\ngrowth over the past   months   a size of 5 4 cm.  Based on\\nthis enlargement, pt was scheduled for surgery.\\n \\nPast Medical History:\\n- CAD s/p ___nd stenting x4\\n- DM2 (diet controlled)\\n- HTN \\n- HLD (on Lipitor for ___ yrs, then simvastatin   past ___ yrs)\\n- Rectal cancer, s/p resection and XRT ___ years ago, with \\ncolostomy\\n \\nSocial History:\\n \\nFamily History:\\nMother died at ___ of CAD.  Father died at ___ of asthma\\n\\n \\nPhysical Exam:\\nPHYSICAL EXAMINATION  \\nVitals: T: 97.6 degrees Farenheit, BP: 118-145/40s-50s mmHg\\nsupine, HR ___ bpm, RR 18  , O2: 98 % on  .  \\nGen: Pleasant,    \\nHEENT: No conjunctival pallor. No icterus. MMM.  \\nNECK: JVP normal. Normal carotid upstroke.  \\nCV PMI in ___ intercostal space, mid clavicular line. RRR.\\nnormal S1,S2. No murmurs, rubs, clicks, ___  \\nLUNGS: CTAB. No wheezes, rales,   rhonchi.  \\nABD: Bilateral incisions with JP drain in place on left.  \\nEXT: WWP, NO CCE.   \\nNEURO:  &Ox3.   \\n\\n \\nPertinent Results:\\nTELEMETRY: Sinus rhythm at 78bppm \\n\\nECG:  sinus rhythm with rate at 65bpm LBBB with slightly more\\ndownsloping TW in 1 and AVL and upward TW in V5 and V6 (inverted\\non prior ECG) ___\\n \\nCardiac Cath at ___ ___\\n Hemodynamics:  The aortic pressure was 120/70, left ventricular\\nend-diastolic pressure was 18.\\n      Left ventricular angiogram visualized discrete\\ninferoposterior hypokinesis with left ventricular ejection\\nfraction of 60%.  There is no mitral regurgitation.\\n       The left main exhibited 20% ostial stenosis.\\n       The left anterior descending is occluded after the first\\nlarge septal and small diagonal.    is a 20 -30% narrowing \\nof\\nthe left anterior descending before it gives the septal and the\\ndiagonal.  There is a  40% narroeing of the diagonal.\\n      The left circumflex is occluded proximally.\\n      The right coronary artery is also occluded proximally.\\n      The graft arteriogram revealed an occluded graft to the\\nright coronary artery.\\n      There is   occluded graft to the circumflex and the\\ndiagonal artery.\\n       \\n      The left internal mammary artery is patent with good\\ninsertion into   left anterior descending with good filling of\\nthe left anterior descending that exhibits mild diffuse \\nplaquing.\\nThere is good filling retrograde of the circumflex marginal from\\nthe left anterior descending and there is a good filling of the\\ndistal right coronary artery that appeared a posterolateral\\nbranch.  I   not revisualize the posterior descending artery.\\n       The native vessels on the left that fills retrograde the\\nright coronary artery via collateral mainly coming from the\\nseptal branches of the left anterior descending\\n\\n___  :50AM BLOOD WBC-5.9 RBC-4.88 Hgb-14.9 Hct-41.6 MCV-85 \\nMCH-30.5 MCHC-35.8* RDW-13.2 Plt ___\\n___ 02:46PM BLOOD Hgb-10.9*# Hct-30.2*# Plt ___\\n___ 05:11AM BLOOD WBC-10.2# Hgb-11.6* Hct-32.3* Plt ___\\n___ 08:00AM BLOOD WBC-10.1 RBC-3.60*# Hgb-10.9* Hct-30.3* \\nMCV-84 MCH-30.4 MCHC-36.1* RDW-13.0 Plt ___\\n___ 08:10AM   WBC-7.9 RBC-3.37* Hgb-10.5* Hct-28.8* \\nMCV-85 MCH-31.2 MCHC- . * RDW-13.1 Plt ___\\n___ 03:10AM BLOOD WBC-5.5 RBC-2.98* Hgb-9.1* Hct-25.2* \\nMCV-84 MCH-30.5  -36.1* RDW-12.8 Plt ___\\n___ 04:10PM BLOOD WBC-5.3 Hct-32.5*# Plt ___\\n___ 08:05AM BLOOD WBC-4.7 RBC-3.82*# Hgb-11.5*# Hct-33.7* \\nMCV-88 MCH-30.2 MCHC-34.2 RDW-12.9 Plt ___\\n___ 09:50AM BLOOD ___ PTT-22.8 ___\\n___ 09:50AM BLOOD Plt ___\\n___ 08:05AM BLOOD Plt ___\\n___ 09 50AM BLOOD UreaN-19 Creat-1.0 Na-144 K-3.8 Cl-109* \\nHCO3-25 AnGap-14\\n___ 02:46PM BLOOD Glucose-139* UreaN-15 Creat-0.7 Na-138 \\nK-3.5 Cl-110* HCO3-21* AnGap-11\\n___ 05:11AM BLOOD Glucose-175* UreaN-11 Creat-0.7 Na-138 \\nK-3.9 Cl-108 HCO3-23 AnGap-11\\n___ 01:51AM BLOOD Glucose-98 UreaN-12 Creat-0.7 Na-140 \\nK-4.1 Cl-107 HCO3-23 AnGap-14\\n___ 08:00AM BLOOD Glucose-108* UreaN-12 Creat-0.8 Na-139 \\nK-3.8 Cl-104 HCO3-22 AnGap-17\\n___ 08:40PM BLOOD Glucose-116* UreaN-19 Creat-0.8 Na-139 \\nK-3.2* Cl-101 HCO3-16* AnGap-25*\\n___ 08:10AM BLOOD Glucose-113* UreaN-18 Creat-0.9 Na-140 \\nK-3.8 Cl-103 HCO3-26 AnGap-15\\n___ 03:10AM BLOOD Glucose-106* UreaN-20 Creat-0.8 Na-140 \\nK-3.8 Cl-105 HCO3-28 AnGap-11\\n___ 08:05AM BLOOD Glucose-104* UreaN-17 Creat-0.7 Na-139 \\nK-4.1 Cl-106 HCO3-26 AnGap-11\\n___ 02:46PM BLOOD ALT-11 AST-15 CK(CPK)-26* AlkPhos-40\\n___ 05:11AM BLOOD ALT-12 AST-17 CK(CPK)-27* AlkPhos-44 \\nTotBili-0.3\\n___ 12:45PM BLOOD CK(CPK)-32*\\n___ 01:51AM BLOOD CK(CPK)-40*\\n___ 09:00AM BLOOD CK(CPK)-86\\n___ 03:00PM BLOOD CK(CPK)-199\\n___ 08:40PM BLOOD CK(CPK)-217\\n___ 08:10AM BLOOD CK(CPK)-169\\n___ 05:25PM BLOOD CK(CPK)-105\\n___ 03:10AM BLOOD CK(CPK)-67\\n___ 09:25AM BLOOD CK(CPK)-52\\n___ 04:10PM BLOOD CK(CPK)-47\\n___ 12:57AM BLOOD CK(CPK)-46*\\n___ 08:05AM BLOOD CK(CPK)-48\\n___ 02:46PM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 05:11AM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 01:51AM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 09:00AM BLOOD CK-MB-11* MB Indx-12.8* cTropnT-0.05*\\n___ 03:00PM BLOOD CK-MB-25* MB Indx-12.6* cTropnT-0.26*\\n___ 08:40PM BLOOD CK-MB-20* MB Indx-9.2* cTropnT-0.35*\\n___ 08:10AM BLOOD CK-MB-11* MB Indx-6.5* cTropnT-0.33*\\n___ 05:25PM BLOOD CK-MB-6 cTropnT-0.35*\\n___ 03:10AM BLOOD CK-MB-5 cTropnT-0.55*\\n___ 09:25AM BLOOD CK-MB-4 cTropnT-0.47*\\n___ 04:10PM BLOOD CK-MB-3 cTropnT-0.54*\\n___ 12:57AM BLOOD CK-MB-3 cTropnT-0.76*\\n___ 08:05AM BLOOD CK-MB-3 cTropnT-0.80*\\n___ 08:00AM BLOOD %HbA1c-5.8 eAG-120\\n___ 05:11AM BLOOD Triglyc-89 HDL-32 CHOL/HD-4.9 LDLcalc-107\\n \\nBrief Hospital Course:\\nThe patient was admitted to the Vascular Surgical Service for \\nevaluation and treatment of a AAA. Pt underwent a EVAR with left \\nto right fem fem BPG. He was extubated in the OR.\\n\\nAfter a brief, uneventful stay in the PACU, the patient arrived \\non the floor NPO, on IV fluids and antibiotics, with a foley \\ncatheter, and IV meds for pain control. The patient was \\nhemodynamically stable.\\n\\nNeuro: The patient received IV pain medications with good effect \\nand adequate pain control. When tolerating oral intake, the \\npatient was transitioned to oral pain medications.\\n\\nCV: Pt with known PAD and stable angina. Pt started experiencing \\nchest pain on POD 1. His ECG was unchanged and initial cardiac \\nenzymes were negative. Cardiology was consulted and his cardiac \\nenzymes were cycled. He did rule in for MI. Troponins peaked at \\n0.8. He remained on telemetry and continued his beta blocker, \\nplavix, aspirin, statin. His most recent cardiac cath films were \\nsent over and cardiac surgery was consulted for redo CABG. Per \\ncardiac surgery, he is not a surgical candidate as he does not \\nhave targets. Cardiology felt that he did not have any PCI \\noptions as well and recommended medical management. We titrated \\nhis isosorbide from 20 to 40mg TID with resolution of his chest \\npain. On the day of discharge, he was ambulating independently \\nand walked up the stairs with physical therapy without anginal \\nsymptoms. \\n\\nPulmonary: The patient remained stable from a pulmonary \\nstandpoint; vital signs were routinely monitored. Good pulmonary \\ntoilet, early ambulation and incentive spirrometry were \\nencouraged throughout hospitalization.\\n\\nGI: Post-operatively, the patient was made NPO with IV fluids. \\nDiet was advanced when appropriate, which was well tolerated. \\n\\nGU: Patient's intake and output were closely monitored, and IV \\nfluid was adjusted when necessary. \\n\\nFEN: Electrolytes were routinely followed, and repleted when \\nnecessary.\\n\\nID: The patient's white blood count and fever curves were \\nclosely watched for signs of infection. Wound care included \\nsterile dressings. Pt did recieve perioperative antibiotics.\\n\\nEndocrine: The patient's blood sugar was monitored throughout \\nhis stay; insulin dosing was adjusted accordingly.\\n\\nHematology: The patient's complete blood count was examined \\nroutinely; he required 2units of PRBCs on ___ for hct of 25.2.\\nProphylaxis: The patient received subcutaneous heparin and \\nvenodyne boots were used during this stay; he was encouraged to \\nget up and ambulate as early as possible.\\n\\nAt the time of discharge, the patient was doing well, afebrile \\nwith stable vital signs. The patient was tolerating a regular \\ndiet, ambulating, voiding without assistance, and pain was well \\ncontrolled, and he was chest pain free. The patient received \\ndischarge teaching and follow-up instructions with understanding \\nverbalized and agreement.\\n \\nMedications on Admission:\\nASA 325', amlodipine 10', detrol LA 4', gemfibrozil 600', \\nibuprofen 600''', isosorbide mononitrate 20''', metoprolol \\nsuccinate 200', nitroglycerin PRN, plavix 75', risperidone 0.5', \\ntrazodone 50' \\n \\nDischarge Medications:\\n1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday).  \\n3. risperidone 0.5 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n5. atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily): See PCP or cardiologist for refills.\\nDisp:*30 Tablet(s)* Refills:*0*\\n6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*2*\\n7. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 \\nhours) as needed for pain.  \\n8. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.  \\n9. isosorbide mononitrate 20 mg Tablet Sig: Two (2) Tablet PO \\nthree times a day.\\nDisp:*180 Tablet(s)* Refills:*2*\\n10. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \\nSublingual Sublingual PRN (as needed) as needed for Chest pain: \\nTake 1 pill and wait 5 minutes. If still have chest pain take \\n___ pill and wait 5 minutes. If still with chest pain take ___ \\npill and call ___. .  \\n11. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at \\nbedtime).  \\n12. metoprolol succinate 200 mg Tablet Extended Release 24 hr \\nSig: One (1) Tablet Extended Release 24 hr PO once a day: Divide \\ninto 2 doses if better tolerated.  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nInfrarenal AAA\\nnstableangina - r/i MI, mayneed redo CABG\\nHTN,  DM2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\n\\nEndovascular Abdominal Aortic Aneurysm (AAA) Discharge \\nInstructions\\n\\nMedications:\\n\\x95If instructe,take Aspirin 325mg (enteric coated) once daily \\n\\x95Do not stop Aspirin unless your Vascular Surgeon instructs you \\nto do so. \\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\nIt is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and CTA \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\n___ drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site or \\nincision)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office. If bleeding does not stop, call ___ for \\ntransfer to closest Emergency Room. \\n\\n \\nFollowup Instructions:\\n___\", \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint:\\nL-sided CP, SOB \\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ F w/ hx of COPD w/ recent admission exacerbation in ___, \\nschitzophrenia, OA who p/w CP and SOB x1d. Normally w/ her COPD \\npt is on home 02 is always SOB, but can walk 3 flights of stairs \\nwithout stopping, occasional cough, and will rarely have sharp \\n  of L-sided CP   pleuritic in nature. Yesterday \\nshe tripped and twisted her L ankle fell to her knees, and later \\ndeveloped R hip pain the next day. Then today her husband \\nnoticed   her breathing was more labored and SOB throughout \\nthe day, no orthopnea Pt could still go up 3 flights of stairs. \\nShe tired using her combivent and home ___ without significant \\nchange. Around midnight or 1am she had sharp left-sided chest \\npain that lasted a couple seconds 3 times in a row and associate \\ndiaphoresis. No associated n/v, radiation. No further episodes \\nof CP afterward Denied any \\nfever/chills/melana/hematochezia/sorethroat/URI symptoms.  \\n.  \\nROS dysuria, 1 episode of loose BM yesterday  \\n\\n \\nPast   History:\\n . COPD/emphysema - no PFTs in our system \\n2. Schizophrenia  \\n3. Psychogenic polydypsia  \\n4. Osteoarthritis  \\n5. Status post hernia repair ___  \\n6. History of fecal and urinary incontinence without spinal cord \\ninjury, possibly worsened by drug side effect  \\n7. Atrial arrhythmia (MAT vs.wandering pacemaker)  \\n8. Positive PPD - unclear history  \\n\\n \\n  History:\\n___\\nFamily History:\\nUnknown (raised in foster care)\\n \\nPhysical Exam:\\nVitals:  .0,  /90, 86, 36, 92%4L  \\nGeneral: pleasant, mild respiratory distress  \\nHEENT: poor dentition, NC/AT, anicteric, MMM, oropharynx clear  \\nNeck: supple, JVP not elevated, no LAD  \\nLungs: shallow breaths, CTAB, no wheezes, rales, ronchi  \\nCV: RRR, normal S1 + S2, no murmurs, rubs, gallops  \\nAbdomen: +BS NT/ND, soft  \\nExt: 1+     edema, normal ROM at L ankle, no pain or point \\n  Neuro: AOx3, CN II-XII grossly intact, no focal deficits  \\n\\n \\nPertinent  :\\nTrop-T: <0.01 CK: 135 MB: 3  \\n.  \\n145 108 13  \\n----------------< 102  \\n4.1   0.7  \\n.  \\nMCV: 95  \\n      12.8  \\n5.7 >---------< 275  \\n       .9  \\nN:59 1 L:32 7 M:5.0 E:2 7 Bas:0.5  \\n.  \\n___: 14.6 PTT: 28.7 INR: 1.3  \\n.  \\nMicro: none  \\n\\n \\nBrief Hospital Course:\\n___ F w/ hx of COPD w/ recent admission exacerbation in ___ schitzophrenia, OA who p/w CP and SOB x1d  \\n \\n# COPD exacerbation Pt appeared to have a mild COPD \\nexacerbation, unlikely to be from infection, no cough/wbc/fevers \\nand cxr clear. Pt was requiring 4L/NC and has increased work of \\nbreathing, and incr RR, suggesting mild exacerbation. Pt \\ncontinues to smoke. No   completed, did not f/u only taking \\ncombivent. It is also possible pt had anxiety/pain ___ ankle \\ninjury and tachypnea from this, but currently denies pain and \\nstill tachyneic. PE unlikely, w/o tachycardia, and recent CTA \\nnegative - no h/o   suggest provoked. Also ___ was negative. \\nThe next day pt was 92%RA, and 96% ambulating on 1L. Pt's was \\nchanged over to prednisone 60mg on day of discharge and to get 3 \\nmore days of prednisone. Pt was also started on Advair 250/50 \\nBID for her COPD, given a pneumococcal vacine, and needs PFTs as \\noutpt.\\n.  \\n# CP- Pt was having sharp pain that was likely pleuritic ___ \\nCOPD exacerbation. Not typical CP to suggest ACS. Not \\nreproducible.  Pt was ruled out with CE x3. \\n \\n#. LLE edema - Pt likely ___ ankle sprain exam not suggestive \\nof fx. No current ankle pain As asymetric will r/o dvt. ___ was \\nnegative bilaterlly. The next morning pt did not have any LLE \\nswelling any longer, and did not complain of any pain.\\n\\n#. UA- Pt complained of dysuria as inpatint and we checked a UA \\nwhich was negative for a UTI. It did show trace proteins and glc \\nof 250. As inpatient her fasting glucose remained < 100. The \\nprotinuria/glucosuria ___ need to be followed as outpatient. \\n  \\n# Pulmonary nodules- Seen on CTA on ___, needs outpt f/u CT. \\n \\n# Schitzophrenia - Continued psych meds, No issues.  \\n\\n \\nMedications on Admission:\\n- Aripiprazole 10mg QDay  \\n- Risperdal 50mg IM q2wks  \\n- Celexa 40mg Qday  \\n- Combivent ___ puffs  \\n- MVI  \\n- ASA 325  \\n- Naproxen 375 q8 prn  \\n- Nicotene 21 mcg  \\n- Prednisone 40mg taper last dose ___  \\n- home 02 uncertain amount  \\n\\n \\nDischarge Medications:\\n1. Prednisone 20 mg Tablet Sig: Three (3) Tablet PO DAILY \\n(Daily) for 3 days.\\nDisp:*9 Tablet(s)* Refills:*0*\\n2. Aripiprazole 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n3. Risperdal Consta 50 mg/2 mL Syringe Sig: One (1)  \\nIntramuscular q2 weeks.  \\n4. Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \\n \\n5. Combivent ___ mcg/Actuation Aerosol Sig: ___ puffs \\nInhalation four times a day.  \\n6. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n7. Nicotine 21 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \\nTransdermal DAILY (Daily).  \\n8. Advair Diskus 250-50 mcg/Dose Disk with Device Sig: One (1)  \\nInhalation twice a day.\\nDisp:*1 discus* Refills:*2*\\n9. Naproxen 375 mg Tablet Sig: One (1) Tablet PO every eight (8) \\nhours.  \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary diagnosis:\\n- COPD exacerbation\\n- chest pain, non-cardiogenic\\n\\nSecondary diagnosis:\\n- Schitzophrenia\\n- history of atrial tachycardia\\n\\n \\nDischarge Condition:\\nGood, ambulatory sat 96% on 1L, 92% on RA\\n\\n \\nDischarge Instructions:\\nYou had chest pain that was not due to a heart attack from the \\ntests we did. Instead the pain is probably referred pain from \\nyour COPD flare. For this you were given steriods and 02, which \\nis now improved. Also you had an ultrasound that also ruled out \\na clot in the deep veins of your legs, and the swelling was \\nprobably from the injury you had. \\n\\nIt is also very important that you stop smoking for the \\ntreatment of your COPD.\\n\\nIf at any point your symptoms return and significantly worsen - \\nincluding shortness of breath, chest pain, or fevers > 101 - \\nplease return to the ED.\\n\\nMedication changes:\\n- Advair was added to help manage your COPD, take this twice per \\nday\\n- Take prednisone for 3 more days for your COPD flare\\n\\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: MEDICINE\\n \\n : \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief  :\\nPrimary Care Physician: ___, MD MPH  \\n.  \\nChief Complaint Shortness of breath,   pain  \\n\\n \\nMajor Surgical or Invasive Procedure:\\nfoley catheter placement.\\n\\n \\nHistory of Present Illness:\\nMr. ___ is a ___ ___ speaking   with a h/o CAD s/p \\nCABG in ___, DM2 HTN, HL, diastolic HF who c/o 3 months of \\nworsening shortness of breath and more recently, worsening chest \\npain.  He can no   take   than ___ steps without feeling both chest pain     of breath.  In terms of the chest \\npain, he describes   as a piercing sensation   the left side \\nof his chest, no radiation to the left side but comes with a \\n\"choking feeling\" or pressure up to his neck.  It is not \\nassociated with sweating, nausea, palpitations, inspiration, or \\nhis eating habits.  It lasts 3 minutes and prompts him to clutch \\nhis chest but resolves spontaneously.  He experiences it with \\nactivity but has also recently felt it at rest or while lying \\ndown.  \\n.\\nHe believes his shortness of breath has also worsened over the \\nlast   months, particularly   exertion.  It often accompanies \\nthe chest pain.  He is not on O2 at home.  He has noticed the development of a dry cough recently.  He continues to sleep with \\n2 pillows per usual at night and denies PND.  He has noticed \\nincreased leg swelling recently.  He was largely unable to \\ncharacterize time periods so corroboration by his PCP or ___ \\nwould be useful.  \\n.\\nHe reports being diligent   taking his medications \\n .\\n.\\nHe was referred to HCA   ___ at ___, patient was felt to be \\nfluid overloaded, and chest pain felt to be strain secondary to \\ndecompensated heart failure. He was given ASA 325mg PO x1   \\nplaced on oxygen 2L NC. Given albuterol nebulizer in ambulance.  \\n\\n.\\nIn the ED, 97.5 66 120/93   100% 2L by  . Physical examination \\nnotable for trace pitting edema to knees bilaterally. Laboratory \\ndata significant for creatinine 2.1 (baseline 1.5-1.6), \\nhematocrit 31.9 (baseline), BNP ___, first set \\ncardiac markers WNL. EKG unchanged from baseline. CXR 2V with \\nquestion of perihilar fullness, no consolidations. Foley placed by urology following dilatation of urethral stricture. \\nIntermittently hypertensive to sBP 190s. Given furosemide 40mg \\nIV x1 after Foley placed.  \\n.  \\nOn arrival to the medicine service, patient reports feeling much \\nbetter. He is without chest pain or shortness of breath at \\npresent.\\n.  \\nROS:\\n(+) per HPI\\n(-) for headache, dizziness, increased sweating, syncope, \\nfevers, chills abdominal pain, changes in bladder habits, \\nweakness, paresthesias, difficulty with coordination, gait \\ndisturbances\\n \\nPast Medical History:\\nCAD s/  CABG in ___ (last stress normal in ___  \\nDM  \\nHypertension  \\nHyperlipidemia  \\nDiastolic CHF\\n \\nSocial History:\\n___\\nFamily History:\\nFather died of heart attack at age ___.\\n \\n  Exam VS: Tc 97.5 Tmax 97.9  HR 51 BP 191/84 RR 18 O2sat 100% 2L\\nGeneral: Comfortable, laying on 2 pillows\\nHEENT: Sclera anicteric; conjunctiva non-injected; dry mucous \\nmembranes; oropharynx clear without lesions, exudate\\nCV: Bradycardic, regular rhythm, no m/r/g  \\nLungs: CTAB without rales or wheezes\\nAbd: Obese, +BS, soft, NT/ND \\nExt: 1+ lower extremity edema to knees bilaterally; 2+ ___ \\npulses\\nSkin: WWP, no rashes\\n \\nPertinent Results:\\n___ 05:08PM   GLUCOSE-158* UREA N-26* CREAT-2.1* SODIUM-139 POTASSIUM-4.8 CHLORIDE-100 TOTAL CO2-28 ANION GAP-16\\n___ 05:08PM   CK(CPK)-42*\\n___ 05:08PM   cTropnT-<0.01\\n___ 05:08PM   CK-MB-2 ___ 05:08PM   WBC-6.8 RBC-3.57* HGB-10.4* HCT-31.9* MCV-89 \\nMCH-29.2 MCHC-32.7 RDW-15.9*\\n  05:08PM   NEUTS-75.1* LYMPHS-17.3* MONOS-4.6 EOS-2.6 \\nBASOS-0 3\\n___ 05:    PLT COUNT-218\\n\\nCXR 2V (___): Stable chest x-ray examination. Please note \\nthe previous left humerus dislocation has been reduced on the \\ncurrent study. No acute pulmonary process identified.  \\n.  \\nEKG ___, 22:42): NSR @ 52.  Leftward axis deviation.  \\nIntervals WNL.  Isolated Q wave in III.  Biphasic T-wave changes \\nin V4-V6, changed from ___.  \\n.  \\nTTE (___): Mild symmetric left ventricular hypertrophy with \\npreserved global biventricular systolic function. Dilated \\nascending aorta.\\nCompared with the prior report (images unavailable for review) \\nof ___, the findings are similar.\\n.  \\nNuclear stress (___): Atypical/non-anginal type symptoms in \\nthe absence of ischemic EKG changes. The image quality is \\nlimited due to soft tissue attenuation and tracer activity \\nadjacent to the heart.  \\n.  \\n \\nBrief Hospital Course:\\n___ ___ speaking patient with a h/o CAD s/p CABG in ___, \\nDM2, HTN, HL, diastolic HF who c/o 3 months of worsening \\nshortness of breath and more recently, worsening chest pain.    \\n.\\n# Chest pain: Known CAD and s/p 4 vessel CABG. Description of \\nchest pain resembled unstable angina, though stress test from \\n___ negative for ischemic changes.  ACS ruled out with 3 \\nsets of negative cardiac enzymes.  EKG showed biphasic T waves \\nin V4-V6, likely attributable to hypertension due to holding of \\nmeds. Chest pain could have been related to hypertension. Pt was \\nstarted on ASA during the admission. He will follow up with his \\nPCP in the outpatient setting to determine if any additional w/u \\nis needed.\\n.\\n# Shortness of breath: Patient described 3 months of worsening \\nSOB on exertion, often accompanying chest pain from above.  \\nPatient denied orthopnea or PND.  BNP was ___ (higher than \\nbaseline from ___, but exam and radiography not concerning for \\nacute exacerbation of diastolic HF.  Last echo in ___ was \\nunremarkable, EF 60-70%.  Performed echo while inpatient showing \\nno change from ___.  Pt was given additiona doses of lasix \\nearly in the admission with good effect. His symptoms were \\nlikely related to mild acute diastolic heart failure. He will be \\ndischarged on home dose of lasix given creatinine bump while \\ninpatient.  \\n.\\n# Renal insufficiency: Cr was 2.1 on admission. Fe urea 47%, \\nsuggestive of intrinsic renal process.  Latest Cr from ___ \\nvisit in early ___ was also 2.1. No microalbuminuria indicating \\ndiabetic nephropathy, likely ___ to chronic uncontrolled HTN.  \\nCr bumped to 2.4 on ___, likely due to increased lasix dosing \\nand resuming of lisinopril on ___ for HTN control. Lasix and \\nlisinopril held for 1 day and resumed on day of discharge with \\nCr 2.3. Pt with difficult to control HTN and responds very well \\nto lisinopril and lasix. Thus, they were continued on admission \\ndoses. He will have a repeat Cr at his PCP\\'s office ___.\\n.\\n# HTN: Pt with SBP in the 220 range when holding lasix and \\nlisinopril. This was treated effectively with hydralazine and \\namlodipine. Pt was started on amlodipine and this was increased \\nto 10mg daily. In addition, metoprolol dosing was decreased \\nsecondary to bradycardia. Despite adding amlodipine, with SBP \\n160\\'s (also likely secondary to decreased metoprolol dosing) and \\ntherefore lasix and lisinopril were added back with good effect. \\nPts BP is much better controlled on these medications. He will \\nfollow up with his PCP this week for further titration if \\nneeded.\\n.\\n# Bradycardia: Patient\\'s HR consistently stayed in the ___, \\nlikely ___ to metoprolol and possibly tizanidine. Pt\\'s \\nmetoprolol was decreased to 25mg BID. \\n.\\n#urinary retention-Likely related to pt\\'s prior history of \\nurinary strictures. Pt with urinary retention in the ED and \\nfoley catheter was placed, but with some difficulty. Therefore, \\nhe was discharged with the foley in place. He will follow up \\nwith urology this week for voiding trial.\\n.\\n# Hyperkalemia: K 5.2 on admission.  Likely ___ to ACEI and/or \\nchronic renal insufficiency.  No findings on EKG.  Resolved.\\n.    \\n# DM2: Held oral hypoglycemics, started HISS.  BG up to 330s x \\n1, responded to humalog.\\n.  \\n#. Hyperlipidemia: Continued statin per home regimen. \\n.  \\n#. Anemia: At baseline, continued ferrous sulfate per home \\nregimen.   \\n.  \\n# FEN: Heart healthy, diabetic diet; fluid restriction 1.5L; \\nreplete lytes as needed  \\n.\\n# Prophylaxis: Heparin SC TID; home PPI; bowel regimen\\n \\nMedications on Admission:\\nATORVASTATIN [LIPITOR] - 10 mg Tablet - 1 Tablet(s) by mouth \\nonce  \\na day  \\nDIABETIC SHOES - - Use as directed. ICD code: 250.8.  \\nFUROSEMIDE - 40 mg Tablet - 1 Tablet(s) by mouth once a day  \\nGLIPIZIDE - 10 mg Tablet Extended Rel 24 hr - 1 Tab,Sust Rel  \\nOsmotic Push 24hr(s) by mouth twice a day  \\nLIDOCAINE [LIDODERM] - 5 %(700 mg/patch) Adhesive Patch,  \\nMedicated - one patch once a day apply to back for 12 of 24 \\nhours  \\nper day  \\nLISINOPRIL - 5 mg Tablet - 1 Tablet(s) by mouth once a day  \\nLORAZEPAM - 1MG Tablet - ONE BY MOUTH AT BEDTIME AS NEEDED FOR  \\nSLEEPING  \\nMETFORMIN - 1,000 mg Tablet - one Tablet(s) by mouth twice a day \\n \\ntake with morning and evening meal  \\nMETFORMIN HCL - 500 mg Tablet - 1 Tablet(s) by mouth once a day  \\n\\ntake at lunch  \\nMETOPROLOL TARTRATE - 50 mg Tablet - 1 Tablet(s) by mouth twice \\na  \\nday **** dose change ****  \\nNITROGLYCERIN [NITROSTAT] - 0.4 mg Tablet, Sublingual - 1  \\nTablet(s) sublingually prn chest pain  \\nOMEPRAZOLE - 20 mg Capsule, Delayed Release(E.C.) - 1 (One)  \\nCapsule(s) by mouth once a day  \\nPIOGLITAZONE [ACTOS] - 15 mg Tablet - 1 Tablet(s) by mouth once \\na day  \\nPREGABALIN [LYRICA] - 75 mg Capsule - 1 Capsule(s) by mouth once \\na day  \\nTERAZOSIN - 10 mg Capsule - 1 Capsule(s) by mouth twice a day  \\nTIZANIDINE - 4 mg Tablet - 1 Tablet(s) by mouth twice a day  \\nBLOOD SUGAR DIAGNOSTIC - Strip - test tid to qid  \\nFERROUS SULFATE - 325 mg (65 mg) Tablet - 1 Tablet(s) by mouth  \\nonce a day  \\nLAC-HYDRIN - 12 % Cream - apply to hands twice a day  \\n \\nDischarge Medications:\\n1. Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. Glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.  \\n3. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \\nOne (1)  Topical as directed.  \\n4. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO at bedtime.  \\n5. Metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. \\n \\n6. Metformin 500 mg Tablet Sig: One (1) Tablet PO once a day: at \\nlunch  time.  \\n7. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \\nSublingual as directed.  \\n8. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \\n9. Actos 15 mg Tablet Sig: One (1) Tablet PO once a day.  \\n10. Lyrica 75 mg Capsule Sig: One (1) Capsule PO once a day.  \\n11. Terazosin 10 mg Capsule Sig: One (1) Capsule PO once a day.  \\n\\n12. Tizanidine 4 mg Capsule Sig: One (1) Capsule PO twice a day. \\n \\n13. Furosemide 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n14. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.\\nDisp:*30 Tablet(s)* Refills:*2*\\n15. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n16. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n17. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \\n(2 times a day).\\nDisp:*60 Tablet(s)* Refills:*2*\\n18. Iron 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO once \\na day.  \\n19. Amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.\\nDisp:*30 Tablet(s)* Refills:*2*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nMajor:\\nchest pain-angina\\nacute diastolic heart failure\\nHTN\\nurinary retention\\nbradycardia\\n.\\nMinor:\\nCAD\\nDM2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nYou were admitted because you had chest pain and leg swelling. \\nFor this, you had blood tests that showed that you did not have \\na heart attack. You were given a medication to improve your leg \\nswelling and breathing. We also did an ultrasound (an \\nechocardiogram) that did not show any changes from the last one. \\nYou had episodes of high blood pressure and were therefore \\nstarted on a new medication called amlodipine. In addition, you \\nexperienced urinary retention and had the placement of a foley \\ncatheter. You should leave this catheter in place until your \\nurology appointment.\\n.\\nMedication changes:\\nYou were started on an aspirin 81mg daily.\\nYou were started on amlodipine 10mg for blood pressure.\\nYour metoprolol was decreased to 25mg twice a day\\n\\nPlease be sure to follow up with your providers as per below.\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___.\\n \\nChief Complaint:\\nFall ___ suspected seizure\\n \\nMajor Surgical or   Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\n___ y/o male with h/o Mental Retardation, HTN, gout, no previous \\n  hx brought in by EMS from group home   syncope and \\npossible seizure.  \\n.  \\n  note,   patient is unable to give a   hx, and most     was obtained from the group home director (contact \\ninformation below). As per the director, the pt was in the \\nkitchen drinking a cup of coffee, chatting   other residents \\nwhen all of sudden his right arm started shaking rhythmically He started spilling coffee all  , and the shaking spread to \\nthe rest of his body. All four limbs were shaking and the \\npatient fell into the   and slumped down on the floor. He \\ndid not hit his head on   way down. The shaking lasted approximately 1:15 minutes, and the director states there was no \\nevidence of urinary or bowel incontinence. The pt himself denies \\na sore tongue, and the director denies evidence of blood from \\nthe mouth. Pt vomited x 1 with small amount (NBNB). After the \\nrhythmic shaking, he was found to be breathing deeply. He opened \\nhis eyes and he had a very red face and eyes. He could not \\nreally speak and seemed confused for 10  . When EMS \\narrived later, he began to pull at the O2 mask that they palced \\non him, but   could not really respond to questions when he \\nleft the group home. The director states he has been a resident \\nat the group home for ___ years now, and has never been known to \\nhave a seizure disorder. He was   today without any \\ncomplaints of bloody stools or bloody urine. Pt has taken all \\nmeds on time with no extra or missed doses.  \\n.  \\nIn the ED, initial vs were: 97 91 112/59 18 97%. later,   was \\nfound to be hypotensive to sbp ___. He was bolused with fluid \\n(1L) and   BP responded appropriately. Labs notable for \\nlactate 1.6, troponin 0.01, K 3.0, Cr 1.3, AG 21, LFTs wnl, \\nserum tox negative, Hct 39.7, INR 1.1. Patient was given 40 meq \\npotassium. By the   he was transferred to the floor, the pt \\nwas A+Ox3 and responding appropriately to questions. CT Head, \\nCXR, EKG were done (see below).  \\n.  \\n  the floor, the patient is comfortable and is unable to answer \\nmost questions about his hx. He denies   LH or dizziness at \\nthis  .  \\n.  \\nReview of  :  \\n(+) Per HPI  \\n(-) Denies fever, chills, night sweats, recent weight loss or \\ngain. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denied cough, shortness of breath. Denied   pain \\nor tightness, palpitations. Denied nausea, vomiting, diarrhea, \\nconstipation or abdominal pain. No recent change in bowel or \\nbladder habits. No dysuria. Denied arthralgias or myalgias.  \\n\\n \\nPast Medical History:\\nHypertension  \\n- Gout  \\n- mental retardation  \\n\\n \\n  History:\\n \\nFamily History:\\npt unable to give extensive FH due to MR. ___ died of MI \\n \\nPhysical Exam:\\nVitals: T98, BP 144/86, P76, RR 18, 99/RA  \\nOrthostatics: Sit: ___ Stand: 119/82 - 94  \\nGeneral: Alert, oriented, no acute distress  \\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck supple, JVP not elevated (5 cm)  \\nLungs: Clear to auscultation bilaterally, no wheezes,  , \\nronchi  \\nCV: Regular   and rhythm, normal S1 + S2, no rubs, gallops, \\nGrade III/VI holosystolic murmur best heard   the apex with \\nradiation throughout the precordium  \\nAbdomen: soft, non-tender, non-distended, bowel sounds present, \\nno rebound tenderness or guarding, no organomegaly  \\nGU: no foley  \\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema  \\nNeuro: CNs2-12 intact, sensation intact bilaterally, motor ___ \\nthroughout. 2+ reflexes in biceps and patella.  \\n\\n \\nPertinent Results:\\nADMISSION LABS\\n___ 02:01PM BLOOD WBC-6.9 RBC-4.85 Hgb-14.2 Hct-39.7* \\nMCV-82 MCH-29.4 MCHC-35.9* RDW-13.2 Plt ___\\n___ 02:01PM BLOOD Neuts-57.4 ___ Monos-5.  Eos-1.6 \\nBaso-1.1\\n___ 02:01PM BLOOD ___ PTT-24.5 ___\\n___ 02:01PM BLOOD Glucose-125* UreaN-21* Creat-1.3* Na-139 \\nK-3.0* Cl-96 HCO3-22 AnGap-24*\\n___ 02:01PM BLOOD ALT-25 AST-32 LD(LDH)-174 AlkPhos-50 \\nTotBili-0.4\\n___ 02:01PM BLOOD Albumin-4.5 Calcium-9.2 Phos-3.0 Mg-2.5\\n___ 02:01PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \\nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\\n___ 07:20AM BLOOD calTIBC-299 Ferritn-77 TRF-230\\n___ 04:56PM BLOOD Lactate-1.6\\n\\nCT HEAD\\nIMPRESSION: No acute intracranial injury.\\n\\nMRI HEAD\\nIMPRESSION: Extremely motion degraded study without evidence of \\nacute \\nintracranial abnormality. \\n\\nCHEST XRAY\\nIMPRESSION: No acute intrathoracic process.\\n\\nEEG: (official read pending, prelim read below)\\nMinimally slow ___ Hz) consistent with mild diffuse \\nencephalopathy, with rare left temporal slowing, no seizure \\nactivity.\\n \\nBrief Hospital Course:\\nThis is a ___ with MR, HTN, gout, who p/w syncope vs seizure. \\nGiven the hx provided by the director of the group home, seizure \\nseems most likely for this gentleman, which is concerning given \\nhis age at his first seizure. Also possible is syncope ___ \\northostasis given his orthostatic VS here, however less likely \\ngiven the convincing HPI for seizure.  \\n.  \\n# Syncope: DDx is broad, however given the patient's story, I am \\nmost concerned for seizure. Other etiologies are certainly \\npossible, however given the history, I think it is important to \\nevaluate him as a seizure patient. Most notable is his \\northostasis on the floor, and we will have to address that as \\nwell. Other causes of syncope that are easy to r/o and that \\nshould be done are infx, arrhythmia, electrolyte disturbances. \\nThe pt does have a 1st degree AV block, however this is usually \\nnot a malignant process and is not symptomatic. AS is not likely \\nas murmur is not c/w AS, rather MR.  \\n.\\nGiven that we were most concerned with seizure, we did a brain \\nMRI (which did not show any pathology) and a 20 minute EEG \\n(pending at time of discharge, however prelim read without \\nseizure activity).  We also c/s neurology who felt that he did \\nnot need any antiepileptics, but rather can f/u with outpt \\nneurology.\\n.  \\n# Orthostatic VS: Pt seems to be volume down given exam and \\northostatic VS.  We hydrated with IVF and held BP meds.  The \\npt's BP meds were held and we discharged the pt without his BP \\nmedications as his BP has been normotensive here without the \\nlisinopril/HCTZ\\n.  \\n# ARF: Pt's Cr is 1.3 up from a baseline of 1.0. Most likely is \\nprerenal, especially given orthostatic VS. We hydrated. We held \\nlisinopril as well.  Unfortunately, the pt did undergo a \\ngadolinium load during his hospitalization.  Regardless, we feel \\nthis can be f/u as an outpatient with a repeat Chem-7 in one \\nweek's time. We asked the patient to avoid NSAIDs as an \\noutpatient and we continued to hold his lisinopril.\\n.  \\n# HTN: As above, we held the lisinopril/HCTZ, even at time of \\ndischarge as he remained normotensive without antihypertensives. \\n This can be readdressed as an outpatient.\\n  \\n# gout: continued colchicine  \\n \\nMedications on Admission:\\nCOLCHICINE 0.6 mg PO daily  \\nLISINOPRIL-HYDROCHLOROTHIAZIDE 20 mg-25 mg Tablet PO daily  \\nACETAMINOPHEN 650 mg Tablet Sustained Release -prn pain  \\nIBUPROFEN [ADVIL] - 200-400 mg prn foot pain  \\n\\n \\nDischarge Medications:\\n1. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. acetaminophen 650 mg Tablet Sustained Release Oral\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPRIMARY:\\n1. fall, suspected seizure\\n\\n \\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nIt was a pleasure taking care of you during your \\nhospitalization.\\nYou were admitted to ___ for a fall and a question of \\nseizure-like activity. You underwent an MRI of your head which \\nshowed nothing abnormal, and an EEG which showed no seizure \\nactivity. We had the inpatient neurology team see you who felt \\nthat you did not need any new medications, and that you should \\nfollow up with an outpatient neurologist soon.\\n.\\nAlso, your Blood pressures were normal without blood pressure \\nmedicine, so we think you can stop taking your blood pressure \\nmedicine for now, and readdress this with your PCP when you see \\nhim next ___.\\n.\\nMEDICATION CHANGES:\\n- Try to avoid using Ibuprofen as your kidneys showed a little \\ndamage.  This will likely go away, however to be safe, we feel \\nyou should avoid Ibuprofen for now.\\n- STOP taking LISINOPRIL/HYDROCHLOROTHIAZIDE\\n.\\nPlease continue your medications as prescribed. Please continue \\nyour appointments as noted below.\\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: NEUROLOGY\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___\\n \\nChief Complaint:\\naltered mental status\\n \\n  Surgical or Invasive Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\nThe patient is   ___ yo man with extensive medical history\\nremarkable for old RT parietal stroke, HTN, hypothyroidism, BPH,\\n , anemia, bowel, bladder incontinence,  , dementia,\\nanxiety, and schizoaffecctive d o. He was brought in to the ED\\nfrom ___ with AMS. \\n\\nPer the nursing home staff pt at   is awake, alert oriented and  , but hard   hearing. Hereqiores\\nassistance for all ADLs and is wheelchair bound. This am he was\\n  staring, drooling,   responsive to sternal rub to which\\nhe grimaced. The staff also noted him to have weaker RT hadgrasp\\nthan usual. He reportedly was not acting like himself and did\\n  have breakfast as usual.\\n\\nHe   evaluated by the ED  , no focal deficits found  \\nhead CT ordered. Per nursing staff on arrival to the ED he was\\nnot very talkative, but able to answer \"okay\" when asked\\nquestions. He gradually returned to baseline within one hour of\\nthis episode.\\n\\nPer the patient he reports he had a stroke the night prior to\\nadmission,   complains he had pain all over, as well as \\nweakness\\nof his right arm, which has improved upon arrival to the\\nhospital. \\n\\n \\nPast Medical  :\\n. Previous RT parietal ___\\n2. Hypothyroidism\\n . HTN\\n4. Gout\\n5. COPD\\n6. BPH\\n7. Bowel and bladder incontinence\\n8. Remote hx of alcohol abuse\\n9. Anxiety\\n10. Dementia\\n11. Schizoaffective d/o\\n12. Chronic anemia \\n\\n \\nSocial History:\\n___\\nFamily History:\\nunknown\\n \\nPhysical Exam:\\nOn admission:\\nGeneral:  NAD\\nHEENT: NCAT,  no oropharyngeal lesions, neck supple\\n___: RRR, no M/R/G\\nPulmonary: Coarse sounds throughout\\nAbdomen: Soft, NT, ND, +BS, no guarding\\nExtremities: Warm, no edema, LT had contracture, BLE in knee\\nflexion.\\n\\nNeurologic Examination:\\nAwake, alert, oriented x 3. Able to relate history without\\ndifficulty. Slightly innatentive, unable to name ___ backward\\nwithout difficulty. Speech is fluent with full sentences, intact\\nrepetition, and intact verbal comprehension. Naming intact.  No\\nparaphasias.  No dysarthria. Normal prosody. Able to register 3\\nobjects and recall ___ at 5 minutes without prompting. No\\napraxia. No evidence of hemineglect. No left-right confusion. \\nAble to follow both midline and appendicular commands.\\n\\n- Cranial Nerves - Lt pupil 3->2 brisk, RT pupil 2 not reactive\\nto light. EOMI, no  . V1-V3 without deficits to light\\ntouch bilaterally. No facial movement asymmetry. Hearing \\nseverely\\n  but able to carry a conversation.  Palate elevation\\nsymmetric.  /Trapezius strength ___ bilaterally. Tongue midline.\\n\\n- Motor - Decreased bulk and increased tone on LUE. No tremor  \\nasterixis.\\n  Delt Bic Tri  FFl FE  IO IP Quad Ham Gastroc \\nL  -    5   4+   -  -   -   3+  3+  3+    -       \\nR  -    5   4+   4+  4+  4+ 3+  3+  3+    -     \\n\\n- Sensory - No deficits to light touch bilaterally.\\n\\n-DTRs:\\n  Bi  Tri ___    \\nL  2+       2+   2+  0\\nR  2+  2    2+   2+  0\\nPlantar response upgoing on the left, and downgoing on the \\nright.\\n\\n- Coordination - attempted finger   nose but patient unable to\\nfollow.\\n\\n- Gait not tested.\\n\\n---\\nOn discharge:\\nMental status: Awake, alert, oriented x 3. Speech is fluent with \\nfull sentences. No dysarthria. Normal prosody. No evidence of \\nhemineglect. No left-right confusion. Able to follow both \\nmidline and appendicular commands. Otherwise unchanged.\\n\\n \\nPertinent Results:\\nImaging:\\n\\nCXR: 5.7 x 4.5 cm well-circumscribed mass at the right lung \\nbase.  The right heart border is not well visualized suggesting \\na right middle lobe location. However, given the deformity of \\nthe underlying right tenth rib and the density of the lesion, \\nthis may reflect a chest wall lesion and Chest CT is recommended \\nfor further evaluation. \\n\\nCT chest: 1. 6.1 x 3.2 x 4.5   mass in the right lower lobe, \\nwhich exerts mass effect upon basal segment bronchi with resultant volume loss. Findings are concerning for lung cancer. \\n2. Additional nodules in the right middle lobe. \\n3. Incompletely characterized nodule in the right adrenal gland, \\nbut statistically likely an adenoma Attention on followup is \\nadvised. \\n4. Severe centrilobular and paraseptal emphysema. \\n5. Compression deformity of the L1 vertebral body of unclear \\nchronicity. \\n\\nCT abdomen/pelvis with contrast: \\n1. 11 mm right adrenal gland nodule statistically likely to \\nrepresent an adenoma, but in the setting of a lung mass, \\nmetastatic disease cannot be excluded.  Recommend evaluation \\nwith non-contrast CT scan. \\n2. 4.5 cm intra-luminal eccentric lesion in the right colon. \\nThis is not fully evaluated on this single phase scan but is \\nconcerning for colon cancer. Recommend evaluation with a \\nnon-contrast abdominal CT scan to assess. \\n\\nCT abdomen/pelvis without contrast: \\n1. Right colon mass seen on prior examination is enhancing and \\nis highly suspicious for colon cancer. \\n2. There is an 11 mm right adrenal adenoma. \\n\\nNon-contrast head CT: \\n1. No evidence of acute large territorial infarct or hemorrhage. \\n\\n2. Age-related involutional changes and sequela of chronic small \\nvessel \\nischemic disease. \\n3. Sinus disease, as described above. \\n\\nMRI head:\\n1. No acute intracranial abnormality without evidence of stroke \\nor mass. \\n2. Confluent periventricular and subcortical white matter FLAIR \\nsignal hyperintensity with background diffuse cortical volume \\nloss, likely representing sequela of chronic microangiopathy. \\n3. Sinus disease. \\n\\nCXR:\\nThe previously described masslike opacity since ___ has \\nsignificantly improved, with residual heterogeneous opacity, \\nsuggesting focal infection or atelectasis over malignancy. There \\nis new mild opacity in the right middle lobe, which could also \\nrepresent worsening pneumonia in the appropriate clinical \\nsetting. \\n\\nLabs:\\n___ 06:10AM BLOOD WBC-9.5 RBC-3.46* Hgb-12.0* Hct-37.0* \\nMCV-107* MCH-34.7* MCHC-32.4 RDW-13.6 RDWSD-53.6* Plt ___\\n___ 06:10AM BLOOD Neuts-70.1 Lymphs-16.2* Monos-9.3 Eos-3.2 \\nBaso-0.4 Im ___ AbsNeut-6.66* AbsLymp-1.54 AbsMono-0.88* \\nAbsEos-0.30 AbsBaso-0.04\\n___ 06:10AM BLOOD Glucose-85 UreaN-22* Creat-1.2 Na-143 \\nK-4.3 Cl-113* HCO3-18* AnGap-16\\n___ 06:05AM BLOOD VitB12-506\\n___ 05:15AM BLOOD %HbA1c-5.2 eAG-103\\n___ 05:15AM BLOOD Triglyc-79 HDL-47 CHOL/HD-2.8 LDLcalc-67\\n___ 05:15AM BLOOD TSH-2.0\\n \\nBrief Hospital Course:\\nMr. ___ is a ___ man with prior R MCA stroke, dementia, and \\nschizoaffective disorder who was admitted for altered mental \\nstatus with blank staring and drooling that lasted for 1hr and \\nalso R sided weakness. He main complaint is back pain, and he \\nwas uncooperative on exam but oriented to date, location, and \\npresident. L sided weakness compared to R that is old per pt and \\nguardian. Mental status back to baseline as of 6pm ___. TIA \\nworkup started as possible cause of AMS, MRI head negative for \\nstroke/mass lesion, no diabetes or HLD found, echo unable to \\nassess for PFO. \\n\\nOf note, found incidental lung lesion on routine CXR in ED. CT \\ntorso showed RLL lung mass, R adrenal gland nodule, and \\nintraluminal R colon lesion concerning for colon cancer. Also L1 \\nvertebral body compression that may explain back pain. Pt and \\nlegal guardian are aware of results from CT scans. Heme/onc was \\nconsulted for help with further management. They have \\nrecommended outpatient workup. This has been communicated to his \\nPCP, ___. Of note, repeat CXR on ___ demonstrated \\ninterval decrease in the size of the lung mass, suggesting \\ninstead an infectious etiology. \\n\\nAlso developed a UTI for which he was treated with IV \\nantibiotics. Discharged home with po antibiotics for 7 days for \\ncomplicated UTI. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Levothyroxine Sodium 125 mcg PO DAILY \\n2. BuPROPion 300 mg PO DAILY \\n3. Colchicine 0.6 mg PO EVERY OTHER DAY \\n4. Fluticasone Propionate 110mcg 1 PUFF IH BID \\n5. TraMADOL (Ultram) 50 mg PO BID:PRN pain \\n6. Lorazepam 0.5 mg PO TID \\n7. Lactulose 30 mL PO QHS \\n8. Doxazosin 4 mg PO HS \\n9. Ibuprofen 200 mg PO DAILY \\n10. Prochlorperazine 5 mg PO Q8H:PRN nausea \\n11. LOPERamide 2 mg PO Q6H:PRN diarhhea \\n12. Guaifenesin 5 mL PO Q4H:PRN cough \\n13. Bisacodyl 10 mg PO DAILY:PRN constipation \\n14. Fleet Enema ___AILY:PRN constipation \\n\\n \\nDischarge Medications:\\n1. BuPROPion 300 mg PO DAILY \\n2. Bisacodyl 10 mg PO DAILY:PRN constipation \\n3. Colchicine 0.6 mg PO EVERY OTHER DAY \\n4. Doxazosin 4 mg PO HS \\n5. Fleet Enema ___AILY:PRN constipation \\n6. Fluticasone Propionate 110mcg 1 PUFF IH BID \\n7. Levothyroxine Sodium 125 mcg PO DAILY \\n8. Lorazepam 0.5 mg PO TID \\n9. TraMADOL (Ultram) 50 mg PO BID:PRN pain \\n10. Acetaminophen 650 mg PO TID:PRN pain, fever \\n11. Aspirin 81 mg PO DAILY \\n12. Multivitamins 1 TAB PO DAILY \\n13. Guaifenesin 5 mL PO Q4H:PRN cough \\n14. Lactulose 30 mL PO QHS \\n15. LOPERamide 2 mg PO Q6H:PRN diarhhea \\n16. Prochlorperazine 5 mg PO Q8H:PRN nausea \\n17. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*14 Tablet Refills:*0\\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nAltered mental status of unknown cause, possible TIA, lung mass, \\nR colonic mass\\n\\n \\nDischarge Condition:\\neating po, awake, alert, oriented, voiding\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\n\\nYou were admitted to the hospital because you seemed to have an \\nepisode of confusion and right sided weakness at your care \\nfacility. The MRI of your head did not show any strokes or \\nmasses, and your EEG did not show evidence that you were having \\na prolonged seizure. Thankfully, you returned to your baseline \\nmental status by the next afternoon. We have pursued a transient \\nischemia attack workup given your possible right sided weakness \\nand altered mental status, and it is normal. \\n\\nWhile you were in the Emergency room, you had a chest Xray that \\nshowed a mass in your right lung, which was confirmed by a CT \\nscan of your chest. A CT scan of your abdomen also showed a R \\ncolonic mass. As we have discussed with you and your legal \\n___, these findings are concerning for \\ncancer. Oncology has seen you in the hospital but are unable to \\nmake any recommendations until a biopsy of either the lung or \\nthe colon is obtained. You will need to be closely followed in \\nthe outpatient setting for further diagnostic workup and \\ntreatment. \\n \\nFollowup Instructions:\\n___', 'Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPenicillins / Erythromycin Base / Streptomycin / Citric Acid / \\nAtenolol / Torsemide / Heparin Agents\\n \\n ___.\\n \\nChief Complaint Respiratory Distress, Hypotension\\n \\nMajor Surgical or   Procedure:\\nRight internal jugular (CVL) (discontinued) \\nArterial   (discontinued PICC (placed ___\\n \\nHistory of Present Illness:\\n___ year old male with multiple co-morbidities,   rectal cancer s/p   and radiation in ___, coronary artery \\ndisease s/p stents, systolic CHF, dilated cardiomyopathy,   \\nfibrillation, history of cardiac   and complete heart blood \\ns/p AICD/pacemaker recent trach/peg   presented with \\nrespiratory distress, fevers and hypotension. The patient \\n    day before   to 85% at ___ \\nalthough improved to 92% with suctioning out copious amounts of \\nthick yellow, brown secretions. Per his wife   daughter, he \\nhad been doing well with the trach, often having it capped in \\nthe last week - up until ___ days ago when he needed to be on \\nthe vent more frequently. He reportedly had a fever to ___ \\nyesterday and 102.0 today at rehab and had a CXR performed there \\nshowing LLL pneumonia; he was treated with Vancomycin 1 gram X1 \\nthere.\\n.\\nOn arrival to the ___ ___ the patient was being bagged by EMS \\nupon arrival, hypotensive to SBP80s, not tachypneic, never \\nfebrile, satting stably on his trach settings. He was mentating \\nwell complaining only of buttocks pain (stable) and answering \\nquestions appropriately. CXR ___ similar to priors and he was \\ntreated with Levofloxacin and Cefepime. Given persistent \\nhypotension SBP80s and decreased UOP   hours) despite \\n1.5L IVF, a RIJ CVL was placed and levophed started at 0.06. He \\nalso had a midline IV from before and 18 gauge PIV. His troponin \\nwas 0.11 so he was also given aspirin 325mg. VS on transfer to \\nMICU: Afebrile, HR70, BP86/40 RR16, 95% on PEEP5, FiO2 60%, \\nTV500.\\n.\\nUpon arrival to the MICU, the patient was resting comfortably in \\nbed. \\n.\\nReview of systems:  \\n(+) Per HPI  \\n(-) Denies headache, sinus tenderness, congestion. Denies chest \\npain, chest  , palpitations, or weakness. Denies nausea, \\nvomiting, diarrhea, constipation, abdominal pain, or changes in \\nbowel habits. \\n\\n \\nPast Medical History:\\n- Rectal cancer s/p excision and XRT (___)\\n- CAD s p stents  \\n- Complete heart block s/p pacemaker \\n- h/o cardiac arrest (now with AICD)  \\n- Afib \\n- Systolic CHF EF 40-45%)  \\n- s/p Fall with multiple rib fractures (___)  \\n- h/o GI bleed\\n \\nSocial History:\\n___\\n  History:\\nFather died in ___ from MI. Mother died in ___ from PE. No \\nfamily history of colon, breast, uterine,   ovarian cancer. No \\nfamily history of seizures. \\n \\nPhysical Exam:\\nAdmission Exam:\\nVitals: T: Afebrile BP: 105/47 P: 61 R: 13 O2: 100%   \\nGeneral: oriented, no acute distress, sleepy\\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck:  , RIJ CVL\\nLungs: Diffusely rhonchorous, rales; no wheezes \\nCV: RRR, ___   murmur heard best over apex with \\ndulling of S1 and S2 over apex. Otherwise S1 S2 clear and of \\ngood quality over rest of precordium.\\nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \\nno rebound tenderness or guarding; ostomy bag   place  \\nGU: three way irrigation foley \\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema; dry stasis changes on bilateral lower extremities  \\n  \\nDischarge Exam: \\nVS 98.9 73 133/69 24 95% trach collar 50%    \\nGeneral Appearance: No acute distress, breathing comfortably on \\ntrach collar.\\nHEENT: PERRL, Conjunctiva pale, Normocephalic, Poor dentition\\nCardiovascular: RRR, ___ holosystolic murmur heard best over \\nRespiratory:  mild rhonchi throughout all lung fields with \\noccasional   wheezes\\nAbdominal: Soft, non- , colostomy, PEG, + BS \\nExtremities: Bilateral ___ edema L>R, Chronic skin changes over \\nbilateral ___ suggestive of chronic venous stasis,   knee \\ntender to palpation \\nSkin:  Warm, well perfused\\nNeurologic: Attentive, Follows simple commands, Responds to: \\nVerbal stimuli, Movement: Purposeful, Tone: Normal, localizes \\npain. Able to point out letters on chart for communicating, \\nappropriate\\n\\n \\nPertinent Results:\\nBlood Counts\\n___ 08:00AM BLOOD WBC-28.2*# RBC-2.71* Hgb-7.9* Hct-24.0* \\nMCV-88 MCH-29.1 MCHC-33.1 RDW-16.6* Plt ___\\n___ 02:30PM BLOOD WBC-11.6* RBC-3.00* Hgb-8. * Hct-26.6* \\nMCV 89 MCH-29.3 MCHC-33.1 RDW-16.6* Plt ___\\n___ 02:53AM BLOOD WBC-8.0 RBC-2.81* Hgb-8.3* Hct-25.0* \\nMCV-89 MCH-29.4 MCHC-33.0 RDW-16.1* Plt Ct-80*\\n\\nElectrolytes\\n___ 08:00AM BLOOD Glucose-139* UreaN-45* Creat-1.5* Na-136 \\nK-5.0 Cl-99 HCO3-29 AnGap-13\\n___ 02:57AM BLOOD Glucose-106* UreaN-50* Creat-1.3* Na-138 \\nK-4.4 Cl-107 HCO3-25 AnGap-10\\n___ 02:53AM BLOOD Glucose-144* UreaN-48* Creat-1.2 Na-139 \\nK-4.3 Cl-103 HCO3-29 AnGap-11\\n\\n \\nBrief Hospital Course:\\nHOSPITAL COURSE\\n___ PMHx rectal cancer s/p resection and XRT w ostomy, systolic \\nCHF (LVEF40-45%), recent trach/peg who presented with \\nrespiratory distress, found to have a pnuemonia, with blood and \\nsputum cultures growing out MRSA, now improved to baseline \\nrespiratory status being discharged to ___ on 2 week course of \\nIV antibioitics\\n.\\nACTIVE\\n# Healthcare Associated Pnuemonia and MRSA Bacteremia - Patient \\npresented with increasing O2 requirements, leukocytosis and \\nhypotension; CXR demonstrated LLL PNA; accompanying elevated \\nLactate, High SvO2 (93%), hypotension and tachycardia suggested \\nsepsis; blood and sputum cultures grew out MRSA.  Patient was \\ninitially fluid resuscitated and briefly required vasopressors.  \\nHe was treated with vancomycin (initially with cefepime and \\nlevofloxacin as well, which were stopped based upon culture \\ndata).  Patient respiratory status improved, and patient was \\nable to be weaned off vent to trach collar.  Given MRSA \\nbacteremia, patient had PICC line changed and underwent TTE that \\ndid not demonstrate signs of valvular lesions; patient was \\nplanned for 2 week course with IV vancomycin.  \\n.\\n# Sacral decubitus ulcer: Significant, likely stage IV.  \\nAppropriate wound care was provided and his pain regimen was \\nincreased to Oxycodone to ___ mg q4 PRN for pain which \\nsuccessfully curbed decubitus pain.\\n.\\n# Coronary artery disease: Stable, continued carvedilol; held \\nlisinopril given hypotension and will need to be restarted; \\nstarted ASA (had been held previously given history of GI \\nbleeds).  \\n.\\n# Afib: CHADS4, but off anticoagulation ___ hemothorax ___.  \\nDiscussed with primary cardiologist who recommended considering \\nrestarting coumadin as outpatient. \\n\\nINACTIVE\\n# Anemia - Continued iron supplementation\\n.\\n# Systolic CHF: EF 40-45%, continued lasix\\n.  \\nTransitional Issues:\\n- Patient is full code\\n- Will need primary care doctors to discuss ___ as \\noutpatient\\n- Continue vancomycin for 2 weeks total course\\n \\nMedications on Admission:\\nMedications (per D/C summary and ___ records): \\n* Acetaminophen 650mg q8 hours PRN pain \\n* Acetaminophen 325mg q8 hours PRN pain \\n* Lidocaine patch X2 \\n* Trazodone 25mg qHS \\n* Carvedilol 3.125mg twice daily \\n* Citalopram 20mg daily \\n* Docusate 10mL twice daily \\n* Ferrous sulfate 325mg elixir daily \\n* Folate 1mg daily \\n* Lasix 40mg daily \\n* Gabapentin 300mg twice daily \\n* Lisinopril 2.5mg daily \\n* Multivitamin daily \\n* Omeprazole 20mg \\n* Protein supplements daily \\n* Albuterol HFA inhaler \\n* Simethicone 80mg every 8 hours \\n* Oxycodone 5 every four hours PRN tracheal pain, dressing \\nchanges\\n* Miconazole powrder qHS \\n* Levofloxacin 750mg daily, completed course ___ \\n* Gentamicin nebulizer 80mg q12 hours nebulizer\\n\\n \\nDischarge Medications:\\n1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every \\n4 hours) as needed for pain.  \\n2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \\nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 \\nhours on, 12 hours off.  \\n3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as \\nneeded for insomnia.  \\n4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) mL PO BID (2 \\ntimes a day).  \\n6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1) \\ndose PO DAILY (Daily).  \\n7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n\\n8. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \\n10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \\nTwo (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, \\nwheeze.  \\n11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, \\nChewable PO TID (3 times a day).  \\n12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS \\n(at bedtime).  \\n13. oxycodone 5 mg Tablet Sig: ___ Tablets PO every four (4) \\nhours as needed for pain: Hold for Sedation or RR<12.  \\n14. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \\nPO DAILY (Daily).  \\n15. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n16. Please change and care for lines per nursing routine\\n17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO twice a \\nday.  \\n18. vancomycin 750 mg Recon Soln Sig: One (1) solution \\nIntravenous twice a day for 24 days.  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPRIMARY\\nHealthcare Associated Pneumonia\\nStaph Bacteremia\\n\\nSECONDARY\\nSystolic CHF \\nAtrial Fibrillation\\n\\n \\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Lethargic but arousable.\\nActivity Status: Bedbound.\\n\\n \\nDischarge Instructions:\\nMr. ___--\\n\\nIt was a pleasure treating you at ___. You were admitted with \\ndifficulty breathing and low blood pressure.  You were found to \\nhave a pneumonia and an infection in your blood. You were \\ntreated with antibiotics and improved.  You will need to \\ncontinue your antibiotics for 2 weeks total.\\n  \\nThe following changes to your medications were made:\\n- STARTED vancomycin (continue until ___\\n- STARTED aspirin\\n- STOPPED inhaled gentamycin\\n \\nFollowup Instructions:\\n___']\n",
      "15\n",
      "15\n",
      "Currently interpreting instance:  0\n",
      "[\"Sex:   M\\n \\n : SURGERY Allergies: \\nGrass ___, Standard / Lactose\\n \\n ___.\\n \\nChief Complaint right popliteal aneurysm\\n \\nMajor Surgical or Invasive Procedure:\\n___:   artery stent graft\\n\\n \\nHistory of Present Illness:\\nMr. ___ has a fairly   aneurysm in  \\nmid right popliteal artery and is mostly full of thrombus and\\nmeasures 3.1 cm.  It is patent and does have palpable pedal\\npulse distally.  He has   of upcoming ankle surgery as well.\\nHe has a past medical   notable for   cancer status\\npost mastectomy and chemotherapy/radiation therapy with duodenal\\nulcer,  , depression,  , microvascular\\n  disease, hyperlipidemia, and COPD.  He had vein\\nmapping performed today which shows the lesser saphenous veins\\nto be small and noncompressible bilaterally.  He has the\\nthrombosis of the right greater   at the level of the\\nknee.  The left greater saphenous is adequate as are both\\n  and cephalic veins.  It was   that he would best \\nbe served by a stent graft. He was set up to have this done \\nelectively\\n \\nPast Medical History:\\nDepression\\nPseudogout\\nThyroid nodule\\nHx Duodenal ulcer ___ dx at OSH; ? secondary to ASA per pt.\\nHypothyroidism\\nCNS microvascular disease\\nHypercholesterolemia\\nNon-ulcer dyspepsia\\nAnemia\\nX-rays showing COPD although no smoking hx per pt.\\nBreast Cancer - T2, N1 ___ nodes),  ,   III, double \\nhormone\\nreceptor positive and  -2/neu negative infiltrating ductal\\n .  Lymphovascular invasion was also present.  He was\\ntreated with a total mastectomy, adjuvant chemotherapy with  \\ncycles of Taxotere and Cytoxan, followed by postmastectomy\\nradiation.  Currently on anastrozole PSH: Umbilical hernia repair ___, Right mastoid operation as \\na teenager, total mastectomy\\n\\n \\nSocial History ___\\nFamily History:\\nnon contributory\\n \\nPhysical Exam:\\nvss afebrile\\n\\nGen - Elderly appearing male in nad, alert and oriented   3\\nCV - RRR\\nLungs - CTA bilat\\nAbd - soft no m/t/o\\nExtremities - R ankle weakness (baseline). Full ROM of bilat ___. \\nRLE edema 1+. No LLE edema. R groin puncture c/d/i\\nPulses - femoral/dp/pt palpable bilat\\n \\nPertinent Results:\\n___ 09:20PM BLOOD WBC-4.4 RBC-3.96* Hgb-11.6* Hct-34.4* \\nMCV-87 MCH-29.4 MCHC-33.8 RDW-13.0 Plt ___\\n___ 07:30AM BLOOD WBC-5.5 RBC-3.99* Hgb-11.7* Hct-34.8* \\nMCV-87 MCH-29.4 MCHC-33.7 RDW-13.1 Plt ___\\n___ 09:20PM BLOOD Glucose-88 UreaN-12 Creat-0.9 Na-142 \\nK- .  Cl-105 HCO3-26 AnGap-15\\n___ 07:30AM BLOOD Glucose-144* UreaN-14 Creat- .0 Na-139 \\nK-4.5 Cl-103 HCO3-30 AnGap-11\\n___ 09:20PM BLOOD Calcium-8.7 Phos-2.9 Mg-1.9\\n___ 07:30AM BLOOD Calcium-8.9 Phos- .7 Mg-2.5\\n \\nBrief Hospital Course:\\nMr ___ was admitted,  'd, consented and taken for right \\npopliteal   graft. Just prior to the operation he had an \\nepisode of sinus tachycardia, but quickly returned to his \\nbaseline which   sinus bradycardia. He tolerated the procedure \\nwell and was transfered to the PACU where he remained \\nhemodynamicaly stable. He did have another episode of sinus \\ntachycardia in the PACU and received several doses of IV \\nmetoprolol.  He rapidly converted to sinus bradycardia with \\nrates in the ___.  His blood pressure was stable throughout \\nthese episodes and he was completely asymptomatic. He was \\ntransfered to the VICU for monitoring overnight. He remained in \\nsinus rhythm with heart rate stable in the ___. Review of \\nrecords and discussion with his PCP revealed that he has had \\nother episodes of sinus tach in the setting of procedures and \\noutpatient work up did not reveal anything significant. His \\nbaseline HR is sinus bradycardia in the high ___.  We had our \\nelectrophysiology team here see   and they felt there was no \\nacute  . They did recommend he follow up with his PCP or \\ncardiologist and have an outpatient echo.  Mr. ___ was \\nfeeling well on POD 1. His lab values were stable, he tolerated \\na regular diet and voided without difficulty.  He did walk with \\nhis cane but was a bit unsteady. ___ evaluated him and felt he \\nwould benefit from a walker and home ___. He was deemed stable \\nfor d/c home with family with a walker and a ___ and home ___. He \\nwill follow up with vascular, and his pcp in the near future. \\n \\nMedications on Admission:\\n anastrozole 1 mg qd;  \\n  colchicine 0.6 mg qd' DIAZEPAM 5MG prn;  levothyroxine 75 mcg \\nqd;  pravastatin 80 mg qd; ranitidine HCl 300 mg bid;        \\n  aspirin 325 qd\\n \\nDischarge Medications:\\n1. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet \\nPO Q6H (every 6 hours) as needed for pain.\\nDisp:*10 Tablet(s)* Refills:*0*\\n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day): while on narcotics.  \\n3. levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. pravastatin 80 mg Tablet Sig: One (1) Tablet PO once a day.  \\n5. anastrozole 1 mg Tablet Sig: One (1) Tablet PO once a day.  \\n6. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO once a day.  \\n7. diazepam 5 mg Tablet Sig: One (1) Tablet PO at bedtime as \\nneeded for insomnia.  \\n8. ranitidine HCl 150 mg Tablet Sig: Two (2) Tablet PO BID (2 \\ntimes a day).  \\n9. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n10. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily) for 1 months: for 1 month then stop.\\nDisp:*30 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nR popiteal artery anuerysm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\nLower Extremity Angioplasty/Stent Discharge Instructions\\n\\nMedications:\\n\\x95Take Aspirin 325mg (enteric coated) once daily \\n\\x95If instructed, take Plavix (Clopidogrel) 75mg once daily\\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\n\\x95It is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and ultrasound \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\ngreen drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office ___. If bleeding does not stop, call \\n___ for transfer to closest Emergency Room.\\n\\nYou need to follow up with your cardiologist and primary care \\ndoctor regarding your baseline bradycardia.  You should have \\nyour thyroid function followed closely.  \\n \\nFollowup Instructions:\\n___\", ' :    \\n \\nService:  \\n \\n : \\nNifedipine /   / IV Dye, Iodine   Contrast Media ___.\\n \\nChief Complaint:\\nInitiating  \\n \\nMajor Surgical or   Procedure:\\nRight sided   dialysis catheter ___\\n\\n \\n  of Present  :\\n___ yo M w/ PMH of   s/p right nephrectomy, stage IV CKD, \\n , gout, CHF   admitted following placement of an HD \\nline for iniation of dialysis. Pt has had   V   and has \\nnoted     but no vomiting and overall feeling \\nunwell  . He had a LUE AV fistual created on ___ \\nhowever as it is too     use this and given his symptoms it was   to place a tunnelled catheter while this amtures. he \\nwas admitted following this ___ procedure and his first session \\nof dialysis. He denies recent fevers or chills or cough. He does \\nreport decreased urine output with \"discomfort\" on   but \\nno burning. He reports abdominal discomfort and nausea but no \\nchanges in his bowel habits or vomiting. He deneis tremor or \\nchest pain He reports using his CPAP occasionally at night. The \\npatient was seen as he finished his first session of dialysis \\nand reports it was going  .  \\n \\nROS: per HPI, denies fever, chills, night sweats, headache, \\nvision changes, rhinorrhea, congestion, sore throat, cough, \\nshortness of breath, chest pain, abdominal pain, vomiting, \\ndiarrhea, constipation, BRBPR, melena, hematochezia, dysuria, \\nhematuria.  \\n\\n \\nPast Medical History:\\n-renal cell carcinoma s/p right nephrectomy in ___  \\n-CKD IV- felt secondary to HTN on the left kidney  \\n-CAD  \\n-Gout  \\n-OSA  \\n-CHF  \\n-Malingnat hyperthermia  \\n-hypercholesterolemia  \\nPast surgical history:  \\nright nephrectomy ___  \\nLeft brachiobasilic arteriovenous fistula ___  \\n\\n \\nSocial History:\\n___\\nFamily History:\\nHis mother is alive at the age of ___ with history of \\nhypertension and hip replacement. His father is also alive. The \\npatient has six siblings who are doing well. He has two adult \\ndaughters who are healthy.\\n \\nPhysical Exam:\\nAdmission Physical Exam\\nVS - 98.7, 158/103, 70, 16, 99RA\\nGENERAL - NAD, comfortable, appropriate, lying in bed getting \\ndialysis\\nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear\\nNECK - supple, no thyromegaly, no JVD\\nHEART - RRR, no MRG appreciated\\nLUNGS -auscultated anteriorly ___ being on dialysis CTAB\\nABDOMEN - NABS, soft/NT/ND, no masses or HSM, no \\nrebound/guarding\\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)\\nSKIN - no rashes or lesions\\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, gait and \\nstrength testing deferred given he was on dialysis \\n\\nDischarge Physical Exam\\nVS: 98.9, 148/96, 74, 20, 98RA BS 139-374\\nGENERAL - well appearing AA male in NAD\\nHEENT - PEERLA\\nCHEST- Right tunnelled catheter in place, no surrounding \\nerythema\\nNECK - supple, no thyromegaly, no JVD\\nHEART - RRR, no   appreciated\\nLUNGS -CTAB\\nABDOMEN - NABS, soft/NT/ND, no   or HSM, no \\nrebound/guarding\\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)\\nSKIN - no rashes or lesions\\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, gait and \\nstrength testing deferred given he was on dialysis \\n \\nPertinent Results:\\nAdmission Labs:\\n___ 09:  BLOOD WBC-14.2* RBC-3.75* Hgb-10.5* Hct-32.6* \\nMCV-87 MCH-28.0 MCHC-32.3 RDW-14.3 Plt ___\\n___ 09:45AM BLOOD ___ ___ 09:45AM BLOOD Glucose-313* Creat-6.2*  -144 K-4.2 \\nCl-100 HCO3-24 AnGap-24*\\n___ 09:45AM BLOOD Albumin-4.1 Calcium-8.7 Phos-5.6*# \\nIron-42*\\n\\nPertinent labs\\n___ 09:45AM BLOOD calTIBC-248* Ferritn-279 TRF-191*\\n___ 09:45AM BLOOD PTH-532*\\n___ 09:45AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE \\nHBcAb-NEGATIVE\\n___ 09:45AM BLOOD HCV Ab-NEGATIVE\\n\\nDischarge labs:\\n___ 07:40AM BLOOD WBC-12. * RBC-3. * Hgb-10.6* Hct-33.1* \\nMCV-88 MCH-28.2 MCHC-32.0 RDW-14.4 Plt ___\\n___ 07:40AM BLOOD  -200* UreaN-60* Creat-4.7* Na-141 \\nK-4.0 Cl-100 HCO3-30 AnGap-15\\n___ 07:40AM BLOOD Calcium-9.1 Phos-5.0* Mg-2.0\\n\\nUrine\\n___ 06:49AM URINE Color-Straw Appear-Clear Sp ___\\n___ 06:49AM URINE Blood-TR Nitrite-NEG Protein-100 \\nGlucose-300 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\\n___ 06:49AM URINE RBC-1 WBC-<1 Bacteri-NONE Yeast-NONE \\nEpi-0\\n\\nMicro:\\n URINE CULTURE (Final ___:    NO GROWTH. \\n\\nImaging:\\nHD line placement: IMPRESSION:   Successful placement of a \\ntunneled HD catheter through the right internal jugular vein \\napproach.  The tip is located in the right atrium and the \\ncatheter is ready for use.\\n \\n \\nBrief Hospital Course:\\nMr. ___ is a  ___ yo M w/ PMH of RCC s/p nephrectomy and now \\nwith ESRD who was initiated on dialysis via newly placed right \\ntunneled dialysis ___ adn is admitted for initiation of \\ndialysis. \\n\\n#ESRD- patient had a R sided tunneled line placement in ___ on \\n___ and he received 3 sessions of dialysis while inpatient \\nwithout complication through this line. He had hepatitis \\nserologies checked which were negative and a PPD was placed and \\nread and was negative at 48hrs.  He continued to make some urine \\nand tolerated the sessions.  His weight on discharge 105.3kg.  \\n-he will continue dialysis via his R tunnelled line MWF schedule\\n-patient started nephrocaps\\n-furosemide was held\\n-potassium supplements were held\\n-patient was instructed to eat a low phos, low sodium diabetic \\ndiet\\n\\n#Hypertension- the patient has significant hypertension and was \\non 5 antihypertensives on admission. Initially there was concern \\nthat with the initiation of dialysis he would require an \\nadjustment to these, however his blood pressures continued to \\nreamin mildly elevated at 140s-150s/90s-100s.  He had no \\nheadaches or vision changes.  \\nPPD was placed on ___ at 1730 on the right medial forearm\\n\\n#Gout- patient was experiencing a gout flare in his right foot \\non admission and had already been taking his steroids in a self \\ndictated taper.He had taken 40mg of prednisone the day prior to \\nadmission and this was felt to likely be the cause of his . He \\nrecieved a taper down to 20mg of prednisone on ___ with \\nimprovement in the pain.\\n\\n#Type II Diabetes- patient had elevated blood sugars during this \\nadmission. His home glipizide was held and he was on novolog \\nsliding scale.  His hyperglycemia was likely ___ a combination \\nof his steroid use and nonadherence to a diabetic diet, drinking \\nlarge amounts of\\n-he was discharged on glipizide 10mg (his home dose) and will \\ncontinue to check his blood sugars at home\\n\\nTransitional Issues:\\n-Patient will start outpatient dilayiss on a MWF schedule\\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. benazepril *NF* 40 mg Oral daily \\n2. calcitriol *NF* 0.25 mcg Oral daily \\n3. Carvedilol 25 mg PO BID \\nhold for sbp<100 or hr<60 \\n4. Felodipine 10 mg PO DAILY \\nhold for sbp<100 or hr<60 \\n5. Furosemide 160 mg PO BID \\nhold for sbp<100 or hr<60 \\n6. GlipiZIDE 10 mg PO BID \\n7. HydrALAzine 150 mg PO BID \\nhold for sbp<100 or hr<60 \\n8. irbesartan *NF* 150 mg Oral daily \\nhold for sbp<100 or hr<60 \\n9. Potassium Chloride 40 mEq PO BID Duration: 24 Hours \\nHold for K > \\n10. PredniSONE 40 mg PO DAILY \\n11. Rosuvastatin Calcium 20 mg PO DAILY \\n12. Aspirin 81 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1. Aspirin 81 mg PO DAILY \\n2. benazepril *NF* 40 mg ORAL DAILY \\n3. Carvedilol 25 mg PO BID \\nhold for sbp<100 or hr<60 \\n4. Felodipine 10 mg PO DAILY \\nhold for sbp<100 or hr<60 \\n5. HydrALAzine 150 mg PO BID \\nhold for sbp<100 or hr<60 \\n6. irbesartan *NF* 150 mg Oral daily \\nhold for sbp<100 or hr<60 \\n7. Rosuvastatin Calcium 20 mg PO DAILY \\n8. Calcium Carbonate 500 mg PO TID W/MEALS \\n9. Nephrocaps 1 CAP PO DAILY \\nRX *B complex-vitamin C-folic acid [Nephrocaps] 1 mg 1 \\ncapsule(s) by mouth daily Disp #*30 Capsule Refills:*0\\n10. GlipiZIDE 10 mg PO BID \\n11. PredniSONE  MD to order daily dose PO DAILY \\n12. Acetaminophen 325-650 mg PO Q6H:PRN pain \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nESRD\\nDiabetes Type II\\nGout\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\nIt was a pleasure taking care of you while you were here at \\n___.\\nYou were admitted to the hospital to start dialysis which you \\nhad 3 sessions of and tolerated well.  You will continue to \\nreceive dialysis as an outpatient on a ___ schedule.  You were \\ntreated for a gout flare while you were here with a steroid \\ntaper. As some of your medications may need to be adjusted such \\nas your glipizide while you are getting dialysis it will be \\nimportant to discuss any changes needed with your outpatient \\nproviders.  \\n\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nibuprofen\\n \\n ___\\n \\nChief Complaint:\\nERCP\\n \\nMajor Surgical or Invasive Procedure:\\n \\nFindings: Esophagus: Limited exam of the esophagus was normal \\nStomach: J-shaped stomach \\nDuodenum: Limited exam of the duodenum was normal \\nMajor  : Normal major papilla \\nCannulation: Cannulation of the pancreatic duct was successful   superficial with a sphincterotome using a free-hand \\ntechnique. Contrast medium   injected resulting in partial \\nopacification.   A   by ___ pancreatic stent was placed \\nsuccessfully   a sphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\n  using a free-hand technique. Contrast medium was \\ninjected resulting in complete opacification.\\n \\nBiliary Tree/Biliary Cannulation: The common bile duct common \\nhepatic duct, right and left hepatic ducts, biliary radicles, \\ncystic duct, and gallbladder were filled with contrast and well \\nvisualized. The course and caliber of the structures were normal \\nwith no evidence of filling defects   in the distal bile \\nduct.  Two round stones ranging in size from 2 mm to 3 mm were \\nseen at   lower third of the common bile duct. A \\nsphincterotomy was performed in the 12 o'clock position using a \\nsphincterotome over an existing guidewire.   small stone as well \\nas sludge were extracted successfully using a Extraction \\nBalloon.   \\n  \\nImpression: Limited exam of the esophagus was normal. \\nJ-shaped stomach.  \\nLimited exam of the duodenum was normal.  \\nCannulation of the pancreatic duct was successful and superficial with a sphincterotome using a free-hand technique.   \\n\\nA 5cm by ___ pancreatic stent was placed successfully using a \\nsphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique.  \\nTwo round stones ranging in size from 2 mm to 3 mm were seen at \\nthe lower third of the common bile duct.  \\nOtherwise, the cholangiogram was normal. \\nA sphincterotomy was performed in the 12  'clock position using \\na sphincterotome over an existing guidewire. \\nA small stone as well as sludge were extracted successfully \\nusing an RX   Balloon.\\n \\nRecommendations: Admit   hospital for monitoring \\nNPO overnight with aggressive IV hydration with LR at 200 cc/hr \\nIf no abdominal pain in the morning, advance diet to clear \\nliquids and   advance as tolerated \\nRecommend interval cholecystectomy. \\nNo aspirin, Plavix, NSAIDS, Coumadin for 5 days. \\nContinue with antibiotics - Ciprofloxacin 500mg BID x 5 days. \\nRepeat ERCP in 2 weeks for pancreatic stent pull \\nFollow-up with Dr. ___ as previously scheduled. \\nFollow for response and complications. If any abdominal pain, \\nfever, jaundice, gastrointestinal bleeding please call ERCP \\nfellow on call ___\\n \\nAdditional notes: Procedure done by Dr ___ fellow. The \\nattending was present for the entire procedure. \\n\\n \\nHistory of   Illness:\\n  Admission Note Date of note: ___, time seen 6 pm\\n\\nPCP:  ___\\n\\nCC:  pancreatitis\\n\\nHPI: Mr. ___ is a ___ yo male with diabetes new atrial \\nfibrillation and hypertension, here for ERCP after recent \\nepisode of pancreatitis in ___.  At that time, he was \\nhospitalized at an outside hospital, and there was no clear \\ncause of his pancreatitis, which was attributed to a diabetes \\nmedication.  He then presented here for EUS in the end of ___ which showed gallbladder sludge, and a fatty pancreas.  He \\npresented today for ERCP with stent placement and \\nsphincterotomy.  Two gallstones were found, and   small stone \\nand sludge was extracted.  \\n\\nIn recovery, he received hydromorphone 0.5 mg X 2, as well as IV \\nfluids.  Indomethacin   not given due to an allergy.  At \\npresent, he   to complain of   mid abdominal pain, \\nwithout radiation.  He also complains of slight headache and \\ndizziness.\\n\\nHe has overall felt relatively poorly over the ___, since his \\ninitial diagnosis of pancreatitis in late ___.  He   had \\nepisodes of dizziness when he has abdominal pain, which usually \\ngoes away when he lies down for a period of time.  He had a   \\nin his right leg, which was evaluated with an ultrasound by his \\npcp and was not found to have a DVT.  He had palpitations early \\nthis ___, but now that he is back in sinus, these have gone \\naway.  He has lost 27 lbs this summer.  He gets spikes of \\nabdominal pain with dietary changes, and re-addition of fat into \\nhis diet.  He has been able to work for the most part.\\n\\nROS as above - otherwise, negative in 6 other systems.\\n\\n \\nPast Medical History:\\nHypertension\\nHyperlipidemia\\nAtrial fibrillation\\nType II diabetes mellitus\\nGERD\\nPancreatitis\\nGallstones\\n \\nSocial History:\\n___\\nFamily History:\\nNo family history of gallstones as far as he knows.\\n \\nPhysical Exam:\\n                                                     \\n\\nPhysical exam\\nafebrile, HR in ___, BP 158/41  97% RA\\nGen:  appears uncomfortable\\nHEENT:  EOMI.  No scleral icterus.  No conjunctival injection.   \\nMucous membranes moist.  \\nNeck:  Supple, no LAD, no JVP elevation.\\nLungs: CTA bilaterally, no wheezes, rales, rhonchi.  Normal \\nrespiratory effort.\\nCV:  bradycardic, regular, no murmurs\\nAbdomen:  soft, tender in Right mid abdomen, with no rebound or \\nguarding.  No hepatosplenomegaly appreciated, and no epigastric \\ntenderness.\\nExtremities:  warm and well perfused, no edema.  Area of \\ntenderness in right lateral calf, with muscle knot.\\nNeurological:  somnolent, but alert and oriented X 3, C face \\nsymmetric.  Following all commands, moving freely in bed.  \\nSkin:  No rashes or ulcers or jaundice.\\nPsychiatric:  Appropriate.\\nGU:  deferred.\\n\\n \\nPertinent Results:\\nRelevant data:\\nNa 136 K 4.6  Cl 103 CO2 24 BUN  24 cr 1.0     \\nALT: 25 AP: 74 Tbili: 0.5 AST: 29 Dbili: 0.1  ___: 100 Lip: 40   \\n  \\nwbc  6.1  Hgb 12.6  Hct 36.3  plts 188\\n___: 11.6  PTT: 31.7  INR: 1.1  \\n\\nERCP:\\nImpression: Limited exam of the esophagus was normal. \\nJ-shaped stomach.  \\nLimited exam of the duodenum was normal.  \\nCannulation of the pancreatic duct was successful and \\nsuperficial with a sphincterotome using a free-hand technique.   \\n\\nA 5cm by ___ pancreatic stent was placed successfully using a \\nsphincterotome stent introducer kit. \\nCannulation of the bile duct was successful and deep with a \\nsphincterotome using a free-hand technique.  \\nTwo round stones ranging in size from 2 mm to 3 mm were seen at \\nthe lower third of the common bile duct.  \\nOtherwise, the cholangiogram was normal. \\nA sphincterotomy was performed in the 12 o'clock position using \\na sphincterotome over an existing guidewire. \\nA small stone as well as sludge were extracted successfully \\nusing an RX Extraction Balloon.\\n\\n \\nBrief Hospital Course:\\n___ yo male here for ERCP after recent development of \\npancreatitis in ___.  He does have significant abdominal pain \\nafter the procedure, without rebound or guarding, hopefully only \\nrelated to post procedure pain and not post ERCP pancreatitis.  \\nHe is bradycardic, in normal sinus, possibly with too much sinus \\nblock on board in sinus after recent development of atrial \\nfibrillation.  This may be causing dizziness, but blood pressure \\nis preserved.  CHADS2 is 1 - but he was started on xarelto, \\ncurrently off, and on hold after procedure.  Initial episode of \\npancreatitis most likely related to gallstones, and will require \\ncholecystectomy after stent removed. \\n\\n##  Cholelithiasis/gallstone pancreatitis: ERCP tolerated well. \\nCannulation of pancreatic duct, sphincterotomy, successful \\npancreatic stent placement. 2 stones were seen in CBD. 1 stone \\nwas extracted. Tolerated procedure well, did not receive \\nindomethacin due to allergy. Xarelto stopped for 5d and started \\n5d course of ciprofloxacin. Was NPO overnight, tolerated clears \\nand advanced diet prior to discharge. \\n\\n##  Recent atrial fibrillation, with bradycardia: noted to have \\nasymptomatic sinus bradycardia to ___, with some improvement on \\ncessation of atenolol. Atenolol is therefore being held on \\ndischarge. Pt has had no episodes of AF or RVR since his \\npancreatitis episode. As above, Xarelto held for 5d. CHADS2 \\nscore of 1. \\n\\n##  type II diabetes mellitus: mildly hyperglycemic overnight \\noff home metformin/glyburide, but resuming on discharge. \\n\\n## Hypertension: as above, held atenolol. BP well controlled \\nwith home lisinopril. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Ferrous Sulfate 65 mg PO DAILY \\n2. FoLIC Acid 1 mg PO DAILY \\n3. Lisinopril 40 mg PO DAILY \\n4. Atenolol 50 mg PO DAILY \\n5. Simvastatin 10 mg PO QPM \\n6. GlyBURIDE 5 mg PO DAILY \\n7. MetFORMIN (Glucophage) 500 mg PO BID \\n8. Rivaroxaban 20 mg PO DAILY \\n9. Omeprazole 20 mg PO DAILY \\n10. Magnesium Oxide 400 mg PO DAILY \\n\\n \\nDischarge Medications:\\n1. Lisinopril 40 mg PO DAILY \\n2. Omeprazole 20 mg PO DAILY \\n3. Ciprofloxacin HCl 500 mg PO Q12H \\nPlease complete 5d course to end evening of ___ \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*7 Tablet Refills:*0\\n4. Ferrous Sulfate 65 mg PO DAILY \\n5. FoLIC Acid 1 mg PO DAILY \\n6. GlyBURIDE 5 mg PO DAILY \\n7. Magnesium Oxide 400 mg PO DAILY \\n8. MetFORMIN (Glucophage) 500 mg PO BID \\n9. Simvastatin 10 mg PO QPM \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\ngallstones, stent placement, sphincterotomy, extraction of \\nsludge and stone\\n\\n \\nDischarge Condition:\\npleasant, NAD\\nmildly bradycardic, no mrg; JVP flat\\nCTAB\\nsntnd, NABS\\nwwp, neg edema\\nA&O grossly, moving all 4, no facial droop\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\nIt was a pleasure caring for you. You were admitted for \\nobservation after your endoscopic retrograde cholangiogram, \\nwhich you tolerated well. \\nOn discharge, please complete your course of antibiotics as \\nprescribed. We have stopped your atenolol given your slow heart \\nrates. We have also held your blood thinner for 5 days. Please \\nresume your blood thinner after that. \\n \\nFollowup Instructions:\\n___\", 'Sex M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint right leg weakness\\n \\nMajor Surgical or Invasive  :\\nNone\\n\\n \\nHistory of Present Illness:\\n___ male with h/o sciatica, afib on coumadin, gout, prostate \\ncancer presenting with with acute onset RLE weakness   \\n  to walk.  Two weeks ago, he had decreased RLE strenth \\ncausing him to trip during tennis.  He fell on his right hip.  4 \\ndays ago, he had pain and weakness in his right him He was \\nadmitted 2d ago to cardiology service for new onset     \\nrvr requiring cardioversion and coumadin.  He had no \\nintravascular interventions.  \\n.\\nHe complains of difficulty getting leg off bed   trouble \\nwalking   inability to raise right foot.\\n\\nIn   ED, initial VS:  97.5 88 101/65 26 98.  Exam showed R \\ngluteus hematoma, tracking.  Good hip flexion ___, decreased \\nplanter and knee strength.    his INR of 3.8, he got 10 mg Vit \\nK, FFP.  For pain, 4 mg morphine.  He had a WBC 27 treated with \\n1gm ceftriaxone.  A foley was placed with 700 cc UOP.  Neuro \\nwanted MRI spine to r/o epidural hematoma.  This was showed age \\nrelated changes but   essentially unchanged.  Ortho felt this \\nwas likely compression of sciatic nerve from     not \\nc/w compartment syndrome.  He got 1L IVF For his AFib: Dr. \\n___ cardiologist) saw in ED for ___  . Dr.   \\n___ changing to ___, but family did not want to Prior \\nto transfer, VS: 96 141/82 19 100/RA, Access: 1 PIV.\\n.\\nOn the floor, he felt well.  His family refused further studies, \\nsuch as the x-rays that were ordered.  He denied pain.\\n\\n \\nPast Medical History:\\n1. Sciatica for \"several years,\" unable to clarify further. \\nTypical pain is centered in R. knee   is worst upon waking.\\n2. Prostate CA, dx ___ ago, managed conservatively: saw ___\\nand observation only.\\n3. AFib with RVR diagnosed and treated 4 days ago at ___. \\nStarted on Coumadin with Lovenox bridge.\\n4. ? Gout given presence of allopurinol in his med list, but not\\n  by patient or in past notes\\n \\nSocial History ___\\nFamily History:\\nFather with MI at ___, later developed colon CA.  Mother died \\nsuddenly, cause unknown at ___ Brother with multi-vessel CABG \\nin his late ___ No known family members with stroke\\n \\nPhysical Exam:\\nDischarge PE:\\nTm=99.9=Tc, HR=70s-100s, BP=130s/50s-60s,  =12, POx=95% RA; \\nBMx1\\nGENERAL:  elderly male lying in bed in NAD, comfortable\\nHEENT:    sclera, dry MM, EOMI, PERRL, OP clear, neck \\nsupple\\nCARDIAC:  Tachycardic, regular rhythm, no m/r/g\\nLUNG:  CTAB\\nABDOMEN:  Soft, NT/ND, NABS\\nEXT:  Large ecchymosis and extensive associated swelling \\nextending from right lower back down to mid-thigh, no clubbing \\nor lower extremity edema, good capillary refill in bilateral \\nextremities with palpable DP pulses \\nNEURO:  A+Ox3, CN ___ intact, Sensation improved in right lower \\nleg, but continues to have sensation deficit around his right \\n  toe.  His right leg motor exam was significant for weak ___ ankle flexors, ___ ankle extensors,   hamstrings, ___ \\nquads,   ___ right iliopsoas.  He can only minimally wiggle \\nhis toes.  Motor strength and sensory is preserved in his left \\nleg.  He has absent reflexes bilaterally.\\n\\n \\nPertinent Results:\\n___ 08:15AM   ___ PTT-35.6*  \\n___ 08:15AM   NEUTS-89.4* LYMPHS-7.7* MONOS-2.7 EOS-0.1 \\nBASOS-0.1\\n___ 08:15AM   PLT COUNT-236\\n___ 08:15AM   WBC-27.1*# RBC-3.52*# HGB-10.4*# HCT-31.0*# \\nMCV-88 MCH-29.5 MCHC-33.5 RDW-15.2\\n___ 08:15AM   GLUCOSE-194* UREA N-37* CREAT-1.9* SODIUM-137 \\nPOTASSIUM-4.1 CHLORIDE-99 TOTAL CO2-21* ANION GAP-21*\\n___ 08:24AM   HGB-11.6* calcHCT-35\\n___ 09:38AM   LACTATE-4.1*\\n.\\n___ CXR:  \\nIMPRESSION: No evidence of acute cardiopulmonary process. \\n.\\n___ CT head w/o contrast: \\nIMPRESSION: No acute intracranial process.\\n.\\n___ MRI of T- and L- spine:\\nMPRESSION: \\n1. No   of hematoma within the thoracic or lumbar spine. \\n2. Severe degenerative changes of the lumbar spine, including \\nsevere spinal canal stenosis at L5/S1 level with impingement on \\nbilateral traversing S1 and the right exiting L5 nerve roots, \\nare stable since the ___ examination. \\n3. Multilevel degenerative changes of the thoracic spine, most \\nsevere at \\nT2-3, with impingement upon the exiting left T2 nerve root \\nimpingement and moderate spinal canal stenosis. \\n4. Status post C5-C7 fusion with posterior fixation hardware and \\nassociated post-surgical changes seen on STIR sequence, \\nincompletely imaged. \\n.\\n___ MRI of pelvis: \\nIMPRESSION: \\n1. Extensive intramuscular hematoma and hypertrophy of the right \\ngluteal \\nmuscles and right piriformis muscle, causing mass effect on the \\nright S1, S2, and S3 nerve roots. \\n2. Narrowed caliber of the right gluteal canal, causing mass \\neffect on the right sciatic nerve. \\n3. Well-circumscribed, benign-appearing left iliac bone lesion, \\nwith imaging features that are most likely compatible with \\nhemangioma. \\n4. Moderate to severe endplate degenerative changes at L4/L5 and \\nL5/S1. \\n.\\n___ Hip X-ray:  \\nIMPRESSION: There is no evidence of an acute bony injury. \\n.\\n___ blood culture: Negative to date\\n \\nBrief Hospital Course:\\nThis is an ___ year old male with PMH of sciatica, prostate CA, \\nand recently diagnosed atrial fibrillation s/p recent \\nhospitalization ___ for cardioversion requiring initiation \\nof Lovenox/Coumadin for stroke prevention presenting with \\nmassive hematoma, RLE weakness, and urinary retention.\\n.\\n#. Hematoma:  The patient developed a large hematoma extending \\nfrom his right flank to his right mid-thigh in the setting of a \\nrecent mechanical fall and initiation of anticoagulation with \\nLovenox and Coumadin with an INR of 3.8 on admission.  His INR \\nwas successfully reversed with vitamin K and FFP in the ED.  His \\nhematocrit fell significantly from a baseline of 46 to 22.8 the \\nAM of ___ and he required 3 units of pRBC transfusion to bring \\nhis hematocrit to around 30 at time of discharge.  No CTA was \\nneeded to rule out extravasation as it appeared that his \\nbleeding stopped after reversal of his INR as evidenced by his \\nappropriate hematocrit response to blood transfusions. He also \\nhad compressive neuropathy from the mass effect of the hematoma \\ncausing limited right lower extremity movement and initial \\nconcern for compartment syndrome.  The mass effect of the \\nhematoma was also likely causing urinary retention which \\nrequired the placement of a Foley catheter.  The urinary \\nretention quickly resolved as the hematoma resorbed and he had a \\nsuccessful trial of void prior to discharge.  Given the lower \\nextremity weakness and urinary retention, spinal cord \\ncompression was ruled out by an MRI on admission.  Orthopedics, \\nvascular, and neurology were all consulted to help manage his \\nacute presentation due to concern for compartment syndrome, \\nconcern for active extravasation and falling hematocrit, and \\nweakness; respectively.  It was determined that the patient did \\nnot have compartment syndrome, so there was no need for surgical \\nintervention.  His physical exam was monitored closely and he \\nnever developed a cold extremity or lost peripheral pulses.  His \\nmotor strength and sensory of his right lower extremity improved \\ndramatically throughout his admission and are documented in the \\nPE section of this document.  With the help of ___, the patient \\nwas able to ambulate with a walker.  An AFO brace was provided \\nfor his right foot given the foot drop he developed as a result \\nof the compressive neuropathy from the hematoma.  Oxycodone was \\nprescribed as needed and worked well for pain control secondary \\nto swelling and compression of his sciatic nerve.  He was \\nadvised not to drive given his new foot drop and use of opiates \\nthat will cause drowsiness. \\n.\\n#. Atrial fibrillation: The patient was diagnosed with new onset \\natrial fibrillation on ___ and was successfully cardioverted.  \\nHe remained in normal sinus rhythm on telemetry throughout his \\nadmission.  After his last hospitalization for cardioversion, he \\nwas discharged on Lovenox/Coumadin and presented to the ED with \\nan INR of 3.8 and evidence of a large hematoma on exam.  \\nCardiology/EP was consulted in the ED to guide further \\nmanagement and recommended starting amiodarone 200mg TID for 1 \\nweek, 200mg BID for 1 week, and then continue on 200mg daily in \\nan attempt to prevent recurrence of atrial fibrillation in the \\nacute period as he is at high risk given the significant amount \\nof stress due to the bleed, pain, and anemia.  It was also \\nagreed that all anticoagulation needed to be discontinued for \\nthe time being as his risk of continued bleeding currently \\noutweighed the preventive stroke benefits of anticoagulation.  \\nFortunately, it was deemed that the left atrial appendage \\nvelocity was vigorous on ECHO and there was no spontaneous ECHO \\ncontrast and no significant aortic thrombus making his risk of \\nstroke reduced, but not non-existent. Unfortunately, he \\ndeveloped a diffuse, pruritic skin rash on his back and chest a \\nfew days after starting amiodarone which was attributed to the \\ndrug.  Therefore, amiodarone was discontinued prior to discharge \\nand no other anti-arrythmics or beta blockers were started.  He \\nwill follow up with Dr. ___ as an outpatient in ___ clinic. \\n \\n.\\n#. CODE: Full code this admission, but DNR/DNI per last \\ndischarge summary\\n \\nMedications on Admission:\\n1. Lovenox ___ mg/mL Syringe Sig: One (1)  Subcutaneous once a \\nday for 3 days.\\n2. Allopurinol ___ mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \\n\\n3. Warfarin 2.5 mg Tablet Sig: Two (2) Tablet PO once a day.\\n4. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO every six (6) \\nhours as needed for pain: do not exceed 4 gram in 24 hours.  \\n5. Multivitamin Tablet Sig: One (1) Tablet PO once a day.  \\n6. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr PO \\nonce a day.\\n \\nDischarge Medications:\\n1. Allopurinol ___ mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \\n\\n2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \\nhours) as needed for pain/fever.  \\n3. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n4. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every ___ hours \\nas needed for pain.\\nDisp:*20 Tablet(s)* Refills:*0*\\n5. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*0*\\n6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as \\nneeded for constipation.\\nDisp:*30 Tablet(s)* Refills:*0*\\n7. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \\nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \\nconstipation.\\nDisp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*0*\\n8. Sarna Anti-Itch 0.5-0.5 % Lotion Sig: Apply  Topical four \\ntimes a day as needed for itching.\\nDisp:*1 bottle* Refills:*0*\\n9. Benadryl Allergy 12.5 mg/5 mL Liquid Sig: Five (5) mL PO \\nevery six (6) hours as needed for itching.\\nDisp:*1 bottle* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary Diagnoses:\\n-Hematoma\\n-Compressive neuropathy\\n-Urinary retention\\n.\\nSecondary diagnosis:\\n-Atrial fibrillation s/p successful cardioversion, now in sinus \\nrhythm\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nYou were admitted to ___ \\nfurther evaluation of right leg weakness and urinary retention.  \\nYou were found to have a large collection of blood called a \\nhematoma that extended from your right flank all the way down to \\nyour right thigh that was compressing the nerves which \\ncontrolled your right leg and bladder.  The hematoma was likely \\nas a result of your fall in combination with the blood thinning \\ndrugs called Lovenox and Coumadin that you were prescribed to \\nprevent a stroke given your recent atrial fibrillation.  You had \\nsignificant bleeding into this hematoma and actually lost half \\nof your blood stores.  You required 4 units of blood \\ntransfusions to restore your blood to a safe level.  You also \\nrequired a urinary catheter to drain your bladder until you \\nregained bladder function.  You will be discharged on opiates \\nfor pain control and should not drive or operate heavy machinery \\nwhile on these drugs.  You should not drive until your right \\nsided foot drop improves.  You were initially started on \\namiodarone to control your heart rate, but developed a skin rash \\nreaction and it was stopped.\\n.\\nThe following changes have been made to your home medication \\nregimen:\\n- You should stop taking Lovenox and Coumadin\\n- You should take oxycodone as needed for the pain\\n- You should take docusate, senna, and bisacodyl while on \\noxycodone to prevent constipation   \\n- You should use Sarna lotion as needed for your itchy rash and \\nyou can use Benadryl 12.5 mg as needed for itch that does not \\nrespond to the lotion.\\n \\nFollowup Instructions:\\n___', \"Sex:   M Service: MEDICINE Allergies: \\nNo Known Allergies / Adverse Drug  \\n \\n ___.\\n \\nChief Complaint:\\nHypokalemia\\n \\n  Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ hx EtOH  , on transplant list, DM2,   ___ \\nhypokalemia to 2.4 from ___ clinic with Dr. ___. His \\nESLD has been complicated by encephalopathy, jaundice and edema. \\nHe was previously maintained on aldactone/lasix, however his \\naldactone was d/c'  ___ and was started on metolazone 1 month \\nprior. After starting metolazone he developed hypokalemia to \\n1.9, after which he was started on K supplementation.  \\nPresented   to transplant clinic for routine  -up found to have K 2.1 with ___ Cr 2.2 from baseline ~1.5. Took \\nMetolazone w/ kalor this AM. His hepatologist today discontinued \\nmetolazone and restarted aldactone.  \\nROS notable for palpitations which he states are intermittent \\nand chronic. No f/c/n/v/d, no abd pain, urinary sx. Returned \\nfrom ___ this weekend, swelling worse in legs from walking. \\nLabs: BUN 55, K 2.1, HCO3 33 c/w contraction alkalosis likely \\n___ diuretic use.  \\nIn the ED, initial vs were 98.8 71 139/69 18 100%. EKG was \\nreportedly negative, although upon review on the floor it shows \\nU-waves. The patient was not given crystalloid/colloid \\nresuscitation or potassium repletion while in the ED.  \\nOn arrival to the floor, patient reports feeling well with \\nminimal complaints.  \\n\\n \\nPast Medical History:\\n- EtOH cirrhosis; complicated by hepatic encephalopathy, \\nesophageal varices (no EGD on record, only per patient report), \\nand jaundice  \\n- Aplastic anemia (per  , diagnosed in ___ several years \\nago) \\n- Insulin-dependent diabetes mellitus  \\n- Chronic kidney disease  \\n- Hypertension  \\n- Breast surgery ___ - ___ with resultant \\nhematoma evacuation x 2\\n \\nSocial History:\\n___\\nFamily History:\\nFather died of alcohol cirrhosis. Extended family members had \\nCVAs, age ___. \\n \\nPhysical Exam:\\nAdmission Exam:\\nVS 98.2 138/73 86 20 98%RA  \\nGEN Alert, oriented, no acute distress  \\nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \\nNECK  , no JVD, no LAD  \\nPULM Good aeration, CTAB no wheezes, rales, ronchi  \\nCV RRR normal S1/S2, no mrg  \\nABD soft NT ND normoactive bowel sounds, +hepatomegaly with \\nliver edge ~3cm below costal margin, nontender. No shifting \\ndullness.  \\nEXT WWP 2+ pulses palpable bilaterally, 2+ pedal edema.  \\nNEURO CNs2-12 intact, motor function grossly normal. -asterixis  \\n\\nSKIN no ulcers or lesions  \\n\\nDischarge Exam:\\n98.3 116/58 64 20 100\\nGen No acute distress. Well nourished\\nHEENT: EOMI. Icteric sclera. NCAT\\nNeck: No JVD\\nCV: RRR. ___ holosystolic murmur. NS1&S2\\nResp:  . Good air flow\\nExt: No c/c/e\\n\\n \\nPertinent Results:\\nAdmission Labs:\\n___ 08 55AM BLOOD WBC-9.1# RBC-3.90*# Hgb-13.4*# Hct-39 1*# \\nMCV-100* MCH-34.3* MCHC-34.3 RDW-14.6 Plt Ct-94*\\n___ 08:55AM BLOOD ___\\n___ 08:55AM BLOOD UreaN-51* Creat-2.2* Na-135 K-2.4* Cl-91* \\nHCO3-32 AnGap-14\\n___ 08:55AM BLOOD  -57* AST-94* AlkPhos-161* TotBili-6.2*\\n___ 08:55AM BLOOD Albumin-4.1 Calcium-9.7 Phos-3.4 Mg-2.1\\n.\\nDischarge Labs:\\n___ 06:55AM BLOOD WBC-4.0 RBC-2.85* Hgb-10.0* Hct-28.9* \\nMCV-101* MCH-35.0* MCHC-34.5 RDW-14.6 Plt Ct-46*\\n___ 06:55AM BLOOD ___ PTT-38.7* ___\\n___ 06:20AM BLOOD Creat-1.2 Na-141 K-3.5 Cl-104 ___ 06:55AM BLOOD ALT-36 AST-62* AlkPhos-90 TotBili-6.7*\\n___ 06:55AM BLOOD Calcium-9.3 Phos-2.4* Mg-2.2\\n.\\nImaging:\\n___: Sinus rhythm. The Q-T interval is prolonged. \\nNon-specific ST-T wave changes. Compared to the previous tracing \\nof ___ the Q-T interval is longer. \\n___: Artifact is present. Sinus rhythm. The Q-T interval is \\nprolonged at 480 milliseconds. Non-specific ST-T wave changes. \\nCompared to the previous tracing of ___ there is no \\ndiagnostic change. \\n\\n \\nBrief Hospital Course:\\n___ yo M with h/o EtOH cirrhosis c/b hepatic encephalopathy that \\npresented to the ED from clinic with a K of 2.1. \\n.\\nActive Issues:\\n#Hypokalemia: Patient was taking thiazide and loop diuretic, \\nincluding metolazone. U-waves present on EKG. Patient reported \\nfatigue and muscle cramps for several weeks prior to admission. \\nDiuretics stopped, and K was repleted. Lasix and spironolactone \\nrestarted 24 hours later. Patient was stable on this regimen and \\nd/c'ed home with K of 3.5. U-waves resolved on EKG at time of \\ndischarge.\\n.\\n#AOCKD: Cr on admission 2.2 likely ___ overdiuresis. Responded \\nwell to IV albumin, and returned to baseline 1.2 on discharge.\\n.\\nChronic Issues\\n.\\n#EtOH Cirrhosis: Pt is on liver transplant list with MELD of 30 \\nin presentation. He has a history of hepatic encephalopathy, so \\nlactulose and rifaximin were continued in-house. No ascites on \\npresentation and no history of paracentesis. History of portal \\ngastropathy on EGD, so nadolol continued. Will return for \\ntransplant work-up.\\n.\\n#Thrombocytopenia: Chronic. S/p BM biopsy on ___ which showed \\nhypocellular marrow with mild dyspoesis of the erythroid and \\nmegakaryocytic lineages. This was felt secondary to chronic \\nconditions rather than MDS.\\n.\\n#IDDM: Well controlled in-house, and d/c'ed on home dose of \\nlantus and SSI\\n.\\nTransitional Issues:\\n#Will need PFTs, ECHO, routine labs for transplant work-up\\n#Will need lytes checked at outpt follow-up after recent med \\nchanges\\n \\nMedications on Admission:\\nPreadmission medications listed are correct and complete.  \\nInformation was obtained from PatientwebOMR.\\n1. Lactulose 30 mL PO QID \\n2. Nadolol 20 mg PO DAILY \\n3. MetFORMIN (Glucophage) 500 mg PO BID \\n4. Furosemide 40 mg PO BID \\n5. Spironolactone 100 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Thiamine 100 mg PO DAILY \\n8. Ascorbic Acid ___ mg PO DAILY \\n9. Glargine 60 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n\\n \\nDischarge Medications:\\n1. Ascorbic Acid ___ mg PO DAILY \\n2. Furosemide 40 mg PO DAILY \\n3. Glargine 60 Units Bedtime\\nInsulin SC Sliding Scale using HUM Insulin\\n4. Lactulose 30 mL PO QID \\n5. Nadolol 20 mg PO DAILY \\n6. Rifaximin 550 mg PO BID \\n7. Spironolactone 100 mg PO DAILY \\n8. Thiamine 100 mg PO DAILY \\n9. MetFORMIN (Glucophage) 500 mg PO BID \\n10. Outpatient Lab Work\\nPlease obtain Basic Metabolic Profile (electrolytes, BUN, \\ncreatinine) and fax results to :\\n\\n ___. \\nLocation: ___ MEDICAL GROUP \\nAddress: ___, ___ \\nPhone: ___ \\nFax: ___ \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary Diagnosis:\\nHypokalemia\\nAcute kidney injury secondary to pre-renal azotemia\\n\\nSecondary Diagnosis:\\nAlcoholic cirrhosis\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nIt was a pleasure caring for you at ___. You were admitted \\nbecause you had a low potassium level. This was likely due to \\none of your medications, metolazone. The low potassium was the \\nlikely cause of your weakness and muscle cramping prior to being \\nadmitted. You were given potassium through your veins and by \\nmouth, and your metolazone was discontinued. At discharge your \\npotassium level was within normal limits. \\n\\nYour diuretics to treat your cirrhosis were initially held on \\nadmission. Both furosemide and spironolactone were started after \\nwe corrected your potassium. Please continue taking these \\nmedications at home. \\n\\nYour kidney function was slightly abnormal on admission. We \\nbelieve that is because you did not have enough fluid going to \\nthem. After giving you albumin, your kidney function returned to \\nnormal. Please remember to drink plenty of fluids at discharge, \\nas your diuretics have a tendency to dry you out.\\n\\nPlease obtain blood work to follow up your electrolytes and \\nrenal function on your current medication regimen within 5 days \\nof discharge.\\n\\n \\nFollowup Instructions:\\n___\", \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPercocet / Codeine\\n \\n ___.\\n \\nChief Complaint:\\nabdominal pain\\n \\nMajor Surgical or Invasive Procedure:\\n___ ERCP\\n___ Percutaneous placement of biliary drain\\n___ Biliary brushings \\n\\n \\nHistory of Present Illness ___ man with stage IIB pancreatic adenocarcinoma s/  \\nWhipple and gemcitabine who presents with   upper quadrant \\nabdominal pain and increasing LFTs. For the past several days he \\nhas intermittent, dull RUQ pain that is 2 out of 10 on the pain scale, lasting 30 minutes to a few hours, without any apparent \\nalleviating or precipitating factor. No nausea,   diarrhea, constipation. No fever or chill. \\n.\\nHis LFTs have been   since   the past  : AST 34 -> 330 \\n(from ___ to ___, ALT 59 -> 369, AP 401 -> 2957, total \\nbili     -> 3.0 (direct bili 2.0). He had an ultrasound on \\n___ that showed intrahepatic ductal dilation. Admitted for \\nfurther management.\\n.\\nReview of Systems:  \\n(+) Per HPI  \\n(-) Denies  , chills, night sweats   weight loss or \\ngain. Denies blurry vision, diplopia, loss of vision photophobia. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denies   pain or tightness,  , lower \\nextremity edema. Denies cough, shortness of breath, or wheezes. \\nDenies nausea, vomiting, diarrhea, constipation, melena, \\nhematemesis, hematochezia. Denies   bleeding, bruising, \\nlymphadenopathy.   dysuria, stool or urine incontinence. \\nDenies   or myalgias. Denies rashes or skin breakdown. \\nNo numbness/tingling in extremities. All other systems negative.\\n \\nPast Medical History:\\nONCOLOGIC HISTORY:\\n# T3N1M0, stage IIB pancreatic adenocarcinoma \\n- developed painless jaundice in the end of ___.\\n- underwent ERCP on ___, which revealed malignant-appearing \\nstricture in the lower common bile duct and brushings were \\nnegative for malignancy. A CT angiogram was performed and showed \\na possible pancreatic tumor in the head of the pancreas \\n- pancreatic FNA performed on ___ revealed atypical cells.  \\n- underwent a Whipple resection with SMV reconstruction on \\n___, and his postoperative course had been complicated by \\ndelayed gastric emptying. Pathology revealed a pT3 1.9 cm poorly \\ndifferentiated ductal adenocarcinoma, which involved ___ lymph \\nnodes involved. In addition, the distal pancreatic margin was involved and there was disease in the SMV. \\n- discharged home on ___ but then developed nausea, vomiting, \\nand likely aspiration leading to pneumonia and was hospitalized \\non ___.  \\n- commenced single agent gemcitabine 1000 mg/m2 weekly 3 of 4 \\nweeks on ___ receiving one cycle in advance of radiation \\ntherapy with concomitant capecitabine (1000 mg  ) which \\nfinished on ___.\\n.\\nOTHER MEDICAL HISTORY:\\nHypertension\\nDiet-controlled diabetes\\n \\nSocial History:\\n___\\nFamily History:\\nFather had IDDM and HTN, brother with DM, HTN \\n \\nPhysical Exam:\\nVS: T 97.1, BP 130/80, HR 75, RR 18, 100%RA\\nGEN: Middle-aged man in NAD, awake, alert  \\nHEENT: EOMI, sclera anicteric, conjunctivae clear, OP moist and \\nwithout lesion\\nNECK: Supple, no JVD  \\nCV: Reg rate, normal S1, S2. No m/r/g.   \\nCHEST: Resp unlabored, no accessory muscle use CTAB, no \\ncrackles, wheezes or rhonchi.  \\nABD: Soft, NT, negative ___, ND, no HSM, bowel sounds \\npresent\\nMSK: normal muscle tone and bulk\\nEXT: No c/c/e, 2+ ___ bilaterally\\nSKIN: No rash, warm skin\\nPSYCH: appropriate, pleasant\\n \\nPertinent Results:\\n___ 11 18AM   UREA N-10 CREAT-0.7\\n___ 11:18AM   ALT(SGPT)-369* AST(SGOT)-330* ALK PHOS-2957* \\nTOT BILI-3.0* DIR BILI-2.0* INDIR BIL-1.0\\n___ 11:18AM   ALBUMIN-4 1\\n___ 11:18AM   WBC-5.1 RBC-3.49* HGB-10.5* HCT-32.5* MCV-93 \\nMCH-30.1 MCHC-32.4 RDW-15.6*\\n___ 11:18AM   NEUTS-77.2* LYMPHS-12.8*  -7.5 EOS-1.4 \\nBASOS-1.1\\n___ 11:18AM   PLT COUNT-446*#\\n.\\nIMAGING:\\n___ RIGHT UPPER QUADRANT ULTRASOUND: Evaluation of the left \\nlobe of   liver is limited due to overlying bowel gas in the \\nmidline. The remainder of the liver shows no focal hepatic mass. \\nThere is mild-to-moderate intrahepatic biliary ductal \\ndilatation, consistent with the history of prior Whipple. Color flow images of the main portal vein show normal hepatopetal \\nflow. Though full doppler examination was not completed, the \\nanterior right portal vein remains thrombosed (as per history) \\non color flow imaging. The common bile duct measures 6 mm at the \\nlevel of the hepatic artery. The patient is status post \\ncholecystectomy. The pancreas is not well visualized.   \\nIMPRESSION:   \\n1. Normal hepatic echotexture without definite focal lesion, \\nthough limited evaluation of the left lobe of the liver due to \\noverlying bowel gas.\\n.   \\n2. Mild-to-moderate intrahepatic biliary ductal dilatation with \\nnormal CBD caliber measuring 6 mm.\\n.  \\n3. Patent main portal vein with persistent thrombosis of the \\nanterior right portal vein on color flow imaging.  \\n.\\n___ MRCP:IMPRESSION: \\n1. Near occlusion of a narrowed main portal vein from mostly \\nchronic \\nappearing thrombus extending from the confluence to the \\nbifurcation, with thrombus that may minimally extend into the \\nright portal vein, new since the ___. Chronic \\nthrombosis of the right anterior portal vein with expected \\nparenchymal evolution of mild scarring.\\n. \\n2. Mild increase in the intra- and extra-hepatic bile ducts, \\nwithout evidence of an obstructing mass at the hepaticojejunal \\nanastomosis, likely reflecting an early stenosis at the site of \\nanastomosis, likely secondary to radiation/surgical changes. No \\nconcerning hepatic lesions. An arterially enhancing hepatic \\nlesion in segment IVb, likely represents active fibrosis.\\n.  \\n3. Extensive progressively enhancing soft tissue extending \\nbetween \\npancreaticojejunal and hepaticojejunal anastomosis, in the porta \\nhepatis and around the interposed jejunostomy loop, likely \\nrepresents post-radiation fibrosis/inflammationintermixed tumor \\ninfiltration cannot be excluded. \\n.\\n4. Diffuse abnormality of the pancreatic parenchyma has \\nprogressed and likely represents chronic pancreatitis and \\nradiation change.\\n.  \\n5. Single rim-enhancing pre-aortic lymph node is concerning for \\npossible metastatic disease, and needs attention on followup \\nimaging.  \\n\\n \\nBrief Hospital Course:\\n___ man with stage IIB pancreatic adenocarcinoma s/p \\nWhipple and adjuvant Gemcitabine followed by chemo(xeloda)/XRT \\nand subsequent additional gemcitabine for a positive surgical \\nmargin and involved LN's who presented with mild right upper \\nquadrant abdominal pain and rapidly rising LFTs without fever. \\nHis most recent chemotherapy was cycle 4 Gemcitabine Day \\n___.\\n.\\n# Elevated LFTs/RUQ pain: An ultrasound was perfomed on \\nadmission and showed ductal dilatation. The patient was admitted \\nfor further work up and treated with prn pain medication. An \\nMRCP was performed on ___ and demonstrated extension of \\nportal vein thrombosis and increase in the intra- and \\nextra-hepatic bile ducts, without evidence of an obstructing \\nmass at the hepaticojejunal anastomosis with the appearance of \\nstenosis rather than disease recurrence. There was enhancing \\nsoft tissue extending between pancreaticojejunal and \\nhepaticojejunal anastomosis, in the porta hepatis and around the \\ninterposed jejunostomy loop, thought to be post-radiation \\nfibrosis, but recurrence could not be ruled out. In addition \\nthere was a suspicious preaortic lypmh node. An ERCP was \\nattempted on ___ but failed. On ___ a successful \\npercutaneous biliary drainage was placed by interventional \\nradiology. The patient's LFT's subsequently decreased and pain \\nwas also relieved. On ___ biliary brushings were done via the \\nexisting biliary tube by ___ for diagnosis of the cause of \\nobstruction prior to the placement of an internal metal stent. \\nPost this procedure pt developed a temp of 100.4 and was started \\non unasyn.Blood cultures were obtained and remained sterile. Pt \\nto continue a course of cipro and flagyl at home fo ra \\ncompletionof 7 days antibiotics.Pt will be contacted by ___ for \\nplacement of  metal stent after results of cytology. \\n.\\n# Diet controlled diabetes: The patient has a history of \\ndiabetes that is diet controlled at home. However, he was \\nmarkedly hyperglycemic throughout this hospital admission and \\nmanaged with an insulin sliding scale. HBA1C was also elevated \\nat 9.2. The ___ service was consulted and recommended to \\nstart glipizide 2.5 mg po bid as patient was very reluctant to \\nstart insulin. Pt will likely need an additional oral \\nhypoglycemic medication ( metformin) and he will follow with his \\nPCP.\\n.\\n# Hypertension: The patient has a history of hypertension, but \\nwas not taking antihypertensive medications on his admission and \\nwas not noted to be hypertensive during his hospitalization.\\n.\\n#Urine fungus: Pt had a urine culture obtained because of fever \\npost procedure, as described above. Urine was positive for \\nfungus. As he was asymptomatic he was not treated.Pt to have a \\nrepeat urine culture as an outpatinet and if has persistent \\nfungus in his urine, given his diabetes, should be treated.\\n\\n \\nMedications on Admission:\\nlorazepam 0.5 mg q4-6hr prn nausea\\nondansetron 4 mg tid prn nausea\\nascorbic acid ___ mg q12h\\naspirin 325 mg daily\\ncalcium carbonate\\n\\n \\nDischarge Medications:\\n1. glipizide 5 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day): \\nhold if you are not eating/vomiting.\\nDisp:*30 Tablet(s)* Refills:*0*\\n2. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 3 \\ndays.\\nDisp:*6 Tablet(s)* Refills:*0*\\n3. metronidazole 500 mg Tablet Sig: One (1) Tablet PO three \\ntimes a day for 3 days.\\nDisp:*9 Tablet(s)* Refills:*0*\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nBiliary obstruction\\nElevated LFTs\\nDiabetes\\nAsymptomatic Candiduria \\nHypertension\\nh/o renal lithiasis\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nYou were admitted with liver (biliary) blockage and increased \\nliver function tests. An ERCP was unsuccessful, but the \\ninterventional radiolgy team was able to place a bile drain \\nthrough your skin and into your liver ducts to relieve the \\nblockage. You also had brushings done by ___ that were sent for \\ncytology studies to determine the cause of the obstruction. You \\ndeveloped fever after the brushings, blood and urine cultures \\nwere obtained and you were started on IV antibiotics.You should \\ncontinue oral antibiotics at home. While you were in the \\nhospital, your blood sugars were quite elevated and you required \\ninsulin shots to manage them.The ___ diabetes service was \\nconsulted and recommeded to start glipizide for now , however,  \\nyou may need to start metformin as well and in the future,you \\nmay need to start insulin.You should continue to check blood \\nsugars at home.\\nNew medications:\\n1. Ciprofloxacin 500 mg po bid x 3 days\\n2. Metronidazole 500 mg po tid x 3 days\\n3. glipizide 2.5 mg po bid\\n \\n \\nFollowup Instructions:\\n___\", \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nAdhesive\\n \\n ___.\\n \\nChief Complaint:\\nSeizure\\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present  :\\n___ woman with melanoma with brain mets s/p chemo, XRT, \\nsurgical resection, immunotherapy presents with likely seizure The patient was at home,   her   s teeth, when   \\nhusband noticed that patient had about 30 seconds of garbled \\nspeech, staring into space,   subsequent confusion. She reports no symptom before the episode. No urine   stool \\nincontinence. She has had 2 similar seizures with   \\nspeech difficulty   the past 6 months.   reports   \\ncompliant with her lamotrigine. No fevers,  , ___ trauma, \\nlocalized weakness.\\n.\\nIn the ED, T 98.6, HR 60   117/69, RR 16, 100%RA. Neuro exam \\nwas nonfocal. ___ CT revealed   extensive melanoma \\nmetastasis, with larger, layering hemorrhage in a metastatic \\nlesion centered in the left parietal lobe, with interval \\ndilation of the temporal horns   was aware Neuro-onc \\nadvised admission to OMED for further management.\\n\\n \\nPast Medical History:\\nONCOLOGIC HISTORY:\\n# Metastatic melanoma:\\n  (1) completed whole brain cranial   on ___ at\\n___,\\n  (2) s/p 1 cycle of temozolomide at ___ schedule at ___ \\n___ 3)  /p craniotomy by ___ on ___ for removal  \\nright frontal brain metastasis, and\\n  (4) s/p Cyberknife radiosurgery to 4 metastases on ___ \\nand\\n___: 2,000 cGy to left superior metastasis, 1,600 cGy to\\nright frontal resection cavity, 1,800 cGy to right high parietal\\nmetastasis, and 2,200 cGy to left temporal metastasis, \\n  (5) s/p   radiosurgery to a right posterior temporal\\nlobe metastasis on ___ to 2,200 cGy, \\n  (6) received temozolomide at a dose of 150 mg/m2/day x 5 days\\nfrom ___ to ___, \\n  (7) started CTLA-4/ipilimumab compassionate use from ___ \\nto ___, \\n  (8) s/p resection of a right deep jugular metastasis on \\n___ ___, M.D.,\\n  (9) s/p Cyberknife to right upper lung metastasis to 4500 cGy\\n(1500 cGy x 3 fractions) from ___ to ___, and\\nCyberknife to   lower lung metastasis to 4500 cGy (1500 cGy x\\n3 ___ to ___,\\n  (10) s/p Cyberknife radiosurgery on ___ to left parietal \\n(to 2200 cGy), left thalamic to ___ cGy), and right frontal\\nmetastases, and \\n  (11) s/p Cyberknife radiiosurgery on ___ to rt \\ncerebellar, lt occipital and lt frontal metastases, all to\\n2200 cGy at 79% isodose line.\\n  (12) status post Ommaya reservoir placement on ___ ___\\n  (___) started ipilimumab (CTLA-4) on ___.\\n.\\nOTHER MEDICAL HISTORY:\\nHand surgery in ___  \\nC-section in ___  \\nBreast implants in ___  \\nDepression\\n \\nSocial History:\\n___\\nFamily History:\\nNon-contributory\\n \\nPhysical Exam:\\nOn admission:\\nGen: middle-aged woman in no acute distress\\nHEENT: EOMI, PERRL, conjunctivae clear, sclerae anicteric, OP \\nwithout lesion\\nNeck: supple\\nLungs: CTAB\\nCV: no JVD, regular rhythm, normal rate, normal S1/S2, no m/r/g\\nAbd: soft, NT, ND BS presents\\nExt: no c/c/e\\nNeuro: awake, oriented x 3, CNs II-XII grossly intact, ___ \\nstrength throughout\\n\\nOn discharge:\\nTm/Tc: 98.3/98.0  BP: 108/62 (108- /62-72 P: 64 (59-71)  R: \\n18  Sat: 99%RA\\nI/O: ___\\nGen: middle-aged woman in no acute distress, AAOx3  \\nHEENT: EOMI, PERRL, conjunctivae clear, sclerae anicteric, MMM, \\nOP without lesions  \\nNeck supple, no cervical or supraclavicular LAD\\nLungs: CTAB, no  /r/r audible  \\nCV: RRR, normal S1/S2, no m/r/g audible\\nAbd: soft, NTND, BS normoactive, no hepatosplenomegaly, no \\nrebound tenderness or guarding\\nExt: WWP, no c/c/e  \\nNeuro: awake, oriented x 3, CNs II-XII   intact, ___ \\nstrength throughout all extremities, 2+ reflexes in all \\nextremities \\n \\nPertinent Results:\\n___  :25PM   GLUCOSE-100 UREA N-  CREAT-0.7 SODIUM-143 \\nPOTASSIUM-3.6 CHLORIDE-106 TOTAL CO2-28 ANION GAP-13\\n___ 09:25PM    -4.6 RBC-3.40* HGB-11.4* HCT-32.2* MCV-95 \\nMCH-33.6* MCHC-35.4* RDW-13.8\\n___ 09:25PM   NEUTS-54.5 ___ MONOS-7.7 EOS-4.5* \\nBASOS-0.9\\n___ 09:25PM   PLT COUNT-225\\n___  :25PM   ___ PTT-28.0 ___\\n.\\nIMAGING:\\n# ___ CT ___:\\n1. Known innumerable brain metastases are more fully appreciated \\non previous MRI examinations. Interval increase in size of the \\npredominantly cystic lesion centered in the left parietal lobe, \\nnow with an increased layering high attenuation component most \\ncompatible with increase in hemorrhage. Otherwise, no new large \\nmass lesions are appreciated. \\n2. Right frontal approach ventriculostomy catheter is in stable \\nposition with tip terminating in the third ventricle with stable \\nconfiguration and size of the lateral ventricles; however, there \\nhas been apparent interval increase in size of the right greater \\nthan left temporal ventricular horns. \\n3. Stable extensive post-radiation and post-surgical change.\\n.\\nMR ___ ___:\\nIMPRESSION: \\n1. Overall, progression of metastatic disease with new lesion \\nseen within the right frontal lobe and increase in size of \\nmultiple other lesions as described above. Some metastatic \\nlesions have decreased in size or disappeared. \\n2. Diffuse white matter FLAIR hyperintensity, stable, consistent \\nwith \\nradiation related changes and post-surgical changes. \\n.\\nCT Chest/Abd/Pelvis ___:\\nIMPRESSION: \\n1. Post-radiation changes in the left lower lung and right \\nperihilar lung. \\n2. No evidence of new metastases. \\n.\\n# CXR ___: Fudicial markers within the right upper and left \\nlower lobes with adjacent linear opacities likely representing \\npost-treatment changes. No pneumonia. \\n.\\n\\nOn discharge:\\n\\n___ 08:05AM BLOOD WBC-3.5* RBC-3.57* Hgb-11.3* Hct-34.2* \\nMCV-96 MCH-31.7 MCHC-33.0 RDW-13.6 Plt ___\\n___ 08:05AM BLOOD Glucose-87 UreaN-12 Creat-0.7 Na-141 \\nK-4.3 Cl-105 HCO3-30 AnGap-10\\n___ 08:05AM BLOOD Calcium-9.5 Phos-3.4 Mg-2.___ woman with melanoma with brain metastases presents \\nwith recurrent seizure.\\n.\\n# Seizure: manifested as speech abnormality, most likely \\ntriggered by brain metastases with associated hemorrhage.  No \\ninjury was sustained during the episode. Patient has had similar \\nseizures in the past 6 months. There was no fever, no evidence \\nof CNS infection.  Lamotrigine dose was increased on admission \\nand upon discharge for further control.\\n.\\n# Metastatic melanoma: patient was found on MRI to have new \\nmetastatic changes on ___ MRI, suggesting progression of \\ndisease.  A CT torso was also performed, which showed no further \\nmetastases.  Radiation oncology was consulted, along with \\nneurosurgery and neuro-oncology, and planned on dicussing \\nfurther treatment strategy after patient's discharge.  Patient \\nhad close follow-up with Dr. ___ Dr. ___ discharge \\nto discuss further management of care.\\n.\\n# Depression:  patient's home dose of escitalopram was continued \\non admission and discharge.\\n\\n \\nMedications on Admission:\\nacetaminophen-codeine 300-30 mg q6h prn pain\\nescitalopram 10 mg daily\\nlamotrigine 125 mg bid\\nlorazepam 0.5 m gbid prn\\nmethylphenidate 10 mg bid\\nzolpidem ___ mg qhs\\ndocusate sodium\\nferrous sulfate 325 mg daily\\nflaxseed oil\\nMVI\\nfish oil\\n \\nDischarge Medications:\\n1. Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday) as needed for anxiety.  \\n3. Zolpidem 5 mg Tablet Sig: ___ Tablets PO HS (at bedtime) as \\nneeded for insomnia.  \\n4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).  \\n5. Ferrous Sulfate 300  mg (60 mg Iron) Tablet Sig: One (1) \\nTablet PO DAILY (Daily).  \\n6. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n7. Omega-3 Fatty Acids     Capsule Sig: One (1) Capsule PO BID \\n(2 times a day).  \\n8. Acetaminophen-Codeine  Oral\\n9. Flaxseed Oil  Oral\\n10. Lamictal 100 mg Tablet Sig: 1.5 Tablets PO twice a day.\\nDisp:*90 Tablet(s)* Refills:*0*\\n11. Methylphenidate 10 mg Tablet Sig: One (1) Tablet PO BID (2 \\ntimes a day).  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPrimary diagnosis: \\n\\nSeizure, recurrent\\n\\nSecondary diagnosis: \\n\\nMetastatic melanoma\\nDepression\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDear. Ms. ___,\\n\\nIt was a pleasure taking care of you at the ___.  You came for \\nfurther evaluation of speech difficulty.  You most likely had a \\nseizure.  While you were here, it was found that you have new \\nbrain lesions, likely representing melanoma metastasis, based on \\nan MRI that was performed.  It is important that you continue to \\ntake your medications and that you follow up with your \\noncologist and neurologist.\\n\\nThe following changes have been made to your medications:\\n\\nWe INCREASED your Lamictal dose to 150 mg twice a day to better \\ncontrol your seizures.\\n \\nFollowup Instructions:\\n___\", 'Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nA.C.E Inhibitors / Codeine / Lidocaine /  \\n \\n ___ Chief Complaint:\\nDizziness and Low Blood Pressure\\n \\nMajor Surgical   Invasive Procedure:\\nhemodialysis\\n \\nHistory of Present Illness:\\n___ yo F with ESRD on HD, DM1, CAD s/p CABG ___, CHF EF 30%(s/  ICD) who was sent   ED from dialysis after experiencing \\nhypotension and dizziness. She had been treated with cefazolin \\n___ and Vanc ___ at HD for positive Coag neg staph \\nbacteremia. On ___, patient underwent exchange over a wire \\nof left femoral tunneled hemodialysis catheter because of \\npersisent bacteremia with coag negative staph.\\n\\n.  \\n\\nIn the ED, initial VS: 98.7 94 105/47 18 97% 2L on SBP 75-80. \\nFSBG low. Refusing central lines, refusing labs, got 22G in arm. \\nGiven Got vanco in ED. CXR unchanged. VS: 98.6 82 100/33 12. \\n\\n.  \\n\\nCurrently, patient reported fatigue and some nausea at dialysis. \\nShe reported that the antibiotics made her feels sick. She \\nreportst that normally her blood pressures run low SBP in \\n70-80s   reports poor   and   PO   over the \\nweekend.  Her boyfriend reports that she has had nausea, \\nvomiting, and diarrhea in the past 3 weeks after dialysis. Also \\nshe reports a lesion on her finger.  \\n\\n.  \\n\\nROS: Denies fever, chills, night sweats, headache, vision \\nchanges, rhinorrhea, congestion, sore throat, cough, shortness \\nof  , chest pain,   pain, constipation, BRBPR, \\nmelena, hematochezia, dysuria, hematuria.  \\n\\n \\n\\n \\nPast   History:\\n- ESRD: Initially HD, transitioned to PD (___)- now back   HD; \\n\\n\\nper renal fellow (___), patient has repeatedly been \\n\\nclotting off catheters so was started on low dose coumadin. No \\n\\nINR target was set - pt was just given 1mg per day. Her INR was \\n\\ninitially 2.5 but   now 1.8. Does make   still; urinates \\n\\n1x/day.\\n\\n-PE (Occurred in setting of catheter placement and SVC \\nthrombosis in ___, but was asymptomatic at that time)-maintained on coumadin \\n\\n- DM Type I: Diagnosed ___ yr ago (Hgb A1C ___\\n\\n- CAD s/p CABG (___), MI x2\\n\\n- CHF (EF 30%) s/p ICD\\n\\n- h o non-sustained v-tach  /p ICD\\n\\n- Hyperlipidemia\\n\\n-   anemia\\n\\n- Hypothyroidism\\n\\n- Cholecystectomy\\n\\n- Osteoporosis\\n\\n- L knee nondisplaced patellar fracture ___\\n\\n- gout   \\n\\n \\nSocial History:\\n___ Family History:\\nFather with DM, CAD MI. Mother with stroke and ___. \\n \\nPhysical Exam:\\nVital Signs\\n Hemodynamic monitoring\\n Fluid Balance\\n 24 hours\\n Since ___ AM\\n \\nTmax: 35.9 C (96.7 F)\\n\\nTcurrent: 35.9 C (96.7 F HR: 89 (78 - 89) bpm\\n\\nBP: 95/39(54) {86/30(42) - 96/44(54 mmHg\\n\\nRR: 16 (15 - 21) insp/min\\n\\nSpO2: 92% \\n\\nHeart rhythm: SR (Sinus Rhythm)\\n\\nHeight: 63 Inch\\n\\n \\n  \\n Total In:\\n  \\n 358 mL\\n \\nPO:\\n  \\n  \\n \\nTF:\\n  \\n  \\n \\nIVF:\\n  \\n 358 mL\\n \\nBlood products:\\n  \\n  \\n \\nTotal out 0 mL\\n 0 mL\\n \\nUrine:\\n  \\n  \\n \\nNG:\\n  \\n  \\n \\nStool:\\n  \\n  \\n \\nDrains:\\n  \\n  \\n \\nBalance:\\n 0 mL\\n 358 mL\\n \\n\\n \\n\\nRespiratory\\n \\nO2 Delivery Device: None\\n SpO2: 92%\\n \\n\\n \\n\\nPhysical Examination\\n\\nGeneral Appearance: Well nourished, No acute distress,  , \\nAnxious\\n\\nEyes / Conjunctiva: PERRL, Pupils dilated, Conjunctiva pale, \\nSclera edema\\n\\nHead, Ears, Nose, Throat: Normocephalic\\n\\nCardiovascular: (PMI Normal), (S1: Normal), (S2: Normal), S4\\n\\nPeripheral Vascular: (Right radial pulse: Not assessed), (Left \\nradial pulse: Not assessed), (Right DP pulse: Present), (  DP \\npulse: Present)\\n\\nRespiratory / Chest: (Expansion: Symmetric), (Breath Sounds: \\nClear : , Diminished: bases)\\n\\nExtremities: Right lower extremity edema: Trace, Left lower \\nextremity edema: Trace\\n\\nSkin:  Warm\\n\\nNeurologic: Attentive,   simple commands, Responds to: \\nVerbal stimuli, Oriented (to): , Movement: Purposeful, Tone: Not \\nassessed\\n \\n\\n \\nPertinent Results:\\n___ 06:39PM   ___ PO2-59* PCO2-40 PH-7.37 TOTAL CO2-24 \\nBASE XS--1\\n___ 06:21PM   GLUCOSE-98 UREA N-26* CREAT-4.0* SODIUM-136 \\nPOTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-22 ANION GAP-18\\n___ 06:21PM   estGFR-Using this ___ 06 21PM   ALT(SGPT)-7 AST(SGOT)-16 CK(CPK)-18* ALK \\nPHOS-271* TOT BILI-0.2\\n___ 06:21PM   CK-MB-NotDone cTropnT-0.10*\\n___ 06:21PM   CALCIUM-7.5* PHOSPHATE-5.9* MAGNESIUM-1.6\\n  06:21PM   CORTISOL-16. \\n___ 06:21PM   WBC-20.4*# RBC-3.38* HGB-10.8* HCT-34.6* \\nMCV-103* MCH 32.1* MCHC-31.3 RDW 17.5*\\n___ 06:21PM   NEUTS-93.5* LYMPHS-3.9* MONOS-1.9* EOS-0.2 \\nBASOS-0.3\\n___ 06:21PM   PLT COUNT-450*#\\n___ 11:15AM   ___\\n.\\nCXR ___. Femoral dialysis catheter tip advanced to the junction of the \\nSVC and right atrium. Please correlate for positional adequacy. \\n2. Cardiomegaly.  \\n.\\nEcho ___\\nThe left atrium is moderately dilated. The right atrium is \\nmoderately dilated. No atrial septal defect is seen by 2D or \\ncolor Doppler. Left ventricular wall thicknesses are normal. The \\nleft ventricular cavity is moderately dilated. There is severe \\nglobal left ventricular hypokinesis (LVEF = 20 %). No masses or \\nthrombi are seen in the left ventricle. Tissue Doppler imaging \\nsuggests an increased left ventricular filling pressure \\n(PCWP>18mmHg). with moderate global free wall hypokinesis. The \\naortic valve leaflets (3) are mildly thickened but aortic \\nstenosis is not present. No masses or vegetations are seen on \\nthe aortic valve. No aortic regurgitation is seen. The mitral \\nvalve leaflets are mildly thickened. No mass or vegetation is \\nseen on the mitral valve. Mild (1+) mitral regurgitation is \\nseen. The left ventricular inflow pattern suggests a restrictive \\nfilling abnormality, with elevated left atrial pressure. The \\ntricuspid valve leaflets are mildly thickened. There is moderate \\npulmonary artery systolic hypertension. There is no pericardial \\neffusion. \\n\\nCompared with the prior study (images reviewed) of ___, no \\nvegetations are seen.  \\n\\nCT Scan ___\\nCT OF THE ABDOMEN WITH INTRAVENOUS CONTRAST: In the visualized \\nthorax, there \\nis a small left pleural effusion and associated relaxation \\natelectasis. \\nAtelectatic changes are also seen at the right lung base, though \\nsome regions \\nsuggest possibility of aspiration as well. The heart is top \\nnormal in size.  \\nThere are dense coronary artery calcifications. There is no \\npericardial \\neffusion. \\n  \\nThere is a small amount of pneumoperitoneum with the bulk of \\nfree air located \\nanterior to the liver. Locules of gas seen anteriorly throughout \\nthe abdomen \\nand inferiorly to below the pelvis (series 2, image 57). \\n  \\nIn the abdomen, evaluation of the solid organs is limited \\nwithout intravenous \\ncontrast. Linear regions of low density adjacent to calcified \\nhepatic \\narteries, particularly in the left ___ be dilated bile \\nducts. The \\natrophic pancreas, spleen, and adrenals appear normal. Vessels \\nare densely \\ncalcified suggesting diabetes. Both kidneys are again atrophic. \\n  \\nThere is distention of small bowel loops to 2.7 cm (series 300B, \\nimage 10). \\nThere is effacement of fat about the small bowel and thickened \\nwalls in the \\nupper loops of bowel. Small locules of air also seen in the \\nsuperior and \\nanterior central small bowel loops (series 2, image 39). No \\ndefinite \\npneumatosis is seen.  \\n  \\nThere is effactment of fat about large bowel. Bowel wall \\nthickness is \\ndifficult to establish without oral contrast but appears \\nabnormal the \\ndescending colon. There is a locule of gas abutting a portion of \\nhepatic \\nflexure of the colon (series 2, image 39). Fluid is seen \\nadjacent to the \\ndescending colon towards the sigmoid (series 2, image 51; series \\n300B, image \\n22).  \\n  \\nThere is no pathologic abdominal lymphadenopathy. The takeoffs \\nof the celiac \\nand superior mesenteric arteries are densely calcified as are \\nall the \\nintra-abdominal vessels. Given no intravenous contrast was \\nadministered, \\nassessing patency is not possible with this study. \\n  \\nCT OF THE PELVIS WITH INTRAVENOUS CONTRAST: A left femoral \\nvenous central \\nline is seen with tip terminating in the right atrium. The \\nbladder \\ndemonstrates air anteriorly, probably from instrumentation. \\nMultiple calcific \\nround densities within the bulky anteverted uterus suggest \\ndystrophic \\ncalcification within fibroids. Fluid tracks down the paracolic \\ngutters more on \\nthe left than right. Adnexa are unremarkable. There is no pelvic \\n\\nlymphadenopathy. \\n  \\nMUSCULOSKELETAL: There is no suspicious osteolytic or \\nosteoblastic lesion. \\nMultilevel degenerative changes are seen in the spine. A small \\numbilical fat- \\ncontaining hernia is seen. \\n  \\nIMPRESSION: \\n  \\n1. Pneumoperitoneum. \\n  \\n2. Abnormal small bowel loops, gas distended, probably will wall \\nthickening \\nand demonstrate fat pericolonic fat effacement. A larger locules \\nof gas is \\nseen abutting a segment of small bowel centrally suggestive of a \\nfocus of \\nperforation. \\n  \\n3. Possible bowel wall thickening involving the colon and \\npericolonic fat \\neffacement involving all large bowel. This may be seen in \\ncolitis \\n(nonspecific). Fluid tracks down the paracolic gutters more on \\nthe left than \\nright. A locule of air abutting a segment of hepatic flexure. \\n  \\n4. Densely calcified aorta and celiac and superior mesenteric \\nartery takeoffs \\nin this context is suspiscious for an ischemic component. \\nHowever, given that \\nno IV contrast was administered, cannot assess vessel patency. \\n  \\n5. Left pleural effusion and associated relaxation atelectasis. \\n  \\n6. Dense vascular calcifications. \\n  \\n7. Small fat-containing umbilical hernia. \\n  \\n8. Atrophic kidneys and pancreas. \\n  \\n\\n \\nBrief Hospital Course:\\nMICU Course:\\n\\nThe patient was admitted to the medical ICU for hypotension and \\nconcern for recurrent bacteremia after dialysis. She did not \\nrequire vasopressor agents, and was treated with vancomycin, on \\nan HD protocol. She was empirically treated for C. diff though \\nresults did not return while she was in the ICU. Echocardiogram \\nshowed no masses or vegetations, though did show her EF was now \\n20%, similar to 25% from most recent other echocardiogram. Renal \\nrecommended starting Florinef after she had an appropriate ___ \\nstim. Her metoprolol was held. \\n\\nDuring an episode of dialysis, she became again hypotensive and \\ndeveloped increased abdominal pain following completion. Serial \\nKUBs became positive for free air, and CT scan of the abdomen \\nconfirmed viscous perforation. She was started on broad spectrum \\nantibiotics, and a surgical consultation was obtained. \\nUnfortunately, given the risk of surgery, it was felt that she \\nwould likely not survive the operation. The surgical risk was \\ndiscussed with the patient, and a plan to pursue comfort \\noriented goal of care was put into place. Palliative care \\nfollowed in consultation. She was continued on antibiotics, and \\nalso on norepinephrine that had been started the evening of the \\nct findings. Dialysis was stopped, and on ___ she had a \\ncardiac arrest, and was declared dead at 1625 without \\nresuscitation efforts. Family was at the bedside. \\n\\n \\nMedications on Admission:\\n-ALLOPURINOL - 100 mg Tablet - 1 Tablet(s) by mouth every other \\nday  \\n-AMIODARONE - 200 mg Tablet - 1 (One) Tablet(s) by mouth once a \\nday  \\n-AMOXICILLIN - 500MG Capsule - TAKE 4 TABLETS ONE HOUR BEFORE \\nPROCEDURE  \\n-NEPHROCAPS 1 mg by mouth once a day  \\n-CALCIUM ACETATE [PHOSLO] 667 mg Capsule PO TID  \\n-HUMALOG - 100 U/ML Solution - SS  \\n-INSULIN GLARGINE [LANTUS]- 100 unit/mL Solution - ___ units \\ndaily  \\n-LEVOTHYROXINE [SYNTHROID] - 125 mcg Tablet - 1 Tablet(s) by \\nmouth once a day, alternating with 112mcg daily  \\n-METOPROLOL SUCCINATE [TOPROL XL] - 25 mg by mouth daily on non \\ndialysis days  \\n-NITROGLYCERIN - 0.4MG Tablet, Sublingual - TAKE AS DIRECTED  \\n-OMEPRAZOLE [PRILOSEC] - 20 mg Capsule, Delayed Release(E.C. by \\nmouth twice a day  \\n-PRAVASTATIN - 40 mg Tablet - by mouth once a day in the evening \\n \\n-WARFARIN - 2 mg Tablet - ___ Tablet(s) by mouth daily or as \\ndirected by ___ clinic  \\n-ASPIRIN - (OTC) - 325 mg Tablet, Delayed Release (E.C.) by \\nmouth once a day  \\n\\n \\nDischarge Disposition:\\nExpired\\n \\nDischarge Diagnosis:\\nHypotension\\nBowel Perforation\\nMesenteric Ischemia\\nCardiac Arrest\\nEnd Stage Renal Disease\\n \\nDischarge Condition:\\nExpired\\n \\n                             ___, MPH ___\\n \\nCompleted by: ___', \"Sex:    \\n \\nService: MEDICINE\\n \\nAllergies: \\nMorphine / Keflex\\n \\n ___.\\n \\nChief Complaint:\\nWeakness\\n \\n  Surgical or Invasive  :\\nNone\\n\\n \\nHistory of Present Illness:\\n___     woman with past   history significant for left \\nsided breast cancer ___ years ago, s/p lumpectomy, radiation and \\nchemotherapy, with left hip bony metastasis ___ years later who \\npresents today with left lower extremity weakness as well as \\nurinary and bowel incontinence of 3 weeks duration.  The patient \\nreports that she has a history of peripheral neuropathy \\nsecondary to her previous chemotherapy and thought that was the \\ncase when she developed ascending numbness to her groin 3 weeks \\nago.  The numbness then progressed up to the level of her \\numbilicus, and she began becoming more weak on her left side.  \\nShe previously had been ambulatory with a walker.\\n.\\n  patient had been in ___ for the winter, but returned to \\n___ with her worsening symptoms and presented to the ED \\nyesterday ___.  She received an MRI of her spine that showed no \\ncord compression but a signal abnormality at T10 that was \\nsuspicious for metastatic disease.  Neurosurgery was consulted \\nbut saw no cord compression, therefore   that there was no \\nindication for emergent laminectomy.\\n.\\nThis morning, the patient continues to complain of the leg \\nweakness.  She denies nausea/vomiting/shortness of breath/chest \\npain.  Of note, the patient reports not having a bowel movement \\nsince the weekend.\\n \\nPast Medical History:\\nMetastatic breast CA\\nHTN\\nHypothyroidism\\nPSVT\\n\\nONC History\\nBreast CA  \\n- ___ mets to bone\\n- s/p 12 lines of chemotherapy\\n \\nSocial History:\\n___\\nFamily History:\\nfather died MI in ___, mother died age ___ brain aneurysm\\n \\nPhysical Exam:\\nAdmission exam:\\n\\nGEN: No acute distress.\\nHEENT Mucous membranes moist, no lesions noted\\nCV: Regular rate and rhythm, no murmurs, rubs ___\\nPULM: Clear to auscultation bilaterally, no wheezes, rales or \\nrhonchi.\\nABD:  , non-tender, non distended, bowel sounds present.\\nEXTR: No edema, 2+ Dorsalis pedis and radial pulses bilaterally.\\nNEURO: Alert and oriented x3.  CN II-XII intact.  Motor exam   \\nbiceps, triceps, deltoids bilaterally.  Right ___ ___ iliopsoas, \\n___ quadriceps, ___ gastrocnemius and anterior tibialis.  Left \\n___ ___ iloposas, ___ quadriceps, ___ gastrocnemius and anterior \\ntibialis.  Babinski equivocal bilaterally.\\nRectal exam: decreased tone per report.\\n\\nDischarge  :\\n\\nGEN: No acute distress.\\nHEENT: Mucous membranes moist, no lesions noted\\nCV: Regular rate and rhythm, no murmurs, rubs ___\\nPULM: Clear to auscultation bilaterally, no wheezes, rales or \\nrhonchi.\\nABD: Soft, non-tender, non distended, hyperactive bowel sounds \\npresent.\\nEXTR: No edema, 2+ Dorsalis pedis and radial pulses bilaterally.\\nNEURO: Alert and oriented x3.  Paresthesias up to level of \\numbilicus.  Motor exam ___ biceps, triceps, deltoids \\nbilaterally.  Right ___ ___ iliopsoas, ___ quadriceps, ___ \\ngastrocnemius and anterior tibialis.  Left ___ ___ iloposas, ___ quadriceps, ___ gastrocnemius ___ anterior tibialis.  Babinski \\nequivocal bilaterally.\\n \\nPertinent Results:\\nMR THORACIC SPINE WITHOUT AND WITH CONTRAST, ___\\nFINDINGS: Again seen is evidence of widespread vertebral body \\nmetastatic\\ndisease with abnormal signal in essentially every vertebral body \\nimaged.\\nThere is also hyperintensity in a number of vertebral bodies on \\nthe short TR images suggesting radiation change. At the T9 and \\nT10 levels, again seen is abnormal increased signal intensity in \\nthe spinal cord on the long TR images with slight expansion of \\nthe cord. This area enhances faintly after contrast \\nadministration. As discussed previously, the differential \\ndiagnosis includes radiation myelopathy or intramedullary \\nmetastatic disease. The enhancing component of the lesion \\nappears unusually linear for an intramedullary neoplasm, and \\nthis finding would favor radiation myelitis. There have been no \\nchanges since the prior examination. No new areas of enhancement \\nare detected.\\n \\nCONCLUSION: Better demonstration of enhancing focus at T9 and \\nT10 within the spinal cord associated with increased signal on \\nthe long TR images and   expansion of the cord. The pattern \\n  more suggestive of radiation myelopathy than of metastatic \\ndisease.\\n\\nMR ___ ___ - Again at T10 level, linear increased \\nsignal on T1- and T2-weighted images identified within the cord \\nwith subtle enhancement. The pattern of signal changes is more suggestive of radiation myelopathy than intramedullary \\nmetastasis as suggested previously but clinical correlation and \\nfollowup would be helpful. No significant change is seen. Bony \\nmetastatic lesion identified in the thoracic vertebral bodies as \\nbefore. No significant new abnormalities. \\n\\nAdmission labs:\\n\\n___ 02:30PM   ___ PTT-60.1* ___\\n___ 02:10PM   GLUCOSE-142* UREA N-14 CREAT-0.7 SODIUM-139 \\nPOTASSIUM-3.7 CHLORIDE-103 TOTAL CO2-24 ANION GAP-16\\n___ 02:10PM   estGFR-Using this\\n___ 02:10PM   ALT(SGPT)-18 AST(SGOT)-24 ALK PHOS-121* TOT \\nBILI-0.4\\n___ 02:10PM   LIPASE-11\\n___ 02:10PM   WBC-6.8 RBC-3.67* HGB-11.2* HCT-33.9* MCV-92 \\nMCH-30.6 MCHC-33.1 RDW-17.0*\\n___ 02:10PM   NEUTS-80.4* LYMPHS-14.6* MONOS-4.0 EOS-0.7 \\nBASOS-0.4\\n___ 02:10PM   PLT COUNT-177\\n\\nDischarge labs:\\n\\n___ 12:40AM BLOOD WBC-14.3* RBC-3.45* Hgb-10.6* Hct-32.7* \\nMCV-95 MCH-30.8 MCHC-32.5 RDW-16.8* Plt ___\\n___ 12:40AM BLOOD Glucose-280* UreaN-32* Creat-0.8 Na-133 \\nK-3.5 Cl-94* HCO3-25 AnGap-18\\n___ 12:40AM BLOOD Calcium-8.7 Phos-3.4 Mg-2.___ F with metastatic cancer admitted with neurogical signs \\nconsistent with spinal cord compression, evidence of T10 \\nintramedullary lesion but no evidence of external metastasis.  \\nMRI from yesterday of ___ was more suggestive of radiation \\nmyelopathy than extrinsic compression.  \\n\\n# Weakness: The patient presented with severe weakness of her \\nLLE, stool and bowel incontinence and numbness in the T10-L2 \\ndermatomes.  On initial whole spine MRI in the emergency room, \\nthere was concern for a possible intramedullary lesion in the \\nspinal cord consistent with this lesion at the T10 level.  \\nConcern for extrinsic compression of the spine by metastatic \\ntumor led to urgent consultation of radiation oncology, \\ninitiation of dexamethasone and 1 session of 400milligray XRT.  \\nHowever, subsequent imaging of the affected area with dedicated \\n___ MRI showed the lesion to be more in line with radiation \\nmyelitis as the patient had previously been irradiated in that \\narea for metastatic disease.  Nevertheless, the patient's \\nneurological exam improved with much improved strength in the \\nlower extremities, but persistent numbness in the aforementioned \\nregions.  The patient remained incontinent throughout her stay.  \\nShe was discharged on 4mg dexamethasone q6h along with bactrim \\nprophylaxis, to be followed up by her outpatient ___ \\n___ oncologist.\\n\\n# Urinary/bowel incontinence: Given radiation myelitis, \\nimprovement of this is unlikely.  Urinary retention was likely, \\nand the patient recieved straight catheterization and will need \\nteaching in rehab for eventual discharge with scheduled \\ncatheterization to empty bladder.  \\n\\n# Hypertension - The patient was hypertensive throughout her \\nstay, which was attributed to the dexamethasone.  Her metoprolol \\n50mg bid was changed to labetolol at the dose of 300 mg BID. She \\nwas also started on chlorthalidone, and her lisinopril was \\nincreased to 40mg daily.  These will likely need to be titrated \\nas blood pressure improves after stabilized on decadron.\\n\\n# Hyperglycemia - the patient also was quite hyperglycemic while \\non the dexamethasone.  She was started on lantus long-acting \\ninsulin, which will need to be titrated down as the \\ndexamethasone is tapered given the patient has no previous \\nhistory of diabetes.\\n\\n# Metastatic breast CA - further treatment deferred to \\noutpatient oncologist.\\n \\nMedications on Admission:\\nVerapamil 240mg SA daily\\nLevoxyl 75mcg daily\\nZoledronic acid 4mg q3months\\nLisinopril 20mg daily\\nLorazepam 1mg qhs\\nMetoprolol 50mg twice daily\\n \\nDischarge Medications:\\n1. Verapamil 240 mg Tablet Sustained Release Sig: One (1) Tablet \\nSustained Release PO Q24H (every 24 hours).  \\n2. Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n3. Zoledronic Acid 4 mg/5 mL Solution Sig: Four (4) mg \\nIntravenous Q3Months.  \\n4. Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \\n \\n5. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime). \\n \\n6. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday).  \\n7. Polyethylene Glycol 3350 17 gram/dose Powder Sig: One (1) \\nPacket\\nPacket PO DAILY (Daily) as needed for constipation.  \\n8. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \\n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  \\n9. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \\nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \\nconstipation.  \\n10. Dexamethasone 2 mg Tablet Sig: Two (2) Tablet PO Q6H (every \\n6 hours): Continue until you follow-up with your ___ oncologist\\n.  \\n11. Chlorthalidone 25 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily): For duration of steroids. Will need to be adjusted by \\nrehab MD.\\n.  \\n12. Insulin Glargine 100 unit/mL Solution Sig: Eight (8) units \\nSubcutaneous once a day: For duration of steroids. Will need to \\nbe adjusted by rehab MD.\\n.  \\n13. Sulfamethoxazole-Trimethoprim 400-80 mg Tablet Sig: One (1) \\nTablet PO DAILY (Daily): For duration of steroids.  \\n14. Labetalol 100 mg Tablet Sig: Three (3) Tablet PO BID (2 \\ntimes a day): For duration of steroids. Will need to be adjusted \\nby rehab MD.\\n.  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\n1. Radiation myelitis\\n2. Metastatic breast cancer\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\n1. You were admitted for leg weakness and incontinence, and we \\nwere concerned that you had cord compression from your cancer. \\nAfter multiple MRIs, we determined in conjunction with the \\nRadiation Oncologists that this was due to radiation myelitis, \\nor damage from prior radiation therapy.  You are receiving \\nsteroids for this, which will continue on discharge until you \\nfollow-up with your ___ Oncologist. The instructions for this \\nare:\\nDexamethasone 4 mg by mouth every 6 hours.\\n\\n2. You also had problems with high blood pressure, and we \\nchanged your blood pressure medications.  You also had problems \\nwith high blood glucose (or sugar) levels, and are getting \\ntreated with insulin. You will need to continue your new blood \\npressure medications and insulin until you stop your steroids. \\nThese medications should be adjusted by the MD on call at your \\nrehab facility as necessary.\\n\\n3. It is very important that you take your medications as \\nprescribed.\\n\\n4. It is very important that you make all of your doctors \\n___.\\n \\nFollowup Instructions:\\n___\", \"Sex M\\n \\nService:  \\n \\n : \\nNo Known Allergies / Adverse Drug Reactions\\n \\n  .\\n \\nChief Complaint:\\nAAA\\n \\nMajor Surgical or Invasive Procedure:\\nEVAR w L to R   fem bypass \\n\\n \\nHistory of Present Illness:\\nMr. ___ is seen in followup today for his aortic aneurysm.\\nAt his visit couple of weeks ago, ultrasound suggested a 6-mm\\ngrowth over the past   months   a size of 5 4 cm.  Based on\\nthis enlargement, pt was scheduled for surgery.\\n \\nPast Medical History:\\n- CAD s/p ___nd stenting x4\\n- DM2 (diet controlled)\\n- HTN \\n- HLD (on Lipitor for ___ yrs, then simvastatin   past ___ yrs)\\n- Rectal cancer, s/p resection and XRT ___ years ago, with \\ncolostomy\\n \\nSocial History:\\n \\nFamily History:\\nMother died at ___ of CAD.  Father died at ___ of asthma\\n\\n \\nPhysical Exam:\\nPHYSICAL EXAMINATION  \\nVitals: T: 97.6 degrees Farenheit, BP: 118-145/40s-50s mmHg\\nsupine, HR ___ bpm, RR 18  , O2: 98 % on  .  \\nGen: Pleasant,    \\nHEENT: No conjunctival pallor. No icterus. MMM.  \\nNECK: JVP normal. Normal carotid upstroke.  \\nCV PMI in ___ intercostal space, mid clavicular line. RRR.\\nnormal S1,S2. No murmurs, rubs, clicks, ___  \\nLUNGS: CTAB. No wheezes, rales,   rhonchi.  \\nABD: Bilateral incisions with JP drain in place on left.  \\nEXT: WWP, NO CCE.   \\nNEURO:  &Ox3.   \\n\\n \\nPertinent Results:\\nTELEMETRY: Sinus rhythm at 78bppm \\n\\nECG:  sinus rhythm with rate at 65bpm LBBB with slightly more\\ndownsloping TW in 1 and AVL and upward TW in V5 and V6 (inverted\\non prior ECG) ___\\n \\nCardiac Cath at ___ ___\\n Hemodynamics:  The aortic pressure was 120/70, left ventricular\\nend-diastolic pressure was 18.\\n      Left ventricular angiogram visualized discrete\\ninferoposterior hypokinesis with left ventricular ejection\\nfraction of 60%.  There is no mitral regurgitation.\\n       The left main exhibited 20% ostial stenosis.\\n       The left anterior descending is occluded after the first\\nlarge septal and small diagonal.    is a 20 -30% narrowing \\nof\\nthe left anterior descending before it gives the septal and the\\ndiagonal.  There is a  40% narroeing of the diagonal.\\n      The left circumflex is occluded proximally.\\n      The right coronary artery is also occluded proximally.\\n      The graft arteriogram revealed an occluded graft to the\\nright coronary artery.\\n      There is   occluded graft to the circumflex and the\\ndiagonal artery.\\n       \\n      The left internal mammary artery is patent with good\\ninsertion into   left anterior descending with good filling of\\nthe left anterior descending that exhibits mild diffuse \\nplaquing.\\nThere is good filling retrograde of the circumflex marginal from\\nthe left anterior descending and there is a good filling of the\\ndistal right coronary artery that appeared a posterolateral\\nbranch.  I   not revisualize the posterior descending artery.\\n       The native vessels on the left that fills retrograde the\\nright coronary artery via collateral mainly coming from the\\nseptal branches of the left anterior descending\\n\\n___  :50AM BLOOD WBC-5.9 RBC-4.88 Hgb-14.9 Hct-41.6 MCV-85 \\nMCH-30.5 MCHC-35.8* RDW-13.2 Plt ___\\n___ 02:46PM BLOOD Hgb-10.9*# Hct-30.2*# Plt ___\\n___ 05:11AM BLOOD WBC-10.2# Hgb-11.6* Hct-32.3* Plt ___\\n___ 08:00AM BLOOD WBC-10.1 RBC-3.60*# Hgb-10.9* Hct-30.3* \\nMCV-84 MCH-30.4 MCHC-36.1* RDW-13.0 Plt ___\\n___ 08:10AM   WBC-7.9 RBC-3.37* Hgb-10.5* Hct-28.8* \\nMCV-85 MCH-31.2 MCHC- . * RDW-13.1 Plt ___\\n___ 03:10AM BLOOD WBC-5.5 RBC-2.98* Hgb-9.1* Hct-25.2* \\nMCV-84 MCH-30.5  -36.1* RDW-12.8 Plt ___\\n___ 04:10PM BLOOD WBC-5.3 Hct-32.5*# Plt ___\\n___ 08:05AM BLOOD WBC-4.7 RBC-3.82*# Hgb-11.5*# Hct-33.7* \\nMCV-88 MCH-30.2 MCHC-34.2 RDW-12.9 Plt ___\\n___ 09:50AM BLOOD ___ PTT-22.8 ___\\n___ 09:50AM BLOOD Plt ___\\n___ 08:05AM BLOOD Plt ___\\n___ 09 50AM BLOOD UreaN-19 Creat-1.0 Na-144 K-3.8 Cl-109* \\nHCO3-25 AnGap-14\\n___ 02:46PM BLOOD Glucose-139* UreaN-15 Creat-0.7 Na-138 \\nK-3.5 Cl-110* HCO3-21* AnGap-11\\n___ 05:11AM BLOOD Glucose-175* UreaN-11 Creat-0.7 Na-138 \\nK-3.9 Cl-108 HCO3-23 AnGap-11\\n___ 01:51AM BLOOD Glucose-98 UreaN-12 Creat-0.7 Na-140 \\nK-4.1 Cl-107 HCO3-23 AnGap-14\\n___ 08:00AM BLOOD Glucose-108* UreaN-12 Creat-0.8 Na-139 \\nK-3.8 Cl-104 HCO3-22 AnGap-17\\n___ 08:40PM BLOOD Glucose-116* UreaN-19 Creat-0.8 Na-139 \\nK-3.2* Cl-101 HCO3-16* AnGap-25*\\n___ 08:10AM BLOOD Glucose-113* UreaN-18 Creat-0.9 Na-140 \\nK-3.8 Cl-103 HCO3-26 AnGap-15\\n___ 03:10AM BLOOD Glucose-106* UreaN-20 Creat-0.8 Na-140 \\nK-3.8 Cl-105 HCO3-28 AnGap-11\\n___ 08:05AM BLOOD Glucose-104* UreaN-17 Creat-0.7 Na-139 \\nK-4.1 Cl-106 HCO3-26 AnGap-11\\n___ 02:46PM BLOOD ALT-11 AST-15 CK(CPK)-26* AlkPhos-40\\n___ 05:11AM BLOOD ALT-12 AST-17 CK(CPK)-27* AlkPhos-44 \\nTotBili-0.3\\n___ 12:45PM BLOOD CK(CPK)-32*\\n___ 01:51AM BLOOD CK(CPK)-40*\\n___ 09:00AM BLOOD CK(CPK)-86\\n___ 03:00PM BLOOD CK(CPK)-199\\n___ 08:40PM BLOOD CK(CPK)-217\\n___ 08:10AM BLOOD CK(CPK)-169\\n___ 05:25PM BLOOD CK(CPK)-105\\n___ 03:10AM BLOOD CK(CPK)-67\\n___ 09:25AM BLOOD CK(CPK)-52\\n___ 04:10PM BLOOD CK(CPK)-47\\n___ 12:57AM BLOOD CK(CPK)-46*\\n___ 08:05AM BLOOD CK(CPK)-48\\n___ 02:46PM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 05:11AM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 01:51AM BLOOD CK-MB-3 cTropnT-<0.01\\n___ 09:00AM BLOOD CK-MB-11* MB Indx-12.8* cTropnT-0.05*\\n___ 03:00PM BLOOD CK-MB-25* MB Indx-12.6* cTropnT-0.26*\\n___ 08:40PM BLOOD CK-MB-20* MB Indx-9.2* cTropnT-0.35*\\n___ 08:10AM BLOOD CK-MB-11* MB Indx-6.5* cTropnT-0.33*\\n___ 05:25PM BLOOD CK-MB-6 cTropnT-0.35*\\n___ 03:10AM BLOOD CK-MB-5 cTropnT-0.55*\\n___ 09:25AM BLOOD CK-MB-4 cTropnT-0.47*\\n___ 04:10PM BLOOD CK-MB-3 cTropnT-0.54*\\n___ 12:57AM BLOOD CK-MB-3 cTropnT-0.76*\\n___ 08:05AM BLOOD CK-MB-3 cTropnT-0.80*\\n___ 08:00AM BLOOD %HbA1c-5.8 eAG-120\\n___ 05:11AM BLOOD Triglyc-89 HDL-32 CHOL/HD-4.9 LDLcalc-107\\n \\nBrief Hospital Course:\\nThe patient was admitted to the Vascular Surgical Service for \\nevaluation and treatment of a AAA. Pt underwent a EVAR with left \\nto right fem fem BPG. He was extubated in the OR.\\n\\nAfter a brief, uneventful stay in the PACU, the patient arrived \\non the floor NPO, on IV fluids and antibiotics, with a foley \\ncatheter, and IV meds for pain control. The patient was \\nhemodynamically stable.\\n\\nNeuro: The patient received IV pain medications with good effect \\nand adequate pain control. When tolerating oral intake, the \\npatient was transitioned to oral pain medications.\\n\\nCV: Pt with known PAD and stable angina. Pt started experiencing \\nchest pain on POD 1. His ECG was unchanged and initial cardiac \\nenzymes were negative. Cardiology was consulted and his cardiac \\nenzymes were cycled. He did rule in for MI. Troponins peaked at \\n0.8. He remained on telemetry and continued his beta blocker, \\nplavix, aspirin, statin. His most recent cardiac cath films were \\nsent over and cardiac surgery was consulted for redo CABG. Per \\ncardiac surgery, he is not a surgical candidate as he does not \\nhave targets. Cardiology felt that he did not have any PCI \\noptions as well and recommended medical management. We titrated \\nhis isosorbide from 20 to 40mg TID with resolution of his chest \\npain. On the day of discharge, he was ambulating independently \\nand walked up the stairs with physical therapy without anginal \\nsymptoms. \\n\\nPulmonary: The patient remained stable from a pulmonary \\nstandpoint; vital signs were routinely monitored. Good pulmonary \\ntoilet, early ambulation and incentive spirrometry were \\nencouraged throughout hospitalization.\\n\\nGI: Post-operatively, the patient was made NPO with IV fluids. \\nDiet was advanced when appropriate, which was well tolerated. \\n\\nGU: Patient's intake and output were closely monitored, and IV \\nfluid was adjusted when necessary. \\n\\nFEN: Electrolytes were routinely followed, and repleted when \\nnecessary.\\n\\nID: The patient's white blood count and fever curves were \\nclosely watched for signs of infection. Wound care included \\nsterile dressings. Pt did recieve perioperative antibiotics.\\n\\nEndocrine: The patient's blood sugar was monitored throughout \\nhis stay; insulin dosing was adjusted accordingly.\\n\\nHematology: The patient's complete blood count was examined \\nroutinely; he required 2units of PRBCs on ___ for hct of 25.2.\\nProphylaxis: The patient received subcutaneous heparin and \\nvenodyne boots were used during this stay; he was encouraged to \\nget up and ambulate as early as possible.\\n\\nAt the time of discharge, the patient was doing well, afebrile \\nwith stable vital signs. The patient was tolerating a regular \\ndiet, ambulating, voiding without assistance, and pain was well \\ncontrolled, and he was chest pain free. The patient received \\ndischarge teaching and follow-up instructions with understanding \\nverbalized and agreement.\\n \\nMedications on Admission:\\nASA 325', amlodipine 10', detrol LA 4', gemfibrozil 600', \\nibuprofen 600''', isosorbide mononitrate 20''', metoprolol \\nsuccinate 200', nitroglycerin PRN, plavix 75', risperidone 0.5', \\ntrazodone 50' \\n \\nDischarge Medications:\\n1. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a \\nday).  \\n3. risperidone 0.5 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n4. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n5. atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily): See PCP or cardiologist for refills.\\nDisp:*30 Tablet(s)* Refills:*0*\\n6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \\ntimes a day).\\nDisp:*60 Capsule(s)* Refills:*2*\\n7. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 \\nhours) as needed for pain.  \\n8. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.  \\n9. isosorbide mononitrate 20 mg Tablet Sig: Two (2) Tablet PO \\nthree times a day.\\nDisp:*180 Tablet(s)* Refills:*2*\\n10. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \\nSublingual Sublingual PRN (as needed) as needed for Chest pain: \\nTake 1 pill and wait 5 minutes. If still have chest pain take \\n___ pill and wait 5 minutes. If still with chest pain take ___ \\npill and call ___. .  \\n11. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at \\nbedtime).  \\n12. metoprolol succinate 200 mg Tablet Extended Release 24 hr \\nSig: One (1) Tablet Extended Release 24 hr PO once a day: Divide \\ninto 2 doses if better tolerated.  \\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nInfrarenal AAA\\nnstableangina - r/i MI, mayneed redo CABG\\nHTN,  DM2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nDivision of Vascular and Endovascular Surgery\\n\\nEndovascular Abdominal Aortic Aneurysm (AAA) Discharge \\nInstructions\\n\\nMedications:\\n\\x95If instructe,take Aspirin 325mg (enteric coated) once daily \\n\\x95Do not stop Aspirin unless your Vascular Surgeon instructs you \\nto do so. \\n\\x95Continue all other medications you were taking before surgery, \\nunless otherwise directed\\n\\x95You make take Tylenol or prescribed pain medications for any \\npost procedure pain or discomfort\\n\\nWhat to expect when you go home:\\nIt is normal to have slight swelling of the legs:\\n\\x95Elevate your leg above the level of your heart (use ___ \\npillows or a recliner) every ___ hours throughout the day and at \\nnight\\n\\x95Avoid prolonged periods of standing or sitting without your \\nlegs elevated\\nIt is normal to feel tired and have a decreased appetite, your \\nappetite will return with time \\n\\x95Drink plenty of fluids and eat small frequent meals\\n\\x95It is important to eat nutritious food options (high fiber, \\nlean meats, vegetables/fruits, low fat, low cholesterol) to \\nmaintain your strength and assist in wound healing\\n\\x95To avoid constipation: eat a high fiber diet and use stool \\nsoftener while taking pain medication\\n\\nWhat activities you can and cannot do:\\n\\x95When you go home, you may walk and go up and down stairs\\n\\x95You may shower (let the soapy water run over groin incision, \\nrinse and pat dry)\\n\\x95Your incision may be left uncovered, unless you have small \\namounts of drainage from the wound, then place a dry dressing or \\nband aid over the area that is draining, as needed\\n\\x95No heavy lifting, pushing or pulling (greater than 5 lbs) for \\n1 week (to allow groin puncture to heal)\\n\\x95After 1 week, you may resume sexual activity\\n\\x95After 1 week, gradually increase your activities and distance \\nwalked as you can tolerate\\n\\x95No driving until you are no longer taking pain medications\\n\\x95Call and schedule an appointment to be seen in ___ weeks for \\npost procedure check and CTA \\n\\nWhat to report to office:\\n\\x95Numbness, coldness or pain in lower extremities \\n\\x95Temperature greater than 101.5F for 24 hours\\n\\x95New or increased drainage from incision or white, yellow or \\n___ drainage from incisions\\n\\x95Bleeding from groin puncture site\\n\\nSUDDEN, SEVERE BLEEDING OR SWELLING (Groin puncture site or \\nincision)\\n\\x95Lie down, keep leg straight and have someone apply firm \\npressure to area for 10 minutes. If bleeding stops, call \\nvascular office. If bleeding does not stop, call ___ for \\ntransfer to closest Emergency Room. \\n\\n \\nFollowup Instructions:\\n___\", \"Sex:   F\\n \\nService: MEDICINE\\n \\nAllergies: \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief Complaint:\\nL-sided CP, SOB \\n \\nMajor Surgical or Invasive Procedure:\\nNone\\n\\n \\nHistory of Present Illness:\\n___ F w/ hx of COPD w/ recent admission exacerbation in ___, \\nschitzophrenia, OA who p/w CP and SOB x1d. Normally w/ her COPD \\npt is on home 02 is always SOB, but can walk 3 flights of stairs \\nwithout stopping, occasional cough, and will rarely have sharp \\n  of L-sided CP   pleuritic in nature. Yesterday \\nshe tripped and twisted her L ankle fell to her knees, and later \\ndeveloped R hip pain the next day. Then today her husband \\nnoticed   her breathing was more labored and SOB throughout \\nthe day, no orthopnea Pt could still go up 3 flights of stairs. \\nShe tired using her combivent and home ___ without significant \\nchange. Around midnight or 1am she had sharp left-sided chest \\npain that lasted a couple seconds 3 times in a row and associate \\ndiaphoresis. No associated n/v, radiation. No further episodes \\nof CP afterward Denied any \\nfever/chills/melana/hematochezia/sorethroat/URI symptoms.  \\n.  \\nROS dysuria, 1 episode of loose BM yesterday  \\n\\n \\nPast   History:\\n . COPD/emphysema - no PFTs in our system \\n2. Schizophrenia  \\n3. Psychogenic polydypsia  \\n4. Osteoarthritis  \\n5. Status post hernia repair ___  \\n6. History of fecal and urinary incontinence without spinal cord \\ninjury, possibly worsened by drug side effect  \\n7. Atrial arrhythmia (MAT vs.wandering pacemaker)  \\n8. Positive PPD - unclear history  \\n\\n \\n  History:\\n___\\nFamily History:\\nUnknown (raised in foster care)\\n \\nPhysical Exam:\\nVitals:  .0,  /90, 86, 36, 92%4L  \\nGeneral: pleasant, mild respiratory distress  \\nHEENT: poor dentition, NC/AT, anicteric, MMM, oropharynx clear  \\nNeck: supple, JVP not elevated, no LAD  \\nLungs: shallow breaths, CTAB, no wheezes, rales, ronchi  \\nCV: RRR, normal S1 + S2, no murmurs, rubs, gallops  \\nAbdomen: +BS NT/ND, soft  \\nExt: 1+     edema, normal ROM at L ankle, no pain or point \\n  Neuro: AOx3, CN II-XII grossly intact, no focal deficits  \\n\\n \\nPertinent  :\\nTrop-T: <0.01 CK: 135 MB: 3  \\n.  \\n145 108 13  \\n----------------< 102  \\n4.1   0.7  \\n.  \\nMCV: 95  \\n      12.8  \\n5.7 >---------< 275  \\n       .9  \\nN:59 1 L:32 7 M:5.0 E:2 7 Bas:0.5  \\n.  \\n___: 14.6 PTT: 28.7 INR: 1.3  \\n.  \\nMicro: none  \\n\\n \\nBrief Hospital Course:\\n___ F w/ hx of COPD w/ recent admission exacerbation in ___ schitzophrenia, OA who p/w CP and SOB x1d  \\n \\n# COPD exacerbation Pt appeared to have a mild COPD \\nexacerbation, unlikely to be from infection, no cough/wbc/fevers \\nand cxr clear. Pt was requiring 4L/NC and has increased work of \\nbreathing, and incr RR, suggesting mild exacerbation. Pt \\ncontinues to smoke. No   completed, did not f/u only taking \\ncombivent. It is also possible pt had anxiety/pain ___ ankle \\ninjury and tachypnea from this, but currently denies pain and \\nstill tachyneic. PE unlikely, w/o tachycardia, and recent CTA \\nnegative - no h/o   suggest provoked. Also ___ was negative. \\nThe next day pt was 92%RA, and 96% ambulating on 1L. Pt's was \\nchanged over to prednisone 60mg on day of discharge and to get 3 \\nmore days of prednisone. Pt was also started on Advair 250/50 \\nBID for her COPD, given a pneumococcal vacine, and needs PFTs as \\noutpt.\\n.  \\n# CP- Pt was having sharp pain that was likely pleuritic ___ \\nCOPD exacerbation. Not typical CP to suggest ACS. Not \\nreproducible.  Pt was ruled out with CE x3. \\n \\n#. LLE edema - Pt likely ___ ankle sprain exam not suggestive \\nof fx. No current ankle pain As asymetric will r/o dvt. ___ was \\nnegative bilaterlly. The next morning pt did not have any LLE \\nswelling any longer, and did not complain of any pain.\\n\\n#. UA- Pt complained of dysuria as inpatint and we checked a UA \\nwhich was negative for a UTI. It did show trace proteins and glc \\nof 250. As inpatient her fasting glucose remained < 100. The \\nprotinuria/glucosuria ___ need to be followed as outpatient. \\n  \\n# Pulmonary nodules- Seen on CTA on ___, needs outpt f/u CT. \\n \\n# Schitzophrenia - Continued psych meds, No issues.  \\n\\n \\nMedications on Admission:\\n- Aripiprazole 10mg QDay  \\n- Risperdal 50mg IM q2wks  \\n- Celexa 40mg Qday  \\n- Combivent ___ puffs  \\n- MVI  \\n- ASA 325  \\n- Naproxen 375 q8 prn  \\n- Nicotene 21 mcg  \\n- Prednisone 40mg taper last dose ___  \\n- home 02 uncertain amount  \\n\\n \\nDischarge Medications:\\n1. Prednisone 20 mg Tablet Sig: Three (3) Tablet PO DAILY \\n(Daily) for 3 days.\\nDisp:*9 Tablet(s)* Refills:*0*\\n2. Aripiprazole 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n3. Risperdal Consta 50 mg/2 mL Syringe Sig: One (1)  \\nIntramuscular q2 weeks.  \\n4. Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \\n \\n5. Combivent ___ mcg/Actuation Aerosol Sig: ___ puffs \\nInhalation four times a day.  \\n6. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n7. Nicotine 21 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \\nTransdermal DAILY (Daily).  \\n8. Advair Diskus 250-50 mcg/Dose Disk with Device Sig: One (1)  \\nInhalation twice a day.\\nDisp:*1 discus* Refills:*2*\\n9. Naproxen 375 mg Tablet Sig: One (1) Tablet PO every eight (8) \\nhours.  \\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPrimary diagnosis:\\n- COPD exacerbation\\n- chest pain, non-cardiogenic\\n\\nSecondary diagnosis:\\n- Schitzophrenia\\n- history of atrial tachycardia\\n\\n \\nDischarge Condition:\\nGood, ambulatory sat 96% on 1L, 92% on RA\\n\\n \\nDischarge Instructions:\\nYou had chest pain that was not due to a heart attack from the \\ntests we did. Instead the pain is probably referred pain from \\nyour COPD flare. For this you were given steriods and 02, which \\nis now improved. Also you had an ultrasound that also ruled out \\na clot in the deep veins of your legs, and the swelling was \\nprobably from the injury you had. \\n\\nIt is also very important that you stop smoking for the \\ntreatment of your COPD.\\n\\nIf at any point your symptoms return and significantly worsen - \\nincluding shortness of breath, chest pain, or fevers > 101 - \\nplease return to the ED.\\n\\nMedication changes:\\n- Advair was added to help manage your COPD, take this twice per \\nday\\n- Take prednisone for 3 more days for your COPD flare\\n\\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: MEDICINE\\n \\n : \\nPatient recorded as having No Known Allergies to Drugs\\n \\n ___.\\n \\nChief  :\\nPrimary Care Physician: ___, MD MPH  \\n.  \\nChief Complaint Shortness of breath,   pain  \\n\\n \\nMajor Surgical or Invasive Procedure:\\nfoley catheter placement.\\n\\n \\nHistory of Present Illness:\\nMr. ___ is a ___ ___ speaking   with a h/o CAD s/p \\nCABG in ___, DM2 HTN, HL, diastolic HF who c/o 3 months of \\nworsening shortness of breath and more recently, worsening chest \\npain.  He can no   take   than ___ steps without feeling both chest pain     of breath.  In terms of the chest \\npain, he describes   as a piercing sensation   the left side \\nof his chest, no radiation to the left side but comes with a \\n\"choking feeling\" or pressure up to his neck.  It is not \\nassociated with sweating, nausea, palpitations, inspiration, or \\nhis eating habits.  It lasts 3 minutes and prompts him to clutch \\nhis chest but resolves spontaneously.  He experiences it with \\nactivity but has also recently felt it at rest or while lying \\ndown.  \\n.\\nHe believes his shortness of breath has also worsened over the \\nlast   months, particularly   exertion.  It often accompanies \\nthe chest pain.  He is not on O2 at home.  He has noticed the development of a dry cough recently.  He continues to sleep with \\n2 pillows per usual at night and denies PND.  He has noticed \\nincreased leg swelling recently.  He was largely unable to \\ncharacterize time periods so corroboration by his PCP or ___ \\nwould be useful.  \\n.\\nHe reports being diligent   taking his medications \\n .\\n.\\nHe was referred to HCA   ___ at ___, patient was felt to be \\nfluid overloaded, and chest pain felt to be strain secondary to \\ndecompensated heart failure. He was given ASA 325mg PO x1   \\nplaced on oxygen 2L NC. Given albuterol nebulizer in ambulance.  \\n\\n.\\nIn the ED, 97.5 66 120/93   100% 2L by  . Physical examination \\nnotable for trace pitting edema to knees bilaterally. Laboratory \\ndata significant for creatinine 2.1 (baseline 1.5-1.6), \\nhematocrit 31.9 (baseline), BNP ___, first set \\ncardiac markers WNL. EKG unchanged from baseline. CXR 2V with \\nquestion of perihilar fullness, no consolidations. Foley placed by urology following dilatation of urethral stricture. \\nIntermittently hypertensive to sBP 190s. Given furosemide 40mg \\nIV x1 after Foley placed.  \\n.  \\nOn arrival to the medicine service, patient reports feeling much \\nbetter. He is without chest pain or shortness of breath at \\npresent.\\n.  \\nROS:\\n(+) per HPI\\n(-) for headache, dizziness, increased sweating, syncope, \\nfevers, chills abdominal pain, changes in bladder habits, \\nweakness, paresthesias, difficulty with coordination, gait \\ndisturbances\\n \\nPast Medical History:\\nCAD s/  CABG in ___ (last stress normal in ___  \\nDM  \\nHypertension  \\nHyperlipidemia  \\nDiastolic CHF\\n \\nSocial History:\\n___\\nFamily History:\\nFather died of heart attack at age ___.\\n \\n  Exam VS: Tc 97.5 Tmax 97.9  HR 51 BP 191/84 RR 18 O2sat 100% 2L\\nGeneral: Comfortable, laying on 2 pillows\\nHEENT: Sclera anicteric; conjunctiva non-injected; dry mucous \\nmembranes; oropharynx clear without lesions, exudate\\nCV: Bradycardic, regular rhythm, no m/r/g  \\nLungs: CTAB without rales or wheezes\\nAbd: Obese, +BS, soft, NT/ND \\nExt: 1+ lower extremity edema to knees bilaterally; 2+ ___ \\npulses\\nSkin: WWP, no rashes\\n \\nPertinent Results:\\n___ 05:08PM   GLUCOSE-158* UREA N-26* CREAT-2.1* SODIUM-139 POTASSIUM-4.8 CHLORIDE-100 TOTAL CO2-28 ANION GAP-16\\n___ 05:08PM   CK(CPK)-42*\\n___ 05:08PM   cTropnT-<0.01\\n___ 05:08PM   CK-MB-2 ___ 05:08PM   WBC-6.8 RBC-3.57* HGB-10.4* HCT-31.9* MCV-89 \\nMCH-29.2 MCHC-32.7 RDW-15.9*\\n  05:08PM   NEUTS-75.1* LYMPHS-17.3* MONOS-4.6 EOS-2.6 \\nBASOS-0 3\\n___ 05:    PLT COUNT-218\\n\\nCXR 2V (___): Stable chest x-ray examination. Please note \\nthe previous left humerus dislocation has been reduced on the \\ncurrent study. No acute pulmonary process identified.  \\n.  \\nEKG ___, 22:42): NSR @ 52.  Leftward axis deviation.  \\nIntervals WNL.  Isolated Q wave in III.  Biphasic T-wave changes \\nin V4-V6, changed from ___.  \\n.  \\nTTE (___): Mild symmetric left ventricular hypertrophy with \\npreserved global biventricular systolic function. Dilated \\nascending aorta.\\nCompared with the prior report (images unavailable for review) \\nof ___, the findings are similar.\\n.  \\nNuclear stress (___): Atypical/non-anginal type symptoms in \\nthe absence of ischemic EKG changes. The image quality is \\nlimited due to soft tissue attenuation and tracer activity \\nadjacent to the heart.  \\n.  \\n \\nBrief Hospital Course:\\n___ ___ speaking patient with a h/o CAD s/p CABG in ___, \\nDM2, HTN, HL, diastolic HF who c/o 3 months of worsening \\nshortness of breath and more recently, worsening chest pain.    \\n.\\n# Chest pain: Known CAD and s/p 4 vessel CABG. Description of \\nchest pain resembled unstable angina, though stress test from \\n___ negative for ischemic changes.  ACS ruled out with 3 \\nsets of negative cardiac enzymes.  EKG showed biphasic T waves \\nin V4-V6, likely attributable to hypertension due to holding of \\nmeds. Chest pain could have been related to hypertension. Pt was \\nstarted on ASA during the admission. He will follow up with his \\nPCP in the outpatient setting to determine if any additional w/u \\nis needed.\\n.\\n# Shortness of breath: Patient described 3 months of worsening \\nSOB on exertion, often accompanying chest pain from above.  \\nPatient denied orthopnea or PND.  BNP was ___ (higher than \\nbaseline from ___, but exam and radiography not concerning for \\nacute exacerbation of diastolic HF.  Last echo in ___ was \\nunremarkable, EF 60-70%.  Performed echo while inpatient showing \\nno change from ___.  Pt was given additiona doses of lasix \\nearly in the admission with good effect. His symptoms were \\nlikely related to mild acute diastolic heart failure. He will be \\ndischarged on home dose of lasix given creatinine bump while \\ninpatient.  \\n.\\n# Renal insufficiency: Cr was 2.1 on admission. Fe urea 47%, \\nsuggestive of intrinsic renal process.  Latest Cr from ___ \\nvisit in early ___ was also 2.1. No microalbuminuria indicating \\ndiabetic nephropathy, likely ___ to chronic uncontrolled HTN.  \\nCr bumped to 2.4 on ___, likely due to increased lasix dosing \\nand resuming of lisinopril on ___ for HTN control. Lasix and \\nlisinopril held for 1 day and resumed on day of discharge with \\nCr 2.3. Pt with difficult to control HTN and responds very well \\nto lisinopril and lasix. Thus, they were continued on admission \\ndoses. He will have a repeat Cr at his PCP\\'s office ___.\\n.\\n# HTN: Pt with SBP in the 220 range when holding lasix and \\nlisinopril. This was treated effectively with hydralazine and \\namlodipine. Pt was started on amlodipine and this was increased \\nto 10mg daily. In addition, metoprolol dosing was decreased \\nsecondary to bradycardia. Despite adding amlodipine, with SBP \\n160\\'s (also likely secondary to decreased metoprolol dosing) and \\ntherefore lasix and lisinopril were added back with good effect. \\nPts BP is much better controlled on these medications. He will \\nfollow up with his PCP this week for further titration if \\nneeded.\\n.\\n# Bradycardia: Patient\\'s HR consistently stayed in the ___, \\nlikely ___ to metoprolol and possibly tizanidine. Pt\\'s \\nmetoprolol was decreased to 25mg BID. \\n.\\n#urinary retention-Likely related to pt\\'s prior history of \\nurinary strictures. Pt with urinary retention in the ED and \\nfoley catheter was placed, but with some difficulty. Therefore, \\nhe was discharged with the foley in place. He will follow up \\nwith urology this week for voiding trial.\\n.\\n# Hyperkalemia: K 5.2 on admission.  Likely ___ to ACEI and/or \\nchronic renal insufficiency.  No findings on EKG.  Resolved.\\n.    \\n# DM2: Held oral hypoglycemics, started HISS.  BG up to 330s x \\n1, responded to humalog.\\n.  \\n#. Hyperlipidemia: Continued statin per home regimen. \\n.  \\n#. Anemia: At baseline, continued ferrous sulfate per home \\nregimen.   \\n.  \\n# FEN: Heart healthy, diabetic diet; fluid restriction 1.5L; \\nreplete lytes as needed  \\n.\\n# Prophylaxis: Heparin SC TID; home PPI; bowel regimen\\n \\nMedications on Admission:\\nATORVASTATIN [LIPITOR] - 10 mg Tablet - 1 Tablet(s) by mouth \\nonce  \\na day  \\nDIABETIC SHOES - - Use as directed. ICD code: 250.8.  \\nFUROSEMIDE - 40 mg Tablet - 1 Tablet(s) by mouth once a day  \\nGLIPIZIDE - 10 mg Tablet Extended Rel 24 hr - 1 Tab,Sust Rel  \\nOsmotic Push 24hr(s) by mouth twice a day  \\nLIDOCAINE [LIDODERM] - 5 %(700 mg/patch) Adhesive Patch,  \\nMedicated - one patch once a day apply to back for 12 of 24 \\nhours  \\nper day  \\nLISINOPRIL - 5 mg Tablet - 1 Tablet(s) by mouth once a day  \\nLORAZEPAM - 1MG Tablet - ONE BY MOUTH AT BEDTIME AS NEEDED FOR  \\nSLEEPING  \\nMETFORMIN - 1,000 mg Tablet - one Tablet(s) by mouth twice a day \\n \\ntake with morning and evening meal  \\nMETFORMIN HCL - 500 mg Tablet - 1 Tablet(s) by mouth once a day  \\n\\ntake at lunch  \\nMETOPROLOL TARTRATE - 50 mg Tablet - 1 Tablet(s) by mouth twice \\na  \\nday **** dose change ****  \\nNITROGLYCERIN [NITROSTAT] - 0.4 mg Tablet, Sublingual - 1  \\nTablet(s) sublingually prn chest pain  \\nOMEPRAZOLE - 20 mg Capsule, Delayed Release(E.C.) - 1 (One)  \\nCapsule(s) by mouth once a day  \\nPIOGLITAZONE [ACTOS] - 15 mg Tablet - 1 Tablet(s) by mouth once \\na day  \\nPREGABALIN [LYRICA] - 75 mg Capsule - 1 Capsule(s) by mouth once \\na day  \\nTERAZOSIN - 10 mg Capsule - 1 Capsule(s) by mouth twice a day  \\nTIZANIDINE - 4 mg Tablet - 1 Tablet(s) by mouth twice a day  \\nBLOOD SUGAR DIAGNOSTIC - Strip - test tid to qid  \\nFERROUS SULFATE - 325 mg (65 mg) Tablet - 1 Tablet(s) by mouth  \\nonce a day  \\nLAC-HYDRIN - 12 % Cream - apply to hands twice a day  \\n \\nDischarge Medications:\\n1. Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. Glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.  \\n3. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \\nOne (1)  Topical as directed.  \\n4. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO at bedtime.  \\n5. Metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. \\n \\n6. Metformin 500 mg Tablet Sig: One (1) Tablet PO once a day: at \\nlunch  time.  \\n7. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \\nSublingual as directed.  \\n8. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \\n9. Actos 15 mg Tablet Sig: One (1) Tablet PO once a day.  \\n10. Lyrica 75 mg Capsule Sig: One (1) Capsule PO once a day.  \\n11. Terazosin 10 mg Capsule Sig: One (1) Capsule PO once a day.  \\n\\n12. Tizanidine 4 mg Capsule Sig: One (1) Capsule PO twice a day. \\n \\n13. Furosemide 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n14. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.\\nDisp:*30 Tablet(s)* Refills:*2*\\n15. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n16. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n17. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID \\n(2 times a day).\\nDisp:*60 Tablet(s)* Refills:*2*\\n18. Iron 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO once \\na day.  \\n19. Amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day.\\nDisp:*30 Tablet(s)* Refills:*2*\\n\\n \\nDischarge Disposition:\\nHome With Service\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nMajor:\\nchest pain-angina\\nacute diastolic heart failure\\nHTN\\nurinary retention\\nbradycardia\\n.\\nMinor:\\nCAD\\nDM2\\n\\n \\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - requires assistance or aid (walker \\nor cane).\\n\\n \\nDischarge Instructions:\\nYou were admitted because you had chest pain and leg swelling. \\nFor this, you had blood tests that showed that you did not have \\na heart attack. You were given a medication to improve your leg \\nswelling and breathing. We also did an ultrasound (an \\nechocardiogram) that did not show any changes from the last one. \\nYou had episodes of high blood pressure and were therefore \\nstarted on a new medication called amlodipine. In addition, you \\nexperienced urinary retention and had the placement of a foley \\ncatheter. You should leave this catheter in place until your \\nurology appointment.\\n.\\nMedication changes:\\nYou were started on an aspirin 81mg daily.\\nYou were started on amlodipine 10mg for blood pressure.\\nYour metoprolol was decreased to 25mg twice a day\\n\\nPlease be sure to follow up with your providers as per below.\\n \\nFollowup Instructions:\\n___', \"Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___.\\n \\nChief Complaint:\\nFall ___ suspected seizure\\n \\nMajor Surgical or   Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\n___ y/o male with h/o Mental Retardation, HTN, gout, no previous \\n  hx brought in by EMS from group home   syncope and \\npossible seizure.  \\n.  \\n  note,   patient is unable to give a   hx, and most     was obtained from the group home director (contact \\ninformation below). As per the director, the pt was in the \\nkitchen drinking a cup of coffee, chatting   other residents \\nwhen all of sudden his right arm started shaking rhythmically He started spilling coffee all  , and the shaking spread to \\nthe rest of his body. All four limbs were shaking and the \\npatient fell into the   and slumped down on the floor. He \\ndid not hit his head on   way down. The shaking lasted approximately 1:15 minutes, and the director states there was no \\nevidence of urinary or bowel incontinence. The pt himself denies \\na sore tongue, and the director denies evidence of blood from \\nthe mouth. Pt vomited x 1 with small amount (NBNB). After the \\nrhythmic shaking, he was found to be breathing deeply. He opened \\nhis eyes and he had a very red face and eyes. He could not \\nreally speak and seemed confused for 10  . When EMS \\narrived later, he began to pull at the O2 mask that they palced \\non him, but   could not really respond to questions when he \\nleft the group home. The director states he has been a resident \\nat the group home for ___ years now, and has never been known to \\nhave a seizure disorder. He was   today without any \\ncomplaints of bloody stools or bloody urine. Pt has taken all \\nmeds on time with no extra or missed doses.  \\n.  \\nIn the ED, initial vs were: 97 91 112/59 18 97%. later,   was \\nfound to be hypotensive to sbp ___. He was bolused with fluid \\n(1L) and   BP responded appropriately. Labs notable for \\nlactate 1.6, troponin 0.01, K 3.0, Cr 1.3, AG 21, LFTs wnl, \\nserum tox negative, Hct 39.7, INR 1.1. Patient was given 40 meq \\npotassium. By the   he was transferred to the floor, the pt \\nwas A+Ox3 and responding appropriately to questions. CT Head, \\nCXR, EKG were done (see below).  \\n.  \\n  the floor, the patient is comfortable and is unable to answer \\nmost questions about his hx. He denies   LH or dizziness at \\nthis  .  \\n.  \\nReview of  :  \\n(+) Per HPI  \\n(-) Denies fever, chills, night sweats, recent weight loss or \\ngain. Denies headache, sinus tenderness, rhinorrhea or \\ncongestion. Denied cough, shortness of breath. Denied   pain \\nor tightness, palpitations. Denied nausea, vomiting, diarrhea, \\nconstipation or abdominal pain. No recent change in bowel or \\nbladder habits. No dysuria. Denied arthralgias or myalgias.  \\n\\n \\nPast Medical History:\\nHypertension  \\n- Gout  \\n- mental retardation  \\n\\n \\n  History:\\n \\nFamily History:\\npt unable to give extensive FH due to MR. ___ died of MI \\n \\nPhysical Exam:\\nVitals: T98, BP 144/86, P76, RR 18, 99/RA  \\nOrthostatics: Sit: ___ Stand: 119/82 - 94  \\nGeneral: Alert, oriented, no acute distress  \\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck supple, JVP not elevated (5 cm)  \\nLungs: Clear to auscultation bilaterally, no wheezes,  , \\nronchi  \\nCV: Regular   and rhythm, normal S1 + S2, no rubs, gallops, \\nGrade III/VI holosystolic murmur best heard   the apex with \\nradiation throughout the precordium  \\nAbdomen: soft, non-tender, non-distended, bowel sounds present, \\nno rebound tenderness or guarding, no organomegaly  \\nGU: no foley  \\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema  \\nNeuro: CNs2-12 intact, sensation intact bilaterally, motor ___ \\nthroughout. 2+ reflexes in biceps and patella.  \\n\\n \\nPertinent Results:\\nADMISSION LABS\\n___ 02:01PM BLOOD WBC-6.9 RBC-4.85 Hgb-14.2 Hct-39.7* \\nMCV-82 MCH-29.4 MCHC-35.9* RDW-13.2 Plt ___\\n___ 02:01PM BLOOD Neuts-57.4 ___ Monos-5.  Eos-1.6 \\nBaso-1.1\\n___ 02:01PM BLOOD ___ PTT-24.5 ___\\n___ 02:01PM BLOOD Glucose-125* UreaN-21* Creat-1.3* Na-139 \\nK-3.0* Cl-96 HCO3-22 AnGap-24*\\n___ 02:01PM BLOOD ALT-25 AST-32 LD(LDH)-174 AlkPhos-50 \\nTotBili-0.4\\n___ 02:01PM BLOOD Albumin-4.5 Calcium-9.2 Phos-3.0 Mg-2.5\\n___ 02:01PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \\nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\\n___ 07:20AM BLOOD calTIBC-299 Ferritn-77 TRF-230\\n___ 04:56PM BLOOD Lactate-1.6\\n\\nCT HEAD\\nIMPRESSION: No acute intracranial injury.\\n\\nMRI HEAD\\nIMPRESSION: Extremely motion degraded study without evidence of \\nacute \\nintracranial abnormality. \\n\\nCHEST XRAY\\nIMPRESSION: No acute intrathoracic process.\\n\\nEEG: (official read pending, prelim read below)\\nMinimally slow ___ Hz) consistent with mild diffuse \\nencephalopathy, with rare left temporal slowing, no seizure \\nactivity.\\n \\nBrief Hospital Course:\\nThis is a ___ with MR, HTN, gout, who p/w syncope vs seizure. \\nGiven the hx provided by the director of the group home, seizure \\nseems most likely for this gentleman, which is concerning given \\nhis age at his first seizure. Also possible is syncope ___ \\northostasis given his orthostatic VS here, however less likely \\ngiven the convincing HPI for seizure.  \\n.  \\n# Syncope: DDx is broad, however given the patient's story, I am \\nmost concerned for seizure. Other etiologies are certainly \\npossible, however given the history, I think it is important to \\nevaluate him as a seizure patient. Most notable is his \\northostasis on the floor, and we will have to address that as \\nwell. Other causes of syncope that are easy to r/o and that \\nshould be done are infx, arrhythmia, electrolyte disturbances. \\nThe pt does have a 1st degree AV block, however this is usually \\nnot a malignant process and is not symptomatic. AS is not likely \\nas murmur is not c/w AS, rather MR.  \\n.\\nGiven that we were most concerned with seizure, we did a brain \\nMRI (which did not show any pathology) and a 20 minute EEG \\n(pending at time of discharge, however prelim read without \\nseizure activity).  We also c/s neurology who felt that he did \\nnot need any antiepileptics, but rather can f/u with outpt \\nneurology.\\n.  \\n# Orthostatic VS: Pt seems to be volume down given exam and \\northostatic VS.  We hydrated with IVF and held BP meds.  The \\npt's BP meds were held and we discharged the pt without his BP \\nmedications as his BP has been normotensive here without the \\nlisinopril/HCTZ\\n.  \\n# ARF: Pt's Cr is 1.3 up from a baseline of 1.0. Most likely is \\nprerenal, especially given orthostatic VS. We hydrated. We held \\nlisinopril as well.  Unfortunately, the pt did undergo a \\ngadolinium load during his hospitalization.  Regardless, we feel \\nthis can be f/u as an outpatient with a repeat Chem-7 in one \\nweek's time. We asked the patient to avoid NSAIDs as an \\noutpatient and we continued to hold his lisinopril.\\n.  \\n# HTN: As above, we held the lisinopril/HCTZ, even at time of \\ndischarge as he remained normotensive without antihypertensives. \\n This can be readdressed as an outpatient.\\n  \\n# gout: continued colchicine  \\n \\nMedications on Admission:\\nCOLCHICINE 0.6 mg PO daily  \\nLISINOPRIL-HYDROCHLOROTHIAZIDE 20 mg-25 mg Tablet PO daily  \\nACETAMINOPHEN 650 mg Tablet Sustained Release -prn pain  \\nIBUPROFEN [ADVIL] - 200-400 mg prn foot pain  \\n\\n \\nDischarge Medications:\\n1. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO DAILY \\n(Daily).  \\n2. acetaminophen 650 mg Tablet Sustained Release Oral\\n\\n \\nDischarge Disposition:\\nHome\\n \\nDischarge Diagnosis:\\nPRIMARY:\\n1. fall, suspected seizure\\n\\n \\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\n \\nDischarge Instructions:\\nIt was a pleasure taking care of you during your \\nhospitalization.\\nYou were admitted to ___ for a fall and a question of \\nseizure-like activity. You underwent an MRI of your head which \\nshowed nothing abnormal, and an EEG which showed no seizure \\nactivity. We had the inpatient neurology team see you who felt \\nthat you did not need any new medications, and that you should \\nfollow up with an outpatient neurologist soon.\\n.\\nAlso, your Blood pressures were normal without blood pressure \\nmedicine, so we think you can stop taking your blood pressure \\nmedicine for now, and readdress this with your PCP when you see \\nhim next ___.\\n.\\nMEDICATION CHANGES:\\n- Try to avoid using Ibuprofen as your kidneys showed a little \\ndamage.  This will likely go away, however to be safe, we feel \\nyou should avoid Ibuprofen for now.\\n- STOP taking LISINOPRIL/HYDROCHLOROTHIAZIDE\\n.\\nPlease continue your medications as prescribed. Please continue \\nyour appointments as noted below.\\n \\nFollowup Instructions:\\n___\", 'Sex:   M\\n \\nService: NEUROLOGY\\n \\nAllergies: \\nNo Known Allergies / Adverse Drug Reactions\\n \\n ___\\n \\nChief Complaint:\\naltered mental status\\n \\n  Surgical or Invasive Procedure:\\nnone\\n\\n \\nHistory of Present Illness:\\nThe patient is   ___ yo man with extensive medical history\\nremarkable for old RT parietal stroke, HTN, hypothyroidism, BPH,\\n , anemia, bowel, bladder incontinence,  , dementia,\\nanxiety, and schizoaffecctive d o. He was brought in to the ED\\nfrom ___ with AMS. \\n\\nPer the nursing home staff pt at   is awake, alert oriented and  , but hard   hearing. Hereqiores\\nassistance for all ADLs and is wheelchair bound. This am he was\\n  staring, drooling,   responsive to sternal rub to which\\nhe grimaced. The staff also noted him to have weaker RT hadgrasp\\nthan usual. He reportedly was not acting like himself and did\\n  have breakfast as usual.\\n\\nHe   evaluated by the ED  , no focal deficits found  \\nhead CT ordered. Per nursing staff on arrival to the ED he was\\nnot very talkative, but able to answer \"okay\" when asked\\nquestions. He gradually returned to baseline within one hour of\\nthis episode.\\n\\nPer the patient he reports he had a stroke the night prior to\\nadmission,   complains he had pain all over, as well as \\nweakness\\nof his right arm, which has improved upon arrival to the\\nhospital. \\n\\n \\nPast Medical  :\\n. Previous RT parietal ___\\n2. Hypothyroidism\\n . HTN\\n4. Gout\\n5. COPD\\n6. BPH\\n7. Bowel and bladder incontinence\\n8. Remote hx of alcohol abuse\\n9. Anxiety\\n10. Dementia\\n11. Schizoaffective d/o\\n12. Chronic anemia \\n\\n \\nSocial History:\\n___\\nFamily History:\\nunknown\\n \\nPhysical Exam:\\nOn admission:\\nGeneral:  NAD\\nHEENT: NCAT,  no oropharyngeal lesions, neck supple\\n___: RRR, no M/R/G\\nPulmonary: Coarse sounds throughout\\nAbdomen: Soft, NT, ND, +BS, no guarding\\nExtremities: Warm, no edema, LT had contracture, BLE in knee\\nflexion.\\n\\nNeurologic Examination:\\nAwake, alert, oriented x 3. Able to relate history without\\ndifficulty. Slightly innatentive, unable to name ___ backward\\nwithout difficulty. Speech is fluent with full sentences, intact\\nrepetition, and intact verbal comprehension. Naming intact.  No\\nparaphasias.  No dysarthria. Normal prosody. Able to register 3\\nobjects and recall ___ at 5 minutes without prompting. No\\napraxia. No evidence of hemineglect. No left-right confusion. \\nAble to follow both midline and appendicular commands.\\n\\n- Cranial Nerves - Lt pupil 3->2 brisk, RT pupil 2 not reactive\\nto light. EOMI, no  . V1-V3 without deficits to light\\ntouch bilaterally. No facial movement asymmetry. Hearing \\nseverely\\n  but able to carry a conversation.  Palate elevation\\nsymmetric.  /Trapezius strength ___ bilaterally. Tongue midline.\\n\\n- Motor - Decreased bulk and increased tone on LUE. No tremor  \\nasterixis.\\n  Delt Bic Tri  FFl FE  IO IP Quad Ham Gastroc \\nL  -    5   4+   -  -   -   3+  3+  3+    -       \\nR  -    5   4+   4+  4+  4+ 3+  3+  3+    -     \\n\\n- Sensory - No deficits to light touch bilaterally.\\n\\n-DTRs:\\n  Bi  Tri ___    \\nL  2+       2+   2+  0\\nR  2+  2    2+   2+  0\\nPlantar response upgoing on the left, and downgoing on the \\nright.\\n\\n- Coordination - attempted finger   nose but patient unable to\\nfollow.\\n\\n- Gait not tested.\\n\\n---\\nOn discharge:\\nMental status: Awake, alert, oriented x 3. Speech is fluent with \\nfull sentences. No dysarthria. Normal prosody. No evidence of \\nhemineglect. No left-right confusion. Able to follow both \\nmidline and appendicular commands. Otherwise unchanged.\\n\\n \\nPertinent Results:\\nImaging:\\n\\nCXR: 5.7 x 4.5 cm well-circumscribed mass at the right lung \\nbase.  The right heart border is not well visualized suggesting \\na right middle lobe location. However, given the deformity of \\nthe underlying right tenth rib and the density of the lesion, \\nthis may reflect a chest wall lesion and Chest CT is recommended \\nfor further evaluation. \\n\\nCT chest: 1. 6.1 x 3.2 x 4.5   mass in the right lower lobe, \\nwhich exerts mass effect upon basal segment bronchi with resultant volume loss. Findings are concerning for lung cancer. \\n2. Additional nodules in the right middle lobe. \\n3. Incompletely characterized nodule in the right adrenal gland, \\nbut statistically likely an adenoma Attention on followup is \\nadvised. \\n4. Severe centrilobular and paraseptal emphysema. \\n5. Compression deformity of the L1 vertebral body of unclear \\nchronicity. \\n\\nCT abdomen/pelvis with contrast: \\n1. 11 mm right adrenal gland nodule statistically likely to \\nrepresent an adenoma, but in the setting of a lung mass, \\nmetastatic disease cannot be excluded.  Recommend evaluation \\nwith non-contrast CT scan. \\n2. 4.5 cm intra-luminal eccentric lesion in the right colon. \\nThis is not fully evaluated on this single phase scan but is \\nconcerning for colon cancer. Recommend evaluation with a \\nnon-contrast abdominal CT scan to assess. \\n\\nCT abdomen/pelvis without contrast: \\n1. Right colon mass seen on prior examination is enhancing and \\nis highly suspicious for colon cancer. \\n2. There is an 11 mm right adrenal adenoma. \\n\\nNon-contrast head CT: \\n1. No evidence of acute large territorial infarct or hemorrhage. \\n\\n2. Age-related involutional changes and sequela of chronic small \\nvessel \\nischemic disease. \\n3. Sinus disease, as described above. \\n\\nMRI head:\\n1. No acute intracranial abnormality without evidence of stroke \\nor mass. \\n2. Confluent periventricular and subcortical white matter FLAIR \\nsignal hyperintensity with background diffuse cortical volume \\nloss, likely representing sequela of chronic microangiopathy. \\n3. Sinus disease. \\n\\nCXR:\\nThe previously described masslike opacity since ___ has \\nsignificantly improved, with residual heterogeneous opacity, \\nsuggesting focal infection or atelectasis over malignancy. There \\nis new mild opacity in the right middle lobe, which could also \\nrepresent worsening pneumonia in the appropriate clinical \\nsetting. \\n\\nLabs:\\n___ 06:10AM BLOOD WBC-9.5 RBC-3.46* Hgb-12.0* Hct-37.0* \\nMCV-107* MCH-34.7* MCHC-32.4 RDW-13.6 RDWSD-53.6* Plt ___\\n___ 06:10AM BLOOD Neuts-70.1 Lymphs-16.2* Monos-9.3 Eos-3.2 \\nBaso-0.4 Im ___ AbsNeut-6.66* AbsLymp-1.54 AbsMono-0.88* \\nAbsEos-0.30 AbsBaso-0.04\\n___ 06:10AM BLOOD Glucose-85 UreaN-22* Creat-1.2 Na-143 \\nK-4.3 Cl-113* HCO3-18* AnGap-16\\n___ 06:05AM BLOOD VitB12-506\\n___ 05:15AM BLOOD %HbA1c-5.2 eAG-103\\n___ 05:15AM BLOOD Triglyc-79 HDL-47 CHOL/HD-2.8 LDLcalc-67\\n___ 05:15AM BLOOD TSH-2.0\\n \\nBrief Hospital Course:\\nMr. ___ is a ___ man with prior R MCA stroke, dementia, and \\nschizoaffective disorder who was admitted for altered mental \\nstatus with blank staring and drooling that lasted for 1hr and \\nalso R sided weakness. He main complaint is back pain, and he \\nwas uncooperative on exam but oriented to date, location, and \\npresident. L sided weakness compared to R that is old per pt and \\nguardian. Mental status back to baseline as of 6pm ___. TIA \\nworkup started as possible cause of AMS, MRI head negative for \\nstroke/mass lesion, no diabetes or HLD found, echo unable to \\nassess for PFO. \\n\\nOf note, found incidental lung lesion on routine CXR in ED. CT \\ntorso showed RLL lung mass, R adrenal gland nodule, and \\nintraluminal R colon lesion concerning for colon cancer. Also L1 \\nvertebral body compression that may explain back pain. Pt and \\nlegal guardian are aware of results from CT scans. Heme/onc was \\nconsulted for help with further management. They have \\nrecommended outpatient workup. This has been communicated to his \\nPCP, ___. Of note, repeat CXR on ___ demonstrated \\ninterval decrease in the size of the lung mass, suggesting \\ninstead an infectious etiology. \\n\\nAlso developed a UTI for which he was treated with IV \\nantibiotics. Discharged home with po antibiotics for 7 days for \\ncomplicated UTI. \\n \\nMedications on Admission:\\nThe Preadmission Medication list is accurate and complete.\\n1. Levothyroxine Sodium 125 mcg PO DAILY \\n2. BuPROPion 300 mg PO DAILY \\n3. Colchicine 0.6 mg PO EVERY OTHER DAY \\n4. Fluticasone Propionate 110mcg 1 PUFF IH BID \\n5. TraMADOL (Ultram) 50 mg PO BID:PRN pain \\n6. Lorazepam 0.5 mg PO TID \\n7. Lactulose 30 mL PO QHS \\n8. Doxazosin 4 mg PO HS \\n9. Ibuprofen 200 mg PO DAILY \\n10. Prochlorperazine 5 mg PO Q8H:PRN nausea \\n11. LOPERamide 2 mg PO Q6H:PRN diarhhea \\n12. Guaifenesin 5 mL PO Q4H:PRN cough \\n13. Bisacodyl 10 mg PO DAILY:PRN constipation \\n14. Fleet Enema ___AILY:PRN constipation \\n\\n \\nDischarge Medications:\\n1. BuPROPion 300 mg PO DAILY \\n2. Bisacodyl 10 mg PO DAILY:PRN constipation \\n3. Colchicine 0.6 mg PO EVERY OTHER DAY \\n4. Doxazosin 4 mg PO HS \\n5. Fleet Enema ___AILY:PRN constipation \\n6. Fluticasone Propionate 110mcg 1 PUFF IH BID \\n7. Levothyroxine Sodium 125 mcg PO DAILY \\n8. Lorazepam 0.5 mg PO TID \\n9. TraMADOL (Ultram) 50 mg PO BID:PRN pain \\n10. Acetaminophen 650 mg PO TID:PRN pain, fever \\n11. Aspirin 81 mg PO DAILY \\n12. Multivitamins 1 TAB PO DAILY \\n13. Guaifenesin 5 mL PO Q4H:PRN cough \\n14. Lactulose 30 mL PO QHS \\n15. LOPERamide 2 mg PO Q6H:PRN diarhhea \\n16. Prochlorperazine 5 mg PO Q8H:PRN nausea \\n17. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days \\nRX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day \\nDisp #*14 Tablet Refills:*0\\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nAltered mental status of unknown cause, possible TIA, lung mass, \\nR colonic mass\\n\\n \\nDischarge Condition:\\neating po, awake, alert, oriented, voiding\\n\\n \\nDischarge Instructions:\\nDear Mr. ___,\\n\\nYou were admitted to the hospital because you seemed to have an \\nepisode of confusion and right sided weakness at your care \\nfacility. The MRI of your head did not show any strokes or \\nmasses, and your EEG did not show evidence that you were having \\na prolonged seizure. Thankfully, you returned to your baseline \\nmental status by the next afternoon. We have pursued a transient \\nischemia attack workup given your possible right sided weakness \\nand altered mental status, and it is normal. \\n\\nWhile you were in the Emergency room, you had a chest Xray that \\nshowed a mass in your right lung, which was confirmed by a CT \\nscan of your chest. A CT scan of your abdomen also showed a R \\ncolonic mass. As we have discussed with you and your legal \\n___, these findings are concerning for \\ncancer. Oncology has seen you in the hospital but are unable to \\nmake any recommendations until a biopsy of either the lung or \\nthe colon is obtained. You will need to be closely followed in \\nthe outpatient setting for further diagnostic workup and \\ntreatment. \\n \\nFollowup Instructions:\\n___', 'Sex:   M\\n \\nService: MEDICINE\\n \\nAllergies: \\nPenicillins / Erythromycin Base / Streptomycin / Citric Acid / \\nAtenolol / Torsemide / Heparin Agents\\n \\n ___.\\n \\nChief Complaint Respiratory Distress, Hypotension\\n \\nMajor Surgical or   Procedure:\\nRight internal jugular (CVL) (discontinued) \\nArterial   (discontinued PICC (placed ___\\n \\nHistory of Present Illness:\\n___ year old male with multiple co-morbidities,   rectal cancer s/p   and radiation in ___, coronary artery \\ndisease s/p stents, systolic CHF, dilated cardiomyopathy,   \\nfibrillation, history of cardiac   and complete heart blood \\ns/p AICD/pacemaker recent trach/peg   presented with \\nrespiratory distress, fevers and hypotension. The patient \\n    day before   to 85% at ___ \\nalthough improved to 92% with suctioning out copious amounts of \\nthick yellow, brown secretions. Per his wife   daughter, he \\nhad been doing well with the trach, often having it capped in \\nthe last week - up until ___ days ago when he needed to be on \\nthe vent more frequently. He reportedly had a fever to ___ \\nyesterday and 102.0 today at rehab and had a CXR performed there \\nshowing LLL pneumonia; he was treated with Vancomycin 1 gram X1 \\nthere.\\n.\\nOn arrival to the ___ ___ the patient was being bagged by EMS \\nupon arrival, hypotensive to SBP80s, not tachypneic, never \\nfebrile, satting stably on his trach settings. He was mentating \\nwell complaining only of buttocks pain (stable) and answering \\nquestions appropriately. CXR ___ similar to priors and he was \\ntreated with Levofloxacin and Cefepime. Given persistent \\nhypotension SBP80s and decreased UOP   hours) despite \\n1.5L IVF, a RIJ CVL was placed and levophed started at 0.06. He \\nalso had a midline IV from before and 18 gauge PIV. His troponin \\nwas 0.11 so he was also given aspirin 325mg. VS on transfer to \\nMICU: Afebrile, HR70, BP86/40 RR16, 95% on PEEP5, FiO2 60%, \\nTV500.\\n.\\nUpon arrival to the MICU, the patient was resting comfortably in \\nbed. \\n.\\nReview of systems:  \\n(+) Per HPI  \\n(-) Denies headache, sinus tenderness, congestion. Denies chest \\npain, chest  , palpitations, or weakness. Denies nausea, \\nvomiting, diarrhea, constipation, abdominal pain, or changes in \\nbowel habits. \\n\\n \\nPast Medical History:\\n- Rectal cancer s/p excision and XRT (___)\\n- CAD s p stents  \\n- Complete heart block s/p pacemaker \\n- h/o cardiac arrest (now with AICD)  \\n- Afib \\n- Systolic CHF EF 40-45%)  \\n- s/p Fall with multiple rib fractures (___)  \\n- h/o GI bleed\\n \\nSocial History:\\n___\\n  History:\\nFather died in ___ from MI. Mother died in ___ from PE. No \\nfamily history of colon, breast, uterine,   ovarian cancer. No \\nfamily history of seizures. \\n \\nPhysical Exam:\\nAdmission Exam:\\nVitals: T: Afebrile BP: 105/47 P: 61 R: 13 O2: 100%   \\nGeneral: oriented, no acute distress, sleepy\\nHEENT: Sclera anicteric, MMM, oropharynx clear  \\nNeck:  , RIJ CVL\\nLungs: Diffusely rhonchorous, rales; no wheezes \\nCV: RRR, ___   murmur heard best over apex with \\ndulling of S1 and S2 over apex. Otherwise S1 S2 clear and of \\ngood quality over rest of precordium.\\nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \\nno rebound tenderness or guarding; ostomy bag   place  \\nGU: three way irrigation foley \\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \\nedema; dry stasis changes on bilateral lower extremities  \\n  \\nDischarge Exam: \\nVS 98.9 73 133/69 24 95% trach collar 50%    \\nGeneral Appearance: No acute distress, breathing comfortably on \\ntrach collar.\\nHEENT: PERRL, Conjunctiva pale, Normocephalic, Poor dentition\\nCardiovascular: RRR, ___ holosystolic murmur heard best over \\nRespiratory:  mild rhonchi throughout all lung fields with \\noccasional   wheezes\\nAbdominal: Soft, non- , colostomy, PEG, + BS \\nExtremities: Bilateral ___ edema L>R, Chronic skin changes over \\nbilateral ___ suggestive of chronic venous stasis,   knee \\ntender to palpation \\nSkin:  Warm, well perfused\\nNeurologic: Attentive, Follows simple commands, Responds to: \\nVerbal stimuli, Movement: Purposeful, Tone: Normal, localizes \\npain. Able to point out letters on chart for communicating, \\nappropriate\\n\\n \\nPertinent Results:\\nBlood Counts\\n___ 08:00AM BLOOD WBC-28.2*# RBC-2.71* Hgb-7.9* Hct-24.0* \\nMCV-88 MCH-29.1 MCHC-33.1 RDW-16.6* Plt ___\\n___ 02:30PM BLOOD WBC-11.6* RBC-3.00* Hgb-8. * Hct-26.6* \\nMCV 89 MCH-29.3 MCHC-33.1 RDW-16.6* Plt ___\\n___ 02:53AM BLOOD WBC-8.0 RBC-2.81* Hgb-8.3* Hct-25.0* \\nMCV-89 MCH-29.4 MCHC-33.0 RDW-16.1* Plt Ct-80*\\n\\nElectrolytes\\n___ 08:00AM BLOOD Glucose-139* UreaN-45* Creat-1.5* Na-136 \\nK-5.0 Cl-99 HCO3-29 AnGap-13\\n___ 02:57AM BLOOD Glucose-106* UreaN-50* Creat-1.3* Na-138 \\nK-4.4 Cl-107 HCO3-25 AnGap-10\\n___ 02:53AM BLOOD Glucose-144* UreaN-48* Creat-1.2 Na-139 \\nK-4.3 Cl-103 HCO3-29 AnGap-11\\n\\n \\nBrief Hospital Course:\\nHOSPITAL COURSE\\n___ PMHx rectal cancer s/p resection and XRT w ostomy, systolic \\nCHF (LVEF40-45%), recent trach/peg who presented with \\nrespiratory distress, found to have a pnuemonia, with blood and \\nsputum cultures growing out MRSA, now improved to baseline \\nrespiratory status being discharged to ___ on 2 week course of \\nIV antibioitics\\n.\\nACTIVE\\n# Healthcare Associated Pnuemonia and MRSA Bacteremia - Patient \\npresented with increasing O2 requirements, leukocytosis and \\nhypotension; CXR demonstrated LLL PNA; accompanying elevated \\nLactate, High SvO2 (93%), hypotension and tachycardia suggested \\nsepsis; blood and sputum cultures grew out MRSA.  Patient was \\ninitially fluid resuscitated and briefly required vasopressors.  \\nHe was treated with vancomycin (initially with cefepime and \\nlevofloxacin as well, which were stopped based upon culture \\ndata).  Patient respiratory status improved, and patient was \\nable to be weaned off vent to trach collar.  Given MRSA \\nbacteremia, patient had PICC line changed and underwent TTE that \\ndid not demonstrate signs of valvular lesions; patient was \\nplanned for 2 week course with IV vancomycin.  \\n.\\n# Sacral decubitus ulcer: Significant, likely stage IV.  \\nAppropriate wound care was provided and his pain regimen was \\nincreased to Oxycodone to ___ mg q4 PRN for pain which \\nsuccessfully curbed decubitus pain.\\n.\\n# Coronary artery disease: Stable, continued carvedilol; held \\nlisinopril given hypotension and will need to be restarted; \\nstarted ASA (had been held previously given history of GI \\nbleeds).  \\n.\\n# Afib: CHADS4, but off anticoagulation ___ hemothorax ___.  \\nDiscussed with primary cardiologist who recommended considering \\nrestarting coumadin as outpatient. \\n\\nINACTIVE\\n# Anemia - Continued iron supplementation\\n.\\n# Systolic CHF: EF 40-45%, continued lasix\\n.  \\nTransitional Issues:\\n- Patient is full code\\n- Will need primary care doctors to discuss ___ as \\noutpatient\\n- Continue vancomycin for 2 weeks total course\\n \\nMedications on Admission:\\nMedications (per D/C summary and ___ records): \\n* Acetaminophen 650mg q8 hours PRN pain \\n* Acetaminophen 325mg q8 hours PRN pain \\n* Lidocaine patch X2 \\n* Trazodone 25mg qHS \\n* Carvedilol 3.125mg twice daily \\n* Citalopram 20mg daily \\n* Docusate 10mL twice daily \\n* Ferrous sulfate 325mg elixir daily \\n* Folate 1mg daily \\n* Lasix 40mg daily \\n* Gabapentin 300mg twice daily \\n* Lisinopril 2.5mg daily \\n* Multivitamin daily \\n* Omeprazole 20mg \\n* Protein supplements daily \\n* Albuterol HFA inhaler \\n* Simethicone 80mg every 8 hours \\n* Oxycodone 5 every four hours PRN tracheal pain, dressing \\nchanges\\n* Miconazole powrder qHS \\n* Levofloxacin 750mg daily, completed course ___ \\n* Gentamicin nebulizer 80mg q12 hours nebulizer\\n\\n \\nDischarge Medications:\\n1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every \\n4 hours) as needed for pain.  \\n2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \\nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 \\nhours on, 12 hours off.  \\n3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as \\nneeded for insomnia.  \\n4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) mL PO BID (2 \\ntimes a day).  \\n6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1) \\ndose PO DAILY (Daily).  \\n7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \\n\\n8. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \\n \\n9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \\n10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \\nTwo (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, \\nwheeze.  \\n11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, \\nChewable PO TID (3 times a day).  \\n12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS \\n(at bedtime).  \\n13. oxycodone 5 mg Tablet Sig: ___ Tablets PO every four (4) \\nhours as needed for pain: Hold for Sedation or RR<12.  \\n14. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \\nPO DAILY (Daily).  \\n15. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  \\n16. Please change and care for lines per nursing routine\\n17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO twice a \\nday.  \\n18. vancomycin 750 mg Recon Soln Sig: One (1) solution \\nIntravenous twice a day for 24 days.  \\n\\n \\nDischarge Disposition:\\nExtended Care\\n \\nFacility:\\n___\\n \\nDischarge Diagnosis:\\nPRIMARY\\nHealthcare Associated Pneumonia\\nStaph Bacteremia\\n\\nSECONDARY\\nSystolic CHF \\nAtrial Fibrillation\\n\\n \\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Lethargic but arousable.\\nActivity Status: Bedbound.\\n\\n \\nDischarge Instructions:\\nMr. ___--\\n\\nIt was a pleasure treating you at ___. You were admitted with \\ndifficulty breathing and low blood pressure.  You were found to \\nhave a pneumonia and an infection in your blood. You were \\ntreated with antibiotics and improved.  You will need to \\ncontinue your antibiotics for 2 weeks total.\\n  \\nThe following changes to your medications were made:\\n- STARTED vancomycin (continue until ___\\n- STARTED aspirin\\n- STOPPED inhaled gentamycin\\n \\nFollowup Instructions:\\n___']\n",
      "Calculating Sufficiency\n"
     ]
    },
    {
     "ename": "OutOfMemoryError",
     "evalue": "CUDA out of memory. Tried to allocate 3.75 GiB. GPU 0 has a total capacity of 15.72 GiB of which 1.84 GiB is free. Including non-PyTorch memory, this process has 13.88 GiB memory in use. Of the allocated memory 9.92 GiB is allocated by PyTorch, and 3.77 GiB is reserved by PyTorch but unallocated. If reserved but unallocated memory is large try setting PYTORCH_CUDA_ALLOC_CONF=expandable_segments:True to avoid fragmentation.  See documentation for Memory Management  (https://pytorch.org/docs/stable/notes/cuda.html#environment-variables)",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mOutOfMemoryError\u001b[0m                          Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[9], line 34\u001b[0m\n\u001b[1;32m     30\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;28mlen\u001b[39m(others_removed))\n\u001b[1;32m     32\u001b[0m \u001b[38;5;66;03m# the extra list is needed since the function expects a list of instances each coming from a different interpretability method\u001b[39;00m\n\u001b[1;32m     33\u001b[0m \u001b[38;5;66;03m# testing multi input by duplicating the arrays, don't actually do this\u001b[39;00m\n\u001b[0;32m---> 34\u001b[0m ind, faith \u001b[38;5;241m=\u001b[39m \u001b[43mfaithfulness\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcalculate_faithfulness\u001b[49m\u001b[43m(\u001b[49m\u001b[43minstances\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m[\u001b[49m\u001b[43mrationalle_removed\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mrationalle_removed\u001b[49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m[\u001b[49m\u001b[43mothers_removed\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mothers_removed\u001b[49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmodel\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtokenizer\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mpredictor_model\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     35\u001b[0m \u001b[38;5;28mprint\u001b[39m(ind)\n\u001b[1;32m     36\u001b[0m \u001b[38;5;28mprint\u001b[39m(faith)\n",
      "File \u001b[0;32m~/csc413/CSC413-Project/faithfulness.py:174\u001b[0m, in \u001b[0;36mcalculate_faithfulness\u001b[0;34m(instances, instances_rationalle_removed, instances_other_removed, model, tokenizer, predictor_func)\u001b[0m\n\u001b[1;32m    171\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mCurrently interpreting instance: \u001b[39m\u001b[38;5;124m\"\u001b[39m, i)\n\u001b[1;32m    173\u001b[0m \u001b[38;5;28mprint\u001b[39m(instances_rationalle_removed[i])\n\u001b[0;32m--> 174\u001b[0m sufficency \u001b[38;5;241m=\u001b[39m \u001b[43mcalculate_sufficency\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpredictions\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43minstances_rationalle_removed\u001b[49m\u001b[43m[\u001b[49m\u001b[43mi\u001b[49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmodel\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtokenizer\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mpredictor_func\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    175\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mSufficency for iteration: \u001b[39m\u001b[38;5;124m\"\u001b[39m, sufficency)\n\u001b[1;32m    177\u001b[0m comprehensiveness \u001b[38;5;241m=\u001b[39m calculate_comprehensiveness(predictions, instances_other_removed[i], model, tokenizer, predictor_func)\n",
      "File \u001b[0;32m~/csc413/CSC413-Project/faithfulness.py:141\u001b[0m, in \u001b[0;36mcalculate_sufficency\u001b[0;34m(predictions, instances_other_removed, model, tokenizer, predictor_func)\u001b[0m\n\u001b[1;32m    139\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mCalculating Sufficiency\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m    140\u001b[0m torch\u001b[38;5;241m.\u001b[39mcuda\u001b[38;5;241m.\u001b[39mempty_cache()\n\u001b[0;32m--> 141\u001b[0m predictions_other_removed \u001b[38;5;241m=\u001b[39m \u001b[43mpredictor_func\u001b[49m\u001b[43m(\u001b[49m\u001b[43minstances_other_removed\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mmodel\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtokenizer\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    142\u001b[0m \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mPredicitons other removed: \u001b[39m\u001b[38;5;124m\"\u001b[39m, predictions_other_removed)\n\u001b[1;32m    144\u001b[0m \u001b[38;5;66;03m# calculate the euclidean distance between the predictions and the predictions with the other words removed\u001b[39;00m\n\u001b[1;32m    145\u001b[0m \u001b[38;5;66;03m# logits are the classification scores\u001b[39;00m\n\u001b[1;32m    146\u001b[0m \u001b[38;5;66;03m# confidence_dif = predictions.logits - predictions_other_removed.logits\u001b[39;00m\n",
      "Cell \u001b[0;32mIn[8], line 22\u001b[0m, in \u001b[0;36mpredictor_model\u001b[0;34m(texts, model, tokenizer)\u001b[0m\n\u001b[1;32m     20\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mpredictor_model\u001b[39m(texts, model, tokenizer):\n\u001b[1;32m     21\u001b[0m     tk \u001b[38;5;241m=\u001b[39m tokenizer(texts, return_tensors\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpt\u001b[39m\u001b[38;5;124m\"\u001b[39m,truncation\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m, max_length\u001b[38;5;241m=\u001b[39mMAX_POSITION_EMBEDDINGS)\u001b[38;5;241m.\u001b[39mto(device)\n\u001b[0;32m---> 22\u001b[0m     outputs \u001b[38;5;241m=\u001b[39m \u001b[43mmodel\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mtk\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     23\u001b[0m     tensor_logits \u001b[38;5;241m=\u001b[39m outputs[\u001b[38;5;241m0\u001b[39m]\n\u001b[1;32m     24\u001b[0m     probas \u001b[38;5;241m=\u001b[39m F\u001b[38;5;241m.\u001b[39msigmoid(tensor_logits)\u001b[38;5;241m.\u001b[39mdetach()\u001b[38;5;241m.\u001b[39mcpu()\u001b[38;5;241m.\u001b[39mnumpy()\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/transformers/models/opt/modeling_opt.py:1259\u001b[0m, in \u001b[0;36mOPTForSequenceClassification.forward\u001b[0;34m(self, input_ids, attention_mask, head_mask, past_key_values, inputs_embeds, labels, use_cache, output_attentions, output_hidden_states, return_dict)\u001b[0m\n\u001b[1;32m   1251\u001b[0m \u001b[38;5;250m\u001b[39m\u001b[38;5;124mr\u001b[39m\u001b[38;5;124;03m\"\"\"\u001b[39;00m\n\u001b[1;32m   1252\u001b[0m \u001b[38;5;124;03mlabels (`torch.LongTensor` of shape `(batch_size,)`, *optional*):\u001b[39;00m\n\u001b[1;32m   1253\u001b[0m \u001b[38;5;124;03m    Labels for computing the sequence classification/regression loss. Indices should be in `[0, ...,\u001b[39;00m\n\u001b[1;32m   1254\u001b[0m \u001b[38;5;124;03m    config.num_labels - 1]`. If `config.num_labels == 1` a regression loss is computed (Mean-Square loss), If\u001b[39;00m\n\u001b[1;32m   1255\u001b[0m \u001b[38;5;124;03m    `config.num_labels > 1` a classification loss is computed (Cross-Entropy).\u001b[39;00m\n\u001b[1;32m   1256\u001b[0m \u001b[38;5;124;03m\"\"\"\u001b[39;00m\n\u001b[1;32m   1257\u001b[0m return_dict \u001b[38;5;241m=\u001b[39m return_dict \u001b[38;5;28;01mif\u001b[39;00m return_dict \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mconfig\u001b[38;5;241m.\u001b[39muse_return_dict\n\u001b[0;32m-> 1259\u001b[0m transformer_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmodel\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m   1260\u001b[0m \u001b[43m    \u001b[49m\u001b[43minput_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1261\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpast_key_values\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_values\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1262\u001b[0m \u001b[43m    \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1263\u001b[0m \u001b[43m    \u001b[49m\u001b[43mhead_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mhead_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1264\u001b[0m \u001b[43m    \u001b[49m\u001b[43minputs_embeds\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43minputs_embeds\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1265\u001b[0m \u001b[43m    \u001b[49m\u001b[43muse_cache\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muse_cache\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1266\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1267\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_hidden_states\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_hidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1268\u001b[0m \u001b[43m    \u001b[49m\u001b[43mreturn_dict\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mreturn_dict\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m   1269\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1270\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m transformer_outputs[\u001b[38;5;241m0\u001b[39m]\n\u001b[1;32m   1271\u001b[0m logits \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mscore(hidden_states)\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/transformers/models/opt/modeling_opt.py:979\u001b[0m, in \u001b[0;36mOPTModel.forward\u001b[0;34m(self, input_ids, attention_mask, head_mask, past_key_values, inputs_embeds, use_cache, output_attentions, output_hidden_states, return_dict)\u001b[0m\n\u001b[1;32m    976\u001b[0m return_dict \u001b[38;5;241m=\u001b[39m return_dict \u001b[38;5;28;01mif\u001b[39;00m return_dict \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mconfig\u001b[38;5;241m.\u001b[39muse_return_dict\n\u001b[1;32m    978\u001b[0m \u001b[38;5;66;03m# decoder outputs consists of (dec_features, past_key_value, dec_hidden, dec_attn)\u001b[39;00m\n\u001b[0;32m--> 979\u001b[0m decoder_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mdecoder\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    980\u001b[0m \u001b[43m    \u001b[49m\u001b[43minput_ids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43minput_ids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    981\u001b[0m \u001b[43m    \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    982\u001b[0m \u001b[43m    \u001b[49m\u001b[43mhead_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mhead_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    983\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpast_key_values\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_values\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    984\u001b[0m \u001b[43m    \u001b[49m\u001b[43minputs_embeds\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43minputs_embeds\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    985\u001b[0m \u001b[43m    \u001b[49m\u001b[43muse_cache\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muse_cache\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    986\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    987\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_hidden_states\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_hidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    988\u001b[0m \u001b[43m    \u001b[49m\u001b[43mreturn_dict\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mreturn_dict\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    989\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    991\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m return_dict:\n\u001b[1;32m    992\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m decoder_outputs\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/transformers/models/opt/modeling_opt.py:894\u001b[0m, in \u001b[0;36mOPTDecoder.forward\u001b[0;34m(self, input_ids, attention_mask, head_mask, past_key_values, inputs_embeds, use_cache, output_attentions, output_hidden_states, return_dict)\u001b[0m\n\u001b[1;32m    884\u001b[0m     layer_outputs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_gradient_checkpointing_func(\n\u001b[1;32m    885\u001b[0m         decoder_layer\u001b[38;5;241m.\u001b[39m\u001b[38;5;21m__call__\u001b[39m,\n\u001b[1;32m    886\u001b[0m         hidden_states,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    891\u001b[0m         use_cache,\n\u001b[1;32m    892\u001b[0m     )\n\u001b[1;32m    893\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m--> 894\u001b[0m     layer_outputs \u001b[38;5;241m=\u001b[39m \u001b[43mdecoder_layer\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    895\u001b[0m \u001b[43m        \u001b[49m\u001b[43mhidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    896\u001b[0m \u001b[43m        \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcausal_attention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    897\u001b[0m \u001b[43m        \u001b[49m\u001b[43mlayer_head_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mhead_mask\u001b[49m\u001b[43m[\u001b[49m\u001b[43midx\u001b[49m\u001b[43m]\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mif\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mhead_mask\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;129;43;01mis\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;129;43;01mnot\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mNone\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;28;43;01melse\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mNone\u001b[39;49;00m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    898\u001b[0m \u001b[43m        \u001b[49m\u001b[43mpast_key_value\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_value\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    899\u001b[0m \u001b[43m        \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    900\u001b[0m \u001b[43m        \u001b[49m\u001b[43muse_cache\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43muse_cache\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    901\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    903\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m layer_outputs[\u001b[38;5;241m0\u001b[39m]\n\u001b[1;32m    905\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m use_cache:\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/transformers/models/opt/modeling_opt.py:535\u001b[0m, in \u001b[0;36mOPTDecoderLayer.forward\u001b[0;34m(self, hidden_states, attention_mask, layer_head_mask, past_key_value, output_attentions, use_cache)\u001b[0m\n\u001b[1;32m    532\u001b[0m     hidden_states \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mself_attn_layer_norm(hidden_states)\n\u001b[1;32m    534\u001b[0m \u001b[38;5;66;03m# Self Attention\u001b[39;00m\n\u001b[0;32m--> 535\u001b[0m hidden_states, self_attn_weights, present_key_value \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mself_attn\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    536\u001b[0m \u001b[43m    \u001b[49m\u001b[43mhidden_states\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mhidden_states\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    537\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpast_key_value\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpast_key_value\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    538\u001b[0m \u001b[43m    \u001b[49m\u001b[43mattention_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mattention_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    539\u001b[0m \u001b[43m    \u001b[49m\u001b[43mlayer_head_mask\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mlayer_head_mask\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    540\u001b[0m \u001b[43m    \u001b[49m\u001b[43moutput_attentions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moutput_attentions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    541\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    542\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m nn\u001b[38;5;241m.\u001b[39mfunctional\u001b[38;5;241m.\u001b[39mdropout(hidden_states, p\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mdropout, training\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mtraining)\n\u001b[1;32m    543\u001b[0m hidden_states \u001b[38;5;241m=\u001b[39m residual \u001b[38;5;241m+\u001b[39m hidden_states\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1511\u001b[0m, in \u001b[0;36mModule._wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1509\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_compiled_call_impl(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)  \u001b[38;5;66;03m# type: ignore[misc]\u001b[39;00m\n\u001b[1;32m   1510\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m-> 1511\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_call_impl\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/torch/nn/modules/module.py:1520\u001b[0m, in \u001b[0;36mModule._call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1515\u001b[0m \u001b[38;5;66;03m# If we don't have any hooks, we want to skip the rest of the logic in\u001b[39;00m\n\u001b[1;32m   1516\u001b[0m \u001b[38;5;66;03m# this function, and just call forward.\u001b[39;00m\n\u001b[1;32m   1517\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_forward_pre_hooks\n\u001b[1;32m   1518\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_backward_pre_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_backward_hooks\n\u001b[1;32m   1519\u001b[0m         \u001b[38;5;129;01mor\u001b[39;00m _global_forward_hooks \u001b[38;5;129;01mor\u001b[39;00m _global_forward_pre_hooks):\n\u001b[0;32m-> 1520\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mforward_call\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m   1522\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m   1523\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "File \u001b[0;32m~/miniconda3/envs/csc413/lib/python3.10/site-packages/transformers/models/opt/modeling_opt.py:215\u001b[0m, in \u001b[0;36mOPTAttention.forward\u001b[0;34m(self, hidden_states, key_value_states, past_key_value, attention_mask, layer_head_mask, output_attentions)\u001b[0m\n\u001b[1;32m    211\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m attention_mask\u001b[38;5;241m.\u001b[39msize() \u001b[38;5;241m!=\u001b[39m (bsz, \u001b[38;5;241m1\u001b[39m, tgt_len, src_len):\n\u001b[1;32m    212\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\n\u001b[1;32m    213\u001b[0m         \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mAttention mask should be of size \u001b[39m\u001b[38;5;132;01m{\u001b[39;00m(bsz,\u001b[38;5;250m \u001b[39m\u001b[38;5;241m1\u001b[39m,\u001b[38;5;250m \u001b[39mtgt_len,\u001b[38;5;250m \u001b[39msrc_len)\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m, but is \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mattention_mask\u001b[38;5;241m.\u001b[39msize()\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    214\u001b[0m     )\n\u001b[0;32m--> 215\u001b[0m attn_weights \u001b[38;5;241m=\u001b[39m \u001b[43mattn_weights\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mview\u001b[49m\u001b[43m(\u001b[49m\u001b[43mbsz\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mnum_heads\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtgt_len\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43msrc_len\u001b[49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m+\u001b[39;49m\u001b[43m \u001b[49m\u001b[43mattention_mask\u001b[49m\n\u001b[1;32m    216\u001b[0m attn_weights \u001b[38;5;241m=\u001b[39m torch\u001b[38;5;241m.\u001b[39mmax(\n\u001b[1;32m    217\u001b[0m     attn_weights, torch\u001b[38;5;241m.\u001b[39mtensor(torch\u001b[38;5;241m.\u001b[39mfinfo(attn_weights\u001b[38;5;241m.\u001b[39mdtype)\u001b[38;5;241m.\u001b[39mmin, device\u001b[38;5;241m=\u001b[39mattn_weights\u001b[38;5;241m.\u001b[39mdevice)\n\u001b[1;32m    218\u001b[0m )\n\u001b[1;32m    219\u001b[0m attn_weights \u001b[38;5;241m=\u001b[39m attn_weights\u001b[38;5;241m.\u001b[39mview(bsz \u001b[38;5;241m*\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mnum_heads, tgt_len, src_len)\n",
      "\u001b[0;31mOutOfMemoryError\u001b[0m: CUDA out of memory. Tried to allocate 3.75 GiB. GPU 0 has a total capacity of 15.72 GiB of which 1.84 GiB is free. Including non-PyTorch memory, this process has 13.88 GiB memory in use. Of the allocated memory 9.92 GiB is allocated by PyTorch, and 3.77 GiB is reserved by PyTorch but unallocated. If reserved but unallocated memory is large try setting PYTORCH_CUDA_ALLOC_CONF=expandable_segments:True to avoid fragmentation.  See documentation for Memory Management  (https://pytorch.org/docs/stable/notes/cuda.html#environment-variables)"
     ]
    }
   ],
   "source": [
    "# create a test with 10 instances for faithfulness evaluation\n",
    "# from transformers import AutoTokenizer\n",
    "\n",
    "# get the lime evaluations of each instance\n",
    "import faithfulness\n",
    "# this reimports the library for easy testing in the notebook\n",
    "import importlib\n",
    "importlib.reload(faithfulness)\n",
    "\n",
    "samples_start = 0\n",
    "samples_end = 10\n",
    "\n",
    "instances = untokenized_dataset[\"train\"][samples_start:samples_end][\"text\"]\n",
    "print(len(instances))\n",
    "\n",
    "print(instances)\n",
    "explainer = LimeTextExplainer(class_names=classes, bow=False)\n",
    "\n",
    "indexed_text, index_array_rationalle = faithfulness.lime_create_index_arrays(instances, predictor_opt, explainer)\n",
    "print(indexed_text)\n",
    "print(index_array_rationalle)\n",
    "\n",
    "# # remove the rationale words\n",
    "rationalle_removed = faithfulness.remove_rationale_words(indexed_text, index_array_rationalle)\n",
    "others_removed = faithfulness.remove_other_words(indexed_text, index_array_rationalle)\n",
    "\n",
    "print(rationalle_removed)\n",
    "\n",
    "print(len(rationalle_removed))\n",
    "print(len(others_removed))\n",
    "\n",
    "# the extra list is needed since the function expects a list of instances each coming from a different interpretability method\n",
    "# testing multi input by duplicating the arrays, don't actually do this\n",
    "ind, faith = faithfulness.calculate_faithfulness(instances, [rationalle_removed, rationalle_removed], [others_removed, others_removed], model, tokenizer, predictor_model)\n",
    "print(ind)\n",
    "print(faith)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.14"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
